concept_id	concept_synonym_name	language_concept_id
42688131	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688133	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688134	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688135	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688137	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688138	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688142	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688146	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688147	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688148	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688150	Methylcellulose 5mg/ml enema (Special Order) (product)	4180186
42688151	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688152	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688155	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688156	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688157	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688159	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688160	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688162	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688163	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688164	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688165	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688167	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688171	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688174	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688175	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688179	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688181	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688182	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688183	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688185	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688186	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688189	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688190	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688196	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688197	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688199	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688201	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688204	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688206	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688207	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688210	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688212	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688214	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688215	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688218	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688219	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688220	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688221	LaBiNIC oral drops (Biofloratech Ltd) (product)	4180186
42688222	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688223	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688224	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688226	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688227	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688228	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688232	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688234	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688237	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688238	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688239	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688241	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688242	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688243	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688244	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688246	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688251	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688260	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688261	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688262	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small left Beige (Gardamed Ltd) (physical object)	4180186
42688263	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short small left Beige (Gardamed Ltd) (physical object)	4180186
42688265	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short large left Beige (Gardamed Ltd) (physical object)	4180186
42688266	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large left Beige (Gardamed Ltd) (physical object)	4180186
42688268	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long small left Beige (Gardamed Ltd) (physical object)	4180186
42688269	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long medium left Beige (Gardamed Ltd) (physical object)	4180186
42688271	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large left Beige (Gardamed Ltd) (physical object)	4180186
42688272	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small right Beige (Gardamed Ltd) (physical object)	4180186
42688282	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small left Beige (Gardamed Ltd) (physical object)	4180186
42688284	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium left Beige (Gardamed Ltd) (physical object)	4180186
42688285	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short large left Beige (Gardamed Ltd) (physical object)	4180186
42688289	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium left Beige (Gardamed Ltd) (physical object)	4180186
42688291	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large left Beige (Gardamed Ltd) (physical object)	4180186
42688292	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small right Beige (Gardamed Ltd) (physical object)	4180186
42688295	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short large right Beige (Gardamed Ltd) (physical object)	4180186
42688298	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long small right Beige (Gardamed Ltd) (physical object)	4180186
42688299	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium right Beige (Gardamed Ltd) (physical object)	4180186
42688300	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long large right Beige (Gardamed Ltd) (physical object)	4180186
42688303	Jobst Elvarex SoftFit for lymphoedema garment lower extremities L-A016 Beige (BSN medical Ltd) (physical object)	4180186
42688304	Jobst Elvarex Soft SoftFit for lymphoedema garment lower extremities L-A016S Beige (BSN medical Ltd) (physical object)	4180186
42688307	Aveeno Bath & Shower oil (Johnson & Johnson Ltd)	4180186
42688307	Aveeno Bath & Shower oil (Johnson & Johnson Ltd) (product)	4180186
42688308	Lunox Sleep Aid 25mg tablets (Crescent Pharma Ltd) (product)	4180186
42688309	Ensure Compact liquid cafe latte (Abbott Laboratories Ltd) (product)	4180186
42688310	Lamberts Vitamin B12 10microgram tablets (Lamberts Healthcare Ltd) (product)	4180186
42688311	Lamberts Vitamin D3 4,000unit capsules (Lamberts Healthcare Ltd) (product)	4180186
42688313	Trifluoperazine 1mg tablets (Ennogen Pharma Ltd) (product)	4180186
42688314	Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) (product)	4180186
42688315	Nordimet 7.5mg/0.3ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688316	FibCLOT 1.5g powder and solvent for solution for infusion vials (LFB Biopharmaceuticals Ltd) (product)	4180186
42688317	Nordimet 10mg/0.4ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688320	Nordimet 17.5mg/0.7ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688321	Nordimet 20mg/0.8ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688322	Nordimet 22.5mg/0.9ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688323	Nordimet 25mg/1ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688324	Votubia 2mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) (product)	4180186
42688325	Votubia 3mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) (product)	4180186
42688327	Truxima 500mg/50ml concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd) (product)	4180186
42688328	Kalms Lavender One-a-Day 80mg capsules (G.R. Lane Health Products Ltd) (product)	4180186
42688330	Imatinib 100mg tablets (Sandoz Ltd) (product)	4180186
42688333	Vimizim 5mg/5ml concentrate for solution for infusion vials (BioMarin (U.K.) Ltd) (product)	4180186
42688335	Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) (product)	4180186
42688338	Relevtec 52.5micrograms/hour transdermal patches (Sandoz Ltd) (product)	4180186
42688339	Relevtec 35micrograms/hour transdermal patches (Sandoz Ltd) (product)	4180186
42688340	Prednisolone 5mg soluble tablets (Phoenix Labs Ltd) (product)	4180186
42688343	SunVit-D3 3,200unit capsules (SunVit-D3 Ltd) (product)	4180186
42688347	Saline Steripoules nebuliser liquid 2.5ml unit dose ampoules (Galen Ltd) (product)	4180186
42688350	Olmesartan medoxomil 10mg tablets (Actavis UK Ltd) (product)	4180186
42688351	Olmesartan medoxomil 20mg tablets (Actavis UK Ltd) (product)	4180186
42688352	Olmesartan medoxomil 40mg tablets (Actavis UK Ltd) (product)	4180186
42688357	Cisplatin 10mg/10ml concentrate for solution for infusion vials (Sandoz Ltd) (product)	4180186
42688358	Cyclophosphamide 500mg powder for solution for injection vials (Sandoz Ltd) (product)	4180186
42688363	G & G Glucosamine with Chondroitin & Vitamin C capsules (G & G Food Supplies Ltd) (product)	4180186
42688366	Zavicefta 2g/0.5g powder for concentrate for solution for infusion vials (Pfizer Ltd) (product)	4180186
42688367	G & G Vitamin D3 1,000unit capsules (G & G Food Supplies Ltd) (product)	4180186
42688368	Vencarm XL 225mg capsules (Aspire Pharma Ltd) (product)	4180186
42688378	Magnesium hydroxide 8% oral suspension (J M Loveridge Ltd) (product)	4180186
42688380	G & G Vitamin B6 100mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688382	Medi Derma-Pro skin protectant ointment 63605 (Medicareplus International Ltd) (physical object)	4180186
42688383	G & G CoQ10 100mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688389	Lymecycline 408mg capsules (Morningside Healthcare Ltd) (product)	4180186
42688390	Carbamazepine 125mg suppositories (A A H Pharmaceuticals Ltd) (product)	4180186
42688391	Imatinib 100mg capsules (A A H Pharmaceuticals Ltd) (product)	4180186
42688398	Valganciclovir 450mg tablets (A A H Pharmaceuticals Ltd) (product)	4180186
42688402	Health Plus Omega-3 EPA capsules (Health+Plus Ltd) (product)	4180186
42688403	Health Plus Super Cod Liver Oil 1000mg capsules (Health+Plus Ltd) (product)	4180186
42688404	G & G Children's Fish Oil 500mg softgels capsules (G & G Food Supplies Ltd) (product)	4180186
42688409	Neocate Junior powder vanilla (Nutricia Ltd) (product)	4180186
42688410	Neocate Junior powder unflavoured (Nutricia Ltd) (product)	4180186
42688411	Neocate Junior powder (Flavour Not Specified) (product)	4180186
42688412	G & G MSM 500mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688414	Calcitonin (salmon) 50units/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688415	Calcitonin (salmon) 100units/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688416	Calcitonin (salmon) 400units/2ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688420	Nortriptyline 50mg tablets (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688421	Olmesartan medoxomil 10mg tablets (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688424	Tramadol 75mg / Paracetamol 650mg tablets (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688429	Voraxaze 1,000unit powder for solution for injection vials (Imported (United States)) (product)	4180186
42688432	Mitomycin 0.04% eye drops (Special Order) (product)	4180186
42688433	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment extra small Beige (BSN medical Ltd) (physical object)	4180186
42688434	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment small Beige (BSN medical Ltd) (physical object)	4180186
42688435	Antistatic Space Chamber Plus (Medical Developments International Ltd) (physical object)	4180186
42688436	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment medium Beige (BSN medical Ltd) (physical object)	4180186
42688437	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment large Beige (BSN medical Ltd) (physical object)	4180186
42688438	Antistatic Space Chamber Plus with small mask (Medical Developments International Ltd) (physical object)	4180186
42688441	Sensotrach Uno Ped dressing 6cm x 7cm 30523 (Severn Healthcare Technologies Ltd) (physical object)	4180186
42688444	Antistatic Space Chamber Plus with large mask (Medical Developments International Ltd) (physical object)	4180186
42688447	Antistatic Space Chamber Plus Compact with medium mask (Medical Developments International Ltd) (physical object)	4180186
42688448	Antistatic Space Chamber Plus Compact with large mask (Medical Developments International Ltd) (physical object)	4180186
42688452	Chemipore-PE tape 7.5cm (Medicareplus International Ltd) (physical object)	4180186
42688453	Chemifix tape 15cm (Medicareplus International Ltd) (physical object)	4180186
42688455	LINC-Flo drainage bag with T tap LM750NDB 750ml (L.In.C. Medical Systems Ltd) (physical object)	4180186
42688456	U-drain consumable extension pack U/D-CTN-001 (U-drain Ltd) (physical object)	4180186
42688457	U-drain consumable pack tapered ridge connector U/D-CTN-004 (U-drain Ltd) (physical object)	4180186
42688461	Imatinib 100mg tablets (Mylan Ltd) (product)	4180186
42688462	Brava skin cleanser wipes 12080 (Coloplast Ltd) (physical object)	4180186
42688463	Imatinib 400mg tablets (Mylan Ltd) (product)	4180186
42688465	Urostemol Prosta capsules (Omega Pharma Ltd) (product)	4180186
42688469	Urostemol Men capsules (Omega Pharma Ltd) (product)	4180186
42688470	Histamine phosphate 125micrograms/ml nebuliser liquid 10ml bottles (Special Order) (product)	4180186
42688471	Histamine phosphate 250micrograms/ml nebuliser liquid 6ml ampoules (Special Order) (product)	4180186
42688472	Urostemol femina capsules (Omega Pharma Ltd) (product)	4180186
42688473	Histamine phosphate 500micrograms/ml nebuliser liquid 10ml bottles (Special Order) (product)	4180186
42688474	AirFluSal 25micrograms/dose / 125micrograms/dose inhaler (Sandoz Ltd) (product)	4180186
42688475	AirFluSal 25micrograms/dose / 250micrograms/dose inhaler (Sandoz Ltd) (product)	4180186
42688479	Conform 2 two piece ostomy system CeraPlus skin barrier floating flange 15200 55mm flange, cut to fit 13mm-40mm (Hollister Ltd) (physical object)	4180186
42688481	Conform 2 two piece ostomy system CeraPlus convex skin barrier floating flange 14100 45mm flange, cut to fit 13mm-25mm (Hollister Ltd) (physical object)	4180186
42688485	Histamine phosphate 2mg/ml nebuliser liquid 6ml ampoules (Special Order) (product)	4180186
42688486	Histamine phosphate 4mg/ml nebuliser liquid 10ml ampoules (Special Order) (product)	4180186
42688491	Amoxicillin 500mg/50ml infusion bags (Special Order) (product)	4180186
42688492	Sicovit B6 50mg/2ml solution for injection vials (Imported (Romania)) (product)	4180186
42688493	Aminophylline 500mg/500ml solution for infusion bottles (Special Order) (product)	4180186
42688494	Oxaliplatin 50mg/10ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) (product)	4180186
42688495	Almuriva 4.6mg/24hours transdermal patches (Sandoz Ltd) (product)	4180186
42688497	Oxaliplatin 100mg/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) (product)	4180186
42688498	Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) (product)	4180186
42688499	Phytomenadione 10mg capsules (Special Order) (product)	4180186
42688503	InVita D3 50,000unit capsules (Consilient Health Ltd) (product)	4180186
42688505	InVita D3 5,600unit capsules (Consilient Health Ltd) (product)	4180186
42688511	Propranolol 10mg/5ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688513	Propranolol 40mg/5ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688514	TransiSoft oral powder 8.5g sachets (HFA Healthcare Products Ltd) (product)	4180186
42688515	Amisulpride 100mg/ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688518	Zacco 10mg/5ml oral suspension (Thame Laboratories Ltd) (product)	4180186
42688519	Disodium edetate 3.72% solution for injection 2ml ampoules (Special Order) (product)	4180186
42688520	Freederm Treatment 4% gel (Dermal Laboratories Ltd) (product)	4180186
42688522	Haloperidol 200micrograms/ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688524	InVita D3 400unit capsules (Consilient Health Ltd) (product)	4180186
42688526	SimAlvia 60mg/300mg capsules (HFA Healthcare Products Ltd) (product)	4180186
42688528	Zonisamide 25mg capsules (Par Laboratories Europe Ltd) (product)	4180186
42688529	Zonisamide 50mg capsules (Par Laboratories Europe Ltd) (product)	4180186
42688532	HealthAid Osteoflex & Omega 3 tablets and capsules (HealthAid Ltd) (product)	4180186
42688537	FSC Fish Oil 1000mg capsules (Bee Health Ltd) (product)	4180186
42688538	FSC Vitamin D 400unit tablets (Bee Health Ltd) (product)	4180186
42688540	Esmolol hydrochloride 2.5g powder for concentrate for solution for infusion vials (AOP Orphan Ltd) (product)	4180186
42688542	Eylamdo 20mg/ml / 5mg/ml eye drops (Aspire Pharma Ltd) (product)	4180186
42688543	Eydelto 20mg/ml eye drops (Aspire Pharma Ltd) (product)	4180186
42688546	Esmolol 2.5g powder for solution for infusion vials 1 vial (product)	4180186
42688549	Generic HealthAid Osteoflex Plus modified-release tablets 30 tablet (product)	4180186
42688550	Generic HealthAid Osteoflex & Omega 3 tablets and capsules 1 pack (product)	4180186
42688551	Tofacitinib 5mg tablets 56 tablet (product)	4180186
42688552	Generic Cutan Hand Sanitiser foam 47 ml (product)	4180186
42688553	Low protein mix 248 gram (product)	4180186
42688554	Low protein gluten free burger mix 248 gram (product)	4180186
42688557	Colecalciferol 400unit capsules 28 capsule (product)	4180186
42688559	Disodium edetate 3.72% solution for injection 2ml ampoules 1 ampoule (product)	4180186
42688560	Disodium edetate 3.72% solution for injection 2ml ampoules 10 ampoule (product)	4180186
42688561	Macrogol 3350 oral powder 8.5g sachets sugar free 28 sachet (product)	4180186
42688562	Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) capsules 50 capsule (product)	4180186
42688565	Colecalciferol 25,000unit capsules 3 capsule (product)	4180186
42688569	Tioguanine 50mg/5ml oral suspension 1 ml (product)	4180186
42688571	Phytomenadione 10mg capsules 1 capsule (product)	4180186
42688572	Cefuroxime 50mg powder for solution for injection vials 1 vial (product)	4180186
42688573	Aminophylline 500mg/500ml solution for infusion bottles 1 bottle (product)	4180186
42688574	Pyridoxine 50mg/2ml solution for injection vials 5 vial (product)	4180186
42688576	Histamine phosphate 40mg/ml nebuliser liquid 5ml ampoules 5 ampoule (product)	4180186
42688577	Histamine phosphate 40mg/ml nebuliser liquid 5ml ampoules 1 ampoule (product)	4180186
42688578	Histamine phosphate 32mg/ml nebuliser liquid 10ml ampoules 5 ampoule (product)	4180186
42688582	Histamine phosphate 4mg/ml nebuliser liquid 10ml ampoules 1 ampoule (product)	4180186
42688585	Histamine phosphate 1mg/ml nebuliser liquid 6ml ampoules 5 ampoule (product)	4180186
42688588	Histamine phosphate 250micrograms/ml nebuliser liquid 6ml ampoules 1 ampoule (product)	4180186
42688590	Generic Urostemol femina capsules 120 capsule (product)	4180186
42688591	Generic Urostemol femina capsules 60 capsule (product)	4180186
42688594	Generic Urostemol Men capsules 120 capsule (product)	4180186
42688597	Sterile subcutaneous drug delivery device 110cm tubing 6mm needle 27gauge 1 device (physical object)	4180186
42688598	Histamine phosphate 30micrograms/ml nebuliser liquid 10ml bottles 1 bottle (product)	4180186
42688599	Generic Urostemol Prosta capsules 80 capsule (product)	4180186
42688600	Generic Urostemol Prosta capsules 40 capsule (product)	4180186
42688601	Generic Urostemol capsules 100 capsule (product)	4180186
42688602	Generic Urostemol capsules 50 capsule (product)	4180186
42688603	Ostomy skin protectives 45 device (physical object)	4180186
42688604	Propofol 500mg/50ml emulsion for infusion ampoules 10 ampoule (product)	4180186
42688606	Tracheostomy dressing sterile 6cm x 7cm 10 dressing (physical object)	4180186
42688609	Mitomycin 0.04% eye drops 1 ml (product)	4180186
42688611	Mitomycin 0.02% eye drops 1 ml (product)	4180186
42688612	Amobarbital sodium 500mg powder for solution for injection vials 1 vial (product)	4180186
42688613	Glucarpidase 1,000unit powder for solution for injection vials 1 vial (product)	4180186
42688616	Alectinib 150mg capsules 224 capsule (product)	4180186
42688617	Rabies vaccine powder and solvent for solution for injection 1ml pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688625	Generic Health Plus Omega Flaxseed Oil 1000mg capsules 90 capsule (product)	4180186
42688626	Generic Health Plus Omega Complex capsules 240 capsule (product)	4180186
42688630	Ostomy skin protectives 250 ml (physical object)	4180186
42688631	Pyridoxine 100mg capsules 120 capsule (product)	4180186
42688632	Riboflavin 50mg capsules 120 capsule (product)	4180186
42688635	Magnesium hydroxide 7.45-8.35% oral suspension BP 500 ml (product)	4180186
42688636	Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml (product)	4180186
42688639	Dolutegravir 25mg tablets 30 tablet (product)	4180186
42688642	Colecalciferol 3,200unit capsules 28 capsule (product)	4180186
42688644	Generic PharmaClinix Acnex Clear cream 50 ml (product)	4180186
42688646	Lavender oil 80mg capsules 14 capsule (product)	4180186
42688648	Everolimus 3mg dispersible tablets sugar free 30 tablet (product)	4180186
42688649	Everolimus 2mg dispersible tablets sugar free 30 tablet (product)	4180186
42688653	Methotrexate 17.5mg/0.7ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688655	Methotrexate 12.5mg/0.5ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688656	Fibrinogen 1.5g powder and solvent for solution for infusion vials 1 vial (product)	4180186
42688657	Methotrexate 10mg/0.4ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688658	Methotrexate 7.5mg/0.3ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688659	Generic Skin Salvation ointment 150 ml (product)	4180186
42688661	Generic Maalox Plus chewable tablets 30 tablet (product)	4180186
42688662	Generic Maalox Plus oral suspension sugar free 180 ml (product)	4180186
42688663	Generic Aveeno Bath & Shower oil 300 ml (product)	4180186
42688667	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 1mg/500ml infusion bags 1 bag (product)	4180186
42688668	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 2mg/500ml infusion bags 1 bag (product)	4180186
42688671	Generic Bach Rescue Remedy oral drops sugar free 10 ml (product)	4180186
42688672	Generic Bach Rescue Remedy spray sugar free 20 ml (product)	4180186
42688673	Generic Bach Rescue Remedy spray sugar free 7 ml (product)	4180186
42688676	Generic K-Y Jelly sterile 82 gram (product)	4180186
42688678	Generic Cathejell Mono 8.5 gram (product)	4180186
42688679	Abiraterone 500mg tablets 56 tablet (product)	4180186
42688680	Generic Cathejell Lidocain 12.5 gram (product)	4180186
42688682	Generic Cathejell Lidocaine C 12.5 gram (product)	4180186
42688683	Generic Cathejell Lidocaine C 8.5 gram (product)	4180186
42688685	Generic Sutherland lubricating jelly 42 gram (product)	4180186
42688686	Generic Sutherland lubricating jelly 5 gram (product)	4180186
42688690	Generic OptiLube sterile lubricating jelly 42 gram (product)	4180186
42688691	Generic OptiLube sterile lubricating jelly 5 gram (product)	4180186
42688693	Generic OptiLube Active sterile lubricating jelly 6 ml (product)	4180186
42688695	Generic OptiLube Active CHG Free sterile lubricating jelly 6 ml (product)	4180186
42688697	Generic Aquagel lubricating jelly 82 gram (product)	4180186
42688698	Generic Aquagel lubricating jelly 42 gram (product)	4180186
42688700	Generic Hydro-Caine Gel 11 ml (product)	4180186
42688701	Generic Hydro-Caine Gel 6 ml (product)	4180186
42688702	Oxycodone 80mg modified-release tablets 28 tablet (product)	4180186
42688703	Oxycodone 20mg modified-release tablets 28 tablet (product)	4180186
42688706	Generic Thealoz Duo Gel eye gel 0.4g unit dose preservative free 30 unit dose (product)	4180186
42688708	Tracheostomy dressing sterile 8cm x 10cm 1 dressing (physical object)	4180186
42688709	Tracheostomy dressing sterile 9cm x 9.8cm 10 dressing (physical object)	4180186
42688710	Tracheostomy dressing sterile 9cm x 9.8cm 1 dressing (physical object)	4180186
42688712	Generic Synolis 40mg/2ml injection pre-filled syringes 3 pre-filled disposable injection (product)	4180186
42688716	Generic Arthrum H 40mg/2ml injection pre-filled syringes 3 pre-filled disposable injection (product)	4180186
42688718	Generic Synopsis 40mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688721	Generic Fermathron 20mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688722	Generic Ostenil Mini 10mg/1ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688726	Fermathron 20mg/2ml injection pre-filled syringes (Biomet Europe) 1 pre-filled disposable injection (product)	4180186
42688728	Euflexxa 20mg/2ml injection pre-filled syringes (Ferring Pharmaceuticals Ltd) 3 pre-filled disposable injection (product)	4180186
42688731	Arthrum H 40mg/2ml injection pre-filled syringes (MWK Healthcare Ltd) 3 pre-filled disposable injection (product)	4180186
42688733	Ostenil Plus 40mg/2ml injection pre-filled syringes (TRB Chemidica (UK) Ltd) 1 pre-filled disposable injection (product)	4180186
42688735	Synolis 40mg/2ml injection pre-filled syringes (Unimedical Ltd) 3 pre-filled disposable injection (product)	4180186
42688739	Fiasp 100units/ml solution for injection 10ml vials (Novo Nordisk Ltd) 1 vial (product)	4180186
42688740	Dexamethasone 2mg tablets (Aspire Pharma Ltd) 50 tablet 5 x 10 tablets (product)	4180186
42688744	Mepilex dressing 20cm x 21cm (Molnlycke Health Care Ltd) 1 dressing (physical object)	4180186
42688747	Neckfix Duo K tracheostomy tube holder 32630 (Severn Healthcare Technologies Ltd) 1 device (physical object)	4180186
42688748	Sensotrach Uno Slit tracheostomy dressing 9cm x 9.8cm 30521 (Severn Healthcare Technologies Ltd) 1 dressing (physical object)	4180186
42688749	Sensotrach Uno Slit tracheostomy dressing 9cm x 9.8cm 30521 (Severn Healthcare Technologies Ltd) 10 dressing (physical object)	4180186
42688750	Sensotrach Duo Slit tracheostomy dressing 9cm x 9.8cm 30609 (Severn Healthcare Technologies Ltd) 1 dressing (physical object)	4180186
42688753	Sensotrach Alu Slit tracheostomy dressing 8cm x 10cm 30030 (Severn Healthcare Technologies Ltd) 10 dressing (physical object)	4180186
42688754	Thealoz Duo Gel eye gel 0.4g unit dose preservative free (Thea Pharmaceuticals Ltd) 30 unit dose (product)	4180186
42688759	Spirit sterile leg bag DSLB500L 500ml bag, 30cm long tube (Bard Ltd) 10 device (physical object)	4180186
42688760	Spirit sterile leg bag DSLB750S 750ml bag, 10cm short tube (Bard Ltd) 10 device (physical object)	4180186
42688764	Onexila XL 10mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688765	Onexila XL 20mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688767	Hydro-Caine Gel (CliniSupplies Ltd) 6 ml 1 x 6ml syringe HYD-006 (product)	4180186
42688768	Hydro-Caine Gel (CliniSupplies Ltd) 11 ml 1 x 11ml syringe HYD-011 (product)	4180186
42688770	Aquagel lubricating jelly (Ecolab Healthcare Division) 42 gram (product)	4180186
42688772	Elite lubricating jelly (Farnhurst Medical Ltd) 50 ml (product)	4180186
42688774	OptiLube Active CHG Free sterile lubricating jelly (Optimum Medical Solutions Ltd) 11 ml 1 x 11ml syringe 1168 (product)	4180186
42688775	OptiLube Active sterile lubricating jelly (Optimum Medical Solutions Ltd) 6 ml 1 X 6ml syringe 1160 (product)	4180186
42688777	OptiLube sterile lubricating jelly (Optimum Medical Solutions Ltd) 5 gram 1 x 5g sachet 1120 (product)	4180186
42688780	OptiLube sterile lubricating jelly (Optimum Medical Solutions Ltd) 6 ml 1 x 6ml syringe (product)	4180186
42688781	OptiLube sterile lubricating jelly (Optimum Medical Solutions Ltd) 11 ml 1 x 11ml syringe (product)	4180186
42688782	Sutherland lubricating jelly (Sutherland Health Ltd) 5 gram 1 x 5g sachet (product)	4180186
42688786	Cathejell Lidocaine C (Teleflex) 12.5 gram CJL 12501 (product)	4180186
42688788	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688789	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688792	Cathejell Lidocain CJLL12501 (Teleflex) 12.5 gram (product)	4180186
42688797	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688799	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688802	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688804	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688806	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688808	Zytiga 500mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets (product)	4180186
42688810	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688812	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688813	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688814	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688815	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688818	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688819	Cathejell Mono (Teleflex) 8.5 gram CJM 08501 (product)	4180186
42688820	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688821	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688822	Cathejell Mono (Teleflex) 12.5 gram CJM 12501 (product)	4180186
42688824	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688825	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688826	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688828	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688829	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688830	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688831	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688832	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688834	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688835	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688836	K-Y Jelly sterile (Thornton & Ross Ltd) 82 gram (product)	4180186
42688838	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688842	K-Y Jelly non-sterile (Thornton & Ross Ltd) 50 gram (product)	4180186
42688856	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688858	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688859	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688864	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688865	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688867	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688868	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688873	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688876	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688877	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688878	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688882	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688884	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688885	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688886	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688887	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688888	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688890	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688893	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688894	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688895	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688899	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688900	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688901	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688902	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688903	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688906	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688908	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688909	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688910	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688911	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688914	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688920	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688921	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688922	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688924	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688927	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688930	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688932	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688933	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688937	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688938	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688939	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688940	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688941	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688944	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688946	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688954	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688955	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688957	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688959	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688962	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688963	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688964	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688965	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688970	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688973	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688976	Bach Rescue Remedy spray (Nelsons) 20 ml (product)	4180186
42688977	Bach Rescue Remedy oral drops (Nelsons) 10 ml (product)	4180186
42688978	Bach Rescue Remedy oral drops (Nelsons) 20 ml (product)	4180186
42688980	Amitriptyline 10mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688984	Eprosartan 600mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688988	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 1mg/500ml infusion bags (Special Order) 1 bag (product)	4180186
42688989	Nortriptyline 10mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets (product)	4180186
42688990	Nortriptyline 25mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets (product)	4180186
42688992	PKU yellow cooler20 liquid (Vitaflo International Ltd) 174 ml (product)	4180186
42688998	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688999	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689002	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689003	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689004	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689005	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689007	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689011	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689014	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689015	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689016	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689017	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689018	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689020	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689021	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689022	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689023	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689026	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689028	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689031	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689038	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689039	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689041	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689043	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689044	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689047	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689048	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689049	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689050	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689053	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689055	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689058	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689061	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689064	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689065	Methylcellulose 5mg/ml enema (Special Order) 1 ml (product)	4180186
42689069	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689070	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689071	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689075	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689076	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689077	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689078	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689079	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689080	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689084	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689085	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689086	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689087	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689093	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689094	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689095	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689097	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689098	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689099	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689100	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689105	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689108	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689109	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689112	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689115	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689118	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689119	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689121	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689122	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689123	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689128	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689131	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689132	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689135	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689140	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689143	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689150	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689152	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689153	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689156	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689157	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689158	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689159	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689160	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689161	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689162	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689163	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689164	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689166	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689169	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689170	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689173	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689176	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689177	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689180	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689181	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689182	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689183	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689185	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689186	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689187	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689188	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689191	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689193	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689196	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689202	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689206	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689209	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689210	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689211	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689213	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689215	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689217	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689218	Droperidol 2.5mg/1ml solution for injection ampoules (Panpharma UK Ltd) 10 ampoule (product)	4180186
42689221	Jobst Elvarex SoftFit for lymphoedema garment upper extremities U-A018 Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689222	Jobst Elvarex Soft SoftFit for lymphoedema garment upper extremities U-A018S Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689225	Maalox Plus chewable tablets (Sanofi) 30 tablet (product)	4180186
42689226	Lunox Sleep Aid 25mg tablets (Crescent Pharma Ltd) 20 tablet 2 x 10 tablets (product)	4180186
42689227	Ensure Compact liquid cafe latte (Abbott Laboratories Ltd) 500 ml 4 x 125ml bottles (product)	4180186
42689228	Lamberts Vitamin B12 10microgram tablets (Lamberts Healthcare Ltd) 100 tablet (product)	4180186
42689230	Skin Salvation ointment (Balmonds Skincare Ltd) 150 ml (product)	4180186
42689231	Tetrabenazine 25mg tablets (AOP Orphan Ltd) 112 tablet (product)	4180186
42689233	Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) 112 tablet (product)	4180186
42689234	Nordimet 7.5mg/0.3ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689235	FibCLOT 1.5g powder and solvent for solution for infusion vials (LFB Biopharmaceuticals Ltd) 1 vial (product)	4180186
42689237	Nordimet 12.5mg/0.5ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689240	Nordimet 20mg/0.8ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689244	Votubia 3mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689245	Votubia 5mg dispersible tablet (Novartis Pharmaceuticals UK Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689246	Truxima 500mg/50ml concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd) 1 vial (product)	4180186
42689248	Kalms Night One-a-Night 500mg tablets (G.R. Lane Health Products Ltd) 21 tablet (product)	4180186
42689249	Imatinib 100mg tablets (Sandoz Ltd) 60 tablet 6 x 10 tablets (product)	4180186
42689250	Imatinib 400mg tablets (Sandoz Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689251	Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd) 90 tablet 9 x 10 tablets (product)	4180186
42689252	Vimizim 5mg/5ml concentrate for solution for infusion vials (BioMarin (U.K.) Ltd) 1 vial (product)	4180186
42689253	Memantine 5mg tablets (Lupin (Europe) Ltd) 7 tablet (product)	4180186
42689257	Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) 28 tablet 1 x (7tabs+7tabs+7tabs+7tabs) (product)	4180186
42689258	Relevtec 70micrograms/hour transdermal patches (Sandoz Ltd) 4 patch (product)	4180186
42689259	Relevtec 52.5micrograms/hour transdermal patches (Sandoz Ltd) 4 patch (product)	4180186
42689260	Relevtec 35micrograms/hour transdermal patches (Sandoz Ltd) 4 patch (product)	4180186
42689263	SunVit-D3 2,200unit capsules (SunVit-D3 Ltd) 28 capsule (product)	4180186
42689264	SunVit-D3 3,200unit capsules (SunVit-D3 Ltd) 28 capsule (product)	4180186
42689268	Saline Steripoules nebuliser liquid 2.5ml unit dose ampoules (Galen Ltd) 20 unit dose (product)	4180186
42689269	Methotrexate 2.5mg tablets (Sandoz Ltd) 24 tablet 2 x 12 tablets (product)	4180186
42689271	Trolactin 200mg modified-release capsules (Actavis UK Ltd) 60 capsule (product)	4180186
42689273	Olmesartan medoxomil 20mg tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42689276	Zonisamide 50mg capsules (Accord Healthcare Ltd) 56 capsule 8 x 7 capsules (product)	4180186
42689277	Zonisamide 100mg capsules (Accord Healthcare Ltd) 56 capsule 8 x 7 capsules (product)	4180186
42689278	Cisplatin 50mg/50ml concentrate for solution for infusion vials (Sandoz Ltd) 1 vial (product)	4180186
42689280	Cyclophosphamide 500mg powder for solution for injection vials (Sandoz Ltd) 1 vial (product)	4180186
42689281	Ralvo 700mg medicated plasters (Grunenthal Ltd) 30 plaster 6 x 5 plasters (product)	4180186
42689283	Tivicay 10mg tablets (ViiV Healthcare UK Ltd) 30 tablet (product)	4180186
42689285	G & G Glucosamine with Chondroitin & Vitamin C capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689286	G & G Magnesium citrate 100mg capsules (G & G Food Supplies Ltd) 90 capsule (product)	4180186
42689288	Zavicefta 2g/0.5g powder for concentrate for solution for infusion vials (Pfizer Ltd) 10 vial (product)	4180186
42689289	G & G Vitamin D3 1,000unit capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689290	Vencarm XL 225mg capsules (Aspire Pharma Ltd) 28 capsule 2 x 14 capsules (product)	4180186
42689292	Vencarm XL 75mg capsules (Aspire Pharma Ltd) 28 capsule 2 x 14 capsules (product)	4180186
42689293	Vencarm XL 37.5mg capsules (Aspire Pharma Ltd) 28 capsule 2 x 14 capsules (product)	4180186
42689295	Phillips' Milk of Magnesia 415mg/5ml oral suspension (Omega Pharma Ltd) 200 ml (product)	4180186
42689298	Magnesium hydroxide 8% oral suspension (A A H Pharmaceuticals Ltd) 500 ml (product)	4180186
42689300	Magnesium hydroxide 8% oral suspension (J M Loveridge Ltd) 200 ml (product)	4180186
42689301	Magnesium hydroxide 8% oral suspension (J M Loveridge Ltd) 500 ml (product)	4180186
42689302	G & G Vitamin B2 50mg capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689303	G & G Vitamin B6 100mg capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689305	Medi Derma-Pro skin protectant ointment 63605 (Medicareplus International Ltd) 115 gram (physical object)	4180186
42689306	G & G CoQ10 100mg capsules (G & G Food Supplies Ltd) 60 capsule (product)	4180186
42689307	G & G Natural Vitamin E 400unit softgels capsules (G & G Food Supplies Ltd) 90 capsule (product)	4180186
42689310	Colchicine 500microgram tablets (Morningside Healthcare Ltd) 100 tablet 10 x 10 tablets (product)	4180186
42689311	Lymecycline 408mg capsules (Morningside Healthcare Ltd) 56 capsule 4 x 14 capsule (product)	4180186
42689312	Health Plus High Potency Omega-3 EPA capsules (Health+Plus Ltd) 30 capsule (product)	4180186
42689314	Lymecycline 408mg capsules (Morningside Healthcare Ltd) 28 capsule 2 x 14 capsule (product)	4180186
42689318	Metformin 1g/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) 150 ml (product)	4180186
42689319	Olmesartan medoxomil 10mg tablets (A A H Pharmaceuticals Ltd) 28 tablet (product)	4180186
42689320	Olmesartan medoxomil 20mg tablets (A A H Pharmaceuticals Ltd) 28 tablet (product)	4180186
42689323	Valganciclovir 450mg tablets (A A H Pharmaceuticals Ltd) 60 tablet (product)	4180186
42689326	Health Plus Omega Complex capsules (Health+Plus Ltd) 240 capsule (product)	4180186
42689327	Health Plus Omega Flaxseed Oil 1000mg capsules (Health+Plus Ltd) 90 capsule (product)	4180186
42689328	Health Plus Omega Flaxseed Oil 450mg capsules (Health+Plus Ltd) 90 capsule (product)	4180186
42689329	Health Plus Omega-3 EPA capsules (Health+Plus Ltd) 30 capsule (product)	4180186
42689330	Health Plus Omega-3 EPA capsules (Health+Plus Ltd) 90 capsule (product)	4180186
42689332	G & G Children's Fish Oil 500mg softgels capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689334	Cytarabine 5g/50ml solution for infusion vials (Accord Healthcare Ltd) 1 vial (product)	4180186
42689335	G & G MSM 500mg & Vitamin C 100mg capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689339	Neocate Junior powder (Flavour Not Specified) 400 gram (product)	4180186
42689340	G & G MSM 500mg capsules (G & G Food Supplies Ltd) 100 capsule (product)	4180186
42689341	Potassium phosphate 17.42% (potassium 2mmol/ml) oral solution (Special Order) 10 ml (product)	4180186
42689342	Acetylcysteine 200mg oral powder sachets sugar free (Alliance Healthcare (Distribution) Ltd) 30 sachet (product)	4180186
42689347	Folic acid 5mg/5ml oral solution sugar free (Alliance Healthcare (Distribution) Ltd) 150 ml (product)	4180186
42689350	Nortriptyline 25mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689353	Olmesartan medoxomil 20mg tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet (product)	4180186
42689354	Olmesartan medoxomil 40mg tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet (product)	4180186
42689357	Vancomycin 1g powder for solution for infusion vials (Alliance Healthcare (Distribution) Ltd) 10 vial (product)	4180186
42689358	Rabipur vaccine powder and solvent for solution for injection 1ml pre-filled syringes (Valneva UK Ltd) 1 pre-filled disposable injection (product)	4180186
42689359	Alecensa 150mg capsules (Roche Products Ltd) 224 capsule 4 x 56 capsules (product)	4180186
42689361	Lamberts Vitamin B12 100microgram tablets (Lamberts Healthcare Ltd) 100 tablet (product)	4180186
42689367	Mitomycin 0.04% eye drops (Special Order) 1 ml (product)	4180186
42689368	Mitomycin 0.04% eye drops (Special Order) 10 ml (product)	4180186
42689372	Antistatic Space Chamber Plus (Medical Developments International Ltd) 1 device (physical object)	4180186
42689375	Antistatic Space Chamber Plus with medium mask (Medical Developments International Ltd) 1 device (physical object)	4180186
42689376	Antistatic Space Chamber Plus with large mask (Medical Developments International Ltd) 1 device (physical object)	4180186
42689377	Antistatic Space Chamber Plus Compact (Medical Developments International Ltd) 1 device (physical object)	4180186
42689378	Antistatic Space Chamber Plus Compact with small mask (Medical Developments International Ltd) 1 device (physical object)	4180186
42689379	Antistatic Space Chamber Plus Compact with medium mask (Medical Developments International Ltd) 1 device (physical object)	4180186
42689383	Optiflausch tracheostomy tube holder 32550 (Severn Healthcare Technologies Ltd) 1 device (physical object)	4180186
42689384	Optiflausch tracheostomy tube holder 32555 Child (Severn Healthcare Technologies Ltd) 1 device (physical object)	4180186
42689385	Sensotrach Uno Ped dressing 6cm x 7cm 30523 (Severn Healthcare Technologies Ltd) 1 dressing (physical object)	4180186
42689386	Sensotrach Uno Ped dressing 6cm x 7cm 30523 (Severn Healthcare Technologies Ltd) 10 dressing (physical object)	4180186
42689387	Nanova therapy unit (KCI Medical Ltd) 1 device (physical object)	4180186
42689388	Chemipore-PE tape 2.5cm (Medicareplus International Ltd) 5 m (physical object)	4180186
42689391	Chemipore-PE tape 7.5cm (Medicareplus International Ltd) 5 m (physical object)	4180186
42689394	LINC-Flo drainage bag with T tap LM750NDB 750ml (L.In.C. Medical Systems Ltd) 10 device (physical object)	4180186
42689396	U-drain consumable pack tapered ridge connector U/D-CTN-004 (U-drain Ltd) 1 device (physical object)	4180186
42689397	Propofol-Lipuro 1% emulsion for infusion 50ml ampoules (B.Braun Melsungen AG) 10 ampoule (product)	4180186
42689398	Colecalciferol 400unit / Calcium carbonate 1.5g chewable tablets (Alissa Healthcare Research Ltd) 56 tablet (product)	4180186
42689399	CoaguChek XS PT Test PST testing strips 07671687019 (Roche Diagnostics Ltd) 24 strip (physical object)	4180186
42689404	Urostemol capsules (Omega Pharma Ltd) 100 capsule (product)	4180186
42689405	Urostemol Prosta capsules (Omega Pharma Ltd) 40 capsule (product)	4180186
42689406	Urostemol Prosta capsules (Omega Pharma Ltd) 80 capsule (product)	4180186
42689407	Histamine phosphate 30micrograms/ml nebuliser liquid 10ml bottles (Special Order) 1 bottle (product)	4180186
42689408	Neria Soft 90 subcutaneous drug delivery device 110cm tubing 6mm needle 27gauge 722110-5226 (Unomedical Ltd) 1 device (physical object)	4180186
42689411	Urostemol Men capsules (Omega Pharma Ltd) 120 capsule (product)	4180186
42689412	Histamine phosphate 125micrograms/ml nebuliser liquid 10ml bottles (Special Order) 1 bottle (product)	4180186
42689413	Histamine phosphate 250micrograms/ml nebuliser liquid 6ml ampoules (Special Order) 5 ampoule (product)	4180186
42689415	Urostemol femina capsules (Omega Pharma Ltd) 60 capsule (product)	4180186
42689416	Urostemol femina capsules (Omega Pharma Ltd) 120 capsule (product)	4180186
42689418	AirFluSal 25micrograms/dose / 125micrograms/dose inhaler (Sandoz Ltd) 120 dose (product)	4180186
42689420	Haliborange Mr.Men Little Miss Calcium & Vitamin D softies chewable tablets (Seven Seas Ltd) 30 tablet (product)	4180186
42689421	Haliborange Kids Vitamin D Calcium softies chewable tablets (Seven Seas Ltd) 30 tablet (product)	4180186
42689422	Conform 2 two piece ostomy system CeraPlus skin barrier floating flange 14200 45mm flange, cut to fit 13mm-30mm (Hollister Ltd) 5 device (physical object)	4180186
42689424	Conform 2 two piece ostomy system CeraPlus skin barrier floating flange 17200 70mm flange, cut to fit 13mm-55mm (Hollister Ltd) 5 device (physical object)	4180186
42689426	Conform 2 two piece ostomy system CeraPlus convex skin barrier floating flange 15100 55mm flange, cut to fit 13mm-38mm (Hollister Ltd) 5 device (physical object)	4180186
42689428	Histamine phosphate 1mg/ml nebuliser liquid 6ml ampoules (Special Order) 1 ampoule (product)	4180186
42689431	Histamine phosphate 2mg/ml nebuliser liquid 6ml ampoules (Special Order) 5 ampoule (product)	4180186
42689435	Histamine phosphate 32mg/ml nebuliser liquid 10ml ampoules (Special Order) 1 ampoule (product)	4180186
42689436	Histamine phosphate 32mg/ml nebuliser liquid 10ml ampoules (Special Order) 5 ampoule (product)	4180186
42689445	Oxaliplatin 100mg/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial (product)	4180186
42689446	Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial (product)	4180186
42689447	Ximaract 50mg powder for solution for injection vials (Bausch & Lomb UK Ltd) 1 vial (product)	4180186
42689448	Phytomenadione 10mg capsules (Special Order) 1 capsule (product)	4180186
42689451	Carmoisine 1% cutaneous solution (Special Order) 1 ml (product)	4180186
42689452	Carmoisine 1% cutaneous solution (Special Order) 10 ml (product)	4180186
42689455	InVita D3 5,600unit capsules (Consilient Health Ltd) 4 capsule (product)	4180186
42689457	Zonisamide 50mg capsules (Zentiva Pharma UK Ltd) 56 capsule 4 x 14 capsules (product)	4180186
42689459	MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule (product)	4180186
42689460	MagnaPhos 97.2mg (4mmol) chewable tablets (TriOn Pharma Ltd) 50 tablet (product)	4180186
42689461	Propranolol 10mg/5ml oral solution sugar free (Thame Laboratories Ltd) 150 ml (product)	4180186
42689462	Propranolol 5mg/5ml oral solution sugar free (Thame Laboratories Ltd) 150 ml (product)	4180186
42689463	Propranolol 40mg/5ml oral solution sugar free (Thame Laboratories Ltd) 150 ml (product)	4180186
42689467	Zacco 5mg/5ml oral suspension (Thame Laboratories Ltd) 150 ml (product)	4180186
42689468	Zacco 10mg/5ml oral suspension (Thame Laboratories Ltd) 150 ml (product)	4180186
42689470	Disodium edetate 3.72% solution for injection 2ml ampoules (Special Order) 1 ampoule (product)	4180186
42689473	Haloperidol 200micrograms/ml oral solution sugar free (Thame Laboratories Ltd) 200 ml (product)	4180186
42689474	Carbocisteine 375mg capsules (Healthcare Pharma Ltd) 120 capsule 8 x 15 capsules (product)	4180186
42689475	InVita D3 400unit capsules (Consilient Health Ltd) 28 capsule 4 x 7 capsules (product)	4180186
42689477	Optison 570micrograms/3ml dispersion for injection vials (GE Healthcare AS) 5 vial (product)	4180186
42689478	SimAlvia 60mg/300mg capsules (HFA Healthcare Products Ltd) 90 capsule 3 x 30 capsules (product)	4180186
42689480	Promin low protein lamb and mint burger mix (Firstplay Dietary Foods Ltd) 248 gram 4 x 62g sachets (product)	4180186
42689481	Genius gluten free seeded brown farmhouse loaf sliced (Genius Foods Ltd) 535 gram (product)	4180186
42689483	Zonisamide 25mg capsules (Par Laboratories Europe Ltd) 14 capsule (product)	4180186
42689484	Zonisamide 50mg capsules (Par Laboratories Europe Ltd) 56 capsule 4 x 14 capsules (product)	4180186
42689485	Zonisamide 100mg capsules (Par Laboratories Europe Ltd) 56 capsule 4 x 14 capsules (product)	4180186
42689486	Xeljanz 5mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets (product)	4180186
42689489	Esmolol hydrochloride 100mg/10ml solution for injection vials (AOP Orphan Ltd) 5 vial (product)	4180186
42689492	HealthAid Vitamin C 100% Pure Ultra-fine powder (HealthAid Ltd) 100 gram (product)	4180186
42689500	Eydelto 20mg/ml eye drops (Aspire Pharma Ltd) 5 ml (product)	4180186
42689502	Hypermobility of thoracic spine (finding)	4180186
42689515	Podiatric and Surgical Clinical Outcome Measurement 10 score (observable entity)	4180186
42689516	Hands-on, Empathy, Aromas, Relaxation, Texture and Sound process (regime/therapy)	4180186
42689521	Immediate resuscitation level emergency care (regime/therapy)	4180186
42689522	Very urgent level emergency care (regime/therapy)	4180186
42689523	Health visitor contact using Family Partnership Model Postnatal Promotional Guide	4180186
42689523	Health visitor contact using Family Partnership Model Postnatal Promotional Guide (procedure)	4180186
42689525	Acute internal medicine (qualifier value)	4180186
42689527	Making Every Contact Count (regime/therapy)	4180186
42689528	Surgical distraction of externally adjustable spinal deformity correction system (procedure)	4180186
42689531	Place of occurrence of injury is garage in home environment (finding)	4180186
42689532	Place of occurrence of injury is hallway in home environment (finding)	4180186
42689535	Place of occurrence of injury is bedroom in home environment (finding)	4180186
42689538	Place of occurrence of injury is dining room in home environment (finding)	4180186
42689539	Place of occurrence of injury is conservatory in home environment (finding)	4180186
42689540	Place of occurrence of injury is swimming pool in home environment (finding)	4180186
42689541	Place of occurrence of injury is outbuilding in home environment (finding)	4180186
42689544	Use of asthma symptom diary (regime/therapy)	4180186
42689545	Injury following morphine use (disorder)	4180186
42689546	Injury following dihydrocodeine use (disorder)	4180186
42689547	Injury following ketamine use (disorder)	4180186
42689551	Injury following solvent inhalation (disorder)	4180186
42689553	Injury following organic hallucinogen use (disorder)	4180186
42689555	PET CT of whole body using 18F FACBC (anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid)	4180186
42689555	Positron emission tomography with computed tomography of whole body using 18F fluciclovine (procedure)	4180186
42689556	Positron emission tomography with computed tomography of whole body using 18F fluorothymidine (procedure)	4180186
42689558	Admission to acute internal medicine department (procedure)	4180186
42689560	Place of occurrence of injury is garden in home environment (finding)	4180186
42689562	Assessment using Patient Health Questionnaire 15	4180186
42689562	Assessment using Patient Health Questionnaire 15 (procedure)	4180186
42689564	Type 2 diabetes mellitus risk assessment invitation first letter (procedure)	4180186
42689564	Type II diabetes mellitus risk assessment invitation first letter	4180186
42689568	Type 2 diabetes mellitus risk assessment telephone invitation (procedure)	4180186
42689568	Type II diabetes mellitus risk assessment telephone invitation	4180186
42689569	Type 2 diabetes mellitus risk assessment invitation short message service text message (procedure)	4180186
42689569	Type II diabetes mellitus risk assessment invitation SMS (short message service) text message	4180186
42689570	Low dose computed tomography of entire skeleton (procedure)	4180186
42689571	Computed tomography nephrostography (procedure)	4180186
42689571	CT nephrostogram	4180186
42689574	Insertion of midline intravenous catheter using ultrasonography guidance (procedure)	4180186
42689574	Ultrasound guided insertion of midline intravenous catheter	4180186
42689575	Automated erythrocytapheresis	4180186
42689575	Automated red blood cell exchange transfusion (procedure)	4180186
42689577	Magnetic resonance imaging of oral cavity with contrast (procedure)	4180186
42689580	Talking Mats (regime/therapy)	4180186
42689582	Little Talkers parent based intervention (regime/therapy)	4180186
42689583	Whole Language approach (regime/therapy)	4180186
42689584	Visualising and Verbalising programme (regime/therapy)	4180186
42689588	Pre-teaching Vocabulary (regime/therapy)	4180186
42689588	PTV - Pre-teaching Vocabulary	4180186
42689589	PACT - Pre-school Autism Communication Therapy	4180186
42689589	Pre-school Autism Communication Therapy (regime/therapy)	4180186
42689594	Detained in hospital under Section 47 of the Mental Health Act 1983 (England and Wales) with Section 49 restrictions (finding)	4180186
42689597	Detained in hospital under Criminal Procedure (Insanity) Act 1964 as amended by the Criminal Procedure (Insanity and Unfitness to Plead) Act 1991 (finding)	4180186
42689599	Referred by mental health assessment team (finding)	4180186
42689602	Referred by Fire and Rescue Service (finding)	4180186
42689604	Referred by search and rescue service (finding)	4180186
42689605	Injury following central nervous system stimulant use (disorder)	4180186
42689606	Injury following central nervous system depressant use (disorder)	4180186
42689607	Injury following methadone use (disorder)	4180186
42689610	Complex venous leg ulcer (disorder)	4180186
42689611	Detained in hospital under Section 45A of the Mental Health Act 1983 (England and Wales) (finding)	4180186
42689614	Second inactivated seasonal influenza vaccination given by midwife (situation)	4180186
42689616	Early Help Assessment process completed (finding)	4180186
42689616	EHA (Early Help Assessment) process completed	4180186
42689617	No haemoptysis (situation)	4180186
42689620	Requires CMV (cytomegalovirus) negative blood components	4180186
42689620	Requires cytomegalovirus negative blood components (finding)	4180186
42689622	Referral to food bank	4180186
42689622	Referral to foodbank (procedure)	4180186
42689623	Left care setting before initial assessment (finding)	4180186
42689624	Left care setting after initial assessment (finding)	4180186
42689627	Accident and Emergency department discharge to ambulatory emergency care service	4180186
42689627	Emergency department discharge to ambulatory emergency care service (procedure)	4180186
42689629	Accident and Emergency department discharge to HDU (high dependency unit)	4180186
42689629	Emergency department discharge to HDU (high dependency unit)	4180186
42689629	Emergency department discharge to high dependency unit (procedure)	4180186
42689635	Referred by hospital emergency department (finding)	4180186
42689637	Able to use prosody in speech (finding)	4180186
42689638	Able to use approximants (finding)	4180186
42689639	Able to use voice output communication aid (finding)	4180186
42689642	Able to use eye pointing communication (finding)	4180186
42689643	Able to use computer keyboard (finding)	4180186
42689644	Able to use adapted computer keyboard (finding)	4180186
42689649	Able to engage in joint attention communication (finding)	4180186
42689649	Able to engage in shared attention	4180186
42689651	Able to access school curriculum (finding)	4180186
42689654	Active Listening for Active Learning (regime/therapy)	4180186
42689655	Time out behaviour strategy (regime/therapy)	4180186
42689659	Able to monitor own comprehension (finding)	4180186
42689660	Assessment of atrial fibrillation using oscillometric blood pressure monitoring device (procedure)	4180186
42689661	Benzodiazepine therapy (procedure)	4180186
42689663	Chronic obstructive pulmonary disease monitoring short message service text message first invitation (procedure)	4180186
42689664	Atrial fibrillation detected (finding)	4180186
42689667	Chronic heart disease monitoring short message service text message first invitation (procedure)	4180186
42689668	Residence and accommodation circumstances unknown (finding)	4180186
42689673	Diabetes monitoring short message service text message third invitation (procedure)	4180186
42689674	Hypertension monitoring invitation short message service text message (procedure)	4180186
42689676	Hypertension monitoring short message service text message second invitation (procedure)	4180186
42689678	Non-binary gender (finding)	4180186
42689680	Rheumatoid arthritis monitoring short message service text message first invitation (procedure)	4180186
42689681	Rheumatoid arthritis monitoring short message service text message second invitation (procedure)	4180186
42689687	Scarf osteotomy of first metatarsal with medial closing wedge (procedure)	4180186
42689689	Suspected neonatal necrotising enterocolitis (situation)	4180186
42689691	Supervised discharge under the Mental Health (Patients in the Community) Act 1995 (finding)	4180186
42689693	Detained in hospital under Section 45A of the Mental Health Act 1983 (England and Wales) with limitation direction ended (finding)	4180186
42689694	Referral to family support clinic (procedure)	4180186
42689699	Requires referral to coroner at time of death (finding)	4180186
42689702	Biopsychosocial assessment started (situation)	4180186
42689703	Biopsychosocial assessment completed (situation)	4180186
42689705	Injury whilst playing football (disorder)	4180186
42689706	Injury whilst playing rugby union (disorder)	4180186
42689707	Injury whilst playing basketball (disorder)	4180186
42689708	Injury whilst playing netball (disorder)	4180186
42689709	Injury whilst playing handball (disorder)	4180186
42689712	Injury whilst playing hockey (disorder)	4180186
42689714	Injury whilst playing baseball (disorder)	4180186
42689715	Injury whilst playing softball (disorder)	4180186
42689716	Injury whilst playing squash (disorder)	4180186
42689717	Injury whilst playing badminton (disorder)	4180186
42689718	Injury whilst playing golf (disorder)	4180186
42689721	Injury whilst playing croquet (disorder)	4180186
42689722	Injury whilst playing bowls (disorder)	4180186
42689724	Injury whilst clay-pigeon shooting (disorder)	4180186
42689725	Injury whilst target shooting (disorder)	4180186
42689726	Injury whilst playing Gaelic football (disorder)	4180186
42689727	Injury whilst playing Australian rules football (disorder)	4180186
42689729	Injury whilst fell running (disorder)	4180186
42689729	Injury whilst mountain running	4180186
42689730	Injury whilst engaged in gymnastics (disorder)	4180186
42689731	Injury during aerobic exercise (disorder)	4180186
42689736	Injury whilst kickboxing (disorder)	4180186
42689738	Injury whilst roller skating (disorder)	4180186
42689739	Injury whilst swimming (disorder)	4180186
42689740	Injury whilst playing water polo (disorder)	4180186
42689745	Injury whilst waterskiing (disorder)	4180186
42689746	Injury whilst ice skating (disorder)	4180186
42689749	Injury whilst cross-country skiing (disorder)	4180186
42689752	Injury whilst caving (disorder)	4180186
42689753	Injury whilst hang gliding (disorder)	4180186
42689755	Injury whilst parachute jumping (disorder)	4180186
42689757	Injury whilst rock climbing (disorder)	4180186
42689758	Injury whilst ice climbing (disorder)	4180186
42689761	Injury whilst playing hurling (disorder)	4180186
42689762	Injury whilst playing real tennis (disorder)	4180186
42689763	Injury whilst attending cinema (disorder)	4180186
42689764	Injury whilst attending music venue (disorder)	4180186
42689765	Injury whilst attending theatre (disorder)	4180186
42689770	Injury whilst engaged in jumping sports activity (disorder)	4180186
42689773	Injury whilst engaged in Taekwondo (disorder)	4180186
42689775	Injury whilst synchronised swimming (disorder)	4180186
42689776	Injury whilst kite surfing (disorder)	4180186
42689779	Injury whilst power-boating (disorder)	4180186
42689780	Injury whilst being towed by powerboat (disorder)	4180186
42689781	Injury whilst off-road quad biking (disorder)	4180186
42689783	Injury whilst engaged in social activity outside the home (disorder)	4180186
42689784	Injury whilst using electronic audiovisual device (disorder)	4180186
42689785	Injury whilst ascending stairs (disorder)	4180186
42689786	Injury whilst walking indoors (disorder)	4180186
42689788	Injury whilst preparing food (disorder)	4180186
42689794	Injury whilst undertaking home maintenance (disorder)	4180186
42689795	Injury whilst sleeping (disorder)	4180186
42689796	Injury whilst cycling on public highway (disorder)	4180186
42689797	Injury whilst off-road cycling (disorder)	4180186
42689799	Injury whilst dancing (disorder)	4180186
42689800	Injury whilst bicycle motocross biking (disorder)	4180186
42689801	Injury whilst engaged in yoga (disorder)	4180186
42689802	Injury whilst engaged in tai chi (disorder)	4180186
42689803	Injury whilst engaged in work activity (disorder)	4180186
42689805	Injury whilst working on farm (disorder)	4180186
42689806	Injury whilst working in factory (disorder)	4180186
42689807	Injury whilst working in mine (disorder)	4180186
42689809	Injury whilst engaged in administrative work (disorder)	4180186
42689812	Injury whilst engaged in security work (disorder)	4180186
42689814	Injury whilst engaged in entertainment work (disorder)	4180186
42689817	Injury whilst motorcycle passenger (disorder)	4180186
42689818	Injury whilst driving motor vehicle on public highway (disorder)	4180186
42689819	Injury whilst motor vehicle passenger (disorder)	4180186
42689821	Injury whilst using toilet facility (disorder)	4180186
42689823	Injury whilst fishing (disorder)	4180186
42689824	Injury whilst cheerleading (disorder)	4180186
42689825	Difficulty organising own clothes (finding)	4180186
42689827	Difficulty recognising social cues (finding)	4180186
42689830	Difficulty remembering places (finding)	4180186
42689831	Difficulty sequencing events (finding)	4180186
42689832	Difficulty sitting down onto bed (finding)	4180186
42689833	Difficulty sorting recycling (finding)	4180186
42689835	Difficulty tolerating being cleaned during toileting (finding)	4180186
42689836	Difficulty tolerating toileting routine (finding)	4180186
42689838	Difficulty understanding humour (finding)	4180186
42689840	Does not manage stress (finding)	4180186
42689849	Does not remember routines (finding)	4180186
42689850	Does not sequence events (finding)	4180186
42689851	Does not shift attention (finding)	4180186
42689853	Does not stop use of energy (finding)	4180186
42689855	Does not transfer to vehicle with supervision (finding)	4180186
42689856	Does not understand generalised pain (finding)	4180186
42689859	Does manage visitors at home (finding)	4180186
42689860	Does mobilise using indoor motorised wheelchair (finding)	4180186
42689862	Does perform work based activities (finding)	4180186
42689863	Does problem solve (finding)	4180186
42689866	Does recognise familiar people (finding)	4180186
42689867	Does recognise need for pressure area care (finding)	4180186
42689868	Does recognise objects by touch (finding)	4180186
42689869	Does reflect on own behaviour (finding)	4180186
42689872	Does set personal goals (finding)	4180186
42689873	Does shop at shopping mall (finding)	4180186
42689874	Does sit down onto bed (finding)	4180186
42689878	Does tolerate changing nappy (finding)	4180186
42689879	Does tolerate self-care routines (finding)	4180186
42689882	Does use online social networking (finding)	4180186
42689883	Unable to stand from sitting on edge of bed (finding)	4180186
42689884	Unable to think creatively (finding)	4180186
42689885	Unable to tolerate changing incontinence pad (finding)	4180186
42689887	Unable to understand and use numbers (finding)	4180186
42689888	Unable to understand pain in body part (finding)	4180186
42689889	Unable to use games console (finding)	4180186
42689890	Unable to wash lower body (finding)	4180186
42689892	Difficulty accessing own home (finding)	4180186
42689895	Difficulty applying for education course (finding)	4180186
42689896	Difficulty applying for voluntary work (finding)	4180186
42689897	Difficulty appraising own abilities (finding)	4180186
42689898	Difficulty rising from chair without assistance (finding)	4180186
42689900	Difficulty assisting in self-care routines (finding)	4180186
42689901	Difficulty assisting with meal preparation (finding)	4180186
42689904	Difficulty caring for pressure areas (finding)	4180186
42689905	Difficulty carrying out daily routine (finding)	4180186
42689907	Difficulty cleaning items at waist height (finding)	4180186
42689912	Difficulty doing laundry (finding)	4180186
42689915	Difficulty drying upper body (finding)	4180186
42689917	Difficulty engaging in structure and routine in daily life (finding)	4180186
42689918	Difficulty establishing life roles (finding)	4180186
42689919	Difficulty establishing structure and routine in daily life (finding)	4180186
42689920	Difficulty feeling confident (finding)	4180186
42689921	Difficulty filling in forms (finding)	4180186
42689923	Difficulty finding way around school environment (finding)	4180186
42689924	Difficulty finding way around work environment (finding)	4180186
42689925	Difficulty getting out of bath (finding)	4180186
42689927	Difficulty getting up from floor (finding)	4180186
42689930	Difficulty identifying choices (finding)	4180186
42689931	Difficulty identifying dangers (finding)	4180186
42689932	Difficulty identifying interests (finding)	4180186
42689933	Difficulty identifying life roles (finding)	4180186
42689934	Difficulty identifying structure and routine in daily life (finding)	4180186
42689937	Difficulty maintaining structure and routine in daily life (finding)	4180186
42689946	Difficulty managing internal steps (finding)	4180186
42689947	Difficulty managing own aggression (finding)	4180186
42689948	Difficulty managing own energy levels (finding)	4180186
42689952	Difficulty managing risk in community (finding)	4180186
42689953	Difficulty managing ureterostomy (finding)	4180186
42689956	Difficulty managing visitors at home (finding)	4180186
42689957	Difficulty mobilising using mobility scooter (finding)	4180186
42689958	Difficulty mobilising over uneven ground (finding)	4180186
42689959	Difficulty mobilising using indoor motorised wheelchair (finding)	4180186
42689962	Difficulty moving items around home (finding)	4180186
42689964	Difficulty participating in classroom activities (finding)	4180186
42689965	Difficulty participating in online gaming (finding)	4180186
42689967	Difficulty participating in self-care at school (finding)	4180186
42689968	Difficulty planning (finding)	4180186
42689969	Difficulty recognising own symptoms (finding)	4180186
42689970	Difficulty recognising spoken words (finding)	4180186
42689972	Difficulty recognising body temperature (finding)	4180186
42689973	Difficulty recognising generalised pain (finding)	4180186
42689975	Difficulty recognising numbers (finding)	4180186
42689977	Difficulty recognising objects by sight (finding)	4180186
42689980	Difficulty reflecting on own behaviour (finding)	4180186
42689982	Difficulty remembering routines (finding)	4180186
42689983	Difficulty responding to own symptoms (finding)	4180186
42689984	Difficulty responding to stimuli (finding)	4180186
42689986	Difficulty setting personal goals (finding)	4180186
42689987	Difficulty shifting attention (finding)	4180186
42689988	Difficulty shopping at shopping mall (finding)	4180186
42689989	Difficulty shopping in supermarket (finding)	4180186
42689990	Difficulty sitting on potty (finding)	4180186
42689991	Difficulty sleeping with sedation (finding)	4180186
42689995	Difficulty sustaining attention (finding)	4180186
42689996	Difficulty sustaining energy level (finding)	4180186
42689997	Difficulty thinking creatively (finding)	4180186
42689998	Difficulty tolerating changing nappy (finding)	4180186
42689999	Difficulty tolerating changing incontinence pad (finding)	4180186
42690000	Difficulty tolerating generalised pain (finding)	4180186
42690002	Difficulty tolerating self-care routines (finding)	4180186
42690003	Difficulty transferring to vehicle with assistance (finding)	4180186
42690009	Difficulty undertaking multiple tasks (finding)	4180186
42690010	Difficulty undertaking single task (finding)	4180186
42690013	Difficulty using local amenities (finding)	4180186
42690015	Difficulty using playground (finding)	4180186
42690016	Difficulty using through floor lift (finding)	4180186
42690019	Difficulty washing upper body (finding)	4180186
42690024	Does not access utility meters (finding)	4180186
42690025	Does not adapt to sensory changes in body part (finding)	4180186
42690026	Does not analyse information (finding)	4180186
42690027	Does not anticipate self-care routines (finding)	4180186
42690028	Does not apply for voluntary work (finding)	4180186
42690029	Does not appraise own abilities (finding)	4180186
42690032	Is not aware of self (finding)	4180186
42690035	Does not care for pressure areas (finding)	4180186
42690040	Does not clean items at waist height (finding)	4180186
42690041	Does not clean own room (finding)	4180186
42690043	Does not control anger (finding)	4180186
42690045	Does not control emotions (finding)	4180186
42690046	Does not direct energy (finding)	4180186
42690048	Does not do homework (finding)	4180186
42690054	Does not establish life roles (finding)	4180186
42690056	Does not feel confident (finding)	4180186
42690058	Does not find way around familiar environment (finding)	4180186
42690059	Does not find way around school environment (finding)	4180186
42690061	Does not get into bed without assistance (finding)	4180186
42690062	Does not get out of bed without assistance (finding)	4180186
42690066	Does not identify dangers (finding)	4180186
42690068	Does not indicate own toileting needs (finding)	4180186
42690069	Does not learn basic skills (finding)	4180186
42690070	Does not learn complex skills (finding)	4180186
42690071	Does not maintain life roles (finding)	4180186
42690072	Does not maintain structure and routine in daily life (finding)	4180186
42690074	Does not make decision on safe information to give over telephone (finding)	4180186
42690076	Does not manage body temperature (finding)	4180186
42690081	Does not manage incontinence products (finding)	4180186
42690082	Does not manage internal stairs (finding)	4180186
42690083	Does not manage own aggression (finding)	4180186
42690084	Does not manage own energy levels (finding)	4180186
42690085	Does not manage own symptoms (finding)	4180186
42690090	Does not manage visitors at home (finding)	4180186
42690092	Does not mobilise over uneven ground (finding)	4180186
42690093	Does not mobilise using outdoor motorised wheelchair (finding)	4180186
42690094	Does not move from sitting on edge of bed to lying in bed (finding)	4180186
42690095	Does not move in cot (finding)	4180186
42690098	Does not participate in school activities (finding)	4180186
42690102	Does not process information (finding)	4180186
42690103	Does not process information accurately (finding)	4180186
42690105	Does not recognise spoken words (finding)	4180186
42690108	Does not recognise need for pressure area care (finding)	4180186
42690111	Does not recognise surroundings (finding)	4180186
42690112	Does not remember past events (finding)	4180186
42690113	Does not remember places (finding)	4180186
42690114	Does not respond to own symptoms (finding)	4180186
42690115	Does not respond to stimuli (finding)	4180186
42690116	Does not sequence tasks and activities (finding)	4180186
42690117	Does not set personal goals (finding)	4180186
42690121	Does not sit down onto bed (finding)	4180186
42690122	Does not sleep (finding)	4180186
42690127	Does not sustain energy level (finding)	4180186
42690128	Does not think creatively (finding)	4180186
42690130	Does not tolerate generalised pain (finding)	4180186
42690131	Does not tolerate pain in body part (finding)	4180186
42690132	Does not tolerate toileting routine (finding)	4180186
42690136	Does not understand and use numbers (finding)	4180186
42690137	Does not understand care for pressure areas (finding)	4180186
42690138	Does not understand humour (finding)	4180186
42690139	Does not understand pain in body part (finding)	4180186
42690140	Does not undertake multiple tasks (finding)	4180186
42690142	Does not undertake voluntary work (finding)	4180186
42690147	Does not use playground (finding)	4180186
42690148	Does not use through floor lift (finding)	4180186
42690149	Does not write for examinations (finding)	4180186
42690150	Does not write for lessons (finding)	4180186
42690152	Does access garden (finding)	4180186
42690153	Does access utility meters (finding)	4180186
42690157	Does anticipate self-care routines (finding)	4180186
42690163	Does assist in self-care routines (finding)	4180186
42690168	Does care for pressure areas (finding)	4180186
42690171	Does clean items at floor level (finding)	4180186
42690172	Does clean items at shoulder height (finding)	4180186
42690173	Does clean own room (finding)	4180186
42690175	Does control anger (finding)	4180186
42690181	Does dry lower body (finding)	4180186
42690182	Does engage in life roles (finding)	4180186
42690183	Does engage in structure and routine in daily life (finding)	4180186
42690186	Does fill forms (finding)	4180186
42690187	Does find way around familiar environment (finding)	4180186
42690188	Does get into bed without assistance (finding)	4180186
42690190	Does have confidence in own skills (finding)	4180186
42690191	Does have functional level of stamina (finding)	4180186
42690192	Does identify choices (finding)	4180186
42690193	Does identify dangers (finding)	4180186
42690195	Does identify risky behaviours (finding)	4180186
42690198	Does learn complex skills (finding)	4180186
42690199	Does maintain life roles (finding)	4180186
42690200	Does make decision on safe entry of visitors (finding)	4180186
42690201	Does make decision on safe information to give over telephone (finding)	4180186
42690202	Does make decisions (finding)	4180186
42690205	Does manage external steps (finding)	4180186
42690209	Does manage internal stairs (finding)	4180186
42690211	Does manage own energy levels (finding)	4180186
42690212	Does manage own physical health needs (finding)	4180186
42690214	Does manage risk in community (finding)	4180186
42690215	Does manage urostomy care (finding)	4180186
42690216	Does mobilise using mobility scooter (finding)	4180186
42690218	Does mobilise using outdoor motorised wheelchair (finding)	4180186
42690221	Does organise own clothes (finding)	4180186
42690223	Does participate in school activities (finding)	4180186
42690227	Does prevent undesirable behaviour (finding)	4180186
42690234	Does recognise generalised pain (finding)	4180186
42690235	Does recognise impact of self on others (finding)	4180186
42690237	Does recognise numbers (finding)	4180186
42690238	Does recognise objects (finding)	4180186
42690239	Does recognise objects by sight (finding)	4180186
42690242	Does recognise surroundings (finding)	4180186
42690247	Does sequence events (finding)	4180186
42690248	Does sequence tasks and activities (finding)	4180186
42690249	Does shift attention (finding)	4180186
42690250	Does shop at supermarket (finding)	4180186
42690251	Does shop online (finding)	4180186
42690255	Does tolerate changing incontinence pad (finding)	4180186
42690258	Does tolerate toileting routine (finding)	4180186
42690259	Does transfer to vehicle independently (finding)	4180186
42690261	Does transport food and drink (finding)	4180186
42690262	Does understand and use money (finding)	4180186
42690266	Does undertake multiple tasks (finding)	4180186
42690268	Does undertake voluntary work (finding)	4180186
42690271	Does use games console (finding)	4180186
42690272	Does use picture exchange for communication (finding)	4180186
42690275	Does use toilet with assistance (finding)	4180186
42690276	Does wash lower body (finding)	4180186
42690277	Does wash upper body (finding)	4180186
42690278	Does write for lessons (finding)	4180186
42690279	Does write messages (finding)	4180186
42690290	Unable to be optimistic (finding)	4180186
42690294	Unable to clean items at floor level (finding)	4180186
42690298	Unable to communicate in event of emergency (finding)	4180186
42690299	Unable to direct energy (finding)	4180186
42690300	Unable to divide attention (finding)	4180186
42690301	Unable to do homework (finding)	4180186
42690304	Unable to engage in life roles (finding)	4180186
42690305	Unable to engage in structure and routine in daily life (finding)	4180186
42690306	Unable to establish life roles (finding)	4180186
42690307	Unable to establish structure and routine in daily life (finding)	4180186
42690312	Unable to get out of bed without assistance (finding)	4180186
42690313	Unable to get up from floor (finding)	4180186
42690319	Unable to indicate own toileting needs (finding)	4180186
42690321	Unable to maintain life roles (finding)	4180186
42690322	Unable to make decision on safe entry of visitors (finding)	4180186
42690323	Unable to make decision on safe information to give over telephone (finding)	4180186
42690324	Unable to make decisions (finding)	4180186
42690325	Unable to manage body temperature (finding)	4180186
42690328	Unable to manage external steps (finding)	4180186
42690331	Unable to manage incontinence products (finding)	4180186
42690332	Unable to manage internal steps (finding)	4180186
42690335	Unable to manage own physical health needs (finding)	4180186
42690336	Unable to manage own symptoms (finding)	4180186
42690338	Unable to manage risk at home (finding)	4180186
42690340	Unable to manage urinary catheter care (finding)	4180186
42690341	Unable to manage urostomy care (finding)	4180186
42690346	Unable to move from sitting on edge of bed to lying in bed (finding)	4180186
42690348	Unable to operate mobile phone (finding)	4180186
42690350	Unable to participate in classroom activities (finding)	4180186
42690354	Unable to participate in self-care at school (finding)	4180186
42690355	Unable to perform work based activity (finding)	4180186
42690356	Unable to recognise own symptoms (finding)	4180186
42690359	Unable to recognise symbols (finding)	4180186
42690360	Unable to recognise body temperature (finding)	4180186
42690361	Unable to recognise generalised pain (finding)	4180186
42690362	Unable to recognise impact of self on others (finding)	4180186
42690365	Unable to recognise numbers (finding)	4180186
42690368	Unable to remember past events (finding)	4180186
42690369	Unable to remember people (finding)	4180186
42690370	Unable to remember routines (finding)	4180186
42690373	Unable to sequence tasks and activities (finding)	4180186
42690375	Unable to shop at corner shop (finding)	4180186
42690376	Unable to shop at supermarket (finding)	4180186
42690377	Unable to shop online (finding)	4180186
42690378	Unable to sit down onto bed (finding)	4180186
42690379	Unable to sleep with sedation (finding)	4180186
42690382	Unable to stop use of energy (finding)	4180186
42690383	Unable to sustain attention (finding)	4180186
42690384	Unable to sustain energy level (finding)	4180186
42690385	Unable to tolerate being cleaned during toileting (finding)	4180186
42690387	Unable to tolerate generalised pain (finding)	4180186
42690392	Unable to transfer to vehicle with supervision (finding)	4180186
42690396	Unable to understand generalised pain (finding)	4180186
42690397	Unable to undertake multiple tasks (finding)	4180186
42690399	Unable to use communication device (finding)	4180186
42690403	Unable to use through floor lift (finding)	4180186
42690405	Unable to wash upper body (finding)	4180186
42690406	Unable to write for examinations (finding)	4180186
42690407	Unable to write messages (finding)	4180186
42690410	Caregiver behaviour is cause for safeguarding concern	4180186
42690410	Carer behaviour is cause for safeguarding concern	4180186
42690410	Carer behavior is cause for safeguarding concern (situation)	4180186
42690410	Caregiver behavior is cause for safeguarding concern	4180186
42690410	Carer behaviour is cause for safeguarding concern (situation)	4180186
42690412	National Health Service continuing healthcare fast track funding required (finding)	4180186
42690414	Abdominal hysterectomy with sacrocolpopexy using mesh (procedure)	4180186
42690415	Transperineal insertion of biodegradable spacer into perirectal space using ultrasonographic guidance (procedure)	4180186
42690417	Transcutaneous stimulation of cervical branch of vagus nerve (procedure)	4180186
42690418	Amber flag sepsis (disorder)	4180186
42690425	Does not sit on potty (finding)	4180186
42690428	Pretransplant evaluation of liver recipient (procedure)	4180186
42690429	Pretransplant evaluation of pancreas recipient (procedure)	4180186
42690430	Pretransplant evaluation of kidney and pancreas recipient (procedure)	4180186
42690438	Pretransplant evaluation of live liver donor (procedure)	4180186
42690440	Doppler ultrasonography of vascular structure of inguinal region (procedure)	4180186
42690440	Doppler ultrasound of vascular structure of inguinal region	4180186
42690440	Doppler ultrasound scan of vascular structure of inguinal region	4180186
42690441	Doppler ultrasonography of vascular structure of hand (procedure)	4180186
42690441	Doppler ultrasound of vascular structure of hand	4180186
42690441	Doppler ultrasound scan of vascular structure of hand	4180186
42690444	Doppler ultrasonography of vascular structure of popliteal fossa (procedure)	4180186
42690444	Doppler ultrasound of vascular structure of popliteal fossa	4180186
42690444	Doppler ultrasound scan of vascular structure of popliteal fossa	4180186
42690450	Postural Assessment Scale for Stroke Patients (assessment scale)	4180186
42690451	Assessment using Postural Assessment Scale for Stroke Patients (procedure)	4180186
42690454	Provision of written information about domiciliary end of life care services (procedure)	4180186
42690456	Three dimensional ultrasound scan of abdominal aortic endovascular aneurysm repair with contrast	4180186
42690456	Three dimensional ultrasonography of abdominal aortic endovascular aneurysm repair with contrast (procedure)	4180186
42690456	Three dimensional ultrasound of abdominal aortic endovascular aneurysm repair with contrast	4180186
42690458	Provision of written information about social support (procedure)	4180186
42690459	Discussion about social support (procedure)	4180186
42690460	Percutaneous transluminal chemoembolisation of hepatic artery using fluoroscopic guidance (procedure)	4180186
42690464	Transplant recipient CMV (cytomegalovirus) antibody negative	4180186
42690464	Transplant recipient cytomegalovirus antibody negative (situation)	4180186
42690465	At risk of radicalisation (finding)	4180186
42690466	Ultrasonography of kidney and bladder (procedure)	4180186
42690466	Ultrasound of kidney and bladder	4180186
42690466	Ultrasound scan of kidney and bladder	4180186
42690467	Articulation stimulability treatment (regime/therapy)	4180186
42690469	Abdominal thrust training (procedure)	4180186
42690469	Heimlich manoeuvre training	4180186
42690476	Cardiac CT with contrast	4180186
42690476	Computed tomography of heart with contrast (procedure)	4180186
42690478	Exercise therapy supervised by healthcare professional (regime/therapy)	4180186
42690479	Streamed from emergency department following initial assessment (situation)	4180186
42690481	Streamed from emergency department to urgent care service following initial assessment (situation)	4180186
42690484	Streamed from emergency department to pharmacy service following initial assessment (situation)	4180186
42690485	Streamed from emergency department to ambulatory emergency care service following initial assessment (situation)	4180186
42690488	Training carer to support symbolic play (situation)	4180186
42690490	Functional communication training (procedure)	4180186
42690491	Able to use personal computer for speech and language therapy (finding)	4180186
42690492	Assessment under the Mental Health Act 1983 (England and Wales) started (situation)	4180186
42690497	Referred by homeless drop-in centre (finding)	4180186
42690499	Ultrasonography of venous return (procedure)	4180186
42690499	Ultrasound of venous return	4180186
42690499	Ultrasound scan of venous return	4180186
42690505	Insertion of cerebral ventriculoatrial shunt using fluoroscopic guidance (procedure)	4180186
42690506	Gastrostomy tube insertion assessment (procedure)	4180186
42690507	Nasogastric tube insertion assessment (procedure)	4180186
42690508	Diagnosing Advanced Dementia Mandate Tool (assessment scale)	4180186
42690509	Diagnosing Advanced Dementia Mandate Tool score (observable entity)	4180186
42690514	Nasogastric tube irrigation education (procedure)	4180186
42690516	Nasogastric tube irrigation management (procedure)	4180186
42690519	Chalder Fatigue Scale (assessment scale)	4180186
42690520	Assessment using Chalder Fatigue Scale (procedure)	4180186
42690521	Chalder Fatigue Scale score (observable entity)	4180186
42690522	Patient streaming from emergency department following assessment (procedure)	4180186
42690527	Referred by adult day care centre (finding)	4180186
42690528	Patient streaming to emergency department following assessment (procedure)	4180186
42690530	Pressure ulcer secondary prevention and treatment pathway (regime/therapy)	4180186
42690538	Attendance details (record artifact)	4180186
42690539	Treatments and interventions (record artifact)	4180186
42690540	Clinical narrative (record artifact)	4180186
42690541	Safeguarding (record artifact)	4180186
42690542	Reviewing clinician (record artifact)	4180186
42690546	Therapy Outcome Measure activity scale observables simple reference set (foundation metadata concept)	4180186
42690546	TOM (Therapy Outcome Measure) activity scale observables simple reference set	4180186
42690548	Therapy Outcome Measure impairment scale observables simple reference set (foundation metadata concept)	4180186
42690548	TOM (Therapy Outcome Measure) impairment scale observables simple reference set	4180186
42690549	Therapy Outcome Measure participation scale observables simple reference set (foundation metadata concept)	4180186
42690549	TOM (Therapy Outcome Measure) participation scale observables simple reference set	4180186
42690553	Activity of daily living related to physical function findings simple reference set (foundation metadata concept)	4180186
42690556	Emergency care admission procedures simple reference set (foundation metadata concept)	4180186
42690557	Measured range of physiological joint movement (excluding spine) observables simple reference set (foundation metadata concept)	4180186
42690559	Neurodynamic assessment findings simple reference set (foundation metadata concept)	4180186
42690563	Podiatric assessment observables simple reference set (foundation metadata concept)	4180186
42690564	Podiatric assessment procedures simple reference set (foundation metadata concept)	4180186
42690567	Podiatric health issues simple reference set (foundation metadata concept)	4180186
42690568	Podiatric minor surgical interventions simple reference set (foundation metadata concept)	4180186
42690570	Podiatric therapeutic interventions simple reference set (foundation metadata concept)	4180186
42690571	Emergency care attendance source simple reference set (foundation metadata concept)	4180186
42690573	Emergency care discharge destination simple reference set (foundation metadata concept)	4180186
42690575	Emergency care injury activity status simple reference set (foundation metadata concept)	4180186
42690577	Emergency care usual residence type simple reference set (foundation metadata concept)	4180186
42690578	Emergency care acuity simple reference set (foundation metadata concept)	4180186
42690579	Mental Health Act legal status findings simple reference set (foundation metadata concept)	4180186
42690581	Podiatric and Surgical Clinical Outcome Measurement 10 (assessment scale)	4180186
42690582	Moderate acute exacerbation of asthma (disorder)	4180186
42690583	Unable to provide accommodation details (finding)	4180186
42690585	Injury following codeine use (disorder)	4180186
42690587	Magnetic resonance imaging of liver and spleen with contrast (procedure)	4180186
42690590	Acquired arteriovenous malformation of stomach (disorder)	4180186
42690592	Injury whilst playing cricket (disorder)	4180186
42690594	Injury whilst wrestling (disorder)	4180186
42690598	Injury whilst using motorised snow vehicle (disorder)	4180186
42690600	Injury whilst engaged in engineering work (disorder)	4180186
42690601	Injury whilst teaching (disorder)	4180186
42690604	Does not problem solve (finding)	4180186
42690606	Does not tolerate being cleaned during toileting (finding)	4180186
42690607	Unable to write for lessons (finding)	4180186
42690608	Difficulty adapting to sensory changes in body part (finding)	4180186
42690610	Difficulty identifying risky behaviours (finding)	4180186
42690612	Difficulty managing body temperature (finding)	4180186
42690613	Difficulty managing generalised pain (finding)	4180186
42690616	Difficulty shopping online (finding)	4180186
42690618	Difficulty writing own name (finding)	4180186
42690619	Does not apply for education course (finding)	4180186
42690620	Does not rise from chair without assistance (finding)	4180186
42690621	Does not get out of bath (finding)	4180186
42690622	Does not have confidence in own skills (finding)	4180186
42690635	Does move from sitting on edge of bed to lying in bed (finding)	4180186
42690640	Unable to access utility meters (finding)	4180186
42690641	Unable to anticipate self-care routines (finding)	4180186
42690642	Unable to rise from chair without assistance (finding)	4180186
42690645	Unable to identify life roles (finding)	4180186
42690646	Unable to manage stress (finding)	4180186
42690647	Unable to remember places (finding)	4180186
42690648	Unable to respond to stimuli (finding)	4180186
42690649	Able to clean own room (finding)	4180186
42690650	Cadaver donor with DCD (donation after cardiac death)	4180186
42690650	Cadaver donor with donation after cardiac death (person)	4180186
42690654	Emergency care arrival mode simple reference set (foundation metadata concept)	4180186
42690656	Difficulty transferring to vehicle independently (finding)	4180186
42690658	Does not move items around home (finding)	4180186
42690661	Unable to understand humour (finding)	4180186
42690662	Type 2 diabetes mellitus risk assessment declined (situation)	4180186
42690662	Type II diabetes mellitus risk assessment declined	4180186
42690663	Life threatening acute exacerbation of asthma (disorder)	4180186
42690665	Place of occurrence of injury is gym in home environment (finding)	4180186
42690667	Injury following spice use	4180186
42690667	Injury following synthetic cannabinoid use (disorder)	4180186
42690669	Referred by school nurse (finding)	4180186
42690670	Type 2 diabetes mellitus risk assessment invitation (procedure)	4180186
42690670	Type II diabetes mellitus risk assessment invitation	4180186
42690671	Magnetic resonance imaging with contrast for radiotherapy planning (procedure)	4180186
42690672	Delayed prescription given (situation)	4180186
42690673	Magnetic resonance imaging of cervix with contrast (procedure)	4180186
42690674	Social Thinking (regime/therapy)	4180186
42690679	Referred by mountain rescue service (finding)	4180186
42690682	Chronic obstructive pulmonary disease monitoring short message service text message invitation (procedure)	4180186
42690684	Computer-Aided Speech and Language Therapy (regime/therapy)	4180186
42690684	Computer-assisted speech and language therapy	4180186
42690686	Altered auditory feedback (regime/therapy)	4180186
42690689	Excision of medial exostosis of toe (procedure)	4180186
42690690	Supervised discharge under section 25A of the Mental Health (Patients in the Community) Act 1995 (England and Wales) (finding)	4180186
42690691	Injury whilst playing rugby league (disorder)	4180186
42690693	Injury whilst playing tennis (disorder)	4180186
42690694	Injury whilst playing pool (disorder)	4180186
42690698	Injury whilst base-jumping (disorder)	4180186
42690699	Injury whilst horse riding (disorder)	4180186
42690700	Injury whilst engaged in archery (disorder)	4180186
42690702	Injury whilst descending stairs (disorder)	4180186
42690704	Injury whilst mountain biking (disorder)	4180186
42690705	Injury whilst engaged in pilates (disorder)	4180186
42690706	Injury whilst engaged in environmental work (disorder)	4180186
42690707	Injury due to activity involving motorcycle riding (disorder)	4180186
42690709	Injury whilst passenger on public transport (disorder)	4180186
42690711	Difficulty recognising familiar people (finding)	4180186
42690712	Difficulty shopping at corner shop (finding)	4180186
42690713	Difficulty using communication device (finding)	4180186
42690714	Does not reflect on own behaviour (finding)	4180186
42690719	Unable to use playground (finding)	4180186
42690721	Difficulty cleaning items at floor level (finding)	4180186
42690724	Difficulty indicating own toileting needs (finding)	4180186
42690725	Difficulty managing own physical health needs (finding)	4180186
42690726	Difficulty moving in cot (finding)	4180186
42690728	Difficulty recognising letters of alphabet (finding)	4180186
42690729	Difficulty understanding generalised pain (finding)	4180186
42690730	Difficulty using picture exchange for communication (finding)	4180186
42690731	Does not access where car is parked (finding)	4180186
42690733	Does not engage in structure and routine in daily life (finding)	4180186
42690734	Does not identify structure and routine in daily life (finding)	4180186
42690736	Does not manage internal steps (finding)	4180186
42690739	Does not plan (finding)	4180186
42690741	Does not recognise pain in body part (finding)	4180186
42690742	Does not remember people (finding)	4180186
42690743	Does not tolerate changing incontinence pad (finding)	4180186
42690744	Does not wash lower body (finding)	4180186
42690746	Does control emotions (finding)	4180186
42690747	Does homework (finding)	4180186
42690748	Does dry upper body (finding)	4180186
42690751	Does learn basic skills (finding)	4180186
42690754	Does manage internal steps (finding)	4180186
42690757	Does sustain energy level (finding)	4180186
42690761	Unable to assess risk (finding)	4180186
42690764	Unable to identify choices (finding)	4180186
42690765	Unable to learn complex skills (finding)	4180186
42690766	Unable to maintain structure and routine in daily life (finding)	4180186
42690767	Unable to manage internal stairs (finding)	4180186
42690768	Unable to move in cot (finding)	4180186
42690769	Unable to problem solve (finding)	4180186
42690776	Transplant donor CMV (cytomegalovirus) antibody positive	4180186
42690776	Transplant donor cytomegalovirus antibody positive (situation)	4180186
42690777	Ultrasonography of retained products of conception (procedure)	4180186
42690777	Ultrasound of retained products of conception	4180186
42690777	Ultrasound scan of retained products of conception	4180186
42690778	Able to produce verbal narratives (finding)	4180186
42690783	Assessment using Hunters Hill Marie Curie Centre Pressure Sore Risk Assessment Tool (procedure)	4180186
42690784	Radiography of endovascular aneurysm repair of abdominal aorta	4180186
42690784	X-ray of endovascular aneurysm repair of abdominal aorta (procedure)	4180186
42690784	X-ray of EVAR (endovascular aneurysm repair) of abdominal aorta	4180186
42690786	Contact for further information (record artifact)	4180186
42709742	Swelling of lower limb (finding)	4180186
42709742	Swollen leg	4180186
42709745	X-ray of lower leg for bone length measurement (procedure)	4180186
42709746	Swelling of upper limb (finding)	4180186
42709748	Lymphoedema of upper limb	4180186
42709748	Lymphedema of upper limb (disorder)	4180186
42709749	Lymphedema of upper arm (disorder)	4180186
42709749	Lymphoedema of upper arm	4180186
42709750	Transplantation of tissue of upper limb (procedure)	4180186
42709752	Second degree burn of multiple sites of upper limb	4180186
42709752	Partial thickness burn of multiple sites of upper limb (disorder)	4180186
42709753	First degree burn of multiple sites of upper arm	4180186
42709753	Burn erythema of multiple sties of upper arm	4180186
42709753	Epidermal burn of multiple sites of upper arm (disorder)	4180186
42709753	Superficial burn of multiple sites of upper arm	4180186
42709755	Malignant neoplasm of long bone of lower limb (disorder)	4180186
42709758	Secondary malignant neoplasm of skin of lower leg (disorder)	4180186
42709759	Secondary malignant neoplasm of skin of upper arm (disorder)	4180186
42709764	Malignant melanoma of skin of lower leg (disorder)	4180186
42709765	Malignant melanoma of skin of upper arm (disorder)	4180186
42709766	Repair of defect of fascia of lower leg (procedure)	4180186
42709768	Reduction of fracture of upper limb with internal fixation (procedure)	4180186
42709770	Superficial injury of lower leg with infection (disorder)	4180186
42709771	Nonvenomous insect bite of lower leg with infection (disorder)	4180186
42709773	Stripping and ligation of vein of lower leg (procedure)	4180186
42709779	Recurrent varicose vein of lower limb (disorder)	4180186
42709780	Manipulation of lower limb (procedure)	4180186
42709781	Manipulation of lower leg (procedure)	4180186
42709782	Transposition of tissue of lower limb (procedure)	4180186
42709783	Transposition of tissue of lower leg (procedure)	4180186
42709784	Transposition of tissue of upper limb (procedure)	4180186
42709786	Transplantation of tissue of lower limb (procedure)	4180186
42709792	Transplantation of tissue of upper arm (procedure)	4180186
42709793	Escharotomy of burnt skin of upper arm (procedure)	4180186
42709794	Escharotomy of burnt skin of upper limb (procedure)	4180186
42709795	Escharotomy of burnt skin of lower limb (procedure)	4180186
42709796	Escharotomy of burnt skin of lower leg (procedure)	4180186
42709798	Absence of upper arm (finding)	4180186
42709800	Excision of upper arm (procedure)	4180186
42709804	Closure of upper arm (procedure)	4180186
42709806	Reconstruction of upper arm (procedure)	4180186
42709808	Elevation of upper limb (procedure)	4180186
42709809	Elevation of upper arm (procedure)	4180186
42709810	Congenital absence of part of upper limb (disorder)	4180186
42709812	Debridement of open fracture of lower limb (procedure)	4180186
42709813	Debridement of open fracture of lower leg (procedure)	4180186
42709814	Incision and drainage of deep abscess of lower limb (procedure)	4180186
42709817	Blister of lower leg with infection (disorder)	4180186
42709818	Fitting of prosthesis of lower leg (procedure)	4180186
42709819	Congenital shortening of upper limb (disorder)	4180186
42709821	Implantation of prosthetic device of lower limb (procedure)	4180186
42709824	Elevation of lower leg (procedure)	4180186
42709825	Incision and drainage of hematoma of lower limb (procedure)	4180186
42709825	Incision and drainage of haematoma of lower limb	4180186
42709826	Incision and drainage of hematoma of lower leg (procedure)	4180186
42709826	Incision and drainage of haematoma of lower leg	4180186
42709828	Incision of varicose vein of lower limb (procedure)	4180186
42709829	Incision of varicose vein of lower leg (procedure)	4180186
42709830	Cellulitis and abscess of lower limb (disorder)	4180186
42709831	Hematoma of lower limb (disorder)	4180186
42709831	Haematoma of lower limb	4180186
42709832	Haematoma of lower leg	4180186
42709832	Hematoma of lower leg (disorder)	4180186
42709837	Injection sclerotherapy of varicose vein of lower leg (procedure)	4180186
42709839	Cellulitis of lower leg (disorder)	4180186
42709842	Bowing of upper arm (finding)	4180186
42709843	Deformity of lower limb (finding)	4180186
42709843	Lower limb deformity	4180186
42709844	Deformity of lower leg (finding)	4180186
42709845	Cellulitis and abscess of upper limb (disorder)	4180186
42709846	Full thickness burn of multiple sites of upper arm (disorder)	4180186
42709846	Third degree burn of multiple sites of upper arm	4180186
42709849	Facultative hypermetropia (disorder)	4180186
42709851	Absolute hypermetropia (disorder)	4180186
42709860	Pigmented actinic keratosis (disorder)	4180186
42709862	Hyperopic astigmatism (disorder)	4180186
42709867	Rupture of periwound skin (finding)	4180186
42709868	Swelling of periwound skin (finding)	4180186
42709871	Wound epithelialisation	4180186
42709871	Wound epithelialization (finding)	4180186
42709873	Fibrinous wound bed (finding)	4180186
42709877	Poorly-defined wound edge	4180186
42709877	Wound edge diffuse (finding)	4180186
42709878	Wound edge sharp (finding)	4180186
42709878	Well-defined wound edge	4180186
42709880	Wound tissue undermining (finding)	4180186
42709881	Pressure point of skin (finding)	4180186
42709882	Pressure point of skin over bony prominence (finding)	4180186
42709885	Viscous discharge from wound (finding)	4180186
42709886	Traumatic infarct (morphologic abnormality)	4180186
42709888	Scab of wound edge (finding)	4180186
42709892	Granulomatous foreign body gingivitis (disorder)	4180186
42709893	Endosteal osteoma (disorder)	4180186
42709897	Numb chin syndrome (disorder)	4180186
42709899	Dilated odontoma (disorder)	4180186
42709899	Dilated odontome	4180186
42709901	Interstitial glossitis (disorder)	4180186
42709905	Transient infantile osteopetrosis (disorder)	4180186
42709905	Transient osteopetrosis	4180186
42709906	Undifferentiated nonkeratinizing squamous cell carcinoma (morphologic abnormality)	4180186
42709907	Tendoperiostitis (disorder)	4180186
42709908	Riga-Fede syndrome	4180186
42709908	Riga-Fede disease (disorder)	4180186
42709912	Diffuse infiltrative lymphocytosis syndrome (disorder)	4180186
42709912	DILS - diffuse infiltrative lymphocytosis syndrome	4180186
42709914	Spacing of posterior maxillary teeth (disorder)	4180186
42709915	Spacing of posterior mandibular teeth (disorder)	4180186
42709918	Orofacial cleft (disorder)	4180186
42709920	Spacing of anterior maxillary teeth (disorder)	4180186
42709921	Hemorrhage into subdural space of neuraxis (disorder)	4180186
42709921	Haemorrhage into subdural space of neuraxis	4180186
42709923	Haemorrhage into subdural space of spine	4180186
42709923	Hemorrhage into subdural space of spine (disorder)	4180186
42709925	Non-traumatic haematoma of subdural space of neuraxis	4180186
42709925	Non-traumatic hematoma of subdural space of neuraxis (disorder)	4180186
42709926	Crowding of anterior maxillary teeth (disorder)	4180186
42709928	Neoplasm of dome of urinary bladder (disorder)	4180186
42709931	Primary malignant neoplasm of dome of urinary bladder (disorder)	4180186
42709935	Type 3a third degree perineal laceration	4180186
42709935	Type 3a third degree laceration of perineum (disorder)	4180186
42709936	Type 3b third degree laceration of perineum (disorder)	4180186
42709936	Type 3b third degree perineal laceration	4180186
42709937	Type 3c third degree perineal laceration	4180186
42709937	Type 3c third degree laceration of perineum (disorder)	4180186
42709938	Patient controlled analgesia device in situ (finding)	4180186
42709939	Stable gait (finding)	4180186
42709944	Avascular necrosis of femoral condyle (disorder)	4180186
42709944	Femoral condylar avascular necrosis	4180186
42709952	Marden Walker syndrome (disorder)	4180186
42709961	Cecal polyp	4180186
42709961	Caecal polyp	4180186
42709961	Polyp of caecum	4180186
42709961	Polyp of cecum (disorder)	4180186
42709962	Lateral vertigo (finding)	4180186
42709963	Nocturnal vertigo (finding)	4180186
42709964	Multiple cysts of breast (disorder)	4180186
42709966	Benign cyst of breast (disorder)	4180186
42709969	Nasogastric tube patent (finding)	4180186
42709970	Nasogastric tube in situ (finding)	4180186
42709974	Metal mitral valve prosthesis in situ (finding)	4180186
42709976	Supernumerary permanent maxillary tooth (disorder)	4180186
42709981	Interleukin-12 deficiency (disorder)	4180186
42709983	Serrated polyp of colon (disorder)	4180186
42709984	Healing abutment (physical object)	4180186
42709985	Placement of healing abutment (procedure)	4180186
42709985	Placement of healing collar	4180186
42709986	Supracondylar osteotomy of humerus (procedure)	4180186
42709989	Cuffed central venous catheter (physical object)	4180186
42709992	Arytenoidopexy	4180186
42709992	Surgical fixation of arytenoid cartilage (procedure)	4180186
42709993	Division of web of larynx (procedure)	4180186
42709994	Vitreoretinal dysplasia (disorder)	4180186
42709995	Uses moist tobacco occasionally (finding)	4180186
42709996	Current every day smoker	4180186
42709996	Smokes tobacco daily (finding)	4180186
42709996	Daily tobacco smoker	4180186
42709998	Congenital anomaly of blood vessel of extremity	4180186
42709998	Congenital anomaly of blood vessel of limb (disorder)	4180186
42709999	Congenital anomaly of blood vessel of lower limb (disorder)	4180186
42710000	Powder (substance)	4180186
42710001	Atherosclerotic plaque disruption with thrombosis of artery (disorder)	4180186
42710002	Supernumerary deciduous maxillary tooth (disorder)	4180186
42710003	Supernumerary deciduous mandibular tooth (disorder)	4180186
42710006	Magnetic resonance imaging for cardiac morphology, function, and velocity under stress	4180186
42710006	Magnetic resonance imaging for cardiac morphology, function, and velocity under stress (procedure)	4180186
42710009	Magnetic resonance imaging for cardiac morphology, function, and velocity under stress with contrast (procedure)	4180186
42710009	Magnetic resonance imaging for cardiac morphology, function, and velocity under stress with contrast	4180186
42710010	Magnetic resonance imaging for cardiac morphology and function under stress (procedure)	4180186
42710010	Magnetic resonance imaging for cardiac morphology and function under stress	4180186
42710011	Magnetic resonance imaging for cardiac morphology and function under stress with contrast (procedure)	4180186
42710011	Magnetic resonance imaging for cardiac morphology and function under stress with contrast	4180186
42710012	Painful scar (finding)	4180186
42710013	Cerebral aneurysm clip in situ (finding)	4180186
42710015	On solids at 4 months (finding)	4180186
42710016	Normal cognition (finding)	4180186
42710017	Delay in seeking medical advice (finding)	4180186
42710018	Functional abdominal pain syndrome (disorder)	4180186
42710020	Feeling safe (finding)	4180186
42710023	Functional drainage tube (finding)	4180186
42710024	Vascular entrapment	4180186
42710024	Entrapment of blood vessel (disorder)	4180186
42710027	Dropped head syndrome (disorder)	4180186
42710028	Streptococcal gangrene	4180186
42710028	Type II necrotizing fasciitis	4180186
42710028	Type II necrotising fasciitis	4180186
42710028	Necrotising fasciitis due to Streptococcus pyogenes	4180186
42710028	Necrotising fasciitis caused by Streptococcus pyogenes	4180186
42710028	Streptococcal necrotising fasciitis	4180186
42710028	Necrotizing fasciitis caused by Streptococcus pyogenes	4180186
42710028	Necrotizing fasciitis due to Streptococcus pyogenes	4180186
42710028	Necrotizing fasciitis caused by Streptococcus pyogenes (disorder)	4180186
42710030	Portal systemic encephalopathy (disorder)	4180186
42710030	Gaustad's syndrome	4180186
42710030	Transient hepatargy syndrome	4180186
42710031	Dural arteriovenous fistula of spinal cord	4180186
42710031	Type I spinal dural arteriovenous fistula	4180186
42710031	Dural arteriovenous fistula of spinal cord (disorder)	4180186
42710031	Type I spinal dural AV fistula	4180186
42710036	Juvenile periodontitis	4180186
42710036	Rapidly progressive periodontitis	4180186
42710036	Aggressive periodontitis (disorder)	4180186
42710037	Flaccidity of muscle of lower limb (finding)	4180186
42710038	Flaccidity of muscle of upper limb (finding)	4180186
42710039	War injury due to air blast (disorder)	4180186
42710040	Long lip	4180186
42710040	Long vertical length of upper lip (finding)	4180186
42710041	Short vertical length of upper lip (finding)	4180186
42710041	Short lip	4180186
42710043	Nonvenomous insect bite of lower leg without infection (disorder)	4180186
42710052	Destructive procedure on lower leg (procedure)	4180186
42710054	Inflammatory thrombosis of superficial vein of lower leg (disorder)	4180186
42710054	Inflammatory thrombosis of superficial vein of lower leg	4180186
42868298	2-oxoadipic acid; alpha Ketoadipate; alpha Ketoadipic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Oxoadipate; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868298	2-Oxoadipate CSF-sCnc	4180186
42868298	2-氧代己二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868301	2Oxoisocaproate CSF-sCnc	4180186
42868301	2-keto-4-methylvalerate; 2-ketoisocaproate; 2-ketoisocaproic acid; 2Oxoisocaproate; 2-oxoisocaproic acid; alpha-ketoisocaproate; alpha-ketoisocaproic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868301	2-氧代异己酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868302	&gt;12h; 12H p IFF; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; After; Blood; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42868302	2-DCE-IF 12H p IFF Bld-mCnc	4180186
42868302	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后12小时:质量浓度:时间点:全血:定量型	4182948
42868304	2-DCE-IF pre IFF 24h Ur-mRate	4180186
42868304	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; Before; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; pre IFF; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868304	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后:质量速率:24小时:尿液:定量型	4182948
42868307	2-DCE-IF 1D p IFF 24h Ur-mCnc	4180186
42868307	1 day; 1D p IFF; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868307	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后1天:质量浓度:24小时:尿液:定量型	4182948
42868309	1 day; 24 hours; 24HR; 2D p IFF; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868309	2-DCE-IF 2D p IFF 24h Ur-mCnc	4180186
42868309	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后2天:质量浓度:24小时:尿液:定量型	4182948
42868310	2-DCE-IF 3D p IFF 24h Ur-mRate	4180186
42868310	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 3D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868310	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后3天:质量速率:24小时:尿液:定量型	4182948
42868311	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 3D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868311	2-DCE-IF 3D p IFF 24h Ur-mCnc	4180186
42868311	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后3天:质量浓度:24小时:尿液:定量型	4182948
42868312	2-DCE-IF 4D p IFF 24h Ur-mRate	4180186
42868312	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 4D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868312	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后4天:质量速率:24小时:尿液:定量型	4182948
42868313	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 4D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868313	2-DCE-IF 4D p IFF 24h Ur-mCnc	4180186
42868313	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后4天:质量浓度:24小时:尿液:定量型	4182948
42868314	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 5D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868314	2-DCE-IF 5D p IFF 24h Ur-mRate	4180186
42868314	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后5天:质量速率:24小时:尿液:定量型	4182948
42868316	2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 6D p IFF; After; Blood; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42868316	2-DCE-IF 6D p IFF Bld-mCnc	4180186
42868316	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后6天:质量浓度:时间点:全血:定量型	4182948
42868317	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 6D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868317	2-DCE-IF 6D p IFF 24h Ur-mRate	4180186
42868317	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后6天:质量速率:24小时:尿液:定量型	4182948
42868319	2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 7D p IFF; After; Blood; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42868319	2-DCE-IF 7D p IFF Bld-mCnc	4180186
42868319	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后7天:质量浓度:时间点:全血:定量型	4182948
42868320	2-DCE-IF 7D p IFF 24h Ur-mRate	4180186
42868320	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 7D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868320	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后7天:质量速率:24小时:尿液:定量型	4182948
42868322	2-EHA; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868322	2-ethylhydracrylate CSF-sCnc	4180186
42868322	2-乙基羟丙酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868326	Me-succinate SerPl-sCnc	4180186
42868326	2-Methylsuccinic acid; Chemistry; Level; Me-succinate; Methylsuccinic acid; Pl; Plasma; Plsm; Point in time; Pyrotartaric acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868326	甲基琥珀酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868327	1 day; 24 hours; 24HR; 3,4-Dihydroxy phenylacetate; 3,4-Dihydroxy phenylacetic acid; 3,4-Dihydroxyphenylacetic acid; 3,4-DiOH-phenylacetate; DOPAC; Dopamine metabolite; DRUG/TOXICOLOGY; Drugs; III; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
42868327	3,4-DiOH-phenylacetate 24h Ur-sCnc	4180186
42868327	3,4-二羟基苯乙酸:物质的量浓度:24小时:尿液:定量型	4182948
42868332	3OH-Adipate CSF-sCnc	4180186
42868332	3-hydroxy-adipate; 3-hydroxyadipic acid; 3OH-Adipate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868332	3-羟基己二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868333	3OH-Adipate SerPl-sCnc	4180186
42868333	3-hydroxy-adipate; 3-hydroxyadipic acid; 3OH-Adipate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868333	3-羟基己二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868334	3-hydroxy-glutarate; 3-hydroxyglutaric acid; 3-OH-GA; 3OH-Glutarate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868334	3OH-Glutarate CSF-sCnc	4180186
42868334	3-羟基戊二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868338	2OH-adipate SerPl-sCnc	4180186
42868338	2-hydroxy-adipate; 2-hydroxyadipic acid; 2OH-adipate; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868338	2-羟基已二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868340	2-hydroxybutyrate; 2-hydroxybutyric acid; Alfa; Alpha hydroxy butyrate; A-OH-Butyr; Chemistry; Hydroxybutyric acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868340	A-OH-Butyr SerPl-sCnc	4180186
42868340	Alpha 羟基丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868343	2OH-isobutyrate CSF-sCnc	4180186
42868343	2-hydroxy-isobutyrate; 2-hydroxyisobutyric acid; 2OH-isobutyrate; Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Hydroxyisobutyric acid; II; Level; Methyl tert-butyl ether metabolite; MTBE metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868343	2-羟基异丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868344	2-hydroxy-isobutyrate; 2-hydroxyisobutyric acid; 2OH-isobutyrate; DRUG/TOXICOLOGY; Drugs; Hydroxyisobutyric acid; II; Level; Methyl tert-butyl ether metabolite; MTBE metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868344	2OH-isobutyrate SerPl-sCnc	4180186
42868344	2-羟基异丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868345	2-Hydroxy-4-methylpentanoate; 2-Hydroxy-4-methylpentanoic acid; 2-hydroxy-isocaproate; 2-hydroxyisocaproic acid; 2OH-isocaproate; alpha-hydroxyisocaproic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868345	2OH-isocaproate CSF-sCnc	4180186
42868345	2-羟基异己酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868352	Department of Health and Human Services, Affordable Care Act Section 4302; Ethnicity; HHS.ACASec4302; Nominal; Point in time; Random; Survey; SURVEY.HHS; Typ	4180186
42868354	Blind, or difficulty seeing; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
42868356	Difficulty walking climbing stairs; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
42868358	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.HHS	4180186
42868360	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Process variables assays; Random	4180186
42868360	Process variables assays PhenX	4180186
42868360	检测的过程变量:-:时间点:^患者:-:PhenX	4182948
42868361	Manufacturer variables assays; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
42868361	Manufacturer variables assays PhenX	4180186
42868361	用于分析的制造商变量:-:时间点:^患者:-:PhenX	4182948
42868362	Chlam; Chlamid; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Process for assays-GC/Chlamydia; Process variables assays; Random	4180186
42868362	Process for assays-GC/Chlamydia PhenX	4180186
42868362	检测的过程变量 - 淋病-衣原体:-:时间点:^患者:-:PhenX	4182948
42868365	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 41; Spec; To be specified in another part of the message; Unspecified	4180186
42868365	Service Cmnt 41-Imp	4180186
42868365	服务注释 41:印象:时间点:XXX:名义型	4182948
42868367	Service Cmnt 43-Imp	4180186
42868367	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 43; Spec; To be specified in another part of the message; Unspecified	4180186
42868367	服务注释 43:印象:时间点:XXX:名义型	4182948
42868369	Service Cmnt 45-Imp	4180186
42868369	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 45; Spec; To be specified in another part of the message; Unspecified	4180186
42868369	服务注释 45:印象:时间点:XXX:名义型	4182948
42868371	Service Cmnt 47-Imp	4180186
42868371	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 47; Spec; To be specified in another part of the message; Unspecified	4180186
42868371	服务注释 47:印象:时间点:XXX:名义型	4182948
42868373	Service Cmnt 49-Imp	4180186
42868373	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 49; Spec; To be specified in another part of the message; Unspecified	4180186
42868373	服务注释 49:印象:时间点:XXX:名义型	4182948
42868380	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 56; Spec; To be specified in another part of the message; Unspecified	4180186
42868380	Service Cmnt 56-Imp	4180186
42868380	服务注释 56:印象:时间点:XXX:名义型	4182948
42868381	Service Cmnt 57-Imp	4180186
42868381	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 57; Spec; To be specified in another part of the message; Unspecified	4180186
42868381	服务注释 57:印象:时间点:XXX:名义型	4182948
42868382	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 58; Spec; To be specified in another part of the message; Unspecified	4180186
42868382	Service Cmnt 58-Imp	4180186
42868382	服务注释 58:印象:时间点:XXX:名义型	4182948
42868383	Service Cmnt 59-Imp	4180186
42868383	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 59; Spec; To be specified in another part of the message; Unspecified	4180186
42868383	服务注释 59:印象:时间点:XXX:名义型	4182948
42868384	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 60; Spec; To be specified in another part of the message; Unspecified	4180186
42868384	Service Cmnt 60-Imp	4180186
42868384	服务注释 60:印象:时间点:XXX:名义型	4182948
42868388	Service Cmnt 64-Imp	4180186
42868388	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 64; Spec; To be specified in another part of the message; Unspecified	4180186
42868388	服务注释 64:印象:时间点:XXX:名义型	4182948
42868393	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 69; Spec; To be specified in another part of the message; Unspecified	4180186
42868393	Service Cmnt 69-Imp	4180186
42868393	服务注释 69:印象:时间点:XXX:名义型	4182948
42868395	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 71; Spec; To be specified in another part of the message; Unspecified	4180186
42868395	Service Cmnt 71-Imp	4180186
42868395	服务注释 71:印象:时间点:XXX:名义型	4182948
42868396	Service Cmnt 72-Imp	4180186
42868396	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 72; Spec; To be specified in another part of the message; Unspecified	4180186
42868396	服务注释 72:印象:时间点:XXX:名义型	4182948
42868399	Service Cmnt 75-Imp	4180186
42868399	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 75; Spec; To be specified in another part of the message; Unspecified	4180186
42868399	服务注释 75:印象:时间点:XXX:名义型	4182948
42868400	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 76; Spec; To be specified in another part of the message; Unspecified	4180186
42868400	Service Cmnt 76-Imp	4180186
42868400	服务注释 76:印象:时间点:XXX:名义型	4182948
42868401	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 77; Spec; To be specified in another part of the message; Unspecified	4180186
42868401	Service Cmnt 77-Imp	4180186
42868401	服务注释 77:印象:时间点:XXX:名义型	4182948
42868402	Service Cmnt 78-Imp	4180186
42868402	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 78; Spec; To be specified in another part of the message; Unspecified	4180186
42868402	服务注释 78:印象:时间点:XXX:名义型	4182948
42868403	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 79; Spec; To be specified in another part of the message; Unspecified	4180186
42868403	Service Cmnt 79-Imp	4180186
42868403	服务注释 79:印象:时间点:XXX:名义型	4182948
42868404	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 80; Spec; To be specified in another part of the message; Unspecified	4180186
42868404	Service Cmnt 80-Imp	4180186
42868404	服务注释 80:印象:时间点:XXX:名义型	4182948
42868407	100WBC; Baso; Basophil; Basophils/Masts; Basos; Bph; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Masts; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868407	Basophils/Masts/leuk NFr CSF	4180186
42868407	嗜碱性粒细胞+肥大细胞/100 个白细胞:计数型分数:时间点:脑脊液:定量型	4182948
42868408	100WBC; Baso; Basophil; Basophils/Masts; Basos; Bph; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Masts; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868408	Basophils/Masts/leuk NFr Snv	4180186
42868408	嗜碱性粒细胞+肥大细胞/100 个白细胞:计数型分数:时间点:滑液:定量型	4182948
42868412	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus 1 Ab; Herpes simplex virus 1 antibody; Herpes simplex virus 1 IgM; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
42868412	HSV1 IgM CSF Ql IA	4180186
42868412	单纯疱疹病毒 1 型 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42868413	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bos spp; f026; f027; f083; f26; f27; f83; Food Allergen Mix fx73; fx73; Gallus spp; Immune globulin E; Immunoglobulin E; Pig; Point in time; Porcine; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sus spp; Swine	4180186
42868413	Food Allergen Mix fx73 IgE Qn	4180186
42868413	(牛肉+鸡肉+猪肉) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42868416	ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; FSME; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR; SUDS; TBEV	4180186
42868416	TBEV IgM Index Ser+CSF IA-aCnc	4180186
42868416	欧洲蜱传脑炎病毒 抗体.IgM 指数:任意型浓度:时间点:血清+脑脊液:定量型:免疫测定法	4182948
42868419	ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; FSME; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR; SUDS; TBEV	4180186
42868419	TBEV IgG Index Ser+CSF IA-aCnc	4180186
42868419	欧洲蜱传脑炎病毒 抗体.IgG 指数:任意型浓度:时间点:血清+脑脊液:定量型:免疫测定法	4182948
42868420	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HRSV; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; Serum; SR; SUDS	4180186
42868420	RSV IgA Ser Ql IA	4180186
42868420	呼吸道合胞病毒 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868423	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; U parvum; U parvum DNA; Unspecified	4180186
42868423	U parvum DNA Spec Ql NAA+probe	4180186
42868423	微小脲原体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868424	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; U parvum; U parvum DNA; U urealyt+U parvum; U urealyticum; U urealyticum+U parvum DNA; Unspecified	4180186
42868424	U urealyt+U parvum DNA Spec Ql NAA+probe	4180186
42868424	解脲脲原体+微小脲原体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868433	40M p 50 g lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p 50 g Lact PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868433	Glucose 40M p 50 g lac PO SerPl-sCnc	4180186
42868433	葡萄糖^在口服50 g乳糖之后40分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868434	IGF BP1 Vag Ql	4180186
42868434	Bind; Chemistry; Fac; Fact; Genital vaginal; HUM; Humulin; i; IGF; IGF BP; IGF BP1; IGFBP; IGFBP1; IGFBP-1; IH7; Insul; Lente; NPH; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Semilente; Sliding; Ultralente; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42868434	胰岛素样生长因子结合蛋白 1:存在情况或阈值:时间点:阴道:序数型	4182948
42868440	Alpha amylase; Ams; Amyl; Amylase P; Chemistry; CR; Crea; Creat; Diastase; Gastro; Gastroenterology; GI; k87; Pancr; Pancreatc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
42868440	Amylase P/Creat Ur-Rto	4180186
42868440	淀粉酶.胰/肌酐:比率:时间点:尿液:定量型	4182948
42868441	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hepatology; i; IAA; Immune globulin G; Immunoglobulin G; Liver; Liver kidney microsome; LKM; LKM1; LKM-1; MEIA; Microsm; Microsom; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
42868441	LKM-1 IgG Ser Ql IA	4180186
42868441	肝肾微粒体 1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868442	PCA-1 IgG Ser Ql IA	4180186
42868442	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Yo Ab	4180186
42868442	浦肯雅细胞胞浆 1 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868443	ABS; Aby; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hu; Hu2; IAA; II; Immune globulin G; Immunoglobulin G; MEIA; Neuronal nuclear type II; Nuc; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RI; Screen; Serology; Serum; SR; SUDS	4180186
42868443	Hu2 IgG Ser Ql IA	4180186
42868443	神经元细胞核 2 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868445	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; hUBF; Human upstream binding transcription factor; IAA; Immune globulin G; Immunoglobulin G; MEIA; NOR 90; NOR90; NOR-90; Nucleolus organizer regions; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; UBTF	4180186
42868445	hUBF IgG Ser Ql IA	4180186
42868445	人上游结合因子 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868446	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Point in time; PR; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; QL; Qual; Qualitative; Random; Screen; Serine protease 3; Serology; Serum; SR; SUDS; Vasculitis	4180186
42868446	Proteinase3 IgG Ser Ql IA	4180186
42868446	蛋白酶 3 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868448	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; American elm; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; Cottonwood; Elm; European alder; f017; f17; Filbert; Gray alder; Grey alder; Hazel nut; Hazelnut; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Speckled alder; SR; t008; t014; t12; t14; t2; t8; TP5; TP5M; Tree Allerg Mix5; Tree mix (early flowering); tx5; White elm; Willow	4180186
42868448	Tree Allerg Mix5 IgE Qn	4180186
42868448	(灰桤木+榛子+美国榆+黄花柳+美洲黑杨) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42868449	Grass Allerg Mix4 IgE Qn	4180186
42868449	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common reed; Common reed grass; f005; f5; g001; g005; g007; g013; g1; g13; g5; g7; GP4; Grass Allerg Mix4; gx4; Immune globulin E; Immunoglobulin E; Italian Ryegrass; Per rye grass; Perennial ryegrass; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye; Rye grass; Ryegrass; Serum; SR; Sw Vernal grass; Sweet vernal grass; Velvet grass; Yorkshire fog	4180186
42868449	(黄花茅+白毛茅+多年生黑麦草+芦苇+黑麦) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42868454	Clinical cytogeneticists; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Molecular pathology; MOLPATH; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
42868454	Clinical cytogeneticist review	4180186
42868454	临床细胞遗传学家审核:印象:时间点:XXX:叙述型	4182948
42868455	BIMS; CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868456	CARE Survey; Finding; Findings; International Classification of Diseases; Nominal; Point in time; Random; Survey	4180186
42868458	Asympt; Asymptomatic; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; Narrative; NBS report overall lab comment; New born; Point in time; Random; Remarks; Report; Scn; Text	4180186
42868458	NBS report overall lab comment	4180186
42868458	新生儿筛查报告总体实验室注释:文本型属性:时间点:^患者:叙述型	4182948
42868459	After; Breathing; End tidal volume; Exp; FEV; FEV1; FEV1%; FEV1/FVC; Forced expiratory volume in 1 second; FVC; Lung; Lungs; p BD; Point in time; PST; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; S prime; VC; Vet; Vol; Vol exp; Volume ratio	4180186
42868459	FEV1/FVC p BD	4180186
42868459	用力呼气 1.0 秒过程中所呼出的体积/用力肺活量^在支气管扩张之后:体积比率:时间点:呼吸系统:定量型	4182948
42868461	Before; Breathing; Dynamic; Exp; FEF 25-75%; Flow; Forced expiratory flow rate; Gases; Lung; Lungs; Point in time; pre BD; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42868461	FEF 25-75% pre BD	4180186
42868461	用力呼气 25-75% 时的气体流量^在支气管扩张之前:体积速率:时间点:呼吸系统:定量型	4182948
42868462	After; Breathing; Dynamic; Exp; FEF 25-75%; Flow; Forced expiratory flow rate; Gases; Lung; Lungs; p BD; Point in time; PST; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42868462	FEF 25-75% p BD	4180186
42868462	用力呼气 25-75% 时的气体流量^在支气管扩张之后:体积速率:时间点:呼吸系统:定量型	4182948
42868463	Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42868463	PEF Airway Predicted	4180186
42868463	呼气气体流量.最大值:体积速率:时间点:呼吸系统.气道:定量型:预计法	4182948
42868465	After; Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; p BD; Peak; Peak expiratory flow; PEF; Point in time; PST; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42868465	PEF p BD Airway	4180186
42868465	呼气气体流量.最大值^在支气管扩张之后:体积速率:时间点:呼吸系统.气道:定量型	4182948
42868468	Before; Breathing; Dynamic; Exp; FEF 50%; FIV 50%; Gases; In; Insp; Inspiratory; Lung; Lungs; Point in time; pre BD; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative volume rate; Respiratory; RS	4180186
42868468	FEF 50%/FIV 50% pre BD	4180186
42868468	用力呼气 50% 时的气体流量/用力吸气 50% 时的气体流量^在支气管扩张之前:相对体积速率:时间点:呼吸系统:定量型	4182948
42868471	Breathing; Exchange; FVC; FVC % change; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Replace; Respiratory; RS; VC	4180186
42868471	FVC % change Respiratory	4180186
42868471	用力肺活量百分比变化:体积比率百分数差:时间点:呼吸系统:定量型	4182948
42868473	Breathing; End tidal volume; Exchange; Exp; FEV; FEV1; FEV1%; FEV1/FVC; Forced expiratory volume in 1 second; FVC; FVC % change; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Replace; Respiratory; RS; S prime; VC; Vet; Vol; Vol exp	4180186
42868473	FEV1/FVC % change	4180186
42868473	用力呼气 1.0 秒过程中所呼出的体积/用力肺活量百分比变化:体积百分数差:时间点:呼吸系统:定量型	4182948
42868476	1 day; 24 hours; 24HR; Breathing; CPAP; Lung; Lungs; Maximum; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; RS	4180186
42868476	CPAP 24h Max Respiratory	4180186
42868476	压力.气道内持续正向:压力或压强:24小时^最大值:呼吸系统:定量型	4182948
42868479	1 day; 24 hours; 24HR; AHI; Apnea+hypopnea; Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory	4180186
42868479	Apnea hypopnea index 24h nRate	4180186
42868479	呼吸暂停低通气指数:计数型速率:24小时:^患者:定量型	4182948
42868481	Ident; Identifier; Nominal; PAP device; Point in time; Pos; Random; Vendor name	4180186
42868481	PAP device Vendor name	4180186
42868481	厂商设备名称:标识符:时间点:气道正压装置:名义型	4182948
42868482	Ident; Identifier; No; Nominal; Num; PAP device; Point in time; Pos; Random; Serial #	4180186
42868482	PAP device Serial #	4180186
42868482	厂商序列号:标识符:时间点:气道正压装置:名义型	4182948
42868484	PAP device Class	4180186
42868484	Nominal; PAP device; Point in time; Pos; Random; Typ	4180186
42868484	分类:类型:时间点:气道正压装置:名义型	4182948
42868488	PAP pnl	4180186
42868488	Pan; PANEL.PULMONARY; Panl; PAP pnl; Pnl; Point in time; Pos; PULMONARY; Random	4180186
42868488	气道正压组套:-:时间点:^患者:-	4182948
42868490	1 day; 24 hours; 24HR; Flow; Lung; PAP device; Pos; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume Rate; vRate	4180186
42868490	Leak 24h median PAP device	4180186
42868490	泄漏:体积速率:24小时^中值:气道正压装置:定量型	4182948
42868493	Diag study note	4180186
42868493	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
42868493	诊断性检查记录:发现:时间点:{环境}:文档型:{角色}	4182948
42868494	E/M smoke cess note	4180186
42868494	Assessment; DOC.ONT; Document; E/M smoke cess note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
42868494	戒烟评价与管理记录:发现:时间点:{环境}:文档型:{角色}	4182948
42868496	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
42868496	约束记录:发现:时间点:{环境}:文档型:{角色}	4182948
42868500	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Entero virus; Enzyme immunoassay; EV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
42868500	EV IgG SerPl Ql IA	4180186
42868500	肠道病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
42868501	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
42868501	CV IgM SerPl Ql IA	4180186
42868501	柯萨奇病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
42868504	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868504	Streptococcus DNA Bld Ql NAA+probe	4180186
42868504	链球菌属单个未知种 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868505	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Coag neg Staph; CoNS; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; NEG; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868505	Coag neg Staph DNA Bld Ql NAA+probe	4180186
42868505	葡萄球菌.凝固酶阴性 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868507	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S haemolyticus; Screen; SDA; Staph; Staph haemolyticus; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868507	S haemolyticus DNA Bld Ql NAA+probe	4180186
42868507	溶血性葡萄球菌 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868508	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K oxytoca; K oxytoca DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868508	K oxytoca DNA Bld Ql NAA+probe	4180186
42868508	产酸克雷伯菌 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868510	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S typhi; S typhi DNA; S typhosa; Sal; Salmonel; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Typh; Typhoid; WB; Whole blood	4180186
42868510	S Typhi DNA Bld Ql NAA+probe	4180186
42868510	伤寒沙门菌 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868511	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868511	C albicans DNA Bld Ql NAA+probe	4180186
42868511	白色假丝酵母 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868516	Dermatophytes chs1 Nail Ql NAA+probe	4180186
42868516	皮肤癣菌几丁质合成酶 1 基因:存在情况或阈值:时间点:甲:序数型:探针法.基因扩增.靶向	4182948
42868516	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Dermatophyte; Dermatophytes chs1; Dermatophytes DNA; DNA NUCLEIC ACID PROBE; DNA probe; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail	4180186
42868517	100WBC; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Megakar nuclei; Naked megakaryocyte nuclei; NMN; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
42868517	Megakar nuclei/leuk NFr Bld Manual	4180186
42868517	巨核细胞细胞核/100 个白细胞:计数型分数:时间点:全血:定量型:手工计数方法	4182948
42868519	Ragocytes/leuk NFr Snv Manual	4180186
42868519	100WBC; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868519	类风湿细胞/100 个白细胞:计数型分数:时间点:滑液:定量型:手工计数方法	4182948
42868521	100WBC; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868521	Siderophages/leuk NFr CSF Manual	4180186
42868521	噬铁细胞/100 个白细胞:计数型分数:时间点:脑脊液:定量型:手工计数方法	4182948
42868522	100WBC; Auto; Automated detection; Cardio; Cardiology; Cell; Cellularity; Elec; Elect; Electr; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Pcar; Percent; Pericardial fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; WBC; WBCs; White blood cell; White blood cells	4180186
42868522	Polys/leuk NFr Pcar Auto	4180186
42868522	分叶核白细胞/100 个白细胞:计数型分数:时间点:心包液:定量型:自动化计数方法	4182948
42868526	100WBC; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Segmented WBC; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868526	Polys/leuk NFr Snv Auto	4180186
42868526	分叶核白细胞/100 个白细胞:计数型分数:时间点:滑液:定量型:自动化计数方法	4182948
42868528	Mononuc Cells/leuk NFr Snv Auto	4180186
42868528	100WBC; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Mononuc; Mononuc Cells; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868528	单个核细胞/100 个白细胞:计数型分数:时间点:滑液:定量型:自动化计数方法	4182948
42868529	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid	4180186
42868529	Mononuc Cells # Plr Auto	4180186
42868529	单个核细胞:计数型浓度:时间点:胸膜液:定量型:自动化计数方法	4182948
42868532	#; ABS; absolute; absolutes; Auto; Automated detection; Cardio; Cardiology; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Heart Disease; HEMATOLOGY/CELL COUNTS; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868532	Mononuc Cells # Pcar Auto	4180186
42868532	单个核细胞:计数型浓度:时间点:心包液:定量型:自动化计数方法	4182948
42868536	Mononuc Cells # Snv Auto	4180186
42868536	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
42868536	单个核细胞:计数型浓度:时间点:滑液:定量型:自动化计数方法	4182948
42868537	ABS; Aby; AlaTOP; Allergen; Allergens; ALLERGY TESTING; Alrgen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin E; Immunoglobulin E; MEIA; MIA; Mult; Multi; Ordinal; Phadiatop; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42868537	MIA IgE Ql IA	4180186
42868537	多种吸入性变应原 抗体.IgE:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868540	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; H dobrova; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868540	H dobrova IgM SerPl Ql IF	4180186
42868540	汉坦病毒 多不拉伐型 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868541	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; H dobrova; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868541	H dobrova IgG SerPl Ql IF	4180186
42868541	汉坦病毒 多不拉伐型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868542	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; H saaremaa; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868542	H saaremaa IgG SerPl Ql IF	4180186
42868542	汉坦病毒 萨列马型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868544	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; PUUV; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868544	PUUV IgM SerPl Ql IF	4180186
42868544	汉坦病毒 普马拉型 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868545	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; PUUV; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868545	PUUV IgG SerPl Ql IF	4180186
42868545	汉坦病毒 普马拉型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868546	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868546	H seoul IgG SerPl Ql IF	4180186
42868546	汉坦病毒 汉城型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868547	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV16; HPV16 and 18; HPV16 and 18 DNA; HPV16+18; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868547	HPV16 and 18 DNA Spec Ql NAA+probe	4180186
42868547	人乳头瘤病毒 16 与 18 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868548	Antigen; Antigens; Bowel movement; EIA; ELFA; ELISA; Entero virus; Enzyme immunoassay; EV; EV Ag; Faecal; Faeces; Fecal; Feces; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS	4180186
42868548	EV Ag Stl Ql IA	4180186
42868548	肠道病毒 抗原:存在情况或阈值:时间点:大便:序数型:免疫测定法	4182948
42868557	2; AGT; Angiotensin 2; CHEMISTRY.CHALLENGE TESTING; Level; Lying; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868557	Angiotensin II sup Plas-mCnc	4180186
42868557	血管紧张素 II^仰卧位:质量浓度:时间点:血浆:定量型	4182948
42868559	Il1Alpha Fld-mCnc	4180186
42868559	Alfa; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CG Antigen-Specific Helper Factor; Chemistry; Epidermal Cell Derived Thymocyte-Activating Factor; ETAF; Fl; Fld; FLU; Fluid; i; IL; IL1; IL-1; IL-1a; Il1Alpha; IL-1α; Level; Lymphocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; T Helper Factor	4180186
42868559	白细胞介素 1 Alpha:质量浓度:时间点:体液:定量型	4182948
42868560	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Costimulator; II; IL; IL2; IL-2; Level; Lymphocyte Mitogenic Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T-Cell Growth Factor; T-Cell Stimulating Factor; TCGF; Thymocyte Stimulating Factor	4180186
42868560	Il2 CSF-mCnc	4180186
42868560	白细胞介素 2:质量浓度:时间点:脑脊液:定量型	4182948
42868564	Il3 Fld-mCnc	4180186
42868564	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Burst-Promoting Factor, Erythrocyte; Chemistry; Colony-Stimulating Factor 2 Alpha; Colony-Stimulating Factor, Mast-Cell; Colony-Stimulating Factor, Multipotential; Eosinophil-Mast Cell Growth-Factor; Fl; Fld; FLU; Fluid; III; IL; IL3; IL-3; Level; Mass concentration; P-Cell Stimulating Factor; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868564	白细胞介素 3:质量浓度:时间点:体液:定量型	4182948
42868567	B-Cell Growth Factor-II; BCGF-II; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Eosinophil Differentiation Factor; IL; IL5; IL-5; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T-Cell Replacing Factor	4180186
42868567	Il5 CSF-mCnc	4180186
42868567	白细胞介素 5:质量浓度:时间点:脑脊液:定量型	4182948
42868568	B/F; B-Cell Growth Factor-II; BCGF-II; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Eosinophil Differentiation Factor; Fl; Fld; FLU; Fluid; IL; IL5; IL-5; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; T-Cell Replacing Factor	4180186
42868568	Il5 Fld-mCnc	4180186
42868568	白细胞介素 5:质量浓度:时间点:体液:定量型	4182948
42868569	Il7 SerPl-mCnc	4180186
42868569	Chemistry; IL; IL7; IL-7; Level; Lymphopoietin-1; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868569	白细胞介素 7:质量浓度:时间点:血清/血浆:定量型	4182948
42868570	Il7 CSF-mCnc	4180186
42868570	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IL; IL7; IL-7; Level; Lymphopoietin-1; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868570	白细胞介素 7:质量浓度:时间点:脑脊液:定量型	4182948
42868571	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; IL; IL7; IL-7; Level; Lymphopoietin-1; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868571	Il7 Fld-mCnc	4180186
42868571	白细胞介素 7:质量浓度:时间点:体液:定量型	4182948
42868572	Il13 CSF-mCnc	4180186
42868572	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IL; IL13; IL-13; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868572	白细胞介素 13:质量浓度:时间点:脑脊液:定量型	4182948
42868574	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dinoprostone; Level; Mass concentration; Neuro; Neurology; PG; PGE2; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868574	Prostaglandin E2 CSF-mCnc	4180186
42868574	前列腺素 E2:质量浓度:时间点:脑脊液:定量型	4182948
42868575	Prostaglandin E1 Fld-mCnc	4180186
42868575	Alprostadil; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; PG; PGE1; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868575	前列腺素 E1:质量浓度:时间点:体液:定量型	4182948
42868576	Alprostadil; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Neuro; Neurology; PG; PGE1; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868576	Prostaglandin E1 CSF-mCnc	4180186
42868576	前列腺素 E1:质量浓度:时间点:脑脊液:定量型	4182948
42868577	Prostaglandin F2A CSF-mCnc	4180186
42868577	Alfa; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; PG; PGF2; PGF2A; PGF2alpha; Point in time; Prostaglandin F2A; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868577	前列腺素 F2 Alpha:质量浓度:时间点:脑脊液:定量型	4182948
42868578	Prostaglandin F2A Fld-mCnc	4180186
42868578	Alfa; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; PG; PGF2; PGF2A; PGF2alpha; Point in time; Prostaglandin F2A; QNT; Quan; Quant; Quantitative; Random	4180186
42868578	前列腺素 F2 Alpha:质量浓度:时间点:体液:定量型	4182948
42868579	Chemistry; Endocrine; Endocrinology; Horm; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Thyroid stimulating hormone; Thyroliberin; Thyrotropic hormone; TRF; TSH; UA; UR; Urn	4180186
42868579	Thyrotropin releasing horm Ur-mCnc	4180186
42868579	促甲状腺激素释放激素:质量浓度:时间点:尿液:定量型	4182948
42868582	Amethoperin; Amethopterin; Convalescent; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; Spec; SR; Substance concentration	4180186
42868582	MTX sp2 SerPl-sCnc	4180186
42868582	氨甲喋呤^第2个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868584	MTX sp4 SerPl-sCnc	4180186
42868584	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; Spec; SR; Substance concentration	4180186
42868584	氨甲喋呤^第4个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868585	MTX sp5 SerPl-sCnc	4180186
42868585	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; Spec; SR; Substance concentration	4180186
42868585	氨甲喋呤^第5个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868587	MTX sp7 SerPl-sCnc	4180186
42868587	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; Spec; SR; Substance concentration	4180186
42868587	氨甲喋呤^第7个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868588	MTX sp8 SerPl-sCnc	4180186
42868588	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; Spec; SR; Substance concentration	4180186
42868588	氨甲喋呤^第8个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868589	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; Spec; SR; Substance concentration	4180186
42868589	MTX sp9 SerPl-sCnc	4180186
42868589	氨甲喋呤^第9个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868590	Antithrombin III; AT3; AT3D; ATIII; Blood; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Serpin C1; Serpin peptidase inhibitor, clade C (antithrombin), member 1; THPH7; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868590	SERPINC1 gene Mut Tested Bld/T	4180186
42868590	SERPINC1 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
42868591	GSTT1 Ab Titr SerPl IF	4180186
42868591	谷胱甘肽硫转移酶 T1 抗体:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
42868591	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Glutathione S-transferase theta-1; GST; GSTT1; GST-T1; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Pl; Plasma; Plsm; Point in time; Random; S prime; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42868592	# chromosome 13; 3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chromosom; Chromosomes; Cnt; Count; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Molecular pathology; MOLPATH; NAA+probe; NAAT; NASBA; No; Nucleic acid sequence based analysis; Num; Number; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868592	# chromosome 13 Amn NAA+probe	4180186
42868592	存在的第13号染色体的数量:数量(计数):时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
42868594	# chromosome 21 Amn NAA+probe	4180186
42868594	# chromosome 21; 3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chromosom; Chromosomes; Cnt; Count; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Molecular pathology; MOLPATH; NAA+probe; NAAT; NASBA; No; Nucleic acid sequence based analysis; Num; Number; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868594	存在的第21号染色体的数量:数量(计数):时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
42868596	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Current unhealed pressure ulcers each stage - LTCH; Hosp; No; Num; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868599	Bowel bladder - LTCH; CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868600	Admin info; Admin info - LTCH; CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868603	Assessment administration - LTCH; CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868604	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; F tular; F tularensis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tularemia	4180186
42868604	F tular IgG SerPl-aCnc	4180186
42868604	土拉弗朗西斯菌 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型	4182948
42868607	RBC Spec Ql Wet Prep	4180186
42868607	Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Prep; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; Spec; To be specified in another part of the message; Unspecified; Wet mount; Wet prep	4180186
42868607	红细胞:存在情况或阈值:时间点:XXX:序数型:湿片法	4182948
42868609	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; nRBC cor; Nuc; Number concentration; Number Concentration (count/vol); Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868609	WBC nRBC cor # Plr	4180186
42868609	白细胞^^经过针对有核红细胞而校正的:计数型浓度:时间点:胸膜液:定量型	4182948
42868610	Nominal; Pan; Panel; PANEL.SURVEY.CMS; Panl; Person name; Pnl; Point in time; Random; Sin verifying assess compl; Survey	4180186
42868612	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Hosp; On what other units pt treated prior; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42868614	Rick Typhus IgG sp1 Titr Ser IF	4180186
42868614	立克次体斑疹伤寒群 抗体.IgG^第1个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42868614	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Random; Rick Typhus; Ricket; Rickettsial; Serum; SmQn; sp1; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Typh; Typhus	4180186
42868617	Rick Typhus IgM sp2 Titr Ser IF	4180186
42868617	立克次体斑疹伤寒群 抗体.IgM^第2个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42868617	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Convalescent; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Random; Rick Typhus; Ricket; Rickettsial; Second; Serum; SmQn; sp2; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Typh; Typhus	4180186
42868620	Addiction; Amph; Amphetam; Amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Speed; UA; UR; Urn	4180186
42868620	Amphetamines Ur Scn-mCnc	4180186
42868620	苯丙胺类:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
42868621	Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; UA; UR; Urn	4180186
42868621	Barbiturates Ur Ql Scn>300 ng/mL	4180186
42868621	巴比妥类药物:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 300 纳克/毫升	4182948
42868623	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;200 ng/mL; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn	4180186
42868623	Benzodiaz Ur Ql Scn>200 ng/mL	4180186
42868623	苯并二氮:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 200 纳克/毫升	4182948
42868624	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; UA; UR; Urn	4180186
42868624	Benzodiaz Ur Ql Scn>300 ng/mL	4180186
42868624	苯并二氮:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 300 纳克/毫升	4182948
42868625	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Marijuana; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; THC; UA; UR; Urn	4180186
42868625	Cannabinoids Ur Scn-mCnc	4180186
42868625	大麻类:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
42868626	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;20 ng/mL; Scr; Screen; Scrn; THC; UA; UR; Urn	4180186
42868626	Cannabinoids Ur Ql Scn>20 ng/mL	4180186
42868626	大麻类:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 20 纳克/毫升	4182948
42868628	%; Antigen; Antigens; Australia antigen; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; GCMS; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf	4180186
42868628	HBV surface Ag SerPl Cfm-%	4180186
42868628	乙型肝炎病毒表面 抗原:任意型分数:时间点:血清/血浆:定量型:毒理学确认试验	4182948
42868631	Nominal; Point in time; Random; Survey; Typ	4180186
42868635	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification; UA; UR; Urn	4180186
42868635	C trach+GC pnl Ur NAA+probe	4180186
42868635	沙眼衣原体与淋病奈瑟菌 rRNA 组套:-:时间点:尿液:-:探针法.基因扩增.靶向	4182948
42868637	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Cervix; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Genital tract; Gen-Probe; Gono; Gonorrhea; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
42868637	C trach+GC pnl Cvx NAA+probe	4180186
42868637	沙眼衣原体与淋病奈瑟菌 rRNA 组套:-:时间点:子宫颈:-:探针法.基因扩增.靶向	4182948
42868638	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Genital vaginal; Gen-Probe; Gono; Gonorrhea; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42868638	C trach+GC pnl Vag NAA+probe	4180186
42868638	沙眼衣原体与淋病奈瑟菌 rRNA 组套:-:时间点:阴道:-:探针法.基因扩增.靶向	4182948
42868640	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis	4180186
42868640	T vaginalis rRNA Cvx Ql NAA+probe	4180186
42868640	阴道毛滴虫 rRNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
42868645	Ascites; Ascitic fluid; Ascitis; Cell; Cellularity; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; Gated cells; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Number fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
42868645	nRBC/total cells NFr Prt	4180186
42868645	红细胞.有核/100 个细胞:计数型分数:时间点:腹膜液:定量型	4182948
42868646	ID; Identity or presence; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N menigitidis; N meningitidis; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
42868646	N men serogroup Spec	4180186
42868646	脑膜炎奈瑟菌血清群:存在与否或特征标识:时间点:XXX:名义型	4182948
42868647	JCPyV Ab SerPl Ql IA	4180186
42868647	JC 病毒 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
42868647	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Human polyomavirus 2; IAA; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
42868650	C14:1DC; Chemistry; Dicarboxylic carnitine; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Very long-chain acyl-CoA dehydrogenase; VLCAD	4180186
42868650	Dicarboxytetradecenoylcarn SerPl-sCnc	4180186
42868650	二羧基十四烯酰肉碱 (C14:1-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
42868652	11OH-THC Bld Ql	4180186
42868652	11-hydroxy-delta(9)-THC; 11-hydroxytetrahydrocannabinol; 11-hydroxy-THC; 11-OH-THC; 11OH-THC; 7-hydroxy-delta(1)-tetrahydrocannabinol; Blood; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Hydrox; Marijuana; Nabilone; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; THC; THC metabolite; WB; Whole blood	4180186
42868652	11-羟基-δ-9-四氢大麻酚:存在情况或阈值:时间点:全血:序数型	4182948
42868654	2-aminoadipate; 2-aminoadipic acid; AAA; AAD; Alfa; Alpha aminoadipic acid; Aminoadipic acid; Chemistry; Fetal; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868654	AAA SerPl Fetus-sCnc	4180186
42868654	Alpha 氨基己二酸:物质的量浓度:时间点:血清/血浆^胎儿:定量型	4182948
42868655	2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; A-Aminobutyr; AANB; A-ANB; Alfa; Alpha aminobutyric acid; Alpha amino-n-butyrate; Alpha amino-n-butyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Chemistry; Fetal; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868655	A-Aminobutyr SerPl Fetus-sCnc	4180186
42868655	Alpha 氨基丁酸:物质的量浓度:时间点:血清/血浆^胎儿:定量型	4182948
42868656	NEURO; Neurology; NIHSS; Pan; Panel; PANEL.SURVEY.NEURO; Panl; Pnl; Point in time; Random; Survey; SURVEY.NEURO	4180186
42868658	Finding; Findings; Levels; Levl; LV; LVL; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868661	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868663	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868664	Arm.lft; Finding; Findings; L; LT; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO; Upper extremity	4180186
42868670	Extinction - inattention; Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868673	Bili; Bilirubins; Billirubin; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL; UA; UR; Urn	4180186
42868673	Bilirub Ur-sCnc	4180186
42868673	胆红素:物质的量浓度:时间点:尿液:定量型	4182948
42868674	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; TC; TCHHDL; Tot; Totl	4180186
42868674	HDLc SerPl-sRto	4180186
42868674	胆固醇.HDL 之中的/胆固醇.总计:物质的量比率:时间点:血清/血浆:定量型	4182948
42868675	Beta VLDL; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; IDLc; Intermediate density lipoprotein cholesterols; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868675	IDLc SerPl-sCnc	4180186
42868675	胆固醇.IDL 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868676	Beta VLDL; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; IDLc; IDLc+VLDL3c; III; Intermediate density lipoprotein cholesterols; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Very low density lipoprotein cholesterols; VLDL3c; VLDLc	4180186
42868676	IDLc+VLDL3c SerPl-sCnc	4180186
42868676	胆固醇.IDL 之中的+胆固醇.VLDL 3 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868677	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; III; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Very low density lipoprotein cholesterols; VLDL3c; VLDLc	4180186
42868677	VLDL3c SerPl-sCnc	4180186
42868677	胆固醇.VLDL 3 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868678	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL + IDL + VLDL; Level; Lipid; NonHDLc; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868678	NonHDLc SerPl-sCnc	4180186
42868678	胆固醇.非 HDL:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868681	Chemistry; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868681	Estrogen SerPl-sCnc	4180186
42868681	雌激素:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868685	Cellcept; DRUG/TOXICOLOGY; Drugs; Level; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868685	Mycophenolate SerPl-sCnc	4180186
42868685	吗替麦考酚酯:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868687	Nordiazepam Ur Cfm-sCnc	4180186
42868687	Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Madar; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Substance concentration; Tranxilium N; UA; UR; Urn; Vegesan	4180186
42868687	去甲基安定:物质的量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
42868688	Oxazepam Ur Cfm-sCnc	4180186
42868688	Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Substance concentration; Temazepam metabolite; UA; UR; Urn	4180186
42868688	去甲羟安定:物质的量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
42868690	2-Hydroxybenzoate; 2-Hydroxybenzoic Acid; DRUG/TOXICOLOGY; Drugs; Level; o-Hydroxybenzoate; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoate; ortho-Hydroxybenzoic Acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sali; Salicilates; Salicylate; Salicylic acid; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868690	Salicylates SerPl Scn-sCnc	4180186
42868690	水杨酸:物质的量浓度:时间点:血清/血浆:定量型:毒理学筛查试验	4182948
42868691	Chemistry; Dialy; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
42868691	T4 Free SerPl Dialy-sCnc	4180186
42868691	甲状腺素.游离型:物质的量浓度:时间点:血清/血浆:定量型:透析法	4182948
42868692	Blood; Cardio; Cardiology; Chemistry; Heart Disease; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tg; Trig; Trigly; Triglycerides; Triglycrides; WB; Whole blood	4180186
42868692	Trigl Bld-sCnc	4180186
42868692	甘油三酯:物质的量浓度:时间点:全血:定量型	4182948
42868693	Bas Metab 2000 Pnl W Ca-I SerPl	4180186
42868693	Bas Metab 2000 Pnl W Ca-I; BMP; Ca; Cal; Chemistry; Ion; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868693	带有离子钙的基础代谢 HCFA 2008 组套:-:时间点:血清/血浆:定量型	4182948
42868696	1 month; 1 month (30 days); 30 days; Dreams of stressful experience; Finding; Findings; Last; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868697	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Stressful experience again; Survey; SURVEY.MTLHLTH	4180186
42868698	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH; Upset when reminded of stressful experience	4180186
42868699	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Past; Physical reactions when reminded stressful expreinece; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868700	1 month; 1 month (30 days); 30 days; Avoid thinking about stressful experience; Finding; Findings; Last; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868701	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868705	1 month; 1 month (30 days); 30 days; Feel emotionally numb in last Mo; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868708	1 month; 1 month (30 days); 30 days; Feeling irritable having angry outbursts; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868709	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868711	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868712	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Transpl surg; Visit note	4180186
42868712	Transpl surg Hosp Prog note	4180186
42868712	病程记录:发现:时间点:医院:文档型:移植外科学	4182948
42868713	Testost SerPl DL<= 3.47 pmol/L-sCnc	4180186
42868713	Chemistry; DL&lt;= 3.47 pmol/L; Left; Level; Levo; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost	4180186
42868713	睾酮:物质的量浓度:时间点:血清/血浆:定量型:检测极限 <= 3.47 pmol/L	4182948
42868714	Testost Free SerPl DL<= 3.47 pmol/L-sCnc	4180186
42868714	Chemistry; DL&lt;= 3.47 pmol/L; FR; Left; Level; Levo; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated	4180186
42868714	睾酮.游离型:物质的量浓度:时间点:血清/血浆:定量型:检测极限 <= 3.47 pmol/L	4182948
42868715	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA DL=20; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
42868715	HIV1 RNA # Plas NAA DL=20	4180186
42868715	HIV 1 型 RNA:计数型浓度:时间点:血浆:定量型:探针法.基因扩增.靶向 检测极限 = 20 拷贝/毫升	4182948
42868717	1.02 kb deletion; 1.02-KB DEL; 1.02kB deletion; 1kb deletion; Batten disease; Blood; BTS; c.461-280_677+382del; CLN3 exon 7+8; CLN3, 1.02-KB DEL; Del; Deletions; Genetics; Heredity; Heritable; Inherited; JNCL; juvenile-onset neuronal ceroid lipo-fuscinosis; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868717	CLN3 exon 7+8 Del Bld/T Ql	4180186
42868717	CLN3 基因外显子 7+8 缺失:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868720	Blood; CC-CKR-2; CCR-2; CCR2 p.V64I; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; Genetics; Heredity; Heritable; Inherited; MCP-1-R; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868720	CCR2 p.V64I Bld/T Ql	4180186
42868720	CCR2 基因.p.V64I:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868721	32 bp deletion; 32bp deletion; Blood; CCCKR5; CC-CKR-5; CCR-5; CCR5 c.794_825del; CD195; Chemokine (C-C motif) receptor 5; chemokine (C-C motif) receptor 5 (gene/pseudogene); CKR5; CKR-5; CMKBR5; Genetics; Heredity; Heritable; IDDM22; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868721	CCR5 c.794_825del Bld/T Ql	4180186
42868721	CCR5 基因.c.794_825del:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868722	Blood; galactose-1-phosphate uridylyltransferase; Galactose-1-phosphate uridylyltransferase gene; GALT p.Q188R; Genetics; GLN188ARG; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs75391579; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868722	GALT p.Q188R Bld/T Ql	4180186
42868722	GALT 基因.p.Q188R:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868726	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Follicle stimulating hormone; FSH; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
42868726	FSH IgG Ser IA-aCnc	4180186
42868726	促卵泡激素 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
42868728	Nuclear IgG Ser IA-Rto	4180186
42868728	ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Serology; Serum; SR; SUDS	4180186
42868728	细胞核 抗体.IgG:比率:时间点:血清:定量型:免疫测定法	4182948
42868729	ABS; Aby; ANA IgG; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-A 52kD; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; SUDS	4180186
42868729	ENA SS-A 52kD IgG Ser IA-aCnc	4180186
42868729	Sjogrens 综合征-a 可提取性核 52kD 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
42868730	Alpha amylase; Ams; Amyl; Amylase P; Ascites; Ascitic fluid; Ascitis; Catalytic Concentration; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Pancr; Pancreatc; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
42868730	Amylase P Prt-cCnc	4180186
42868730	淀粉酶.胰:催化浓度:时间点:腹膜液:定量型	4182948
42868731	Cardio; Cardiology; Chemistry; Heart Disease; Pcar; PC-TRIG; Pericard fld+SerPl; Pericardial Fluid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; S-TRIG; Tg; Trig; Trigl Pcar; Trigly; Triglycerides; Triglycrides	4180186
42868731	Trigl Pcar/Ser	4180186
42868731	甘油三酯.心包液/甘油三酯.血清:相对比率:时间点:心包液+血清/血浆:定量型	4182948
42868734	Amylase.prt fld/SerPl	4180186
42868734	Alpha amylase; Ams; Amyl; Amylase.prt fld; Ascites; Ascitic fluid; Ascitis; Chemistry; Diastase; k87; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868734	淀粉酶.腹膜液/淀粉酶.血清:相对比率:时间点:腹膜液+血清/血浆:定量型	4182948
42868736	Creat Plr/Ser	4180186
42868736	Chemistry; CR; Crea; Creat; Creat Plr; Pl; Plasma; Pleural; Pleural fluid; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPl+Plr; SerPlas; Serum; Serum or plasma; SR; thoracentesis fluid	4180186
42868736	肌酐.胸膜液/肌酐.血清:相对比率:时间点:血清/血浆+胸膜液:定量型	4182948
42868739	Prot Prt/SerPl	4180186
42868739	Ascites; Ascitic fluid; Ascitis; Chemistry; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Prt; Prt; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868739	蛋白质.腹膜液/蛋白质.血清:相对比率:时间点:腹膜液+血清/血浆:定量型	4182948
42868740	Chemistry; Chol; Chol Plr; Choles; Cholest; Cholesterol total; Cholesterols; Lipid; Lung; Pl; Plasma; Pleural; Pleural fluid; Plsm; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Respiratory; Ser; SerP; SerPl; SerPl+Plr; SerPlas; Serum; Serum or plasma; SR; thoracentesis fluid	4180186
42868740	Chol Plr/Ser	4180186
42868740	胆固醇.胸膜液/胆固醇.血清:相对比率:时间点:血清/血浆+胸膜液:定量型	4182948
42868741	Chemistry; Lung; PF-TRIG; Pl; Plasma; Pleural; Pleural fluid; Plsm; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Respiratory; Ser; SerP; SerPl; SerPl+Plr; SerPlas; Serum; Serum or plasma; SR; S-TRIG; Tg; thoracentesis fluid; Trig; Trigl Plr fld; Trigly; Triglycerides; Triglycrides	4180186
42868741	Trigl Plr fld/Ser	4180186
42868741	甘油三酯.胸膜液/甘油三酯.血清:相对比率:时间点:血清/血浆+胸膜液:定量型	4182948
42868742	Alpha amylase; Ams; Amyl; Amylase P; Amylase.pancreatic plr fld; Catalytic Concentration; Chemistry; Diastase; k87; Lung; Pancr; Pancreatc; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; thoracentesis fluid	4180186
42868742	Amylase P Plr-cCnc	4180186
42868742	淀粉酶.胰:催化浓度:时间点:胸膜液:定量型	4182948
42868744	Patient Health Questionnaire; PHQ; PHQ 4; PHQ4; PHQ-4; PHQ-4 total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Tot; Totl	4180186
42868746	GAD 7; GAD7; GAD-7; GAD-7 total score; Patient Health Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Tot; Totl	4180186
42868747	ALL1; ALL-1; Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; HRX; HTRX; HTRX1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(X;11)(FOXO4,MLL); Tissue; Tissue, unspecified; translocation; TRX1; WB; Whole blood; Whole blood or Tissue	4180186
42868747	t(X;11)(FOXO4,MLL) Bld/T Ql	4180186
42868747	t(X;11)(q13.1;q23)(FOXO4,MLL) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868748	1p32; AF-1P; ALL1; ALL-1; Arbitrary; Blood; DNA; epidermal growth factor receptor pathway substrate 15; gene fusion; gene translocation; Genetics; Heredity; Heritable; HRX; HTRX; HTRX1; i; Inherited; MLLT5; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(1;11)(EPS15,MLL); Tissue; Tissue, unspecified; translocation; TRX1; WB; Whole blood; Whole blood or Tissue	4180186
42868748	t(1;11)(EPS15,MLL) Bld/T Ql	4180186
42868748	t(1;11)(p32;q23)(EPS15,MLL) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868753	Arbitrary; Blood; CAIN; CAN; D9S46E; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; KIAA0023; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; N214; Nucleoporin 214 kd; Ordinal; p250; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9;9)(NUP214,SET); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868753	t(9;9)(NUP214,SET) Bld/T Ql	4180186
42868753	t(9;9)(q34;q34)(NUP214,SET) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868755	ALL1; ALL-1; Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; HRX; HTRX; HTRX1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(11;17)(MLL,MLLT6); Tissue; Tissue, unspecified; translocation; TRX1; WB; Whole blood; Whole blood or Tissue	4180186
42868755	t(11;17)(MLL,MLLT6) Bld/T Ql	4180186
42868755	t(11;17)(q23;q21)(MLL,MLLT6) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868756	Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; NR1B1; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; Screen; T prime; t(11;17)(ZBTB16,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868756	t(11;17)(ZBTB16,RARA) Bld/T Ql	4180186
42868756	t(11;17)(q23;q21.1)(ZBTB16,RARA) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868757	ALL1; ALL-1; Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; HRX; HTRX; HTRX1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(11;19)(MLL,ELL); Tissue; Tissue, unspecified; translocation; TRX1; WB; Whole blood; Whole blood or Tissue	4180186
42868757	t(11;19)(MLL,ELL) Bld/T Ql	4180186
42868757	t(11;19)(q23;p13.1)(MLL,ELL) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868758	Arbitrary; Blood; DNA; ets variant gene 6; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(12;22)(ETV6,MN1); TEL; Tel oncogene; TEL1; Tissue; Tissue, unspecified; translocation; Translocation ets leukemia; WB; Whole blood; Whole blood or Tissue	4180186
42868758	t(12;22)(ETV6,MN1) Bld/T Ql	4180186
42868758	t(12;22)(p13;q12.1)(ETV6,MN1) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868762	inv(16)(p13;q22) Bld/T Ql	4180186
42868762	Acute myeloid leukemia; AML; Arbitrary; Blood; DNA; gene fusion; gene translocation; inv(16)(CBFB,MYH11) gene inversion; inv(16)(p13;q22); Inversion 16; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.INV; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868762	inv(16)(p13.1;q22.1)(MYH11,CBFB) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868763	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B hominis; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868763	B hominis DNA Stl Ql NAA+probe	4180186
42868763	人芽囊原虫 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
42868766	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; D fragilis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868766	D fragilis DNA Stl Ql NAA+probe	4180186
42868766	脆双核阿米巴 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
42868770	Anemia management Pnl; End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42868779	Feel sexually attractive past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868780	Bothered by hair loss past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868781	Family might get same illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868782	Effect stress on illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868783	Bothered by change wt past 7D; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH; Wt	4180186
42868786	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Urinate more frequently past 7D	4180186
42868787	Burns when urinate past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868790	Emotional ups and downs past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868792	Concerns about ability have childr past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868798	Able to put thoughts together past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868801	Able to read like I used to past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868802	Able to write like I used to past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868803	Able to drive vehicle past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868804	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble feeling sensation past 7D	4180186
42868805	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had seizures past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868806	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Weakness in arms or legs past 7D	4180186
42868813	Able to find right words to say past 7D; Average; Avg; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH	4180186
42868816	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Swelling or cramps in stomach past 7D	4180186
42868818	Control of bowels past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868819	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I can digest my food well past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868820	Diarrhea in past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868821	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Good appetite in past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868825	Able to maintain balance past 7D; Bal; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868826	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I am able to walk in past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868827	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have strength in arms past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868838	Deglutition; Difficulty swallowing solid foods past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868839	Deglutition; Difficulty swallowing soft foods past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868841	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain in chest when swallow past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868842	Choke when swallow past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868843	Able to enjoy meals family friends past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868845	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble digesting food past 7D	4180186
42868848	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gained weight past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wt	4180186
42868851	Disch; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Vaginal discharge past 7D	4180186
42868852	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Vaginal bleeding past 7D	4180186
42868854	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Loss of appetite past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868855	Digestive problems interfere w activities past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868859	Bothered by chg eating habits past 7D; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
42868860	Discomfort pain when eat past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868861	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Stomach problems that worry past 7D; Survey; SURVEY.GNHLTH	4180186
42868863	Feel sad past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868865	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Losing hope in fight agnst illness past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868866	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868868	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry condition will get worse past 7D	4180186
42868872	Accepted my illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868873	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Sleeping well past 7D; Survey; SURVEY.GNHLTH	4180186
42868875	Content with quality of life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH	4180186
42868884	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get emotional support from family past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868885	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get support from friends past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868886	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My family has accepted illness past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868887	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Satisfied w family commun about illness past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42868889	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gender; Last; Ordinal; Ql; Qual; Qualitative; Satisfied with sex life past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42868890	Appear; Appr; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH; Unhappy about chg in appearance past 7D	4180186
42868891	Appearance; Bothered by jaundice past 7D; Colour; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868893	Change in the way food tastes past 7D; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
42868894	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have had chills past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868899	Able to communicate with others past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868900	Can eat solid foods past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868901	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain in mouth throat neck past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868902	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Mouth is dry past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868904	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Voice has usual quality and strength past 7D	4180186
42868907	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Swallow naturally and easily past 7D	4180186
42868908	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I smoke cigarettes tobacco past 7D; Last; Ordinal; Othr; Prods; Product; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868909	Alc; alcoholic; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I drink alcohol beer wine past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868911	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit physical activity because condition past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868912	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Thinking clear past 7D	4180186
42868915	Breathing is easy past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868916	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Regret smoking in the past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42868917	bod; Bodies; Bothered by lumps or swelling past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868918	Difficulty planning for future in past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868919	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Uncertain about future health past 7D	4180186
42868920	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Sx	4180186
42868922	Bothered by itching past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868923	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble sleeping at night past 7D	4180186
42868926	Arterial Stenosis; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Surg; Survey; SURVEY.GNHLTH; Swelling as result of surgery past 7D	4180186
42868927	Bothered by amt swelling past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868928	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Movement of swollen area painful past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868930	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Swelling keeps from wearing clothes I want past 7D	4180186
42868935	Aches and pains in bones past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868936	Blood in stool past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868938	Difficulty thinking clearly past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868939	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble walking b/c pain past 7D	4180186
42868942	Difficulty moving neck shoulders past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868944	Bothered by worsening eyesight past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868945	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble smelling past 7D	4180186
42868946	Enjoy taste of food past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868947	Bothered by blocked nose past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868951	Cramps in stomach area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868953	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42868956	Bruise easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868958	Bothered by odor from vulva past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868960	Bothered by discomfort groin legs past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868961	Bothered by itching vulva area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868962	Bothered by pain vulva area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868964	Discomfort when sitting past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868969	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Physical well-being; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868970	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social - family well-being; Survey; SURVEY.GNHLTH	4180186
42868972	Functional Assessment of Chronic Illness Therapy; Functional well-being; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868973	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868974	FACT; FACT-Br; FACT-Br - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868975	FACIT; FACIT general measures panel; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868978	FACT; FACT-C; FACT-C - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868982	FACT; FACT-En; FACT-En - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868984	FACT; FACT-H&N; FACT-H_N - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868985	FACIT; FACT; FACT-Hep; FACT-Hep - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868987	FACIT; FACT; FACT-Leu; FACT-Leu - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868989	FACIT; FACT; FACT-M; FACT-M - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868990	FACT; FACT-MM; FACT-MM - version 4; Functional Assessment of Chronic Illness Therapy; Mult; Multi; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868992	FACIT; FACT; FACT-O; FACT-O - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868995	FACIT; FANLTC; FANLTC - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869000	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869001	Feel discouraged about illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869002	FACIT; FACIT - FAPSI-8; FACT; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869003	FACIT; FACIT - FBlSI; FACT; FBlSI; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869005	FACIT; FACT; FACT - FBrSI 15; FBrSI; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869008	FACIT; FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT FBSI-16; NCCN-FBSI-16; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869009	FACIT; FACT; FCSI; FCSI-9; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869011	FACIT; FACIT - FHNSI; FACT; FHNSI; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869018	FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FKSI-19; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869019	FACIT; FACIT - FLSI 6; FACT; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869020	FACIT; FACT - FLSI-12; FLSI; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869025	FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FOSI-18; NCCN-FACT FOSI-18; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869026	FACIT; FACIT - FAPSI-8; FACT; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869027	Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FPSI-17; NCCN-FACT FPSI-17; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869028	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain keeps me from doing things past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869031	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Mouth sores past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869032	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Numbness tingling in hands past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869033	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain hands feet exposed to cold past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869035	Bothered by skin problems past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869036	Difficulty urinating past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869040	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Weakness in legs past 7D	4180186
42869041	FACIT; FACIT-TS-BTCSQ; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Tx	4180186
42869042	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx for bone disease take up time	4180186
42869044	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Worry about side effects from tx bone disease	4180186
42869045	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx bone disease cause me pain	4180186
42869046	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx bone disease inconvenient	4180186
42869050	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx bone disease stressful to family	4180186
42869051	Bothered side effects tx bone disease; Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869054	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Having blood drawn inconvenient; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42869055	FACT; FACT-EF; FACT-EF - version 1; Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869057	Feel uncomfortably full tube feeding past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869058	Constipation tube feeding past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869059	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Vomiting tube feeding past 7D	4180186
42869062	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tube feeding limits activities friends past 7D	4180186
42869063	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tube feeding eat drink by mouth past 7D	4180186
42869064	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Miss food drink by mouth feeding tube past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869066	Feeding tube means health worse past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869067	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about tube coming out past 7D	4180186
42869068	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry tube getting plugged past 7D	4180186
42869070	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry losing wt because feeding tube past 7D; Wt	4180186
42869071	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Lost control food choices b/c feeding tube past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869072	Dependent on others b/c feeding tube past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869074	Confident about nutrition b/c feeding tube past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869079	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin scalp itches past 7D; Survey; SURVEY.GNHLTH	4180186
42869084	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin condition interferes social life past 7D; Survey; SURVEY.GNHLTH	4180186
42869085	Embarrassed by my skin condition past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869086	Avoid going out public b/c skin past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869087	Feel unattractive b/c skin past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869089	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Side effects tx interfered household tasks past 7D; Survey; SURVEY.GNHLTH; Tx	4180186
42869090	Eyes are dry past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869092	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Sensitivity fingernails difficult household tasks past 7D; Survey; SURVEY.GNHLTH	4180186
42869093	Bothered increased facial hair past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869097	Discomfort in feet past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869099	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Ringing buzzing ears past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42869102	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble walking past 7D	4180186
42869103	FACT; FACT&GOG-NTX-12; FACT-GOG-NTX-12 - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869104	Difficulty breathing exposed cold past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869106	FACT; FACT&GOG-NTX-4; FACT-GOG-NTX-4 - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869107	FACT; FACT-BMT; FACT-BMT - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869108	Concerned about keeping job past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work	4180186
42869109	Feel distant other people past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869111	Effects tx worse than imagined past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869114	Finding; Findings; Frequent colds-infections past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869115	Eyesight is blurry past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869117	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Illness is hardship for family past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869119	FACT; FACT-BRM; FACT-BRM - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869122	Depressed easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869124	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Motivated to do things past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869125	FACIT; FACT; FACT-Taxane; FACT-Taxane - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869126	Feel bloated past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869128	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Legs feet swollen past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869129	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain fingertips past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869130	Bothered hands nails look past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869131	Can remember things past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869134	Agglut; Agglutination; Agglutinins; Agglutins; AGT; CA; Cold agglutinin titration; degree; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
42869134	CA Ser Ql 22 deg C inc	4180186
42869134	冷凝集素:存在情况或阈值:时间点:血清:序数型:22℃孵育	4182948
42869137	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble with bowels past 7D	4180186
42869138	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain in joints past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869139	ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Johnes disease; M avium; M avium paraTB; MEIA; Microbiology; Mlk; Myco; Mycobact; Mycobacterium paratuberculosis; Ordinal; Paratuberculosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; ssp; SUDS; Tuberculosis; Vet; Veterinary	4180186
42869139	M avium paraTB Ab Mlk Ql IA	4180186
42869139	鸟型分枝杆菌副结核亚种 抗体:存在情况或阈值:时间点:乳:序数型:免疫测定法	4182948
42869145	Amt eat sufficient to meet needs past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869146	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worried about weight past 7D; Wt	4180186
42869149	Arterial Stenosis; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Interest in food drops past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869150	Difficulty eating rich foods past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869151	Family pressuring me to eat past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869153	Finding; Findings; Functional Assessment of Chronic Illness Therapy; General health improving past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869154	Abd; Abdo; Abdomen; FACIT; FACIT-AD; FACIT-AD - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869155	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Stomach pain interferes functioning past 7D; Survey; SURVEY.GNHLTH	4180186
42869157	Emotionally distressed past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869160	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869163	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about spreading infection past 7D	4180186
42869166	Can manage things around infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869169	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hidden this problem past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869170	Concerns about ability become pregnant past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869171	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about peoples attitudes past 7D	4180186
42869172	Embarrassed about infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869173	Blame myself for infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869175	Difficulty telling partner about infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869176	Finding; Findings; Frustrated by infection past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869177	Depressed about infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869179	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get emotional support from partner past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869187	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit physical activity b/c diarrhea past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869189	Embarrassed by diarrhea past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869190	Abd; Abdo; Abdomen; Abdominal cramps discomfort d/t diarrhea past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869194	FACIT; FACIT-F; FACIT-F - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869195	Feel listless washed out past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869196	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble starting things b/c tired past 7D	4180186
42869197	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble finishing things b/c tired past 7D	4180186
42869201	Finding; Findings; Frustrated by being too tired past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869202	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit social activity b/c tired past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869203	FACIT; FACIT - fatigue; FACIT - fatigue 13 - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869204	FACIT; FACT; FACT-An; FACT-An - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869206	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Motivated to do usual activities past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869207	FACT; FACT-B + 4; FACT-B + 4 - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869210	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Poor range arm move this side past 7D; Ql; Qual; Qualitative; Rnge; Screen; Survey; SURVEY.GNHLTH; Upper extremity	4180186
42869211	Arm this side numb past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Upper extremity	4180186
42869216	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have bone pain sit or lie still past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869219	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble walking b/c bone pain past 7D	4180186
42869220	Bone pain interferes w ability care myself past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869221	Bone pain interferes w social activities past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869222	Bone pain wakes me up night past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869225	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry that bone pain get worse past 7D	4180186
42869228	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had trouble forming thoughts past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869229	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Thinking slow past 7D	4180186
42869231	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had trouble finding familiar place past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869234	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had trouble recalling name of object past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869236	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Used the wrong word past 7D	4180186
42869239	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work hard to pay attention past 7D	4180186
42869240	Finding; Findings; Forgotten names after introduced past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869241	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Reactions everyday situations slow past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42869243	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Others told trouble remembering info past 7D; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869244	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work harder keep track what I was doing past 7D	4180186
42869247	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Use written lists more often past 7D	4180186
42869248	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble keeping track if interrupted past 7D	4180186
42869251	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Others told trouble thinking cleary past 7D; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869254	Able to concentrate past 7D; Cnc; Conc; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869256	Been able to remember things past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; L; Last; LT; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869259	Arterial Stenosis; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Mind sharp as always past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869260	Arterial Stenosis; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Memory good as always past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869261	2; Able shift back forth between thinking activities past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869263	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869264	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Upset about these problems past 7D	4180186
42869266	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Problems interfered w ability do thing past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869268	FACIT; FACT; FACT-ES; FACT-ES - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869271	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gender; Have lost interest in sex past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869272	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have breast sensitivity past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869273	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have mood swings past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869274	Am irritable past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869275	FACT; FACT-N; FACT-N - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869277	Avoid public places fear of infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869279	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx; Worry condition not improve if tx delayed past 7D	4180186
42869281	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Low blood counts interfere w relationships past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869282	Bothered by headaches past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869283	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Need to rest during the day past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869287	Bothered by pinpoint bruising past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869288	Bothered by blood in urine stool past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869291	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx; Worry tx delayed, b/c low blood counts past 7D	4180186
42869293	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about serious bleeding past 7D	4180186
42869299	FACIT; FAIT-F; FAIT-F - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869301	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit sexual activity b/c conditionpast 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869303	Condition wakes keeps me up at night past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869305	FACIT; FAIT-U; FAIT-U - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869307	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Must urinate freq avoid leaking past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869311	Cramping in pelvic area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869313	Confidence in doctors past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869315	Dr gave explanations could understand past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869316	Dr explained benefits of tx past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869317	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869318	B mallei; C&S; Cult; Cultures; Equinia; Farcy; Glanders; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Pseudomonas mallei; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
42869318	B mallei Spec Ql Cult	4180186
42869318	鼻疽伯克霍尔德氏菌:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
42869320	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pseudomal; B pseudomallei; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Melioidosis; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pseudomonas pseudomallei; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869320	B pseudomal DNA Spec Ql NAA+probe	4180186
42869320	类鼻疽伯克霍尔德氏菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869322	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; B mallei; DFA; Equinia; FA; Farcy; Fluorescent antibody; Fluoresent; Glanders; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Pseudomonas mallei; QL; Qual; Qualitative; Random; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
42869322	B mallei Ag Spec Ql IF	4180186
42869322	鼻疽伯克霍尔德氏菌 抗原:存在情况或阈值:时间点:XXX:序数型:免疫荧光法	4182948
42869323	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; B pseudomal; B pseudomallei; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Melioidosis; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Pseudomonas pseudomallei; QL; Qual; Qualitative; Random; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
42869323	B pseudomal Ag Spec Ql IF	4180186
42869323	类鼻疽伯克霍尔德氏菌 抗原:存在情况或阈值:时间点:XXX:序数型:免疫荧光法	4182948
42869325	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
42869325	RABV Ab CSF Ql IA	4180186
42869325	狂犬病病毒 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42869326	狂犬病病毒 抗体.中和:存在情况或阈值:时间点:血清:序数型:中和试验	4182948
42869326	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Serum; Serum virus neutralization; SR; SVN; Virus neutralization test; VNT	4180186
42869326	RABV NAb Ser Ql Nt	4180186
42869329	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
42869329	RABV IgG CSF Ql IF	4180186
42869329	狂犬病病毒 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
42869330	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
42869330	RABV IgM CSF Ql IF	4180186
42869330	狂犬病病毒 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
42869336	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869339	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869343	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869344	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869347	Add; Functional Assessment of Chronic Illness Therapy; Left; Levo; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869348	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869351	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869352	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869355	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869356	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869357	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869360	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869361	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869369	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869370	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869372	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869373	Cluster of differentiation; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Physical well-being; Physical well-being - FACIT-CD; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869376	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
42869376	Cryptoc Ag Tiss Ql IF	4180186
42869376	隐球菌属单个未知种 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
42869377	Antigen; Antigens; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
42869377	Cryptoc Ag Tiss Ql ImStn	4180186
42869377	隐球菌属单个未知种 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
42869378	Antigen; Antigens; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS	4180186
42869378	Cryptoc Ag Ser Ql IA.rapid	4180186
42869378	隐球菌属单个未知种 抗原:存在情况或阈值:时间点:血清:序数型:免疫测定法.快速	4182948
42869380	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869381	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869382	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gender; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42869384	Abd; Abdo; Abdomen+; Abdominal; Asp; Cerebral spinal fluid; Cerebrospinal Fl; CSF asp; Document; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Neuro; Neurology; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spinal; Spinal Cord; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; ULS; Ultrasound	4180186
42869384	US Guided L-spine CSF asp	4180186
42869384	旨在抽吸脑脊液的引导:发现:时间点:腹部>脊椎.腰段:文档型:超声	4182948
42869385	Asp; Cerebral spinal fluid; Cerebrospinal Fl; CSF asp; Document; Dorsal spine; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; Neuro; Neurology; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spinal; Spinal Cord; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Th/sp; Thorax; T-spine; ULS; Ultrasound	4180186
42869385	US Guided T-spine CSF asp	4180186
42869385	旨在抽吸脑脊液的引导:发现:时间点:胸部>脊椎.胸段:文档型:超声	4182948
42869389	C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; C-spine; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
42869389	CT Guided C-spine Nerve block	4180186
42869389	旨在神经阻滞的引导:发现:时间点:颈部>脊椎.颈段:文档型:CT	4182948
42869390	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
42869390	CT Guided T-spine Nerve block	4180186
42869390	旨在神经阻滞的引导:发现:时间点:胸部>脊椎.胸段:文档型:CT	4182948
42869391	C/sp; Cerv; C-spine; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; PC Vertebroplasty; Perc; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
42869391	RF Guided C-spine PC Vertebroplasty	4180186
42869391	旨在经皮椎体成形术的引导:发现:时间点:颈部>脊椎.颈段:文档型:放射荧光透视法	4182948
42869393	Document; Dorsal spine; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; PC Vertebroplasty; Perc; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
42869393	RF Guided T-spine PC Vertebroplasty	4180186
42869393	旨在经皮椎体成形术的引导:发现:时间点:胸部>脊椎.胸段:文档型:放射荧光透视法	4182948
42869394	C/sp; Cerv; C-spine; Document; Echography; Finding; Findings; Imaging; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spinal; Spinal Cord; ULS; Ultrasound	4180186
42869394	US C-spine	4180186
42869394	多层:发现:时间点:颈部>脊椎.颈段:文档型:超声	4182948
42869395	Document; Dorsal spine; Echography; Finding; Findings; Imaging; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; ULS; Ultrasound	4180186
42869395	US T-spine	4180186
42869395	多层:发现:时间点:胸部>脊椎.胸段:文档型:超声	4182948
42869396	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Stereo	4180186
42869396	Deprecated L-spine CT Stereo	4180186
42869398	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Stereo; Th/sp; T-spine	4180186
42869398	Deprecated T-spine CT Stereo	4180186
42869399	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Discogram; Discography; Diskogram; Document; Dorsal spine; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; W contr ID; WC	4180186
42869399	CT T-spine W contr ID	4180186
42869399	多层^采用椎间盘内对比剂:发现:时间点:胸部>脊椎.胸段:文档型:CT	4182948
42869400	1V; CXR; Document; Dorsal spine; Film; Finding; Findings; Imaging; Plain Films; Point in time; Rad; Radiology; Random; Single View; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; VW; XR port; Xray; X-ray	4180186
42869400	XR port T-spine 1V	4180186
42869400	视图:发现:时间点:胸部>脊椎.胸段:文档型:X射线摄影术.便携式	4182948
42869402	Ocular history	4180186
42869402	DOC.MISC; Finding; Findings; Hx; MISC; Narrative; Point in time; Random; Report	4180186
42869402	眼病史:发现:时间点:^患者:叙述型	4182948
42869405	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Refraction; Report; VA	4180186
42869405	Deprecated Visual acuity	4180186
42869406	Refractive measurements	4180186
42869406	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869406	屈光度测定:发现:时间点:^患者:叙述型	4182948
42869409	Finding; Findings; Job; My Mood Monitor Checklist; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
42869410	Finding; Findings; My Mood Monitor Checklist; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
42869414	My Mood Monitor Checklist; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869415	My Mood Monitor Checklist; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869417	National EMS Information Services; Nominal; Point in time; Random; Typ	4180186
42869417	药物治疗授权:类型:时间点:^患者:名义型:NEMSIS	4182948
42869419	National EMS Information Services; Nominal; Point in time; Random; Typ	4180186
42869419	心电图:类型:时间点:^患者:名义型:NEMSIS	4182948
42869421	Finding; Findings; Interp; Interpret; Interpt; Intrp; Meth; Method of; National EMS Information Services; Nominal; Point in time; Random	4180186
42869421	心电图解释方法:发现:时间点:^患者:名义型:NEMSIS	4182948
42869423	单元运送和装备能力:发现:时间点:急救医疗服务单元:名义型	4182948
42869423	Trnsprt+Equip capability EMS unit	4180186
42869423	Emergency Medical Service(s); Finding; Findings; NEMSIS; Nominal; Point in time; Random; Trnsprt+Equip capability	4180186
42869425	Finding; Findings; National EMS Information Services; Nominal; Point in time; Random	4180186
42869425	工作人员反应角色:发现:时间点:^患者:名义型:NEMSIS	4182948
42869426	National EMS Information Services; Nominal; Persons; Point in time; Random; Typ	4180186
42869426	操作执行人员:类型:时间点:^患者:名义型:NEMSIS	4182948
42869428	Exam finding location Abd NEMSIS	4180186
42869428	Abd; Abdo; Abdomen+; Abdominal; Finding; Findings; National EMS Information Services; Nominal; Point in time; Random	4180186
42869428	检查发现位置:发现:时间点:腹部:名义型:NEMSIS	4182948
42869429	EXT; Finding; Findings; National EMS Information Services; Nominal; Point in time; Random	4180186
42869429	Exam finding location Extr NEMSIS	4180186
42869429	检查发现位置:发现:时间点:肢体:名义型:NEMSIS	4182948
42869430	Eyeball; Finding; Findings; National EMS Information Services; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual	4180186
42869430	检查发现位置:发现:时间点:眼睛:名义型:NEMSIS	4182948
42869431	Location; National EMS Information Services; Nominal; Point in time; Random	4180186
42869431	静脉注射部位:位置:时间点:^患者:名义型:NEMSIS	4182948
42869434	End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42869435	ADMIN; Nominal; Occupation; Point in time; Random; Typ; Work	4180186
42869435	职务称号:类型:时间点:工作人员:名义型	4182948
42869436	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hemoglobinopathies suspected; Identity or presence; Nominal; Point in time; Random; WB; Whole blood	4180186
42869436	Hemoglobinopathies suspected DBS	4180186
42869436	所怀疑的血红蛋白病:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
42869437	Chemistry; Dehydrog; Dehyrdogenase; Erythrocytes; G6PD; G-6-PD; G6PDH; Glu; Gluc; Glucose-6-PD; Glucose-6-PDH; Glucoseur; GPD; Hematology; Heme; i Phos; Inorganic phosphate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
42869437	G6PD cSub RBC	4180186
42869437	葡萄糖-6-磷酸脱氢酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
42869438	FDA insert PMI-Common side effects	4180186
42869438	DOCUMENT.REF; FDA insert; Narrative; PMI-Common side effects; Report; SPL; Structured Product Labelling	4180186
42869438	PMI - 常见副作用小节:-:-:^FDA 包装说明书:叙述型	4182948
42869442	FDA insert PMI-Tell doc before taking	4180186
42869442	DOCUMENT.REF; FDA insert; Narrative; PMI-Tell doc before taking; Report; SPL; Structured Product Labelling	4180186
42869442	PMI - 服用前告知医生小节:-:-:^FDA 包装说明书:叙述型	4182948
42869444	DOCUMENT.REF; FDA insert; Narrative; PMI-Important info; Report; SPL; Structured Product Labelling	4180186
42869444	FDA insert PMI-Important info	4180186
42869444	PMI - 重要信息小节:-:-:^FDA 包装说明书:叙述型	4182948
42869445	FDA insert PMI - Uses section	4180186
42869445	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42869445	PMI - 用途小节:-:-:^FDA 包装说明书:叙述型	4182948
42869446	#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42869446	Mononuc Cells # Fld Auto	4180186
42869446	单个核细胞:计数型浓度:时间点:体液:定量型:自动化计数方法	4182948
42869448	HPC # Bld Auto	4180186
42869448	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; HPC; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42869448	造血祖细胞:计数型浓度:时间点:全血:定量型:自动化计数方法	4182948
42869450	Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Immature platelets; Number fraction; Percent; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RP; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood; Young platelets	4180186
42869450	Platelets.reticulated NFr Bld Auto	4180186
42869450	血小板.网织/100 个血小板:计数型分数:时间点:全血:定量型:自动化计数方法	4182948
42869452	100WBC; Auto; Automated detection; Blood; Elec; Elect; Electr; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Imm; Imm Granulocytes; Immat; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
42869452	Imm Granulocytes/leuk NFr Bld Auto	4180186
42869452	粒细胞.不成熟/100 个白细胞:计数型分数:时间点:全血:定量型:自动化计数方法	4182948
42869453	Polys/leuk NFr Fld Auto	4180186
42869453	100WBC; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; WBC; WBCs; White blood cell; White blood cells	4180186
42869453	分叶核白细胞/100 个白细胞:计数型分数:时间点:体液:定量型:自动化计数方法	4182948
42869454	100WBC; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mononuc; Mononuc Cells; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
42869454	Mononuc Cells/leuk NFr Fld Auto	4180186
42869454	单个核细胞/100 个白细胞:计数型分数:时间点:体液:定量型:自动化计数方法	4182948
42869457	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42869457	RV RNA Stl NAA+probe	4180186
42869457	轮状病毒 RNA:存在与否或特征标识:时间点:大便:名义型:探针法.基因扩增.靶向	4182948
42869458	Bowel movement; double stranded RNA; double-stranded RNA; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Polyacrylamide gel electrophoresis; Random; RNA; Rota virus; ROTAV; Rotaviral; Rotavirus ds; Rotavirus little(ds); Rotaviurs; RV; Stl; Stool = Fecal	4180186
42869458	RV dsRNA Stl PAGE	4180186
42869458	轮状病毒 dsRNA:存在与否或特征标识:时间点:大便:名义型:聚丙稀酰胺凝胶电泳法	4182948
42869460	RV IgG Titr Ser IA	4180186
42869460	轮状病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869460	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869465	Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MARV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
42869465	MARV Ag Spec Ql IA	4180186
42869465	马尔堡病毒 抗原:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
42869468	EBOV IgM Titr Ser IA	4180186
42869468	埃博拉病毒 抗体.IgM:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869468	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EBO; EBOV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869469	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EBO; EBOV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42869469	EBOV IgM Ser Ql IA	4180186
42869469	埃博拉病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869470	PK cSub RBC	4180186
42869470	Chemistry; Erythrocytes; PK; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
42869470	丙酮酸激酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
42869471	Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; BRT; Bruc; Brucellosis; Contagious abortion; HIRT; ID; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ring aggl; Screen; Undulant fever; Vet; Veterinary	4180186
42869471	B abortus Ab Mlk Ql HIRT	4180186
42869471	牛种布鲁氏菌 抗体:存在情况或阈值:时间点:乳:序数型:凝集试验法.环状试验.热灭活	4182948
42869475	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869475	Enterococ DNA Spec Ql NAA+probe	4180186
42869475	肠球菌属单个未知种 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869476	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M avium; M avium Cmplx; Microbiology; Misc; Miscellaneous; Myco; Mycobact; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Tuberculosis; Unspecified	4180186
42869476	M avium Cmplx DNA Spec Ql NAA+probe	4180186
42869476	鸟型分枝杆菌复合菌群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869479	Personnel Cell phone #	4180186
42869479	ADMIN; Cell phone #; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
42869479	移动电话号码:电话号码:时间点:工作人员:名义型	4182948
42869480	ADMIN; Home phone #; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
42869480	Personnel Home phone #	4180186
42869480	家庭电话号码:电话号码:时间点:工作人员:名义型	4182948
42869484	ADMIN; Nominal; Point in time; Random	4180186
42869484	电子邮件地址:电子邮件地址:时间点:工作人员:名义型	4182948
42869485	9-digit postal code; ADMIN; Location; Nominal; Point in time; Random; ZIP code	4180186
42869485	Personnel 9-digit postal code	4180186
42869485	9 位邮政编码:位置:时间点:工作人员:名义型	4182948
42869490	Address; ADMIN; Nominal; Point in time; Random	4180186
42869490	Personnel Preferred mailing addr	4180186
42869490	首选通信地址:地址:时间点:工作人员:名义型	4182948
42869492	ADMIN; HumanName.prefix; Nominal; Person name; Point in time; Random	4180186
42869492	姓名前缀:人员姓名:时间点:工作人员:名义型	4182948
42869494	ADMIN; Nominal; Person name; Point in time; Random	4180186
42869494	中间名首字母:人员姓名:时间点:工作人员:名义型	4182948
42869495	Personnel First name	4180186
42869495	ADMIN; Given name; Nominal; Person name; Point in time; Random	4180186
42869495	名字:人员姓名:时间点:工作人员:名义型	4182948
42869499	FDA insert Provider letter	4180186
42869499	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42869499	医疗保健服务提供者信函:-:-:^FDA 包装说明书:叙述型	4182948
42869500	Admin; ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42869501	Admin; End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD survey; Pan; Panl; Personnel contact info Pnl; Pnl; Point in time; Random; Survey	4180186
42869502	Admin; End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Facility Pnl; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42869503	Admin; Cnt; Count; Dialy; End Stage Renal Disease; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Tot; Totl	4180186
42869510	My Mood Monitor Checklist; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
42869514	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42869514	RV RNA Islt NAA+probe	4180186
42869514	轮状病毒 RNA:存在与否或特征标识:时间点:分离株:名义型:探针法.基因扩增.靶向	4182948
42869518	RV IgA Titr Ser IA	4180186
42869518	轮状病毒 抗体.IgA:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869518	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869519	RV Ab Titr Ser IA	4180186
42869519	轮状病毒 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869519	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869520	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Screen; Serum; SR; SUDS	4180186
42869520	RV Ab Ser Ql IA	4180186
42869520	轮状病毒 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869523	Antigen; Antigens; EBO; EBOV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
42869523	EBOV Ag Spec Ql IA	4180186
42869523	埃博拉病毒 抗原:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
42869525	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EBO; EBOV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42869525	EBOV IgG Ser Ql IA	4180186
42869525	埃博拉病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869529	Arbitrary concentration; bckgrd cor; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; Microbiology; Mitogen IGNF; Point in time; Pulmonary; Pulmonology; QFT; QNT; Quan; Quant; Quantiferon; Quantitative; Random; Respiratory; WB; Whole blood	4180186
42869529	Mitogen IGNF bckgrd cor Bld-aCnc	4180186
42869529	丝裂原刺激型 gamma 干扰素^^经过针对本底而校正的:任意型浓度:时间点:全血:定量型	4182948
42869533	Antigen; Antigens; Bunyavirus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rift valley fever; RVFV; Screen; Serum; SR; SUDS	4180186
42869533	RVFV Ag Ser Ql IA	4180186
42869533	裂谷热病毒 抗原:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869536	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bunyavirus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rift valley fever; RVFV; Screen; Serum; SR; SUDS	4180186
42869536	RVFV IgM Ser Ql IA	4180186
42869536	裂谷热病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869538	黄热病病毒 抗体.中和:滴定度:时间点:脑脊液:定量型:中和试验	4182948
42869538	YFV NAb Titr CSF Nt	4180186
42869538	ABS; Aby; American plague; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; Neuro; Neurology; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum virus neutralization; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT; yellow jack; YFV	4180186
42869540	Finding; Findings; Findings to clinician managing care; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42869541	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Epidermolytic toxin A; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; S aureus ETA; S aureus eta gene; Screen; SDA; Spec; Staph; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869541	S aureus eta gene Spec Ql NAA+probe	4180186
42869541	金黄色葡萄球菌表皮剥脱毒素 A eta 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869542	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Epidermolytic toxin B; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; S aureus ETB; S aureus etb gene; Screen; SDA; Spec; Staph; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869542	S aureus etb gene Spec Ql NAA+probe	4180186
42869542	金黄色葡萄球菌表皮剥脱毒素 B etb 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869545	Calcium ?Tm Ur-sCnc	4180186
42869545	?Tm; Ca; Cal; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
42869545	钙:物质的量浓度:XXX:尿液:定量型	4182948
42869546	MetanephS 24h Ur-sCnc	4180186
42869546	1 day; 24 hours; 24HR; Chemistry; Level; Metanephrine+normetanephrine; MetanephS; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
42869546	间甲肾上腺素类:物质的量浓度:24小时:尿液:定量型	4182948
42869548	T pallidum Ab Titr SerPl Aggl	4180186
42869548	梅毒螺旋体 抗体:滴定度:时间点:血清/血浆:定量型:凝集试验法	4182948
42869548	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Syphilis; T pallidum; Titer; Titered; Titre; TP-PA; Treponemal; Ttr	4180186
42869549	Before; Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42869549	PEF pre therapy Airway	4180186
42869549	呼气气体流量.最大值^在治疗之前:体积速率:时间点:呼吸系统.气道:定量型	4182948
42869555	Nominal; Point in time; Random; Reason med not prescribed; Survey; SURVEY.GNHLTH; Typ	4180186
42869557	Living Arrangement; Living Arrangements; Nominal; Point in time; Random; Residence; SDOH; Survey; SURVEY.GNHLTH; Typ	4180186
42869558	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869559	Serotonin EntSub Plts	4180186
42869559	5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; C10H12N2O; Chemistry; Enteramine; Entitic substance; Platelet; Plt; Plts; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes	4180186
42869559	5-羟色胺:实体物质的量:时间点:血小板:定量型	4182948
42869561	Feel sad since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869564	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Suicide thoughts since last screen; Survey; SURVEY.MTLHLTH	4180186
42869565	Difficulty sleeping since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869566	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sleeping too much since last screen; Survey; SURVEY.MTLHLTH	4180186
42869567	Finding; Findings; Lost appetite since last screen; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869569	Feel tense since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH; T prime	4180186
42869571	Anxiety attacks since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869572	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH; Worry about dying since last screen	4180186
42869573	Finding; Findings; My Mood Monitor Checklist; Nervous since last screen; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869575	Finding; Findings; Jumpy since last screen; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869579	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Repeat acts since last screen; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869581	Can't focus since last screen; Cnc; Conc; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH; T prime	4180186
42869582	Finding; Findings; Interp; Interpret; Interpt; Intrp; My Mood Monitor Checklist; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42869585	Bld mixed venous; Blood - mixed venous; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42869585	Hct VFr.DF BldMV	4180186
42869585	血细胞压积:体积分数.小数型:时间点:混合静脉全血:定量型	4182948
42869586	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42869586	Hct VFr.DF BldC	4180186
42869586	血细胞压积:体积分数.小数型:时间点:毛细血管全血:定量型	4182948
42869591	OxyHgb MFr.DF BldV	4180186
42869591	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Point in time; QNT; Quan; Quant; Quantitative; Random; SO2; Tot; Totl; Venous	4180186
42869591	氧合血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:静脉全血:定量型	4182948
42869593	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Point in time; QNT; Quan; Quant; Quantitative; Random; SO2; Tot; Totl	4180186
42869593	OxyHgb MFr.DF BldC	4180186
42869593	氧合血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:毛细血管全血:定量型	4182948
42869594	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SO2; Tot; Totl	4180186
42869594	OxyHgb MFr.DF BldA	4180186
42869594	氧合血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:动脉全血:定量型	4182948
42869595	Blood; Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Point in time; QNT; Quan; Quant; Quantitative; Random; SO2; Tot; Totl; WB; Whole blood	4180186
42869595	OxyHgb MFr.DF Bld	4180186
42869595	氧合血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869596	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Calc; calc from oxygen partial pressure; Calculation; Chemistry; from pO2; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; Venous	4180186
42869596	SaO2 DF BldV from pO2	4180186
42869596	氧饱和度:质量分数.小数型:时间点:静脉全血:定量型:依据氧分压计算	4182948
42869597	Blood - capillary; Calc; calc from oxygen partial pressure; Calculation; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; from pO2; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2	4180186
42869597	SaO2 DF BldC from pO2	4180186
42869597	氧饱和度:质量分数.小数型:时间点:毛细血管全血:定量型:依据氧分压计算	4182948
42869598	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; calc from oxygen partial pressure; Calculation; Chemistry; from pO2; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2	4180186
42869598	SaO2 DF BldA from pO2	4180186
42869598	氧饱和度:质量分数.小数型:时间点:动脉全血:定量型:依据氧分压计算	4182948
42869599	Blood; Calc; calc from oxygen partial pressure; Calculation; Chemistry; from pO2; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; WB; Whole blood	4180186
42869599	SaO2 DF Bld from pO2	4180186
42869599	氧饱和度:质量分数.小数型:时间点:全血:定量型:依据氧分压计算	4182948
42869600	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; Venous	4180186
42869600	SaO2 DF BldV	4180186
42869600	氧饱和度:质量分数.小数型:时间点:静脉全血:定量型	4182948
42869602	Bld cord; Chemistry; Cord BldV; Cord venous blood; Gyn; Gynecology; O2; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SAT; Satn; SO2; tO2	4180186
42869602	SaO2 DF BldCoV	4180186
42869602	氧饱和度:质量分数.小数型:时间点:脐带静脉全血:定量型	4182948
42869603	Bld cord; Chemistry; Cord arterial blood; Cord BldA; Gyn; Gynecology; O2; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SAT; Satn; SO2; tO2	4180186
42869603	SaO2 DF BldCoA	4180186
42869603	氧饱和度:质量分数.小数型:时间点:脐带动脉全血:定量型	4182948
42869604	Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Gyn; Gynecology; O2; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SAT; Satn; SO2; tO2	4180186
42869604	SaO2 DF BldCo	4180186
42869604	氧饱和度:质量分数.小数型:时间点:脐带全血:定量型	4182948
42869605	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; O2; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SAT; Satn; SO2; tO2	4180186
42869605	Deprecated SaO2 DF BldC Oximetry	4180186
42869607	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2	4180186
42869607	SaO2 DF BldA	4180186
42869607	氧饱和度:质量分数.小数型:时间点:动脉全血:定量型	4182948
42869608	Blood; Chemistry; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; WB; Whole blood	4180186
42869608	SaO2 DF Bld	4180186
42869608	氧饱和度:质量分数.小数型:时间点:全血:定量型	4182948
42869610	Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Other; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869610	Hgb Other MFr.DF Bld Elph	4180186
42869610	血红蛋白.其他/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:电泳	4182948
42869611	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Other; High performance liquid chromatography; High pressure liquid chromatography; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869611	Hgb Other MFr.DF Bld HPLC	4180186
42869611	血红蛋白.其他/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869612	Hgb S MFr.DF Bld	4180186
42869612	Blood; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; WB; Whole blood	4180186
42869612	血红蛋白 S/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869613	Blood; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; WB; Whole blood	4180186
42869613	Hgb S MFr.DF Bld HPLC	4180186
42869613	血红蛋白 S/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869614	Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; WB; Whole blood	4180186
42869614	Hgb S MFr.DF Bld Elph	4180186
42869614	血红蛋白 S/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:电泳	4182948
42869615	Hgb M MFr.DF Bld	4180186
42869615	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb M; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869615	血红蛋白 M/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869617	Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb H; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869617	Hgb H MFr.DF Bld Elph	4180186
42869617	血红蛋白 H/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:电泳	4182948
42869618	Hgb F MFr.DF Bld Kleih Betke	4180186
42869618	Acid elution; Blood; Fetal hemoglobin; Fetal maternal hemorrhage screen; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; KB; Kleih Betke; Kleihauer stain; Kleihauer test; Kleihauer-Betke stain; Kleihauer-Betke test; Kleihauer-Braun-Betke; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869618	血红蛋白 F/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:Kleihauer-Betke 试验	4182948
42869630	Blood; Chemistry; Endocrine; Endocrinology; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869630	HbA1c MFr.DF Bld	4180186
42869630	血红蛋白 A1c/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869631	Hgb A MFr.DF Bld	4180186
42869631	Blood; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869631	血红蛋白 A/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869633	Hgb A MFr.DF Bld Elph	4180186
42869633	Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869633	血红蛋白 A/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:电泳	4182948
42869634	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Venous	4180186
42869634	MetHgb MFr.DF BldV	4180186
42869634	高铁血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:静脉全血:定量型	4182948
42869635	MetHgb MFr.DF BldMV	4180186
42869635	Bld mixed venous; Blood - mixed venous; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
42869635	高铁血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:混合静脉全血:定量型	4182948
42869640	Bld mixed venous; Blood - mixed venous; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl	4180186
42869640	COHgb MFr.DF BldMV	4180186
42869640	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:混合静脉全血:定量型	4182948
42869641	COHgb MFr.DF BldCoV	4180186
42869641	Bld cord; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Cord BldV; Cord venous blood; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
42869641	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:脐带静脉全血:定量型	4182948
42869644	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl	4180186
42869644	COHgb MFr.DF BldA	4180186
42869644	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:动脉全血:定量型	4182948
42869647	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 8 AM; 8AM; AM diurnal peak; c155; CHEMISTRY.CHALLENGE TESTING; circadian high; Compound E; Level; Morning; Oral fluid; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
42869647	Cortisone AM peak Sal-sCnc	4180186
42869647	可的松^早晨峰值标本:物质的量浓度:时间点:唾液:定量型	4182948
42869648	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 12 AM; 12AM; c155; CHEMISTRY.CHALLENGE TESTING; circadian low; Compound E; Evening; late night specimen; Level; Midnight; Oral fluid; PM diurnal trough; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
42869648	Cortisone PM Sal-sCnc	4180186
42869648	可的松^晚上波谷标本:物质的量浓度:时间点:唾液:定量型	4182948
42869649	1 day; 11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 24 hours; 24HR; c155; Chemistry; Compound E; Cortisone free; FR; Non-protein bound; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
42869649	Cortisone free 24h Ur-sRate	4180186
42869649	可的松.游离型:物质的量速率:24小时:尿液:定量型	4182948
42869650	Asympt; Asymptomatic; BP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; PEDS; Peds B/P screening results; Point in time; QL; Qual; Qualitative; Random; Scn; Screen; Survey; SURVEY.GNHLTH	4180186
42869651	BP; Gender; PEDS; Peds B/P percentile; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
42869652	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rate emotional problems; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869653	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rate physical health; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869655	Expect health get worse; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869656	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869657	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Seem to get sick easier; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869659	4 weeks; Feel tired past 4W; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869663	4 weeks; Finding; Findings; Last; Lot of energy past 4W; Ordinal; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869664	4 weeks; Calm peaceful past 4W; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869666	4 weeks; Finding; Findings; Last; Nervous person past 4W; Ordinal; Persons; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869668	4 weeks; Control; Did pain interfere normal work past 4W; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869669	4 weeks; Finding; Findings; How much bodily pain past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869670	4 weeks; Control; Finding; Findings; Last; Ordinal; Phys health interfered soc act past 4W; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869671	4 weeks; Arterial Stenosis; Didn't work as carefully past 4W; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; T prime; Veterans RAND	4180186
42869673	4 weeks; Arterial Stenosis; Cut down time spent work past 4W; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869674	4 weeks; Arterial Stenosis; Difficulty performing work past 4W; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869677	4 weeks; Arterial Stenosis; Cut down amount you work past 4W; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869679	Finding; Findings; Limit walking one block; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869684	Finding; Findings; Limit climbing sev flights stairs; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869688	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; SF-12; SF-36; SURVEY.GNHLTH; Veterans RAND; VR-36	4180186
42869690	Assessment; Dextro; Eval; H&P; History and physical; P prime; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Parents' Evaluation of Developmental Status-Developmental Milestones; PEDS; PEDS-DM; Pnl; Point in time; Random; S prime; Survey; SURVEY.GNHLTH	4180186
42869692	Asympt; Asymptomatic; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Scn; Survey; SURVEY.GNHLTH; TWEAK	4180186
42869694	MLHFQ; Pan; Panel; PANEL.MLHFQ; Panl; Pnl; Point in time; Random; Survey	4180186
42869696	KCCQ; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869697	Asympt; Asymptomatic; Car, relax, alone, forget, friends, trouble (CRAFFT); CRAFFT; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Scn; Survey; SURVEY.GNHLTH	4180186
42869698	Asympt; Asymptomatic; MAST; MAST-G; Michigan Alcoholism Screening Test-Geriatric Version; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Scn; Survey; SURVEY.GNHLTH	4180186
42869699	Asympt; Asymptomatic; MAST; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Scn; Survey; SURVEY.GNHLTH	4180186
42869703	Hip and Knee Outcomes Instrument - American Academy of Orthopaedic Surgeons; Lower extremity joint; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869704	FaB; Fall Behavioral Scale; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869708	BINS; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869709	ASQ; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869712	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869714	FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869715	FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869716	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869719	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869722	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869723	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869724	Emotional stability; GMH; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869725	Emotional stability; GMH; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869726	GPH; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869727	GPH; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869728	Emotional stability; Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869729	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869730	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869731	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869735	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869736	Emotional stability; Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869737	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869740	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869741	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869744	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869745	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869751	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869753	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869759	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869762	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869767	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869768	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869769	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869774	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869776	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869777	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869780	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869784	ESRD; ESRD survey; Immunizations; Nominal; Point in time; Random; Survey; Typ; Vaccination exclusion med reason; Vaccine	4180186
42869785	Dextro; End Stage Renal Disease; ESRD survey; Nominal; Oral vit D analog prescribed; Osteoporosis; Point in time; Random; Rickets; Survey; Typ; Vitamin D deficiency	4180186
42869790	AV graft assessed frequency; Count/time; ESRD; ESRD survey; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869791	AV graft assessed w intra-access flow; Dynamic; ESRD; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869792	AV graft assessed frequency; Count/time; DOP; DUPLEX; Echography; ESRD; ESRD survey; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Survey; ULS; Ultrasound	4180186
42869795	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Testing AV graft performed w SVP	4180186
42869798	Before; End Stage Renal Disease; ESRD survey; Finding; Findings; Measur art pre-pump press performed; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869801	ESRD; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42869808	Date AV fistula creation; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869809	Dialy; End Stage Renal Disease; ESRD survey; Exchange; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Survey	4180186
42869810	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42869811	ESRD; ESRD survey; Finding; Findings; Hep; Hep B vaccin received; Hepatis; Hepatit; Immunizations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Vaccine	4180186
42869812	ESRD; ESRD survey; Finding; Findings; Immunizations; Nominal; Pneumococcal vacc received; Point in time; Random; Survey; Vaccine	4180186
42869818	End Stage Renal Disease; ESRD survey; Fe; Nominal; Point in time; Random; Survey; Typ	4180186
42869819	End Stage Renal Disease; ESRD survey; Fe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869820	End Stage Renal Disease; ESRD survey; Fe; Nominal; Point in time; Random; Survey; Typ	4180186
42869821	End Stage Renal Disease; ESRD survey; Fe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869822	End Stage Renal Disease; ESRD survey; Fe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rx; Screen; Survey	4180186
42869823	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Fe; Iron Pnl; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42869826	ESRD; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869827	ESRD; ESRD survey; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869828	After; Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; Post-dialysis target wt prescribed; PST; QL; Qual; Qualitative; Random; Screen; Survey; Wt	4180186
42869829	After; Date last formal post dialysis wt; Dialy; End Stage Renal Disease; ESRD survey; Past; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Survey; Wt	4180186
42869831	BP; BP home reading; ESRD; ESRD survey; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869832	End Stage Renal Disease; ESRD survey; Finding; Findings; Na; Na+; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sodium restrict educ received; Survey	4180186
42869833	Date echocardiogram; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869835	Dialy; Dialysate sodium conc exceed 138 mEq; Dialysate sodium concen exceed 138 mEq/L; End Stage Renal Disease; ESRD survey; Finding; Findings; Left; Levo; month; Na; Na+; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869837	End Stage Renal Disease; ESRD survey; Finding; Findings; Na; Na+; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869839	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Fld; Fluid and weight Pnl; Pan; Panl; Pnl; Point in time; Random; Survey; Wt	4180186
42869840	End Stage Renal Disease; Immunizations; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Typ; Vaccin exclusion - pt reason; Vaccine	4180186
42869842	BOMC; BOMC test; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869843	CDR; CDR Scale; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869844	NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.NEURO; Tot; Totl	4180186
42869846	KOOS; KOOS JR; KOOS score; KOOS, JR; Lower extremity joint; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Ulcer	4180186
42869847	HOOS; HOOS JR; HOOS score; HOOS, JR; Lower extremity joint; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869850	ADL score; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869851	Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Sx	4180186
42869853	Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Point in time; QNT; QoL score; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869854	Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869859	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Disch; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; Vital signs+ox Pnl	4180186
42869860	Mini-Mental Status Examination; MMS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
42869861	Mini-Mental Status Examination; MMS; MMSE; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869866	National EMS Information Services; Nominal; Point in time; Random; Typ	4180186
42869866	已尝试的复苏术:类型:时间点:^患者:名义型:NEMSIS	4182948
42869871	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 24 Mo; Totl	4180186
42869873	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 20 Mo; Totl	4180186
42869876	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 14 Mo; Totl	4180186
42869881	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 6 Mo; Totl	4180186
42869882	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 4 Mo; Totl	4180186
42869883	ASQ; II; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 2 Mo; Totl	4180186
42869885	DOC.MISC; EXT; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869885	Eye external	4180186
42869885	眼外部:发现:时间点:^患者:叙述型	4182948
42869886	Ocular alignment and motility	4180186
42869886	DOC.MISC; Finding; Findings; MISC; Mot; Narrative; Point in time; Random; Report	4180186
42869886	眼位与眼球运动:发现:时间点:^患者:叙述型	4182948
42869888	Eye posterior segment	4180186
42869888	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869888	眼后段:发现:时间点:^患者:叙述型	4182948
42869890	Ancillary eye tests	4180186
42869890	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869890	辅助性眼睛试验:发现:时间点:^患者:叙述型	4182948
42869893	DOC.MISC; MISC; Miscellaneous; Nominal; Other; Path; Point in time; Random; Report section; Spec; To be specified in another part of the message; Unspecified	4180186
42869893	病理学报告.小节标题:-:时间点:XXX:名义型	4182948
42869895	Date and time; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42869896	Date peritoneal dialysis adeq measure; Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869897	Bdy surface; bod; Bodies; BSA; BSA measurement method; ESRD; ESRD survey; Meth; Method of; Nominal; Point in time; Random; Surf; Survey; Typ	4180186
42869898	End Stage Renal Disease; ESRD survey; FCN; Finding; Findings; Func; Funct; Kidney; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Std process followed for residual renal function in Kt calc; Survey	4180186
42869899	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; Prescription chgd following PD adeq measure; Ql; Qual; Qualitative; Random; Rx; Screen; Survey	4180186
42869900	End Stage Renal Disease; ESRD survey; M of HD completed when BUN drawn; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869911	Arm.rght; Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.NEURO; Upper extremity	4180186
42869912	Finding; Findings; Leg-R; Lower extremity; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.NEURO	4180186
42869913	Blood; BSA pred.male; Chemistry; EGFR; Estimated GFR; GFR; GFR/1.73 sq M; Glom; Kidney; Modification of Diet in Renal Disease; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; Pred GFR; Pred GFR.male; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
42869913	GFR/BSA pred.male SerPlBld MDRD-ArVRat	4180186
42869913	肾小球滤过率/1.73 平方米.预测型.男性:单位面积体积速率:时间点:血清/血浆/全血:定量型:基于肌酐的公式 (MDRD)	4182948
42869916	Control; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking 50 steps normal speed w/o stopping past 7D; Survey; SURVEY.GNHLTH; Walking 50 steps normal speed w /o stopping past 7D	4180186
42869918	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB preparing meals past 7D; Survey; SURVEY.GNHLTH	4180186
42869921	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB making a bed past 7D; Survey; SURVEY.GNHLTH	4180186
42869923	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB carrying 10-20 lbs one room to another past 7D; Survey; SURVEY.GNHLTH	4180186
42869926	FACIT; FACIT-Dyspnea; FACIT-Dyspnea - 10 items; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869928	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB taking a bath past 7D; Survey; SURVEY.GNHLTH	4180186
42869930	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB putting on socks past 7D; Survey; SURVEY.GNHLTH	4180186
42869931	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB standing 5M past 7D; Survey; SURVEY.GNHLTH	4180186
42869932	Control; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB did you get walking 10 steps past 7D; Survey; SURVEY.GNHLTH	4180186
42869937	Finding; Findings; Functional Assessment of Chronic Illness Therapy; II; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB lifting less than 5 lbs past 7D; Survey; SURVEY.GNHLTH	4180186
42869942	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB getting in or out of a car past 7D; Survey; SURVEY.GNHLTH	4180186
42869943	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB dining out past 7D; Survey; SURVEY.GNHLTH	4180186
42869944	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Movements; Ordinal; Ql; Qual; Qualitative; Screen; SOB low-intensity leisure activity past 7D; Survey; SURVEY.GNHLTH	4180186
42869946	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking, faster 50 steps w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869948	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB singing or humming past 7D; Survey; SURVEY.GNHLTH	4180186
42869949	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB talking while walking past 7D; Survey; SURVEY.GNHLTH	4180186
42869950	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB scrubbing the floor past 7D; Survey; SURVEY.GNHLTH	4180186
42869960	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel useful past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869961	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I make each day count past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869962	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I have peace of mind past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869963	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel hopeful past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869967	FACIT; FACIT-Sp-12; FACIT-Sp-12 - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869968	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869969	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869970	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869972	Feel sense of purpose in life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869973	Able to reach deep into myself for comfort past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869975	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My life lacks meaning and purpose past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869976	Find strength in faith past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869978	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Whatever happens with illness things okay past 7D	4180186
42869980	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel connected to a higher power past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869981	Feel connected to other people past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869982	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869983	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869985	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel forgiven past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869987	Feel sense of thankfulness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869991	FACIT; FACIT - SWiP - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869992	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pharmacist advises proper use of my medicines past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869994	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have confidence in pharmacist-s past 7D; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42869995	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pharmacist available to answer questions past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869996	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pharmacist helps obtain medicines past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869997	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pharmacist aware tx-related needs past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869998	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pharmacist responds tx-related needs past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870001	Finding; Findings; Functional Assessment of Chronic Illness Therapy; How do you rate side effects of tx so far; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870002	Drs help evaluate effects of tx so far; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870004	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Satisfied with effects of tx so far; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870005	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Recommend tx to others w your illness; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870007	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870008	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Tx	4180186
42870010	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870011	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870012	Drs give explanations you could understand; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870015	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870019	Drs show genuine concern for you; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870023	Able to talk to Drs when needed to; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870025	Control; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx staff discuss how tx may affect daily activities	4180186
42870027	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx staff discuss how tx may affect emotion	4180186
42870028	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870029	Feel Drs had experience treating illness; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870030	Drs knew latest med developments for illness; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870033	Drs discuss other treatments; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx; Txs	4180186
42870034	Encouraged to participate in decisions about health care; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870035	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870036	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870039	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Nurses give explanations you could understand; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870040	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870045	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have confidence in your Drs; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870046	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Trust Drs suggestions for tx; Tx	4180186
42870047	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870049	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Would you choose clinic office again	4180186
42870050	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870054	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Take condition into account when making plans past 7D	4180186
42870055	Bothered by muscle pains past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Musc; Muscl; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870056	Emotional well-being - FAMS; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870059	Feel useless past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870060	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870061	Finding; Findings; Frustrated by condition past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870062	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870065	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870067	Bothered by muscle spasms past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Musc; Muscl; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870069	During difficult times know things okay past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870072	Functional and global well-being; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870075	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; species; spp; Survey; SURVEY.GNHLTH	4180186
42870076	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; species; spp; Survey; SURVEY.GNHLTH	4180186
42870077	AIDS; FACIT; FAHI; FAHI - version 4; Functional Assessment of Chronic Illness Therapy; Human immunodeficiency virus; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870078	Appear; Appr; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Unhappy with appearance past 7D	4180186
42870079	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hard to tell about infection past 7D; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870080	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about spreading infection past 7D	4180186
42870083	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Thinking slower than before past 7D	4180186
42870084	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble learning new tasks directions past 7D	4180186
42870085	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social - family well-being; Social - family well-being - FAMS; Survey; SURVEY.GNHLTH	4180186
42870086	FACIT; Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FAACT - adoles - v1; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870089	Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FAACT panel parent_child v1; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870092	FACIT; FACT; Functional Assessment of Chronic Illness Therapy; II; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FACT-Br child v2; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870093	FACT; Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FACT-Br; Peds-FACT-Br parent_adoles v1; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870095	FACIT; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FACIT-F; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870097	Eat enough to do whatever I need past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870099	Arterial Stenosis; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Soon as start eating, feel like stopping past 7D; Started; Survey; SURVEY.GNHLTH	4180186
42870102	Been throwing up past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870103	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have pain in stomach past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870104	Feel like I am getting better past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870106	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D could do my usual things at home; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870109	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have trouble running like other people past 7D; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870110	Arms or legs feel weak past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870111	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I get ill easily past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870112	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have trouble writing with a pen or pencil past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870114	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; When try to do something believe I will do it well past 7D	4180186
42870118	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about getting another cancer past 7D	4180186
42870120	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hosp; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry when go back to the hospital past 7D	4180186
42870121	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I get nervous - frightened easily past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870124	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about able go to college b/c of illness past 7D	4180186
42870130	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Would rather do something by myself past 7D	4180186
42870133	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worried about how thin I am past 7D	4180186
42870134	Finding; Findings; Functional Assessment of Chronic Illness Therapy; How feel about eating, food, food affects life past 7D; Last; Narrative; Report; Survey; SURVEY.GNHLTH	4180186
42870137	Children avoid playing with me I am different past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870140	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child trouble getting dressed past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870144	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child gets ill easily past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870147	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child seems happy past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870149	Cancer exp makes my child stronger past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Persons; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870151	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Inf; Last; My child feels inferior others past 4W; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870152	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child worries getting another cancer past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870154	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hosp; Last; My child worries when back to the hospital past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870158	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child worries about go to college b/c of illness past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870161	Emotional well-being FAACTadoles; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870164	4 weeks; Child has fewer friends past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870169	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child thinks I spoil past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870170	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870171	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870173	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
42870173	出生证明:发现:时间点:{环境}:文档型:{角色}	4182948
42870174	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Illness taught child to appreciate life past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870175	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Illness makes child stronger past 4W; Last; Ordinal; Persons; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870176	Feel that other children better than me past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870178	Emotional well being FAACTpeds parent_adoles; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870180	Child tries to do something believes will do it well past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870181	Child feels inferior past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Inf; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870183	Child is moody irritable past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870184	Child worries when back to hospital past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hosp; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870186	Child worries about having good life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870193	Child prefers to do something alone past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870194	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870195	Arterial Stenosis; Child eats as much as s-he wants past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870197	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wt	4180186
42870198	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870201	Child is afraid to eat may make sick past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870205	Child feels like getting better past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870207	Bal; Child loses balance easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870208	Child has trouble getting dressed past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870209	Child has trouble running past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870210	Child gets tired easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870211	Child's arms legs weak past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870212	Child gets ill easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870216	Emotional well being -FAACTpeds parent_child; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870217	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social well being -FAACTpeds parent_child; Social well-being; Survey; SURVEY.GNHLTH	4180186
42870219	Child prefers to play alone past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870225	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get ill easily past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870227	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel happy past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870230	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Illness experience taught to appreciate life past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870233	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Switch from good to bad moods past 4W	4180186
42870240	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Other people pick on me past 4W; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870243	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel lonely past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870246	4 weeks; Bothered by unable to see well past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870247	4 weeks; Bothered by unable to hear well past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870250	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Need to work harder to get school work done past 4W; Occupation; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870252	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I forget things easily past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870254	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have to read things several times to understand past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870257	Emotional well-being - FACT-Br -peds-adoles; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870259	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social - family well-being; Social - family well-being - FACT-Br-peds; Survey; SURVEY.GNHLTH	4180186
42870260	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Physical well-being; Physical well-being FACT-Br peds-parent; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870261	Emotional well being FACT-Br peds-parent_adoles; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870262	Emotional well-being FACT-Br peds-parent_child; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870267	4 weeks; Child bothered by poor hearing past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870274	4 weeks; Child read things several times to understand past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870275	4 weeks; Child plays games or sports reacts more slowly past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870277	4 weeks; Child feels inferior to other children past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Inf; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870279	Being tired made me sad past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870283	bod; Bodies; Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey; V.Peritnl Dialysis	4180186
42870284	ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey	4180186
42870285	Emotional well-being FAACT-peds-child; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870286	Able to laugh see funny side of things past 7D; Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870291	Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS; Things getting on top of me past 7D	4180186
42870293	Edinburgh Postnatal Depression Scale; Felt sad or miserable past 7D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870295	Edinburgh Postnatal Depression Scale; Finding; Findings; Harming myself has occurred to me past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870297	Blood; c.-2A&gt;G; Deafness, autosomal recessive 61; DFNB61; Genetics; Heredity; Heritable; Inherited; IVS2-2A&gt;G; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; PRES; QL; Qual; Qualitative; Random; Screen; Sensorineural hearing loss; SLC26A5 c.-53-2A&gt;G; SNHL; solute carrier family 26 (anion exchanger), member 5; Solute carrier family 26 member 5; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870297	SLC26A5 c.-53-2A>G Bld/T Ql	4180186
42870297	SLC26A5 基因.c.-53-2A>G:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42870299	Blood; CD140A; Document; Finding; Findings; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Next generation sequencing; NGS; PDGFR2; PDGFR-2; PDGFRA exon 18; platelet-derived growth factor receptor, alpha polypeptide; Point in time; Random; RHEPDGFRA; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870299	PDGFRA exon 18 Mut Anl Bld/T Seq	4180186
42870299	PDGFRA 基因外显子 18 突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
42870303	Y chr AZFc region Del Bld/T	4180186
42870303	Blood; Chromosom; Chromosomes; Del; Deletions; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; Y chr AZFc region; Y chromosome microdeletion	4180186
42870303	Y 染色体 AZFc 区 缺失:存在与否或特征标识:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
42870305	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.GI; Alkaline phosphatase.total; ALKP; ALP; ALP Intest; ALP Intest 2; ALP-3; ALPI; AP; Catalytic Concentration; Chemistry; IAP; II; Intest; Intestine; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870305	ALP Intest 2 SerPl-cCnc	4180186
42870305	碱性磷酸酶.小肠型 2:催化浓度:时间点:血清/血浆:定量型	4182948
42870307	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Plac; ALP Plac 2; AP; Catalytic Concentration; Chemistry; II; Phos; Phosphtase; Pl; Placent; Placenta; Placntl; PLAP; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870307	ALP Plac 2 SerPl-cCnc	4180186
42870307	碱性磷酸酶.胎盘型 2:催化浓度:时间点:血清/血浆:定量型	4182948
42870309	Neutrophils.dysplastic Bld Ql Smear	4180186
42870309	Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Neut; Neutr; Neutrophil; neutrophils dysplasia; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
42870309	嗜中性粒细胞.异型增生:存在情况或阈值:时间点:全血:序数型:显微镜检查.光学	4182948
42870310	Epidermal Mix 70 IgE Qn	4180186
42870310	(豚鼠上皮细胞+仓鼠上皮细胞+小鼠+家兔上皮细胞+大鼠) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42870310	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dander; e006; e082; e084; e6; e82; e84; Epidermal Mix 70; Epithelia; ex70; f213; Golden hamster epithelium; Hmtr Epith; Immune globulin E; Immunoglobulin E; ip70; Mice; Murine; Mus musculus; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Rodent mix; Serum; SR	4180186
42870312	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C herbarum; Canine; Cat epithelium; Cat hair; Common silver birch; D pteronyss; D pteronyssinus; d001; d1; Dog hair; e005; e1; e5; European house dust mite; f005; f5; Feline; Felis domesticus; g006; g6; HDM; Hormodendrum; House dust mite; IFR; Immune globulin E; Immunoglobulin E; Inhalant Allerg Mix 8; Inhalation allergens; ip8; Isoflavone reductase; ix8; m002; m2; Mugwort; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Regional Allergen Mix D; Rye; Serum; Silver Birch; SR; t3; Timothy; Timothy grass; w006; w6	4180186
42870312	Inhalant Allerg Mix 8 IgE Qn	4180186
42870312	(北艾+白桦+猫毛屑+多主枝孢+屋尘螨+狗毛屑+草地梯牧草+黑麦) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42870314	Inhalant Allerg Mix 6 IgE Qn	4180186
42870314	3gAllergy IP6; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C herbarum; Common silver birch; g006; g6; Hormodendrum; IFR; Immune globulin E; Immunoglobulin E; Inhalant Allerg Mix 6; IP6; Isoflavone reductase; m002; m2; Mugwort; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; rx6; Serum; Siemens IP6; Silver Birch; SR; t3; Timothy; Timothy grass; w006; w6	4180186
42870314	(草地梯牧草+北艾+多主枝孢+细链格孢+白桦) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42870318	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D had trouble starting things; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870319	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D had trouble finishing things; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870321	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D got upset too tired to do what wanted to do; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870323	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D too tired to eat; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870324	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D needed help doing usual things at home; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870326	After; Cnt; Count; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Mot; Number; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Motile; URO; Urology	4180186
42870326	Sperm Motile post ejac Smn	4180186
42870326	精子.可运动型^在射精之后:数量(计数):时间点:精液:定量型	4182948
42870327	Document; Pan; PANEL.SURVEY.CMS; Panl; PE; Pnl; Point in time; Random; Survey	4180186
42870328	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870329	CMS - head and face exam Pnl; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870330	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870332	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870334	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870335	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870338	GU; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870339	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870340	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870341	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870342	Integument; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870344	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870345	Document; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
42870347	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870348	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870356	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870365	Blood; Cardiac CRP; Cardio; Cardiology; Chemistry; CRP; Heart Disease; HS; hsCRP; hs-CRP; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React; WB; Whole blood	4180186
42870365	CRP Bld HS-mCnc	4180186
42870365	C 反应蛋白:质量浓度:时间点:全血:定量型:高灵敏度方法	4182948
42870366	Blood; COAGULATION; D Dimer; D dimer FEU; Dextro; EIA; ELFA; ELISA; Enzyme immunoassay; Fragment D-dimer; Hematology; Heme; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; WB; Whole blood	4180186
42870366	D dimer FEU Bld IA-mCnc	4180186
42870366	纤维蛋白 D-二聚体 FEU:质量浓度:时间点:全血:定量型:免疫测定法	4182948
42870367	Document; H/O; Hx; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pres illness; Present illness Hx; Random; Survey	4180186
42870368	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Campy; Campy sp DNA.diarrhea; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; pathogenic campylobacter species; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42870368	Campy sp DNA.diarrhea Stl Ql NAA+probe	4180186
42870368	弯曲菌属.DNA.致泻性:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
42870369	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Numorphan; Numorphone; Opana; Oral fluid; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn; Vicodin	4180186
42870369	oxyCODONE+oxyMORphone Sal Ql Scn	4180186
42870369	羟考酮+羟吗啡酮:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
42870372	FACIT; FACT; FACT-P - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870373	Add; Functional Assessment of Chronic Illness Therapy; P prime; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870374	Aches and pains that bother me past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870375	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Satisfied with level of comfort past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42870378	FACIT; FACIT-Sp - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870380	2; Asympt; Asymptomatic; Centers for Medicare and Medicaid Assessment; Finding; Findings; Level II (PASRR); Levels; Levl; LV; LVL; Nominal; Point in time; Random; Scn; Survey	4180186
42870382	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
42870385	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870385	FDA insert Indexing - billing	4180186
42870385	索引 - 记账单位:-:-:^FDA 包装说明书:叙述型	4182948
42870389	Finding; Findings; Integument; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.MDS	4180186
42870390	Assoc; Finding; Findings; Integument; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
42870393	Conditions related to ID/DD status; MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
42870394	Finding; Findings; MDS version 3; Ordinal; Other organic condition related to ID/DD; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
42870399	1 month; 1 month (30 days); 30 days; End Stage Renal Disease; ESRD survey; Finding; Findings; Last; month; OP; OP antibiotics prescribed past Mo; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
42870400	End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Srce; Survey; Typ	4180186
42870403	Date and time; ESRD; ESRD survey; Med; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42870405	Date and time; ESRD; ESRD survey; Med; Point in time; QNT; Quan; Quant; Quantitative; Random; Rx; Survey; Time stamp; Timestamp	4180186
42870407	ESRD; ESRD survey; Finding; Findings; Med; Nominal; Point in time; Random; Survey	4180186
42870409	Antibiotic Pnl; End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD survey; Med; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42870411	Date and time; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42870413	End Stage Renal Disease; ESRD survey; Hospitalization hx; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870415	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Sx	4180186
42870416	End Stage Renal Disease; ESRD survey; Finding; Findings; Hospitalization hx; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870417	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870423	EYE; EYE.PX; L; L optic n; Length Ratio; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42870423	L optic n Cup-disc ratio Ophthalmoscopy	4180186
42870423	视盘凹陷与视盘直径比率:长度比率:时间点:视神经.左侧:定量型:检眼镜检查法	4182948
42870424	EYE; EYE.PX; Length Ratio; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R optic n; Random; RT	4180186
42870424	R optic n Cup-disc ratio Ophthalmoscopy	4180186
42870424	视盘凹陷与视盘直径比率:长度比率:时间点:视神经.右侧:定量型:检眼镜检查法	4182948
42870425	Eye; EYE.PX; Eyeball; Fibers; Finding; Findings; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Opt disc ret nerv abnor; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; Screen; Vision; Visual; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
42870425	Opt disc ret nerv abnor Eye-L Ophthal	4180186
42870425	视乳头或者视网膜神经纤维层结构异常:发现:时间点:眼睛.左侧:序数型:检眼镜检查法	4182948
42870427	Eye; EYE.PX; Eyeball; Finding; Findings; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
42870427	L eye Macular edema Ophthalmoscopy	4180186
42870427	黄斑水肿:发现:时间点:眼睛.左侧:序数型:检眼镜检查法	4182948
42870429	Diabet retinop sev; Endocrine; Endocrinology; Eye; EYE.PX; Eyeball; Finding; Findings; L; L eye; Levels; Levl; LT; LV; LVL; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
42870429	L eye Diabet retinop sev Ophthalmoscopy	4180186
42870429	糖尿病视网膜病变严重程度:发现:时间点:眼睛.左侧:序数型:检眼镜检查法	4182948
42870430	Diabet retinop sev; Endocrine; Endocrinology; Eye; EYE.PX; Eyeball; Finding; Findings; Levels; Levl; LV; LVL; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; RT; Screen; Vision; Visual	4180186
42870430	R eye Diabet retinop sev Ophthalmoscopy	4180186
42870430	糖尿病视网膜病变严重程度:发现:时间点:眼睛.右侧:序数型:检眼镜检查法	4182948
42870431	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; St. Louis University Mental Status Examination; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
42870436	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870438	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42870440	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42870441	Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870445	Dialy; End Stage Renal Disease; ESRD survey; No; Nominal; Num; Point in time; Random; Survey; Telecommunication number; Telephone number	4180186
42870447	Dialy; End Stage Renal Disease; ESRD survey; EXT; No; Nominal; Num; Phone #; Phone # ext; Point in time; Random; Survey; Telecommunication number; Telephone number	4180186
42870448	Cnt; Count; Dialy; End Stage Renal Disease; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870452	Date and time; Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42870454	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Occupation; Point in time; Random; Survey; Work	4180186
42870455	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870456	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870458	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42870459	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42870460	Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870461	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870464	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870465	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Occupation; Point in time; Random; Survey; Typ; Work	4180186
42870466	Dialy; End Stage Renal Disease; ESRD survey; Ident; Identifier; National Provider Identifier; Nominal; Point in time; Random; Survey	4180186
42870467	Dialy; End Stage Renal Disease; ESRD survey; Ident; Identifier; Nominal; Point in time; Random; Survey	4180186
42870468	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Hospitalization hx; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42870469	Cnt; Count; Dialy; End Stage Renal Disease; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870470	Dialy; End Stage Renal Disease; ESRD survey; No; Nominal; Num; Phone #; Point in time; Random; Survey; Telecommunication number; Telephone number	4180186
42870471	End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Source of info; Srce; Survey	4180186
42870473	End Stage Renal Disease; ESRD survey; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Typ	4180186
42870475	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Seel sad, unhappy last 2W or more; Survey; SURVEY.MTLHLTH	4180186
42870478	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Thoughts of suicide last 2W	4180186
42870479	Difficulty sleeping last 2W; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870481	Finding; Findings; Lost some appetite last 2W; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870486	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Worry about dying losing control last 2W	4180186
42870489	Finding; Findings; Jumpy startled easily in the last 2W; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870490	Avoid places bad experience last 2W; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870492	Can't get things out of mind last 2W; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; T prime	4180186
42870493	Finding; Findings; Must repeat certain acts last 2W; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870494	Finding; Findings; Inspection; My Mood Monitor Checklist; Need to check recheck things last 2W; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870496	Finding; Findings; In your life - unusually irritable or angry; My Mood Monitor Checklist; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42870497	Finding; Findings; In your life - unusually excited; My Mood Monitor Checklist; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42870499	Act/Nor; Clot; Clottable; Coag; Coagulation assay; Control; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RlTm; TCT; Throm; Thrombin clotting time; Thrombin time; Tilt tube; TT	4180186
42870499	Thrombin time/normal	4180186
42870499	凝血酶诱导型凝血过程 实际的/正常的:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
42870503	Activated partial thromboplastin time; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
42870503	aPTT-LA imm NP PPP	4180186
42870503	表面诱导型凝血过程.狼疮敏感性.因子替换^紧接着在添加正常血浆之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
42870506	VGKC Ab Ser-aCnc	4180186
42870506	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; k; K+; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; VG; V-G; VGKC	4180186
42870506	电压门控钾离子通道 抗体:任意型浓度:时间点:血清:定量型	4182948
42870509	HHV8 IgG Titr CSF IF	4180186
42870509	疱疹病毒 8 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
42870509	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Herpesvirus; HHV; HHV8; HHV-8; Human herpes virus; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Kaposi's Sarcoma-Associated Herpesvirus; KSHV; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42870510	20M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42870510	Pyruvate 20M p chal Bld-mCnc	4180186
42870510	丙酮酸^在XXX刺激之后20分钟:质量浓度:时间点:全血:定量型	4182948
42870511	活化凝血时间.白陶土诱导型:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
42870511	ACT; ACT Kaolin Ind; Activ; Activated coagulation time; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation assay; Coagulation time; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; RlTm; R-time; Tilt tube	4180186
42870511	Rel ACT PPP Kaolin induc	4180186
42870512	Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Xarelto	4180186
42870512	Rivaroxaban PPP Chro-aCnc	4180186
42870512	利伐沙班:任意型浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
42870513	Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; Pradax; Pradaxa; Prazaxa; QNT; Quan; Quant; Quantitative; Random	4180186
42870513	Dabigatran PPP Chro-aCnc	4180186
42870513	达比加群:任意型浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
42870515	ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; PFGE pnl; PH; Pnl; Point in time; Public Health; PublicHealth; Random	4180186
42870515	PFGE pnl Islt	4180186
42870515	脉冲场凝胶电泳组套:-:时间点:分离株:-	4182948
42870516	ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nat (USA) PFGE pattern; Nominal; PH; Point in time; Public Health; PublicHealth; Random	4180186
42870516	Nat (USA) PFGE pattern Islt	4180186
42870516	全国（美国） PFGE 模式:标识符:时间点:分离株:名义型	4182948
42870519	Lymphocyte prolif mitogen pnl Bld FC	4180186
42870519	Blood; Dynamic; FC; LPA; LPT; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Lymphocyte prolif mitogen pnl; Pan; PANEL.SEROLOGY; Panl; PHA; Pnl; Point in time; Random; Serology; WB; Whole blood	4180186
42870519	淋巴细胞增殖丝裂原组套:-:时间点:全血:-:流式细胞测量术	4182948
42870521	Blood; Dynamic; FC; Leu4; Leu-4; LPA; LPT; LPT PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Number fraction; Percent; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Stim; T3; WB; Whole blood	4180186
42870521	LPT PW/CD3 NFr Bld FC	4180186
42870521	淋巴细胞增殖.美洲商陆丝裂原刺激/CD3:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
42870522	Lymphocyte prolif Ag pnl Bld FC	4180186
42870522	Ag; Blood; Dynamic; FC; LPA; LPT; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Lymphocyte prolif Ag pnl; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; PHA; Pnl; Point in time; Random; WB; Whole blood	4180186
42870522	淋巴细胞增殖抗原组套:-:时间点:全血:-:流式细胞测量术	4182948
42870524	Cplaint per dispatch; Finding; Findings; NEMSIS; Nominal; Point in time; Random	4180186
42870524	Cplaint per dispatch Reported.dispatch	4180186
42870524	调度时的主诉:发现:时间点:^患者:名义型:报告法.调度	4182948
42870525	2q37.3; AGT; AGT1; AGXT1; alanine-glyoxylate aminotransferase; Blood; Document; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; Inherited; L-alanine: glyoxylate aminotransferase 1; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; oxalosis I; PCR; PH1; Point in time; primary hyperoxaluria type 1; Random; serine:pyruvate aminotransferase; SPAT; SPT; Tissue; Tissue, unspecified; TLH6; WB; Whole blood; Whole blood or Tissue	4180186
42870525	AGXT gene Fam Mut Anl Bld/T	4180186
42870525	AGXT 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870526	FDA label OTC medical device	4180186
42870526	DOCUMENT.REGULATORY; FDA label; Narrative; Over-the-counter; Report	4180186
42870526	非处方医疗装置标签:-:-:^FDA 产品标签:叙述型	4182948
42870527	FDA label Prescription medical device	4180186
42870527	DOCUMENT.REGULATORY; FDA label; Narrative; Report; Rx	4180186
42870527	处方医疗装置标签:-:-:^FDA 产品标签:叙述型	4182948
42870529	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Dir; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870529	LDLc SerPl Direct Assay-sCnc	4180186
42870529	胆固醇.LDL 之中的:物质的量浓度:时间点:血清/血浆:定量型:直接分析法	4182948
42870530	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; Epstein-Barr virus; Hetero; Heteroph; Hetr; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; WB; Whole blood	4180186
42870530	Heteroph Ab Bld Ql IA	4180186
42870530	异嗜性 抗体:存在情况或阈值:时间点:全血:序数型:免疫测定法	4182948
42870531	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; f017; f17; f428; Filbert; Hazel nut; Hazelnut; Hazelnut (rCor a) 1; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
42870531	Hazelnut (rCor a) 1 IgE Qn	4180186
42870531	榛子 重组 (rCor a) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
42870532	C0; Carnitine Free; Carnitine.total; Ejaculate; FC; FERTILITY TESTING; FR; Genitourinary; GU; Level; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Substance concentration; URO; Urology	4180186
42870532	Carnitine Free Smn-sCnc	4180186
42870532	肉碱.游离型 (C0):物质的量浓度:时间点:精液:定量型	4182948
42870533	Clot; Clottable; COAGULATION; Coagulation assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube	4180186
42870533	Rosner index PPP	4180186
42870533	罗斯纳指数:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
42870534	3 days; 72 hours; 72HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Mass rate; mRate; N; N2; Nit; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
42870534	N2 72h Stl-mRate	4180186
42870534	氮:质量速率:72小时:大便:定量型	4182948
42870538	Encounter; Evaluation and management; Evaluation and management note; History; Narrative; NEMSIS; notes; Point in time; Random; Report; Summ of encounter note; Summary; Visit note	4180186
42870538	Summ of encounter note	4180186
42870538	就医记录摘要:历史记录:时间点:{环境}:叙述型:{角色}	4182948
42870543	Blood; CD105; CD105 Ag; Document; END; Endoglin; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; HHT1; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; ORW; ORW1; Osler-Rendu-Weber syndrome 1; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870543	ENG Fam Mut Anl Bld/T	4180186
42870543	ENG 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870544	Blood; Christmas factor; Coagulation Factor 9 gene; coagulation factor IX; Coagulation Factor IX gene; Document; Fam Mut Anl; Finding; Findings; FIX; Genetics; HEMB; Heredity; Heritable; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; P19; PCR; Point in time; PTC; Random; THPH8; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870544	F9 gene Fam Mut Anl Bld/T	4180186
42870544	F9 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870546	Blood; Document; Fam Mut Anl; FH; FHC; Finding; Findings; Genetics; Heredity; Heritable; Inherited; LDLCQ2; LMTED; Low Density Lipoprotein Receptor; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870546	LDLR gene Fam Mut Anl Bld/T	4180186
42870546	LDLR 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870551	Blood; COAGULATION; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; Random; TEG after heparinase pnl; WB; Whole blood	4180186
42870551	TEG after heparinase pnl Bld	4180186
42870551	肝素酶添加后血栓弹力描记术组套:-:时间点:全血:-	4182948
42870553	Lactose tolerance pnl SerPl-sCnc	4180186
42870553	CHEMISTRY.CHALLENGE TESTING; Lactose tolerance pnl; Level; LTT; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870553	乳糖耐量组套^剂量未加详细说明:物质的量浓度:时间点:血清/血浆:-	4182948
42870554	CHEMISTRY.CHALLENGE TESTING; Lactose tolerance pnl; Level; LTT; Mass concentration; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870554	Lactose tolerance pnl SerPl-mCnc	4180186
42870554	乳糖耐量组套^剂量未加详细说明:质量浓度:时间点:血清/血浆:-	4182948
42870557	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
42870557	Ma1 Ab Ser Ql IB	4180186
42870557	Ma1 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
42870558	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot	4180186
42870558	Ma1 Ab CSF Ql IB	4180186
42870558	Ma1 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
42870559	Ascites; Ascitic fluid; Ascitis; Chemistry; ENO2; enolase 2; Gamma-enolase; Level; Mass concentration; NSE; Peritoneal fluid; Phosphopyruvate dehydratase; Phosphopyruvate hydratase.gamma subunit; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Spec; Tumor marker	4180186
42870559	NSE Prt-mCnc	4180186
42870559	烯醇化酶.神经元特异性:质量浓度:时间点:腹膜液:定量型	4182948
42870561	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870561	C albicans DNA Vag Ql NAA+probe	4180186
42870561	白色假丝酵母 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42870563	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bact; BV score; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Scale; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870563	BV score Vag Ql NAA+probe	4180186
42870563	细菌性阴道病评分:评分:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42870564	3 Self-Sustaining Sequence Replication; 3SR SR; A vaginae; A vaginae DNA; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870564	A vaginae DNA Vag Ql NAA+probe	4180186
42870564	阴道阿托波氏菌 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42870565	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Assoc; Bact; BVAB2; BVAB2 DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870565	BVAB2 DNA Vag Ql NAA+probe	4180186
42870565	细菌性阴道病相关细菌 2 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42870566	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mega1; Mega1 DNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870566	Mega1 DNA Vag Ql NAA+probe	4180186
42870566	巨球菌属 1 型 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42870567	Bact; Genital vaginal; Gyn; Gynecology; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870567	Bacterial vaginosis Vag-Imp	4180186
42870567	细菌性阴道病:印象:时间点:阴道:序数型	4182948
42870568	Chemistry; Gyn; Gynecology; Malig; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; ROMA; ROMA score; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870568	ROMA score premen SerPl	4180186
42870568	卵巢恶性肿瘤风险算法评分^绝经前:评分:时间点:血清/血浆:定量型	4182948
42870569	Chemistry; Gyn; Gynecology; Malig; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; ROMA; ROMA score; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870569	ROMA score postmen SerPl	4180186
42870569	卵巢恶性肿瘤风险算法评分^绝经后:评分:时间点:血清/血浆:定量型	4182948
42870570	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bact; BV DNA + score Pnl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870570	BV DNA + score Pnl Vag NAA+probe	4180186
42870570	细菌性阴道病 DNA 与评分组套:-:时间点:阴道:-:探针法.基因扩增.靶向	4182948
42870573	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dependal-M; Furoxone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
42870573	Furazolidone Susc Islt	4180186
42870573	呋喃唑酮:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
42870574	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C jejuni; Campy; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
42870574	C jejuni Ab Ser Ql CF	4180186
42870574	空肠弯曲菌 抗体:存在情况或阈值:时间点:血清:序数型:补体结合试验	4182948
42870576	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42870576	HEV RNA Bld Ql NAA+probe	4180186
42870576	戊型肝炎病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42870579	ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random	4180186
42870579	Local assigning authority Islt	4180186
42870579	本地分配机构:标识符:时间点:分离株:名义型	4182948
42870580	ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nat PFGE cluster/CDC cluster; Nominal; PH; Point in time; Public Health; PublicHealth; Random	4180186
42870580	Nat PFGE cluster/CDC cluster Islt	4180186
42870580	全国（美国） PFGE 簇代码或 CDC 簇:标识符:时间点:分离株:名义型	4182948
42870583	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
42870583	HIV 1 & 2 Ab SerPl IA.rapid	4180186
42870583	HIV 1 型 与 2 型 抗体:存在与否或特征标识:时间点:血清/血浆:名义型:免疫测定法.快速	4182948
42870584	FDA label Statement of identity	4180186
42870584	DOCUMENT.REF; FDA label; Narrative; Report	4180186
42870584	特性声明小节:-:-:^FDA 产品标签:叙述型	4182948
42870585	DOCUMENT.REF; FDA label; Narrative; Report	4180186
42870585	FDA label Health claim	4180186
42870585	健康声明小节:-:-:^FDA 产品标签:叙述型	4182948
42870587	Agf98; Celiac; Celiac disease; Dermatitis Herpetiformis; DGP; DH; F98; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; Gliadine; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Protein-glutamine gamma glutamyltransferase; Random; Report; Serology; Serum; SR; TG2; tTG; tTG antibodies; tTG IgA+DGP IgA+IgG; tTg/DGP	4180186
42870587	tTG IgA+DGP IgA+IgG Ser-Imp	4180186
42870587	组织谷氨酰胺转移酶抗体.IgA+麦醇溶蛋白肽抗体.IgA 与 IgG:印象:时间点:血清:叙述型	4182948
42870589	Drugs of abuse Pnl Ur Scn	4180186
42870589	DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
42870589	滥用药物组套:-:时间点:尿液:-:毒理学筛查试验	4182948
42870590	Cell Cnt Pnl Pcar	4180186
42870590	Cell Cnt Pnl; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; PCAR; Pericardial Fluid; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42870590	细胞计数组套:-:时间点:心包液:定量型	4182948
42870593	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870593	FDA insert Diagram of device	4180186
42870593	装置示意图:-:-:^FDA 包装说明书:叙述型	4182948
42870594	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870594	FDA insert Risks	4180186
42870594	风险:-:-:^FDA 包装说明书:叙述型	4182948
42870595	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870595	FDA insert Compatible accessories	4180186
42870595	兼容附件:-:-:^FDA 包装说明书:叙述型	4182948
42870596	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870596	FDA insert Alarms	4180186
42870596	警报:-:-:^FDA 包装说明书:叙述型	4182948
42870597	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870597	FDA insert Troubleshooting	4180186
42870597	故障诊断与维修:-:-:^FDA 包装说明书:叙述型	4182948
42870598	Disposal/Waste handling; DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
42870598	FDA insert Disposal/Waste handling	4180186
42870598	销毁与废弃物处理:-:-:^FDA 包装说明书:叙述型	4182948
42870600	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Congenital rubella syndrome; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; German measles; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RUBV; Screen; SUDS	4180186
42870600	RUBV IgM Fld Ql IA	4180186
42870600	风疹病毒 抗体.IgM:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
42870601	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; MuV; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS	4180186
42870601	MuV IgM Fld Ql IA	4180186
42870601	流行性腮腺炎病毒 抗体.IgM:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
42870606	Dicarboxyoleylcarn Amn-sCnc	4180186
42870606	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18:1DC; C18:1-DC; Chemistry; Dicarboxylic carnitine; Dicarboxyoleoylcarnitine; i; Level; Octadecenediolcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
42870606	二羧基油酰肉碱 (C18:1-DC):物质的量浓度:时间点:羊水:定量型	4182948
42870607	Orotate SerPl-sCnc	4180186
42870607	Chemistry; Level; Orotic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870607	乳清酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870608	C18:1DC; C18:1-DC; Chemistry; Dicarboxylic carnitine; Dicarboxyoleoylcarnitine; i; Level; Octadecenediolcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
42870608	Dicarboxyoleylcarn Ur-sCnc	4180186
42870608	二羧基油酰肉碱 (C18:1-DC):物质的量浓度:时间点:尿液:定量型	4182948
42870612	C8DC; C8-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870612	Suberylcarn CSF-sCnc	4180186
42870612	环庚基肉碱 (C8-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
42870615	2OH-isovalerate CSF-sCnc	4180186
42870615	2-HIA; 2-hydroxy-isovalerate; 2-hydroxyisovaleric acid; 2OH-isovalerate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870615	2-羟基异戊酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42870618	2HPA; 2-hydroxy-phenylacetate; 2-hydroxyphenylacetic acid; 2OH-phenylacetate; DRUG/TOXICOLOGY; Drugs; Hydroxyphenylacetic acid; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870618	2OH-phenylacetate SerPl-sCnc	4180186
42870618	2-羟基苯乙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870620	2OH-sebacate SerPl-sCnc	4180186
42870620	2OH-sebacate; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870620	2-羟基癸二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870623	2Me3OH-butyrate; 2-Methyl,3-Hydroxy butyrate; 2-methyl,3-hydroxybutyric acid; 2-Methyl-3-Hydroxybutyrate; 3-Hydroxy-2-Methylbutanoate; 3-Hydroxy-2-Methylbutanoic acid; 3-Hydroxy-2-Methylbutyrate; 3-Hydroxy-2-Methyl-butyrate; 3-hydroxy-2-methylbutyric acid; 3-Hydroxy-2-Methyl-butyric acid; alpha-methyl-beta-hydroxybutyrate; alpha-methyl-beta-hydroxybutyric acid; C5OH; C5-OH; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; HMBA; Hydroxybutyric acid; II; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870623	2Me3OH-butyrate CSF-sCnc	4180186
42870623	2-甲基-3-羟基丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42870625	2Me-butyrylglycine SerPl-sCnc	4180186
42870625	2-MBG; 2Me-butyrylglycine; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870625	2-甲基丁酰甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870627	C14:2; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Tdecadienoylcarn	4180186
42870627	Tdecadienoylcarn CSF-sCnc	4180186
42870627	十四烷二烯酰肉碱 (C14:2):物质的量浓度:时间点:脑脊液:定量型	4182948
42870628	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C14:2; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tdecadienoylcarn	4180186
42870628	Tdecadienoylcarn Amn-sCnc	4180186
42870628	十四烷二烯酰肉碱 (C14:2):物质的量浓度:时间点:羊水:定量型	4182948
42870630	Dicarboxytetradecenoylcarn/Creat Ur-sRto	4180186
42870630	C14:1DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Very long-chain acyl-CoA dehydrogenase; VLCAD	4180186
42870630	二羧基十四烯酰肉碱 (C14:1-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
42870633	2,5-DOB; Addiction; brolamfetamine; Bromo DMA; Bromo-DMA; Dimethoxybromoamphetamine; DOB; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; II; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
42870633	2,5-DOB Ur Ql	4180186
42870633	2,5-二甲氧基-4-溴安非他明:存在情况或阈值:时间点:尿液:序数型	4182948
42870634	21DOC SerPl-sCnc	4180186
42870634	21-DB; 21DOC; Chemistry; DOC; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870634	21-脱氧皮质酮:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870750	Bordetella pertussis+Bordetella parapertussis.filamentous hemagglutinin Ab	4180186
42870801	CFTR gene.c.394delTT	4180186
42870804	CCR5 gene.c.794_825del	4180186
42870850	Rabies virus Ab.IgM	4180186
42870864	SLC26A5 gene.c.-53-2A>G	4180186
42871105	European tick borne encephalitis virus Ab.IgM	4180186
42871111	Rabies virus Ab.IgG	4180186
42872381	Numbness and tingling sensation of skin (finding)	4180186
42872381	Numbness and tingling of skin	4180186
42872382	Vaginal pessary in situ (finding)	4180186
42872384	Partner relationship problem (finding)	4180186
42872384	Personal condition, partner relational problem	4180186
42872386	Acquired penile adhesion (disorder)	4180186
42872387	Opioid dependence, on agonist therapy (disorder)	4180186
42872391	Sebaceous naevus	4180186
42872391	Sebaceous nevus (disorder)	4180186
42872392	Congenital labial adhesion (disorder)	4180186
42872395	Flu vaccine needed	4180186
42872395	Influenza vaccine needed (situation)	4180186
42872398	Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum (disorder)	4180186
42872399	Primary adenocarcinoma of pancreas (disorder)	4180186
42872399	Pancreatic adenocarcinoma	4180186
42872400	Placental abnormality, antepartum (finding)	4180186
42872401	Mild dehydration (disorder)	4180186
42872403	Chlamydia trachomatis infection in pregnancy (disorder)	4180186
42872405	Anemia, pre-end stage renal disease on erythropoietin protocol (disorder)	4180186
42872405	Anemia, pre-ESRD erythropoietin protocol	4180186
42872406	Foetal growth retardation, antenatal	4180186
42872406	Fetal growth retardation, antenatal (disorder)	4180186
42872409	Atypical ductal hyperplasia of breast (disorder)	4180186
42872412	Severe mixed bipolar I disorder (disorder)	4180186
42872413	Severe depressed bipolar I disorder (disorder)	4180186
42872416	Non-allergic rhinitis (disorder)	4180186
42872419	Stenosis of intervertebral foramina (disorder)	4180186
42872422	Pseudomonas otitidis (organism)	4180186
42872424	Serratia nematodiphila (organism)	4180186
42872426	Sporosarcina thermotolerans (organism)	4180186
42872427	Cerebral hemorrhage following injury (disorder)	4180186
42872427	Traumatic cerebral hemorrhage	4180186
42872427	Traumatic intracerebral haemorrhage	4180186
42872427	Traumatic intracerebral hemorrhage	4180186
42872427	Traumatic cerebral haemorrhage	4180186
42872427	Cerebral haemorrhage following injury	4180186
42872429	Tsukamurella spongiae (organism)	4180186
42872430	Neisseria wadsworthii (organism)	4180186
42872432	Spontaneous hemorrhage	4180186
42872432	Nontraumatic hemorrhage (morphologic abnormality)	4180186
42872432	Spontaneous haemorrhage	4180186
42872432	Nontraumatic haemorrhage	4180186
42872433	Nontraumatic hematoma (morphologic abnormality)	4180186
42872433	Nontraumatic haematoma	4180186
42872434	Intracranial hematoma (disorder)	4180186
42872434	Intracranial haematoma	4180186
42872435	Foetal or neonatal period	4180186
42872435	Fetal or neonatal period (qualifier value)	4180186
42872437	Perinatal cutaneous petechiae (disorder)	4180186
42872438	Perinatal hemorrhage (disorder)	4180186
42872438	Perinatal haemorrhage	4180186
42872439	Structure of pericranium (body structure)	4180186
42872440	Structure of subpericranial space (body structure)	4180186
42872440	Structure of subpericranial space	4180186
42872440	Subpericranial space (body structure)	4180186
42872445	Positron emission tomography with computed tomography (procedure)	4180186
42872445	PET CT	4180186
42872447	Single photon emission computed tomography with computed tomography (procedure)	4180186
42872447	SPECT CT	4180186
42872448	Primary intertransverse fusion of lumbar spine (procedure)	4180186
42872449	Exploration of skin of neck (procedure)	4180186
42872451	Porphyromonas somerae (organism)	4180186
42872454	Ornithinibacillus bavariensis (organism)	4180186
42872455	Ornithinibacillus californiensis (organism)	4180186
42872458	Genus Wautersiella (organism)	4180186
42872458	Genus Wautersiella	4180186
42872462	Genus Paenalcaligenes	4180186
42872462	Genus Paenalcaligenes (organism)	4180186
42872463	Paenalcaligenes hominis (organism)	4180186
42872465	Genus Nosocomiicoccus (organism)	4180186
42872465	Genus Nosocomiicoccus	4180186
42872466	Nosocomiicoccus ampullae (organism)	4180186
42872468	Bacillus pycnus	4180186
42872468	Rummeliibacillus pycnus (organism)	4180186
42872469	Nephrostomy using ultrasound guidance (procedure)	4180186
42872469	Ultrasound guided nephrostomy	4180186
42872473	Angulation osteotomy of diaphysis (procedure)	4180186
42872473	Angulation diaphyseal osteotomy	4180186
42872474	Rotational osteotomy of diaphysis (procedure)	4180186
42872474	Rotation diaphyseal osteotomy	4180186
42872475	Fiberoptic endoscopic dilation of esophagus (procedure)	4180186
42872475	Fibreoptic endoscopic dilation of oesophagus	4180186
42872475	Dilatation of oesophagus using fibreoptic endoscope	4180186
42872481	Mycobacterium monacense (organism)	4180186
42872485	Not for cardiopulmonary resuscitation (finding)	4180186
42872485	Not for attempted cardiopulmonary resuscitation	4180186
42872486	E. coli serogroup O6	4180186
42872486	Escherichia coli serotype O6	4180186
42872486	Escherichia coli O6	4180186
42872486	Escherichia coli serogroup O6 (organism)	4180186
42872486	E. coli O6	4180186
42872487	Escherichia coli serogroup O8 (organism)	4180186
42872487	Escherichia coli serotype O8	4180186
42872487	E. coli serogroup O8	4180186
42872487	E. coli O8	4180186
42872487	Escherichia coli O8	4180186
42872488	Escherichia coli serotype O104:H4 (organism)	4180186
42872488	E. coli serotype O104:H4	4180186
42872492	Cesarean section through inverted T shaped incision of uterus (procedure)	4180186
42872492	Caesarean section through inverted T shaped incision of uterus	4180186
42872496	Laparoscopic excision of ovary	4180186
42872496	Laparoscopic excision of ovary (procedure)	4180186
42872498	Sialendoscopic removal of calculus from parotid gland using wire basket (procedure)	4180186
42872501	Sialendoscopic removal of calculus from submandibular gland using wire basket (procedure)	4180186
42872502	Sialendoscopic removal of calculus from submandibular gland using grasping forceps (procedure)	4180186
42872505	Sialendoscopically assisted removal of calculus from submandibular duct by intraoral approach (procedure)	4180186
42872506	Sialendoscopic laser lithotripsy of calculus of parotid gland (procedure)	4180186
42872507	Sialendoscopic laser lithotripsy of calculus of submandibular gland (procedure)	4180186
42872508	Laparoscopic subtotal excision of gallbladder	4180186
42872508	Laparoscopic subtotal excision of gallbladder (procedure)	4180186
42872509	Laparoscopic cholecystostomy (procedure)	4180186
42872510	Laser recanalization of intestine (procedure)	4180186
42872510	Laser recanalisation of intestine	4180186
42872515	Computed tomography arteriography of coronary artery bypass graft with contrast (procedure)	4180186
42872515	CT angiography of coronary artery bypass graft with contrast	4180186
42872515	Computed tomography arteriography of coronary artery bypass graft with contrast	4180186
42872515	Computed tomography angiography of coronary artery bypass graft with contrast (procedure)	4180186
42872515	Computed tomography angiography of coronary artery bypass graft with contrast	4180186
42872515	CT arteriogram of coronary artery bypass graft with contrast	4180186
42872516	Adjustment to internal fixation device (procedure)	4180186
42872517	Ligation of sphenopalatine artery (procedure)	4180186
42872517	SPA (sphenopalatine artery) ligation	4180186
42872517	Sphenopalatine artery ligation	4180186
42872518	Conversion to cemented total replacement of joint (procedure)	4180186
42872520	Manipulation of joint using traction (procedure)	4180186
42872522	Endarterectomy of suprarenal artery (procedure)	4180186
42872523	Endoscopic destruction of lesion of prostate (procedure)	4180186
42872527	Exploration of skin of head (procedure)	4180186
42872530	Osteoarthritis of patellofemoral joint (disorder)	4180186
42872530	Osteoarthritis of patellofemoral joint	4180186
42872531	Narrowband ultraviolet B phototherapy (procedure)	4180186
42872531	Narrowband UVB phototherapy	4180186
42872535	Drainage of dental abscess by intraoral approach (procedure)	4180186
42872536	Magnetic resonance imaging of aorta with contrast	4180186
42872536	Magnetic resonance imaging of aorta with contrast (procedure)	4180186
42872538	Magnetic resonance imaging of abdominal aorta with contrast (procedure)	4180186
42872538	Magnetic resonance imaging of abdominal aorta with contrast	4180186
42872539	Conversion from hybrid total knee replacement (procedure)	4180186
42872540	High ligation and stripping of long saphenous vein and multiple avulsions of varicose veins (procedure)	4180186
42872542	Closed laceration AND/OR contusion (morphologic abnormality)	4180186
42872543	Closed contusion (morphologic abnormality)	4180186
42872544	Open contusion (morphologic abnormality)	4180186
42872545	Listeria monocytogenes serotype 1/2a (organism)	4180186
42872550	Listeria monocytogenes serotype 3b (organism)	4180186
42872552	Listeria monocytogenes serotype 4a (organism)	4180186
42872554	Listeria monocytogenes serotype 4ab (organism)	4180186
42872555	Listeria monocytogenes serotype 4d (organism)	4180186
42872556	Listeria monocytogenes serotype 4e (organism)	4180186
42872558	Sialendoscope (physical object)	4180186
42872559	Grasping forceps (physical object)	4180186
42872561	Traumatic brain injury with prolonged loss of consciousness (more than 24 hours) without return to pre-existing conscious level (disorder)	4180186
42872562	Sutured wound (morphologic abnormality)	4180186
42872564	Open laceration AND/OR contusion (morphologic abnormality)	4180186
42872565	Endoscopic ultrasonography (procedure)	4180186
42872565	Endoscopic ultrasound	4180186
42872565	Endoscopic ultrasound scan	4180186
42872567	Magnetic resonance imaging T2 mapping (procedure)	4180186
42872567	MRI T2 mapping	4180186
42872575	Digital breast tomosynthesis (procedure)	4180186
42872576	Conversion to hybrid total knee replacement (procedure)	4180186
42872583	Therapeutic fiberoptic endoscopic surgical procedure on upper gastrointestinal tract (procedure)	4180186
42872583	Therapeutic fibreoptic endoscopic surgical procedure on upper gastrointestinal tract	4180186
42872583	Therapeutic operation on upper gastrointestinal tract using fibreoptic endoscope	4180186
42872584	Registration of visual impairment (procedure)	4180186
42872586	Removal of foreign body from urinary tract (procedure)	4180186
42872588	Removal of foreign body from skin of head (procedure)	4180186
42872590	Removal of slough from burnt skin (procedure)	4180186
42872593	Removal of intermaxillary fixation screw (procedure)	4180186
42872595	Curettage of neoplasm of bone (procedure)	4180186
42872595	Curettage of tumour of bone	4180186
42872600	Excision of lesion of anterior abdominal wall (procedure)	4180186
42872602	Operation on pulmonary vein great vessel (procedure)	4180186
42872605	Plains bison	4180186
42872605	Bison bison subspecies bison	4180186
42872605	Bison bison subspecies bison (organism)	4180186
42872606	Bundibugyo ebolavirus (organism)	4180186
42872609	Biopsy of lesion of cerebellum (procedure)	4180186
42872612	Biopsy of lesion of temporal lobe (procedure)	4180186
42872614	Biopsy of lesion of parietal lobe (procedure)	4180186
42872616	Biopsy of lesion of frontal lobe (procedure)	4180186
42872621	Genus Parechovirus (organism)	4180186
42872621	Parechovirus	4180186
42872622	Human parechovirus (organism)	4180186
42872627	Irkut virus (organism)	4180186
42872631	Lujo virus (organism)	4180186
42872632	Biopsy of lesion of skin (procedure)	4180186
42872632	Biopsy of skin lesion	4180186
42872635	Biopsy of lesion of joint (procedure)	4180186
42872637	Shave biopsy and cauterization of skin (procedure)	4180186
42872637	Shave biopsy and cauterisation of skin	4180186
42872639	Dressing of skin of neck (procedure)	4180186
42872640	Application of vacuum assisted closure device to skin of head (procedure)	4180186
42872640	Application of negative pressure wound dressing to skin of head	4180186
42872644	Open biopsy of lesion of peritoneal cavity (procedure)	4180186
42872645	Open ligation of fallopian tube (procedure)	4180186
42872648	Open drainage of abscess of abdomen (procedure)	4180186
42872650	Open removal of clip from fallopian tube (procedure)	4180186
42872651	Open removal of ring from fallopian tube (procedure)	4180186
42872653	Open embolectomy of artery (procedure)	4180186
42872655	Open embolectomy of inferior mesenteric artery (procedure)	4180186
42872656	Open embolectomy of superior mesenteric artery (procedure)	4180186
42872657	Open embolectomy of suprarenal artery (procedure)	4180186
42872658	Open embolization of artery (procedure)	4180186
42872658	Open embolisation of artery	4180186
42872663	Open operation on intraarticular structure (procedure)	4180186
42872664	Open reduction of injury to epiphyseal growth plate (procedure)	4180186
42872666	Insulin pump present (finding)	4180186
42872667	Diagnostic extraction of bone marrow (procedure)	4180186
42872668	Diagnostic puncture of bone (procedure)	4180186
42872670	Therapeutic endoscopic operation on cavity of joint (procedure)	4180186
42872672	Therapeutic drilling of bone (procedure)	4180186
42872674	Excision of lesion of skin of head (procedure)	4180186
42872677	Excision of lipoma of subcutaneous tissue of head (procedure)	4180186
42872684	Fusion of joint with extraarticular bone graft (procedure)	4180186
42872685	Reconstruction of intraarticular ligament (procedure)	4180186
42872688	Extraamniotic injection of abortifacient (procedure)	4180186
42872692	Bypass of axillary artery (procedure)	4180186
42872696	Bypass of superior mesenteric artery (procedure)	4180186
42872697	Bypass of suprarenal artery (procedure)	4180186
42872697	Bypass of adrenal artery	4180186
42872699	Bypass of carotid artery (procedure)	4180186
42872701	Open excision of lesion of uterus (procedure)	4180186
42872703	Closed traumatic abnormality (morphologic abnormality)	4180186
42872705	Atypical lobular hyperplasia of breast (disorder)	4180186
42872708	Repair of artery using vein graft (procedure)	4180186
42872710	Repair of brachial artery (procedure)	4180186
42872712	Repair of common iliac artery (procedure)	4180186
42872713	Repair of vertebral artery (procedure)	4180186
42872722	Severe major depression (disorder)	4180186
42872723	Influenza caused by Influenza A virus subtype H7 (disorder)	4180186
42872723	Influenza caused by Influenza A virus subtype H7	4180186
42872724	Influenza caused by Influenza A virus subtype H9 (disorder)	4180186
42872724	Influenza caused by Influenza A virus subtype H9	4180186
42872725	Structure of auriculotemporal region (body structure)	4180186
42872727	Mastoid region structure (body structure)	4180186
42872728	Supra-auricular region structure (body structure)	4180186
42872729	Temple region	4180186
42872729	Structure of temporal region (body structure)	4180186
42872729	Temple region structure	4180186
42872730	Lamina dura	4180186
42872730	Structure of lamina dura of tooth socket (body structure)	4180186
42872732	Injury of cervical region of back (disorder)	4180186
42872733	Entire fascia of foot (body structure)	4180186
42872735	Assessment using impact of event scale revised (procedure)	4180186
42872737	World Health Organization surgical safety checklist first edition (assessment scale)	4180186
42872737	World Health Organisation surgical safety checklist first edition	4180186
42872739	Rockall score (assessment scale)	4180186
42872740	Assessment using Rockall score (procedure)	4180186
42872743	Housing dependency scale score (observable entity)	4180186
42872744	Thirty second chair stand test (assessment scale)	4180186
42872748	Children's global assessment scale (assessment scale)	4180186
42872748	CGAS - children's global assessment scale	4180186
42872753	Assessment using action for dysphasic adults comprehension battery (procedure)	4180186
42872753	Assessment using ADA (action for dysphasic adults) comprehension battery	4180186
42872754	Action for dysphasic adults comprehension battery score (observable entity)	4180186
42872754	ADA (action for dysphasic adults) comprehension battery score	4180186
42872759	Assessment using conversation analysis profile for people with cognitive impairment (procedure)	4180186
42872760	Whooley depression screen (assessment scale)	4180186
42872761	Mobility inventory for agoraphobia (assessment scale)	4180186
42872765	Assessment using voice handicap index (procedure)	4180186
42872765	Assessment using VHI (voice handicap index)	4180186
42872767	Framingham coronary heart disease 10 year risk score (observable entity)	4180186
42872769	Trihydroxycoprostanic acid (substance)	4180186
42872770	Hyocholic acid (substance)	4180186
42872771	Lymphocyte antigen CD138 (substance)	4180186
42872771	CD138 (cluster of differentiation 138) antigen	4180186
42872771	Cluster of differentiation 138	4180186
42872771	Cluster of differentiation 138 antigen	4180186
42872771	CD138 - cluster of differentiation 138	4180186
42872771	Syndecan-1 (substance)	4180186
42872771	Syndecan-1	4180186
42872772	Lymphocyte antigen CD65L (substance)	4180186
42872774	Human leukocyte antigen B3 (substance)	4180186
42872774	HLA-B3 antigen	4180186
42872775	Allergy to tramadol (finding)	4180186
42872776	International student (occupation)	4180186
42872776	Overseas student	4180186
42872777	Lymphocyte negative for CD33 antigen and positive for CD34 antigen (cell)	4180186
42872778	Issuing of certificate of fitness (procedure)	4180186
42872781	Suturing of uterus using hemostatic brace suturing technique (procedure)	4180186
42872781	Suturing of uterus using haemostatic brace suturing technique	4180186
42872781	B-Lynch brace suture	4180186
42872785	Prosthetic replacement of extraarticular ligament (procedure)	4180186
42872786	Uncemented total replacement of joint (procedure)	4180186
42872787	Examination of vagina using Cusco bivalve speculum (procedure)	4180186
42872787	Vaginal examination using Cusco bivalve speculum	4180186
42872789	Primary excision of intervertebral disc (procedure)	4180186
42872790	Primary closure of defect of septum of heart (procedure)	4180186
42872791	Primary hybrid total replacement of joint (procedure)	4180186
42872793	Revision of uncemented total replacement of joint (procedure)	4180186
42872797	Revision of excision of intervertebral disc (procedure)	4180186
42872798	Revision of intertransverse fusion of lumbar spine (procedure)	4180186
42872801	Revision of closure of defect of septum of heart (procedure)	4180186
42872803	Revision of fusion of joint and external fixation (procedure)	4180186
42872804	Revision of fusion of joint and internal fixation (procedure)	4180186
42872805	Delivery of face to pubes presentation	4180186
42872805	Delivery of face to pubis presentation	4180186
42872805	Delivery of occipitoposterior presentation (procedure)	4180186
42872806	Operation on arteriovenous fistula of dura mater (procedure)	4180186
42872807	Destruction of pilonidal sinus (procedure)	4180186
42872810	Osteotomy and internal fixation (procedure)	4180186
42872811	Excision of mucous cyst of finger (procedure)	4180186
42872811	Excision of digital mucous cyst of finger	4180186
42872811	Excision of digital mucous cyst	4180186
42872814	Entire back (body structure)	4180186
42872816	Brushing of teeth (procedure)	4180186
42872817	Notification of miscarriage (procedure)	4180186
42872818	Maintenance of battery of cardiac pacemaker system (procedure)	4180186
42872822	Revision of prosthesis of abdominal aorta (procedure)	4180186
42872824	Revision of closed reduction of fracture (procedure)	4180186
42872828	Replacement of pulse generator of implantable cardioverter defibrillator using fluoroscopic guidance (procedure)	4180186
42872828	Fluoroscopy guided replacement of pulse generator of implantable cardioverter defibrillator	4180186
42872831	Laparoscopic sacrocolpopexy (procedure)	4180186
42872832	Magnetic resonance imaging of multiple pregnancy	4180186
42872832	Magnetic resonance imaging of multiple pregnancy (procedure)	4180186
42872833	Surgical procedure on internal thoracic artery by transluminal approach (procedure)	4180186
42872834	Induction chemotherapy (procedure)	4180186
42872836	Injection of substance into uterine cavity (procedure)	4180186
42872841	Removal of etonogestrel radiopaque contraceptive implant (procedure)	4180186
42872842	Primary anterior excision of lumbar disc (procedure)	4180186
42872842	Primary anterior lumbar discectomy	4180186
42872843	Primary cemented total replacement of joint (procedure)	4180186
42872844	Primary fusion of joint and internal fixation (procedure)	4180186
42872846	Intermittent urinary incontinence (finding)	4180186
42872847	Non-organic primary nocturnal enuresis (finding)	4180186
42872850	Primary nocturnal enuresis (finding)	4180186
42872852	Responds to pain (finding)	4180186
42872855	Uses vaginal hormone releasing ring (finding)	4180186
42872857	Yolk sac present (finding)	4180186
42872860	Genus Avihepatovirus (organism)	4180186
42872860	Avihepatovirus	4180186
42872863	Senecavirus	4180186
42872863	Genus Senecavirus (organism)	4180186
42872864	Genus Teschovirus (organism)	4180186
42872864	Teschovirus	4180186
42872866	Infection caused by Grimontia hollisae	4180186
42872866	Infection caused by Grimontia hollisae (disorder)	4180186
42872868	Adjustment to extraocular muscle (procedure)	4180186
42872868	Adjustment to muscle of eye	4180186
42872870	Insertion of nontunneled hemodialysis catheter (procedure)	4180186
42872870	Insertion of nontunneled haemodialysis catheter	4180186
42872875	Human rhinovirus C (organism)	4180186
42872877	Specimen from urinary bladder (specimen)	4180186
42872879	Collection of first stream urine specimen (procedure)	4180186
42872879	Collection of first void urine specimen	4180186
42872880	Laryngotracheal separation (procedure)	4180186
42872882	Bacillus anthracis avirulent strain (organism)	4180186
42872882	Nonproteolytic Bacillus anthracis	4180186
42872883	Mass of palatine tonsil (disorder)	4180186
42872883	Tonsillar mass	4180186
42872884	Nodule of nasal cavity (finding)	4180186
42872885	Chronic hepatitis E (disorder)	4180186
42872886	Hypermetria (finding)	4180186
42872887	Aspergillus cervinus (organism)	4180186
42872890	Lucas terrier dog breed	4180186
42872890	Lucas terrier dog breed (organism)	4180186
42872891	Reversible posterior leucoencephalopathy syndrome	4180186
42872891	Posterior reversible encephalopathy syndrome (disorder)	4180186
42872891	Reversible posterior leukoencephalopathy syndrome	4180186
42872893	Fringe eared oryx	4180186
42872893	Oryx beisa subspecies callotis	4180186
42872893	Oryx beisa subspecies callotis (organism)	4180186
42872894	Beisa oryx	4180186
42872894	Oryx beisa subspecies beisa	4180186
42872894	Oryx beisa subspecies beisa (organism)	4180186
42872899	Adenocarcinoma, pancreatobiliary-type	4180186
42872899	Pancreatobiliary-type carcinoma (morphologic abnormality)	4180186
42872900	Micropapillary carcinoma (morphologic abnormality)	4180186
42872902	Mixed acinar-ductal carcinoma (morphologic abnormality)	4180186
42872905	Angiocentric glioma (morphologic abnormality)	4180186
42872906	Pituicytoma (morphologic abnormality)	4180186
42872908	Cohen cannula (physical object)	4180186
42872909	Kahn cannula (physical object)	4180186
42872910	Anal sacculitis	4180186
42872910	Inflammation of anal sac (disorder)	4180186
42872911	Systemic Epstein Barr virus positive T-cell lymphoproliferative disease of childhood	4180186
42872911	Systemic Epstein Barr virus positive T-cell lymphoproliferative disease of childhood (morphologic abnormality)	4180186
42872912	Hydroa vacciniforme-like lymphoma (morphologic abnormality)	4180186
42872914	Plasmablastic lymphoma (morphologic abnormality)	4180186
42872916	Large B-cell lymphoma arising in human herpesvirus type 8 associated multicentric Castleman disease (morphologic abnormality)	4180186
42872916	Large B-cell lymphoma arising in human herpesvirus type 8 associated multicentric Castleman disease	4180186
42872917	Fibroblastic reticular cell tumour	4180186
42872917	Fibroblastic reticular cell tumor (morphologic abnormality)	4180186
42872918	Acute mixed lineage leukemia	4180186
42872918	Mixed phenotype acute leukaemia	4180186
42872918	Mixed phenotype acute leukemia (morphologic abnormality)	4180186
42872918	Acute mixed lineage leukaemia	4180186
42872920	Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged (morphologic abnormality)	4180186
42872920	Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged	4180186
42872924	Atrial standstill (disorder)	4180186
42872924	Atrial arrest	4180186
42872925	B lymphoblastic leukaemia / lymphoma - category	4180186
42872925	B lymphoblastic leukemia / lymphoma - category (morphologic abnormality)	4180186
42872927	Pseudomonas mohnii (organism)	4180186
42872928	Massilia aurea (organism)	4180186
42872930	African pygmy hedgehog	4180186
42872930	Atelerix albiventris (organism)	4180186
42872930	Four toed hedgehog	4180186
42872931	Yorkiepoo dog breed	4180186
42872931	Yorkiepoo dog breed (organism)	4180186
42872933	Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 (morphologic abnormality)	4180186
42872933	Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214	4180186
42872934	Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (morphologic abnormality)	4180186
42872934	Acute myeloid leukaemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	4180186
42872936	Luteimonas aestuarii (organism)	4180186
42872938	Aeromicrobium tamlense (organism)	4180186
42872941	Genus Negativicoccus	4180186
42872941	Genus Negativicoccus (organism)	4180186
42872945	Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement (morphologic abnormality)	4180186
42872945	Myeloid or lymphoid neoplasm with PDGFRA rearrangement	4180186
42872945	Myeloid and lymphoid neoplasms with PDGFRA rearrangement	4180186
42872946	Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement (morphologic abnormality)	4180186
42872946	Myeloid neoplasm with PDGFRB rearrangement	4180186
42872947	Myeloid or lymphoid neoplasm with FGFR1 abnormality	4180186
42872947	Myeloid or lymphoid neoplasm with fibroblast growth factor receptor 1 abnormality (morphologic abnormality)	4180186
42872948	PTLD	4180186
42872948	Post transplant lymphoproliferative disorder, no ICD-O subtype	4180186
42872948	Post transplant lymphoproliferative disorder, no International Classification of Diseases for Oncology subtype	4180186
42872948	Post transplant lymphoproliferative disorder, no International Classification of Diseases for Oncology subtype (morphologic abnormality)	4180186
42872949	Polymorphic post transplant lymphoproliferative disorder (morphologic abnormality)	4180186
42872950	Refractory cytopenia with unilineage dysplasia (morphologic abnormality)	4180186
42872953	Serrated adenocarcinoma (morphologic abnormality)	4180186
42872954	B lymphoblastic leukaemia lymphoma, no ICD-O subtype	4180186
42872954	B lymphoblastic leukemia lymphoma, no International Classification of Diseases for Oncology subtype	4180186
42872954	B lymphoblastic leukemia lymphoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)	4180186
42872955	B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)	4180186
42872955	B lymphoblastic leukaemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1	4180186
42872956	B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged (morphologic abnormality)	4180186
42872956	B lymphoblastic leukaemia lymphoma with t(v;11q23); MLL rearranged	4180186
42872958	B lymphoblastic leukemia lymphoma with hyperdiploidy (morphologic abnormality)	4180186
42872958	B lymphoblastic leukaemia lymphoma with hyperdiploidy	4180186
42872959	B lymphoblastic leukemia lymphoma with hypodiploidy (Hypodiploid ALL) (morphologic abnormality)	4180186
42872959	B lymphoblastic leukaemia lymphoma with hypodiploidy (Hypodiploid ALL)	4180186
42872963	Malignant lymphoma, diffuse large B-cell, immunoblastic (morphologic abnormality)	4180186
42872964	T-cell rich large B-cell lymphoma	4180186
42872964	Histiocyte-rich large B-cell lymphoma	4180186
42872964	T-cell rich/histiocyte-rich large B-cell lymphoma	4180186
42872964	T-cell/histiocyte rich large B-cell lymphoma (morphologic abnormality)	4180186
42872967	Hybrid falcon	4180186
42872967	Falco intragenus hybrid (organism)	4180186
42872968	Cocal virus (organism)	4180186
42872970	Secondary dressing (physical object)	4180186
42872972	Petrolatum gauze dressing (physical object)	4180186
42872973	Wet to moist dressing (physical object)	4180186
42872974	Negative pressure wound dressing (physical object)	4180186
42872977	Wet to dry dressing (physical object)	4180186
42872982	Results reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872984	Sensory modality assessment and rehabilitation technique score (observable entity)	4180186
42872985	Allergies reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872986	Adverse drug reactions reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872988	Social history reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872992	Results reference set for GP/FP health issue (foundation metadata concept)	4180186
42872993	Sensory modality assessment and rehabilitation technique (assessment scale)	4180186
42872998	Social history reference set for GP/FP health issue (foundation metadata concept)	4180186
42873002	Map source concept is outside of the scope of ICPC-2 (foundation metadata concept)	4180186
42873005	Map of source concept to ICPC-2 is context dependent (foundation metadata concept)	4180186
42873009	ICPC-2 code is ambiguous (foundation metadata concept)	4180186
42873010	Source SNOMED CT concept is retired from ICPC-2 map scope (foundation metadata concept)	4180186
42873011	Magnetic resonance imaging chemical shift imaging (procedure)	4180186
42873011	MRI chemical shift imaging	4180186
42873012	Application of elastic support bandage (procedure)	4180186
42873013	Enucleation of dental cyst of upper jaw (procedure)	4180186
42873014	Enucleation of dental cyst of lower jaw (procedure)	4180186
42873015	Enucleation of radicular cyst of upper jaw (procedure)	4180186
42873017	Enucleation of dentigerous cyst of upper jaw (procedure)	4180186
42873018	Enucleation of dentigerous cyst of lower jaw (procedure)	4180186
42873019	Enucleation of odontogenic keratocyst of upper jaw (procedure)	4180186
42873021	Curettage of products of conception from uterus (procedure)	4180186
42873022	University of Alabama at Birmingham pain behavior scale (assessment scale)	4180186
42873022	UAB pain behaviour scale	4180186
42873022	UAB pain behavior scale	4180186
42873023	Radiotherapy planning using cone beam computed tomography (procedure)	4180186
42873023	Radiotherapy planning using CBCT	4180186
42873024	Radiotherapy planning using four dimensional computed tomography (procedure)	4180186
42873024	Radiotherapy planning using 4D CT	4180186
42873029	Inactivated Influenza split virion subtype H1N1v-like strain unadjuvanted vaccine (product)	4180186
42873030	Cusco speculum (physical object)	4180186
42873033	Open commissurotomy of tricuspid valve (procedure)	4180186
42873038	Structure of subpial space of neuraxis (body structure)	4180186
42873040	Structure of subpial space of spinal cord (body structure)	4180186
42873041	Haemorrhage into subpial space of neuraxis	4180186
42873041	Hemorrhage into subpial space of neuraxis (disorder)	4180186
42873046	Hemorrhage in putamen (disorder)	4180186
42873046	Haemorrhage in putamen	4180186
42873047	Excision of cerebral hemisphere (procedure)	4180186
42873048	Rhodococcus equi	4180186
42873048	Corynebacterium equi (organism)	4180186
42873049	Strain of hamstring muscle (disorder)	4180186
42873051	Anomalous origin of left coronary artery from pulmonary artery (disorder)	4180186
42873054	Coarctation of suprarenal abdominal aorta (disorder)	4180186
42873056	Major systemic to pulmonary collateral artery supplying both lungs (disorder)	4180186
42873063	Coarctation of aorta between left common carotid artery and right common carotid artery (disorder)	4180186
42873065	Vascular ring with right aortic arch and left ligamentum arteriosum (disorder)	4180186
42873065	Vascular ring with right aortic arch and left ligamentum arteriosum	4180186
42873068	Assessment using strengths and difficulties questionnaire (procedure)	4180186
42873068	Assessment using SDQ (strengths and difficulties questionnaire)	4180186
42873069	Assessment using Edinburgh postnatal depression scale (procedure)	4180186
42873069	Assessment using EPDS (Edinburgh postnatal depression scale)	4180186
42873070	Edinburgh postnatal depression scale score (observable entity)	4180186
42873070	EPDS (Edinburgh postnatal depression scale) score	4180186
42873071	Thiopental specific immunoglobulin E (substance)	4180186
42873071	Thiopentone specific immunoglobulin E	4180186
42873071	Thiopentone specific IgE	4180186
42873072	Lymphocyte antigen CD41a (substance)	4180186
42873076	Panic disorder severity scale score (observable entity)	4180186
42873077	Assessment of suitability of footwear (procedure)	4180186
42873078	Assessment of tunnelled central venous catheter entry site	4180186
42873078	Assessment of tunneled central venous catheter entry site (procedure)	4180186
42873080	Assessment of eligibility for clinical trial (procedure)	4180186
42873081	Attention to ventriculoperitoneal shunt (procedure)	4180186
42873083	Attention to cerebroventricular shunt (procedure)	4180186
42873084	Primary microsurgical graft to cranial nerve (procedure)	4180186
42873085	Secondary microsurgical graft to cranial nerve (procedure)	4180186
42873088	Destruction of perivascular sympathetic nerve (procedure)	4180186
42873089	Destruction of splanchnic sympathetic nerve (procedure)	4180186
42873091	Destruction of lacrimal gland (procedure)	4180186
42873092	Excision of lesion of nasal turbinate (procedure)	4180186
42873093	Biopsy of lesion of nasal sinus (procedure)	4180186
42873095	Biopsy of lesion of lung (procedure)	4180186
42873098	Intubation of duodenum	4180186
42873098	Insertion of tube into duodenum (procedure)	4180186
42873099	Insertion of tube into jejunum (procedure)	4180186
42873099	Intubation of jejunum	4180186
42873101	Destruction of thoracic sympathetic nerve (procedure)	4180186
42873103	Panic disorder severity scale (assessment scale)	4180186
42873109	Haemorrhage into subarachnoid space of neuraxis	4180186
42873109	Hemorrhage into subarachnoid space of neuraxis (disorder)	4180186
42873110	Haemorrhage into subarachnoid space of spine	4180186
42873110	Hemorrhage into subarachnoid space of spine (disorder)	4180186
42873111	Oceanobacillus caeni (organism)	4180186
42873116	Paenibacillus xylanexedens (organism)	4180186
42873117	Pseudomonas argentinensis (organism)	4180186
42873119	Pseudomonas taiwanensis (organism)	4180186
42873120	Prevotella histicola (organism)	4180186
42873124	Haemorrhage into meningeal space of neuraxis	4180186
42873124	Hemorrhage into meningeal space of neuraxis (disorder)	4180186
42873127	Xenophilus aerolatus (organism)	4180186
42873131	Acinetobacter gyllenbergii (organism)	4180186
42873132	Aeromonas piscicola (organism)	4180186
42873133	Aeromonas taiwanensis (organism)	4180186
42873135	Bacillus litoralis (organism)	4180186
42873139	Yersinia similis (organism)	4180186
42873141	Lactobacillus plantarum subspecies argentoratensis	4180186
42873141	Lactobacillus plantarum subspecies argentoratensis (organism)	4180186
42873141	Lactiplantibacillus plantarum subsp. argentoratensis	4180186
42873141	Lactiplantibacillus argentoratensis	4180186
42873141	Lactiplantibacillus argentoratensis (organism)	4180186
42873141	Lactobacillus argentoratensis	4180186
42873141	Lactobacillus plantarum subsp. argentoratensis	4180186
42873142	Microbacterium ginsengisoli (organism)	4180186
42873143	Microbacterium invictum (organism)	4180186
42873144	Staphylococcus devriesei (organism)	4180186
42873147	Micrococcus yunnanensis (organism)	4180186
42873148	Ochrobactrum haematophilum (organism)	4180186
42873149	Pseudomonas pohangensis (organism)	4180186
42873150	Gordonia lacunae (organism)	4180186
42873151	Asaia lannensis (organism)	4180186
42873152	Inquilinus ginsengisoli (organism)	4180186
42873155	Dietzia papillomatosis (organism)	4180186
42873156	Corynebacterium tuscaniae	4180186
42873156	Corynebacterium tuscaniense (organism)	4180186
42873158	Pseudomonas oleovorans subspecies lubricantis (organism)	4180186
42873158	Pseudomonas oleovorans subspecies lubricantis	4180186
42873161	Hypothyroidism in pregnancy, antepartum (disorder)	4180186
42873163	Hypertension complicating pregnancy, childbirth and the puerperium, antepartum (disorder)	4180186
42873165	Acquired pronation deformity of ankle (disorder)	4180186
42873167	Single epileptic seizure (finding)	4180186
42873169	Sprain of shoulder rotator cuff (disorder)	4180186
42873171	Repetitive strain injury of arm or forearm (disorder)	4180186
42873172	Strain of knee (disorder)	4180186
42898160	Long Term Care Visit	4180186
43020393	Hepatitis C virus genotype 4 (organism)	4180186
43020398	Hepatitis C virus subtype 2a (organism)	4180186
43020399	Hepatitis C virus subtype 3a (organism)	4180186
43020401	Hepatitis C virus subtype 5a (organism)	4180186
43020403	Hepatitis C virus subtype 4a (organism)	4180186
43020404	Hepatitis C virus genotype 1 (organism)	4180186
43020405	Hepatitis C virus genotype 2 (organism)	4180186
43020406	Hepatitis C virus genotype 3 (organism)	4180186
43020407	Hepatitis C virus genotype 5 (organism)	4180186
43020408	Hepatitis C virus genotype 6 (organism)	4180186
43020409	Hepatitis C virus subtype 1c (organism)	4180186
43020410	Hepatitis C virus subtype 2c (organism)	4180186
43020411	Hepatitis C virus subtype 4c (organism)	4180186
43020412	Hepatitis C virus subtype 4d (organism)	4180186
43020414	Educated to junior high school level (finding)	4180186
43020418	Congenital choroid plexus cyst (disorder)	4180186
43020419	Negative screening for depression on Patient Health Questionnaire 9	4180186
43020419	Negative screening for depression on Patient Health Questionnaire 9 (finding)	4180186
43020421	Systolic heart failure, stage C	4180186
43020421	Systolic heart failure stage C (disorder)	4180186
43020423	Posterior tibial artery insufficiency (disorder)	4180186
43020426	Adult onset stammering	4180186
43020426	Adult onset stuttering (finding)	4180186
43020428	Adult onset stuttering and stammering (finding)	4180186
43020429	Adult victim of sexual abuse (finding)	4180186
43020429	Adult abuse, sexual	4180186
43020431	Episodic phencyclidine abuse (disorder)	4180186
43020432	Atherosclerosis of native arteries of the extremities (disorder)	4180186
43020434	Health condition feared but not present (finding)	4180186
43020437	Malignant hypertensive chronic kidney disease stage 5 (disorder)	4180186
43020438	Low lumbar myelomeningocele (disorder)	4180186
43020439	Borderline cognitive developmental delay (disorder)	4180186
43020440	Acquired arteriovenous fistula aneurysm (disorder)	4180186
43020442	Adult abuse, emotional	4180186
43020442	Adult victim of emotional abuse (finding)	4180186
43020444	Primary degenerative dementia (disorder)	4180186
43020446	Sedative withdrawal (disorder)	4180186
43020449	Adult victim of physical abuse (finding)	4180186
43020449	Adult abuse, physical	4180186
43020450	Child abuse, physical	4180186
43020450	Child victim of physical abuse (finding)	4180186
43020451	Severe manic bipolar I disorder (disorder)	4180186
43020452	Identity disorder of childhood (disorder)	4180186
43020453	Infection of cardiac graft (disorder)	4180186
43020456	Malignant hypertensive chronic kidney disease stage 3 (disorder)	4180186
43020457	Malignant hypertensive chronic kidney disease stage 4 (disorder)	4180186
43020460	Acute ST segment elevation myocardial infarction involving left anterior descending coronary artery (disorder)	4180186
43020461	Acute ST segment elevation myocardial infarction involving left main coronary artery (disorder)	4180186
43020463	Problem behavior in adult (finding)	4180186
43020463	Problem behaviour in adult	4180186
43020465	Rheumatic mitral valve annular calcification (disorder)	4180186
43020466	Rheumatic mitral valve prolapse (disorder)	4180186
43020468	Child in welfare custody (finding)	4180186
43020471	Fear of injury (finding)	4180186
43020473	Abuse of herbal medicine or folk remedy (disorder)	4180186
43020474	High risk bisexual behavior (finding)	4180186
43020474	High risk bisexual behaviour	4180186
43020475	High risk heterosexual behavior (finding)	4180186
43020475	High risk heterosexual behaviour	4180186
43020477	Total anomalous pulmonary venous connection to coronary sinus (disorder)	4180186
43020479	Inadequate social skills (finding)	4180186
43020481	Type A behaviour pattern	4180186
43020481	Type A behavior pattern (finding)	4180186
43020483	Reactive depressive psychosis, single episode (disorder)	4180186
43020488	Problem related to release from prison (finding)	4180186
43020491	Aneurysm of intracranial portion of internal carotid artery (disorder)	4180186
43020492	Anomalous origin of left coronary artery from pulmonary artery (disorder)	4180186
43020497	Occlusion of right carotid artery (disorder)	4180186
43020497	Occlusion of right carotid artery	4180186
43020498	Stenosis of left carotid artery (disorder)	4180186
43020498	Stenosis of left carotid artery	4180186
43020499	Dextrotransposition of the great arteries (disorder)	4180186
43020500	Aneurysm of descending thoracic aorta (disorder)	4180186
43020501	Child victim of maltreatment (finding)	4180186
43020502	Unspecified psychological disorder (disorder)	4180186
43020506	Epiphyseal fracture, Salter-Harris type VII	4180186
43020506	Salter-Harris type VII (morphologic abnormality)	4180186
43020509	Failure of growth of foetal right cardiac ventricle	4180186
43020509	Failure of growth of fetal right cardiac ventricle (disorder)	4180186
43020510	Failure of growth of fetal left cardiac ventricle (disorder)	4180186
43020510	Failure of growth of foetal left cardiac ventricle	4180186
43020513	Sciurus niger (organism)	4180186
43020513	Fox squirrel	4180186
43020514	Sciurus niger subspecies niger	4180186
43020514	Sciurus niger subspecies niger (organism)	4180186
43020514	Southern fox squirrel	4180186
43020520	Florbetapir (18-F) (substance)	4180186
43020520	Florbetapir [F-18]	4180186
43020521	Flutemetamol (18-F) (substance)	4180186
43020521	Flutemetamol F^18^	4180186
43020524	E. coli Orough:nonmotile	4180186
43020524	Escherichia coli serotype Orough:nonmotile (organism)	4180186
43020526	Escherichia coli serotype Orough:H7 (organism)	4180186
43020526	E. coli Orough:H7	4180186
43020531	E. coli Orough:H25	4180186
43020531	Escherichia coli serotype Orough:H25 (organism)	4180186
43020533	Escherichia coli serotype Orough:H19 (organism)	4180186
43020533	E. coli Orough:H19	4180186
43020539	Escherichia coli serotype O178:H19 (organism)	4180186
43020539	E. coli serotype O178:H19	4180186
43020540	Escherichia coli serotype O178:H7 (organism)	4180186
43020540	E. coli serotype O178:H7	4180186
43020541	Escherichia coli serotype O177	4180186
43020541	E. coli O177	4180186
43020541	E. coli serogroup O177	4180186
43020541	Escherichia coli serogroup O177 (organism)	4180186
43020541	Escherichia coli O177	4180186
43020543	E. coli serogroup O175	4180186
43020543	Escherichia coli O175	4180186
43020543	Escherichia coli serogroup O175 (organism)	4180186
43020543	Escherichia coli serotype O175	4180186
43020543	E. coli O175	4180186
43020546	Escherichia coli serotype O20:nonmotile (organism)	4180186
43020546	E. coli serotype O20:nonmotile	4180186
43020549	Sinolith of maxillary sinus	4180186
43020549	Antrolith of maxillary sinus (finding)	4180186
43020551	Refractory ascites (disorder)	4180186
43020556	Flat curve of Spee (finding)	4180186
43020559	Systemic to pulmonary collateral artery as part of dual lung supply	4180186
43020559	Systemic to pulmonary collateral artery contributing to dual lung supply (disorder)	4180186
43020560	Surgically constructed interatrial communication (disorder)	4180186
43020562	Recurrent interatrial communication after prior cardiovascular surgical procedure (disorder)	4180186
43020565	Point mutation (finding)	4180186
43020575	Anomalous origin of right coronary artery and circumflex artery from aortic sinus to right of nonfacing aortic sinus and anomalous origin of left anterior descending artery from aortic sinus to left on nonfacing aortic sinus (disorder)	4180186
43020575	Anomalous origin of right coronary artery and circumflex artery from sinus 1 and anomalous origin of left anterior descending artery from sinus 2	4180186
43020576	Anomalous origin of left anterior descending artery and right coronary artery from sinus 1 and anomalous origin of circumflex artery from sinus 2	4180186
43020576	Anomalous origin of left anterior descending artery and right coronary artery from aortic sinus to right of nonfacing aortic sinus and anomalous origin of circumflex artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020577	Abnormal preening behavior (finding)	4180186
43020577	Abnormal preening behaviour	4180186
43020578	Resource guarding (finding)	4180186
43020584	Escherichia coli serotype O153:H7 (organism)	4180186
43020584	E. coli serotype O153:H7	4180186
43020588	E. coli serotype O152:nonmotile	4180186
43020588	Escherichia coli serotype O152:nonmotile (organism)	4180186
43020591	Escherichia coli O149	4180186
43020591	Escherichia coli serotype O149	4180186
43020591	E. coli serogroup O149	4180186
43020591	E. coli O149	4180186
43020591	Escherichia coli serogroup O149 (organism)	4180186
43020592	E. coli serotype O148:H28	4180186
43020592	Escherichia coli serotype O148:H28 (organism)	4180186
43020593	E. coli serogroup O146	4180186
43020593	E. coli O146	4180186
43020593	Escherichia coli O146	4180186
43020593	Escherichia coli serotype O146	4180186
43020593	Escherichia coli serogroup O146 (organism)	4180186
43020595	Escherichia coli serotype O146:H28 (organism)	4180186
43020595	E. coli serotype O146:H28	4180186
43020596	E. coli serotype O146:H21	4180186
43020596	Escherichia coli serotype O146:H21 (organism)	4180186
43020599	Escherichia coli serotype O145:H34 (organism)	4180186
43020599	E. coli serotype O145:H34	4180186
43020600	Escherichia coli serotype O145:H28 (organism)	4180186
43020600	E. coli serotype O145:H28	4180186
43020601	E. coli serotype O145:H25	4180186
43020601	Escherichia coli serotype O145:H25 (organism)	4180186
43020603	Escherichia coli serotype O174:H28 (organism)	4180186
43020603	E. coli serotype O174:H28	4180186
43020604	E. coli serotype O174:H21	4180186
43020604	Escherichia coli serotype O174:H21 (organism)	4180186
43020605	Escherichia coli serotype O174:H2 (organism)	4180186
43020605	E. coli serotype O174:H2	4180186
43020607	Escherichia coli serotype O172:H11 (organism)	4180186
43020607	E. coli serotype O172:H11	4180186
43020608	E. coli serotype O172:H2	4180186
43020608	Escherichia coli serotype O172:H2 (organism)	4180186
43020609	E. coli serotype O172:H16	4180186
43020609	Escherichia coli serotype O172:H16 (organism)	4180186
43020613	Occlusion of coronary sinus (disorder)	4180186
43020617	Perforation of tricuspid valve leaflet (disorder)	4180186
43020617	Perforation of tricuspid leaflet	4180186
43020619	Thrombosis of mitral valve (disorder)	4180186
43020620	Obstruction of pulmonary valve due to neoplasm (disorder)	4180186
43020620	Obstruction of pulmonary valve due to tumour	4180186
43020620	Obstruction of pulmonary valve due to tumor	4180186
43020622	Calcification of pulmonary valve (disorder)	4180186
43020624	Disruption of pulmonary valve annulus (disorder)	4180186
43020626	Obstruction of aortic valve due to neoplasm (disorder)	4180186
43020626	Obstruction of aortic valve due to tumour	4180186
43020626	Obstruction of aortic valve due to tumor	4180186
43020627	Thrombosis of aortic valve (disorder)	4180186
43020634	Calcification of common atrioventricular valve (disorder)	4180186
43020637	Myxomatous degeneration of right atrioventricular (not morphologically tricuspid) valve leaflet (disorder)	4180186
43020637	Myxomatous degeneration of right atrioventricular (nontricuspid) valve leaflet	4180186
43020639	Myxomatous degeneration of left atrioventricular (nonmitral) valve leaflet	4180186
43020639	Myxomatous degeneration of left atrioventricular (not morphologically mitral) valve leaflet (disorder)	4180186
43020642	E. coli serotype O166:H15	4180186
43020642	Escherichia coli serotype O166:H15 (organism)	4180186
43020649	Nannizziopsiosis	4180186
43020649	Necrotising mycotic dermatitis	4180186
43020649	Necrotizing mycotic dermatitis (disorder)	4180186
43020649	Yellow fungus disease	4180186
43020651	Pleuroperitoneal fistula (disorder)	4180186
43020652	Inflammatory cardiomyopathy (disorder)	4180186
43020653	Disorder of heart muscle associated with rejection of cardiac transplant	4180186
43020653	Disorder of myocardium associated with rejection of cardiac transplant (disorder)	4180186
43020655	Disorder of myocardium due to sickle cell hemoglobinopathy (disorder)	4180186
43020655	Disorder of heart muscle due to sickle cell hemoglobinopathy	4180186
43020655	Disorder of heart muscle due to sickle cell haemoglobinopathy	4180186
43020655	Disorder of myocardium due to sickle cell haemoglobinopathy	4180186
43020656	Pacing-induced cardiomyopathy (disorder)	4180186
43020657	Heart failure due to end stage congenital heart disease (disorder)	4180186
43020658	Hypertrophic cardiomyopathy with genetic marker (disorder)	4180186
43020659	Dilated cardiomyopathy with genetic marker (disorder)	4180186
43020661	Type A interruption of aortic arch distal to subclavian artery	4180186
43020661	Interruption of aortic arch distal to subclavian artery (disorder)	4180186
43020662	Interruption of aortic arch between subclavian artery and common carotid artery (disorder)	4180186
43020662	Type B interruption of aortic arch between subclavian artery and common carotid artery	4180186
43020665	Acquired tortuosity of branch of aortic arch (disorder)	4180186
43020669	Fatal infantile mitochondrial cardiomyopathy (disorder)	4180186
43020670	Continuing pregnancy after intrauterine death of one twin with intrauterine retention of dead twin (disorder)	4180186
43020676	E. coli serotype O157:H29	4180186
43020676	Escherichia coli serotype O157:H29 (organism)	4180186
43020677	E. coli serotype O157:H16	4180186
43020677	Escherichia coli serotype O157:H16 (organism)	4180186
43020685	E. coli serotype O141:H49	4180186
43020685	Escherichia coli serotype O141:H49 (organism)	4180186
43020686	E. coli serotype O141:H14	4180186
43020686	Escherichia coli serotype O141:H14 (organism)	4180186
43020687	E. coli serogroup O140	4180186
43020687	Escherichia coli O140	4180186
43020687	E. coli O140	4180186
43020687	Escherichia coli serotype O140	4180186
43020687	Escherichia coli serogroup O140 (organism)	4180186
43020688	Abscess of truncal valve (disorder)	4180186
43020690	Thoracopagus with separate hearts and pericardial sacs (disorder)	4180186
43020695	Escherichia coli serotype O2:H7 (organism)	4180186
43020695	E. coli serotype O2:H7	4180186
43020698	Escherichia coli serotype O136:nonmotile (organism)	4180186
43020698	E. coli serotype O136:nonmotile	4180186
43020702	Escherichia coli serotype O132:H31 (organism)	4180186
43020702	E. coli serotype O132:H31	4180186
43020705	E. coli serotype O128:H28	4180186
43020705	Escherichia coli serotype O128:H28 (organism)	4180186
43020706	E. coli serotype O128:H2	4180186
43020706	Escherichia coli serotype O128:H2 (organism)	4180186
43020707	Escherichia coli serotype O128:H7 (organism)	4180186
43020707	E. coli serotype O128:H7	4180186
43020708	Escherichia coli serotype O128:H12 (organism)	4180186
43020708	E. coli serotype O128:H12	4180186
43020709	E. coli serotype O128:H45	4180186
43020709	Escherichia coli serotype O128:H45 (organism)	4180186
43020710	Escherichia coli serotype O126:H8 (organism)	4180186
43020710	E. coli serotype O126:H8	4180186
43020712	E. coli serotype O137:H41	4180186
43020712	Escherichia coli serotype O137:H41 (organism)	4180186
43020714	E. coli serotype O142:H6	4180186
43020714	Escherichia coli serotype O142:H6 (organism)	4180186
43020715	E. coli serotype O143:nonmotile	4180186
43020715	Escherichia coli serotype O143:nonmotile (organism)	4180186
43020716	Escherichia coli serotype O126:H27 (organism)	4180186
43020716	E. coli serotype O126:H27	4180186
43020719	Escherichia coli serotype O124:H30 (organism)	4180186
43020719	E. coli serotype O124:H30	4180186
43020721	Escherichia coli serotype O123	4180186
43020721	Escherichia coli O123	4180186
43020721	E. coli O123	4180186
43020721	E. coli serogroup O123	4180186
43020721	Escherichia coli serogroup O123 (organism)	4180186
43020722	E. coli serotype O123:nonmotile	4180186
43020722	Escherichia coli serotype O123:nonmotile (organism)	4180186
43020723	Escherichia coli serotype O123:H11 (organism)	4180186
43020723	E. coli serotype O123:H11	4180186
43020724	Escherichia coli serotype O121:H19 (organism)	4180186
43020724	E. coli serotype O121:H19	4180186
43020725	E. coli serotype O121:nonmotile	4180186
43020725	Escherichia coli serotype O121:nonmotile (organism)	4180186
43020726	Escherichia coli serotype O121:H7 (organism)	4180186
43020726	E. coli serotype O121:H7	4180186
43020728	E. coli serotype O119:H4	4180186
43020728	Escherichia coli serotype O119:H4 (organism)	4180186
43020729	Escherichia coli serotype O119:H28 (organism)	4180186
43020729	E. coli serotype O119:H28	4180186
43020734	E. coli O3	4180186
43020734	Escherichia coli O3	4180186
43020734	Escherichia coli serotype O3	4180186
43020734	Escherichia coli serogroup O3 (organism)	4180186
43020734	E. coli serogroup O3	4180186
43020737	E. coli serotype O2:H45	4180186
43020737	Escherichia coli serotype O2:H45 (organism)	4180186
43020738	Escherichia coli serotype O3:H4 (organism)	4180186
43020738	E. coli serotype O3:H4	4180186
43020739	E. coli serotype O6:H16	4180186
43020739	Escherichia coli serotype O6:H16 (organism)	4180186
43020741	E. coli serotype O6:nonmotile	4180186
43020741	Escherichia coli serotype O6:nonmotile (organism)	4180186
43020744	E. coli serotype O7:H7	4180186
43020744	Escherichia coli serotype O7:H7 (organism)	4180186
43020746	Escherichia coli serotype O8:H19 (organism)	4180186
43020746	E. coli serotype O8:H19	4180186
43020749	E. coli serotype O11:H26	4180186
43020749	Escherichia coli serotype O11:H26 (organism)	4180186
43020750	Escherichia coli serotype O14:H11 (organism)	4180186
43020750	E. coli serotype O14:H11	4180186
43020753	E. coli serotype O14:H7	4180186
43020753	Escherichia coli serotype O14:H7 (organism)	4180186
43020756	E. coli serotype O22:H5	4180186
43020756	Escherichia coli serotype O22:H5 (organism)	4180186
43020757	E. coli serotype O22:H8	4180186
43020757	Escherichia coli serotype O22:H8 (organism)	4180186
43020759	Escherichia coli serotype O24:H25 (organism)	4180186
43020759	E. coli serotype O24:H25	4180186
43020760	E. coli serotype O25:H42	4180186
43020760	Escherichia coli serotype O25:H42 (organism)	4180186
43020762	Escherichia coli serotype O25:H156 (organism)	4180186
43020762	E. coli serotype O25:H156	4180186
43020764	Escherichia coli serotype O26:nonmotile (organism)	4180186
43020764	E. coli serotype O26:nonmotile	4180186
43020765	Escherichia coli serotype O26:H46 (organism)	4180186
43020765	E. coli serotype O26:H46	4180186
43020767	Escherichia coli serotype O27:H20 (organism)	4180186
43020767	E. coli serotype O27:H20	4180186
43020769	E. coli serotype O28:H25	4180186
43020769	Escherichia coli serotype O28:H25 (organism)	4180186
43020772	Escherichia coli O38	4180186
43020772	Escherichia coli serogroup O38 (organism)	4180186
43020772	E. coli O38	4180186
43020772	Escherichia coli serotype O38	4180186
43020772	E. coli serogroup O38	4180186
43020773	Escherichia coli serogroup O42 (organism)	4180186
43020773	Escherichia coli O42	4180186
43020773	E. coli O42	4180186
43020773	E. coli serogroup O42	4180186
43020773	Escherichia coli serotype O42	4180186
43020775	Escherichia coli serotype O43	4180186
43020775	E. coli serogroup O43	4180186
43020775	Escherichia coli serogroup O43 (organism)	4180186
43020775	Escherichia coli O43	4180186
43020775	E. coli O43	4180186
43020776	E. coli serotype O43:H2	4180186
43020776	Escherichia coli serotype O43:H2 (organism)	4180186
43020777	Escherichia coli serotype O45:H2 (organism)	4180186
43020777	E. coli serotype O45:H2	4180186
43020778	Escherichia coli serotype O45:H77 (organism)	4180186
43020778	E. coli serotype O45:H77	4180186
43020779	E. coli serotype O45:H8	4180186
43020779	Escherichia coli serotype O45:H8 (organism)	4180186
43020780	Disorder of foetal myocardium	4180186
43020780	Disorder of fetal myocardium (disorder)	4180186
43020784	Fetal hypertrophic cardiomyopathy associated with renal disease (disorder)	4180186
43020784	Foetal hypertrophic cardiomyopathy associated with renal disease	4180186
43020786	Ulnar impingement syndrome	4180186
43020786	Ulnar impaction syndrome (disorder)	4180186
43020788	Loose suture of corneal graft (finding)	4180186
43020789	Type I Raeder paratrigeminal syndrome	4180186
43020789	Type I Raeder's paratrigeminal syndrome	4180186
43020789	Type I paratrigeminal syndrome (disorder)	4180186
43020791	Gestational diabetes mellitus uncontrolled (finding)	4180186
43020795	Narrowing or closure of fetal ductus arteriosus	4180186
43020795	Narrowing or closure of fetal ductus arteriosus (disorder)	4180186
43020795	Narrowing or closure of foetal arterial duct	4180186
43020795	Narrowing or closure of foetal ductus arteriosus	4180186
43020796	Narrowing of foetal ductus arteriosus	4180186
43020796	Narrowing of fetal ductus arteriosus (disorder)	4180186
43020796	Narrowing of foetal arterial duct	4180186
43020796	Narrowing of fetal ductus arteriosus	4180186
43020799	Willow oak pollen	4180186
43020799	Quercus phellos pollen (substance)	4180186
43020801	Quercus laevis pollen allergen (substance)	4180186
43020801	Turkey oak pollen allergen	4180186
43020805	Quercus lyrata pollen (substance)	4180186
43020805	Overcup oak pollen	4180186
43020808	Quercus nigra pollen allergen (substance)	4180186
43020808	Water oak pollen allergen	4180186
43020809	Quercus alba pollen allergen (substance)	4180186
43020809	White oak pollen allergen	4180186
43020810	White oak pollen	4180186
43020810	Quercus alba pollen (substance)	4180186
43020813	Elaeagnus angustifolia pollen (substance)	4180186
43020813	Russian olive pollen	4180186
43020813	Silver berry pollen	4180186
43020813	Oleaster pollen	4180186
43020813	Elaeagnus augustifolia pollen	4180186
43020814	Elaeagnus angustifolia pollen allergen (substance)	4180186
43020814	Elaeagnus augustifolia pollen allergen	4180186
43020814	Oleaster pollen allergen	4180186
43020814	Russina olive pollen allergen	4180186
43020814	Silver berry pollen allergen	4180186
43020815	Black locust pollen allergen	4180186
43020815	False acacia pollen allergen	4180186
43020815	Robinia pseudoacacia pollen allergen (substance)	4180186
43020818	Morus alba pollen allergen (substance)	4180186
43020818	White mulberry pollen allergen	4180186
43020820	Broussonetia papyrifera pollen (substance)	4180186
43020820	Paper mulberry pollen	4180186
43020823	Ailanthus altissima pollen (substance)	4180186
43020823	Tree of heaven pollen	4180186
43020824	Ailanthus altissima pollen allergen (substance)	4180186
43020824	Tree of heaven pollen allergen	4180186
43020827	Carya pollen allergen (substance)	4180186
43020827	Hickory pollen allergen	4180186
43020828	Hackberry pollen	4180186
43020828	Celtis pollen (substance)	4180186
43020829	Zea mays pollen (substance)	4180186
43020829	Corn pollen	4180186
43020830	Corn pollen allergen	4180186
43020830	Zea mays pollen allergen (substance)	4180186
43020831	Surgically constructed drainage of coronary sinus to pulmonary venous atrium (disorder)	4180186
43020832	Surgically constructed drainage of coronary sinus to systemic venous atrium (disorder)	4180186
43020833	Coronary sinus hypertension as complication of procedure (disorder)	4180186
43020835	Obstruction of superior caval vein as complication of procedure	4180186
43020835	Obstruction of superior vena cava as complication of procedure (disorder)	4180186
43020837	Post procedural inferior vena cava obstruction	4180186
43020837	Obstruction of inferior caval vein as complication of procedure	4180186
43020837	Obstruction of inferior vena cava as complication of procedure (disorder)	4180186
43020843	Disorder of right atrium (disorder)	4180186
43020847	Disorder of left atrium as complication of procedure (disorder)	4180186
43020848	Escherichia coli serotype O48:H21 (organism)	4180186
43020848	E. coli serotype O48:H21	4180186
43020849	Escherichia coli serotype O49:nonmotile (organism)	4180186
43020849	E. coli serotype O49:nonmotile	4180186
43020851	Escherichia coli serotype O50:H7 (organism)	4180186
43020851	E. coli serotype O50:H7	4180186
43020852	E. coli serotype O50:H2	4180186
43020852	Escherichia coli serotype O50:H2 (organism)	4180186
43020854	E. coli serogroup O52	4180186
43020854	Escherichia coli serotype O52	4180186
43020854	E. coli O52	4180186
43020854	Escherichia coli serogroup O52 (organism)	4180186
43020854	Escherichia coli O52	4180186
43020856	Escherichia coli serogroup O53 (organism)	4180186
43020856	Escherichia coli serotype O53	4180186
43020856	E. coli O53	4180186
43020856	E. coli serogroup O53	4180186
43020856	Escherichia coli O53	4180186
43020857	Escherichia coli serotype O53:H7 (organism)	4180186
43020857	E. coli serotype O53:H7	4180186
43020858	Escherichia coli serotype O55:H12 (organism)	4180186
43020858	E. coli serotype O55:H12	4180186
43020861	E. coli serotype O55:nonmotile	4180186
43020861	Escherichia coli serotype O55:nonmotile (organism)	4180186
43020862	Escherichia coli serogroup O60 (organism)	4180186
43020862	E. coli serogroup O60	4180186
43020862	Escherichia coli serotype O60	4180186
43020862	Escherichia coli O60	4180186
43020862	E. coli O60	4180186
43020865	E. coli serotype O63:H6	4180186
43020865	Escherichia coli serotype O63:H6 (organism)	4180186
43020868	Volvulus of midgut	4180186
43020868	Malrotation of intestine with midgut volvulus (disorder)	4180186
43020868	Volvulus neonatorum	4180186
43020869	Bridging bronchus (disorder)	4180186
43020870	Arterial tortuosity syndrome (disorder)	4180186
43020873	Acute infective endocarditis (disorder)	4180186
43020873	Acute infectious endocarditis	4180186
43020874	Viral endocarditis (disorder)	4180186
43020876	Infective endocarditis of right ventricular wall (disorder)	4180186
43020876	Infectious endocarditis of right ventricular wall	4180186
43020877	Infective endocarditis of left ventricular wall (disorder)	4180186
43020877	Infectious endocarditis of left ventricular wall	4180186
43020879	Infective endarteritis of ductus arteriosus (disorder)	4180186
43020879	Infective endarteritis of ductus arteriosus	4180186
43020884	Escherichia coli O118:H2	4180186
43020884	Escherichia coli serotype O118:H2 (organism)	4180186
43020885	E. coli O117	4180186
43020885	Escherichia coli serotype O117	4180186
43020885	E. coli serogroup O117	4180186
43020885	Escherichia coli serogroup O117 (organism)	4180186
43020885	Escherichia coli O117	4180186
43020886	Escherichia coli O117:H7	4180186
43020886	Escherichia coli serotype O117:H7 (organism)	4180186
43020887	Thrombus of physiologic left atrium as complication of procedure (disorder)	4180186
43020888	Obstruction of pulmonary great vein due to compression by right atrial dilatation (disorder)	4180186
43020889	Excessive restriction of interatrial communication as complication of procedure (disorder)	4180186
43020891	Excessive restriction of ventricular septal defect as complication of procedure (disorder)	4180186
43020896	Fetal biventricular dysfunction (disorder)	4180186
43020896	Foetal biventricular dysfunction	4180186
43020897	Congenital intrapericardial cyst (disorder)	4180186
43020898	Congenital extrapericardial cyst (disorder)	4180186
43020901	Acquired occlusion of superior vena cava (disorder)	4180186
43020902	Stenosis of subvalvular region of neopulmonary valve	4180186
43020902	Stenosis of subvalvular region of neopulmonary valve (disorder)	4180186
43020903	Stenosis of subvalvular region of neoaortic valve	4180186
43020903	Stenosis of subvalvular region of neoaortic valve (disorder)	4180186
43020904	Right ventricular dysfunction due to disorder of left ventricle (disorder)	4180186
43020906	Right ventricular outflow tract obstruction due to foreign body (disorder)	4180186
43020906	Right ventricular outflow tract obstruction due to foreign material	4180186
43020910	Pulmonary venous hypertension due to disorder of left heart (disorder)	4180186
43020910	Pulmonary venous hypertension due to disorder of left heart	4180186
43020911	Stenosis of pulmonary great vein as complication of procedure (disorder)	4180186
43020913	Subaortic stenosis as complication of procedure (disorder)	4180186
43020914	Acquired subaortic stenosis associated with functionally univentricular heart (disorder)	4180186
43020915	Acquired subaortic stenosis due to restrictive ventricular septal defect associated with functionally univentricular heart (disorder)	4180186
43020918	Subpulmonary stenosis as complication of procedure (disorder)	4180186
43020921	Congenital subpulmonary stenosis due to restrictive ventricular defect associated with functionally univentricular heart (disorder)	4180186
43020922	Subpulmonary stenosis associated with functionally univentricular heart as complication of procedure (disorder)	4180186
43020924	Acquired cardiovascular abnormality associated with atrioventricular septal defect (disorder)	4180186
43020925	Obstruction of right atrial tunnel after prior total cavopulmonary connection procedure (disorder)	4180186
43020926	Endocarditis as complication of procedure (disorder)	4180186
43020930	Arrhythmia due to vegetation of infectious endocarditis	4180186
43020930	Arrhythmia due to vegetation of infective endocarditis (disorder)	4180186
43020931	Cardiovascular abnormality due to infectious myocarditis	4180186
43020931	Cardiovascular abnormality due to infective myocarditis (disorder)	4180186
43020932	Mechanical hemolysis due to cardiovascular prosthetic patch (disorder)	4180186
43020932	Mechanical haemolysis due to cardiovascular prosthetic patch	4180186
43020934	Presbyphagia (finding)	4180186
43020935	Eosinophilic ureteritis (disorder)	4180186
43020937	Pleuroscopy (procedure)	4180186
43020937	Local anesthetic thoracoscopy	4180186
43020937	MT - medical thoracoscopy	4180186
43020937	Local anaesthetic thoracoscopy	4180186
43020941	Cecoureterocele (disorder)	4180186
43020942	Foetal echocardiography screening	4180186
43020942	Fetal echocardiography screening (procedure)	4180186
43020943	Foetal chromosomal abnormality screening	4180186
43020943	Fetal chromosomal abnormality screening (procedure)	4180186
43020946	Disorder of atrioventricular (not morphologically mitral or tricuspid) valve prosthesis (disorder)	4180186
43020946	Disorder of atrioventricular (nonmitral, nontricuspid) valve prosthesis	4180186
43020947	Disorder of right atrioventricular (nontricuspid) valve prosthesis	4180186
43020947	Disorder of right atrioventricular (not morphologically tricuspid) valve prosthesis (disorder)	4180186
43020948	Disorder of tricuspid valve prosthesis (disorder)	4180186
43020949	Disorder of pulmonary valve prosthesis (disorder)	4180186
43020952	Insertion of hormone releasing intrauterine contraceptive device (procedure)	4180186
43020952	Insertion of intrauterine system	4180186
43020952	Insertion of IUS (intrauterine system)	4180186
43020953	Removal of hormone releasing intrauterine contraceptive device (procedure)	4180186
43020953	Removal of intrauterine system	4180186
43020953	Removal of IUS (intrauterine system)	4180186
43020955	Stenosis of foetal tricuspid valve	4180186
43020955	Stenosis of fetal tricuspid valve (disorder)	4180186
43020957	Regurgitation of fetal pulmonary valve (disorder)	4180186
43020957	Regurgitation of foetal pulmonary valve	4180186
43020961	Stenosis of fetal right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43020961	Stenosis of foetal right atrioventricular (not morphologically tricuspid) valve	4180186
43020961	Stenosis of foetal right atrioventricular (nontricuspid) valve	4180186
43020961	Stenosis of fetal right atrioventricular (nontricuspid) valve	4180186
43020962	Regurgitation of foetal left atrioventricular (not morphologically mitral) valve	4180186
43020962	Regurgitation of fetal left atrioventricular (nonmitral) valve	4180186
43020962	Regurgitation of fetal left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43020962	Regurgitation of foetal left atrioventricular (nonmitral) valve	4180186
43020963	Stenosis of foetal left atrioventricular (not morphologically mitral) valve	4180186
43020963	Stenosis of fetal left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43020963	Stenosis of fetal left atrioventricular (nonmitral) valve	4180186
43020963	Stenosis of foetal left atrioventricular (nonmitral) valve	4180186
43020964	Regurgitation of fetal common atrioventricular valve (disorder)	4180186
43020964	Regurgitation of foetal common atrioventricular valve	4180186
43020966	Escherichia coli O116	4180186
43020966	E. coli serogroup O116	4180186
43020966	E. coli O116	4180186
43020966	Escherichia coli serotype O116	4180186
43020966	Escherichia coli serogroup O116 (organism)	4180186
43020968	Escherichia coli serotype O116:H21 (organism)	4180186
43020968	Escherichia coli O116:H21	4180186
43020969	E. coli O115	4180186
43020969	E. coli serogroup O115	4180186
43020969	Escherichia coli O115	4180186
43020969	Escherichia coli serotype O115	4180186
43020969	Escherichia coli serogroup O115 (organism)	4180186
43020976	Escherichia coli O112:nonmotile	4180186
43020976	Escherichia coli serotype O112:nonmotile (organism)	4180186
43020979	Escherichia coli serotype O111:nonmotile (organism)	4180186
43020979	Escherichia coli O111:nonmotile	4180186
43020980	Escherichia coli serotype O111:H8 (organism)	4180186
43020980	Escherichia coli O111:H8	4180186
43020981	Escherichia coli O111:H12	4180186
43020981	Escherichia coli serotype O111:H12 (organism)	4180186
43020984	Escherichia coli serotype O110	4180186
43020984	Escherichia coli serogroup O110 (organism)	4180186
43020984	E. coli O110	4180186
43020984	Escherichia coli O110	4180186
43020984	E. coli serogroup O110	4180186
43020987	Escherichia coli O110:H19	4180186
43020987	Escherichia coli serotype O110:H19 (organism)	4180186
43020989	Escherichia coli serotype O109:H25 (organism)	4180186
43020989	Escherichia coli O109:H25	4180186
43020990	Escherichia coli serotype O104:H7 (organism)	4180186
43020990	Escherichia coli O104:H7	4180186
43020991	Escherichia coli O104:H21	4180186
43020991	Escherichia coli serotype O104:H21 (organism)	4180186
43020992	Escherichia coli O104:nonmotile	4180186
43020992	Escherichia coli serotype O104:nonmotile (organism)	4180186
43020993	Escherichia coli serotype O103:H2 (organism)	4180186
43020993	Escherichia coli O103:H2	4180186
43020997	Escherichia coli O103:H11	4180186
43020997	Escherichia coli serotype O103:H11 (organism)	4180186
43020998	E. coli O101	4180186
43020998	E. coli serogroup O101	4180186
43020998	Escherichia coli serotype O101	4180186
43020998	Escherichia coli O101	4180186
43020998	Escherichia coli serogroup O101 (organism)	4180186
43021000	Escherichia coli O100:nonmotile	4180186
43021000	Escherichia coli serotype O100:nonmotile (organism)	4180186
43021001	Escherichia coli serogroup O98 (organism)	4180186
43021001	Escherichia coli serotype O98	4180186
43021001	E. coli serogroup O98	4180186
43021001	E. coli O98	4180186
43021001	Escherichia coli O98	4180186
43021002	Escherichia coli O98:H8	4180186
43021002	Escherichia coli serotype O98:H8 (organism)	4180186
43021004	Escherichia coli O91:nonmotile	4180186
43021004	Escherichia coli serotype O91:nonmotile (organism)	4180186
43021005	Escherichia coli O91:H21	4180186
43021005	Escherichia coli serotype O91:H21 (organism)	4180186
43021006	Escherichia coli O91:H10	4180186
43021006	Escherichia coli serotype O91:H10 (organism)	4180186
43021008	Escherichia coli O91:H14	4180186
43021008	Escherichia coli serotype O91:H14 (organism)	4180186
43021009	Escherichia coli O9:nonmotile	4180186
43021009	Escherichia coli serotype O9:nonmotile (organism)	4180186
43021010	Escherichia coli O88:H25	4180186
43021010	Escherichia coli serotype O88:H25 (organism)	4180186
43021011	Escherichia coli serotype O86:H34 (organism)	4180186
43021011	Escherichia coli O86:H34	4180186
43021012	Escherichia coli O86:nonmotile	4180186
43021012	Escherichia coli serotype O86:nonmotile (organism)	4180186
43021013	Escherichia coli serotype O85	4180186
43021013	Escherichia coli O85	4180186
43021013	E. coli O85	4180186
43021013	E. coli serogroup O85	4180186
43021013	Escherichia coli serogroup O85 (organism)	4180186
43021017	Escherichia coli O84:H2	4180186
43021017	Escherichia coli serotype O84:H2 (organism)	4180186
43021018	Escherichia coli serotype O84:H16 (organism)	4180186
43021018	Escherichia coli O84:H16	4180186
43021021	Escherichia coli serotype O82:H8 (organism)	4180186
43021021	Escherichia coli O82:H8	4180186
43021023	Escherichia coli serotype O80:nonmotile (organism)	4180186
43021023	Escherichia coli O80:nonmotile	4180186
43021025	Escherichia coli O79:H19	4180186
43021025	Escherichia coli serotype O79:H19 (organism)	4180186
43021027	Escherichia coli O78:H12	4180186
43021027	Escherichia coli serotype O78:H12 (organism)	4180186
43021030	Escherichia coli serotype O76:H21 (organism)	4180186
43021030	Escherichia coli O76:H21	4180186
43021032	Escherichia coli serotype O76:H19 (organism)	4180186
43021032	Escherichia coli O76:H19	4180186
43021033	E. coli O74	4180186
43021033	E. coli serogroup O74	4180186
43021033	Escherichia coli O74	4180186
43021033	Escherichia coli serotype O74	4180186
43021033	Escherichia coli serogroup O74 (organism)	4180186
43021035	Escherichia coli serotype O73	4180186
43021035	Escherichia coli serogroup O73 (organism)	4180186
43021035	E. coli serogroup O73	4180186
43021035	E. coli O73	4180186
43021035	Escherichia coli O73	4180186
43021036	Escherichia coli serotype O73:H45 (organism)	4180186
43021036	Escherichia coli O73:H45	4180186
43021037	Escherichia coli O73:H18	4180186
43021037	Escherichia coli serotype O73:H18 (organism)	4180186
43021041	E. coli serogroup O70	4180186
43021041	Escherichia coli O70	4180186
43021041	Escherichia coli serogroup O70 (organism)	4180186
43021041	Escherichia coli serotype O70	4180186
43021041	E. coli O70	4180186
43021043	Infectious endocarditis of tricuspid valve	4180186
43021043	Infective endocarditis of tricuspid valve (disorder)	4180186
43021047	Abscess of cardiovascular heterograft (disorder)	4180186
43021049	Infective endocarditis of right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43021049	Infectious endocarditis of right atrioventricular (not morphologically tricuspid) valve	4180186
43021049	Infective endocarditis of right atrioventricular (nontricuspid) valve	4180186
43021051	Abscess of common atrioventricular valve (disorder)	4180186
43021052	Systemic to pulmonary collateral artery from descending thoracic aorta (disorder)	4180186
43021053	Systemic to pulmonary collateral artery from abdominal aorta (disorder)	4180186
43021054	Dichorionic diamniotic twin pregnancy (disorder)	4180186
43021055	Monochorionic twin pregnancy (disorder)	4180186
43021058	Infective endocarditis at site of ventricular septal defect (disorder)	4180186
43021058	Infectious endocarditis at site of ventricular septal defect	4180186
43021059	Infectious endarteritis at site of aortopulmonary window	4180186
43021059	Infective endarteritis at site of aortopulmonary window (disorder)	4180186
43021060	Infective endocarditis at site of interatrial communication (disorder)	4180186
43021060	Infectious endocarditis at site of interatrial communication	4180186
43021061	Abscess of right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43021061	Abscess of right atrioventricular (nontricuspid) valve	4180186
43021064	Aneurysm of patch of atrioventricular septal defect (disorder)	4180186
43021066	Aneurysm of patch of right ventricular outflow tract (disorder)	4180186
43021067	Infective constrictive pericarditis (disorder)	4180186
43021067	Infectious constrictive pericarditis	4180186
43021068	Spontaneous closure of acquired interatrial communication (finding)	4180186
43021070	Regurgitation of foetal truncal valve	4180186
43021070	Regurgitation of fetal truncal valve (disorder)	4180186
43021071	Stenosis of fetal truncal valve (disorder)	4180186
43021071	Stenosis of foetal truncal valve	4180186
43021072	Open fracture of bone of wrist and/or hand (disorder)	4180186
43021075	Taking anal swab for chlamydia (procedure)	4180186
43021078	Swab from lesion of skin (specimen)	4180186
43021079	Swab from lower leg (specimen)	4180186
43021082	Swab from tongue (specimen)	4180186
43021083	Swab from tonsil (specimen)	4180186
43021084	Peritoneal swab	4180186
43021084	Swab from peritoneal cavity structure (specimen)	4180186
43021085	Swab from pericardial sac structure (specimen)	4180186
43021085	Pericardial swab	4180186
43021087	Swab from ulcer (specimen)	4180186
43021090	Swab from uterus (specimen)	4180186
43021090	Uterine swab	4180186
43021091	Swab from vesicle (specimen)	4180186
43021092	Swab from Bartholin cyst (specimen)	4180186
43021093	Swab from esophagus (specimen)	4180186
43021093	Esophageal swab	4180186
43021093	Swab from oesophagus	4180186
43021093	Oesophageal swab	4180186
43021094	Swab from Bartholin gland (specimen)	4180186
43021095	Swab from placenta (specimen)	4180186
43021097	Pharyngeal swab	4180186
43021097	Swab from pharynx (specimen)	4180186
43021101	Swab from bed sore	4180186
43021101	Swab from pressure ulcer (specimen)	4180186
43021104	Laryngeal swab	4180186
43021104	Swab from larynx (specimen)	4180186
43021106	Swab from appendix (specimen)	4180186
43021107	Swab from lip (specimen)	4180186
43021109	Swab from abscess of brain (specimen)	4180186
43021112	Swab from blister (specimen)	4180186
43021113	Swab from hip region (specimen)	4180186
43021114	Swab from hand (specimen)	4180186
43021116	Swab from gum	4180186
43021116	Swab from gingiva (specimen)	4180186
43021116	Gingival swab	4180186
43021118	Swab from chest drain insertion site	4180186
43021118	Swab from chest tube insertion site (specimen)	4180186
43021119	Swab from central venous catheter (specimen)	4180186
43021120	Swab from abdomen (specimen)	4180186
43021120	Abdominal swab	4180186
43021123	Main lactiferous duct structure (body structure)	4180186
43021123	Lobar duct of breast	4180186
43021124	Structure of intralobular lactiferous ductule (body structure)	4180186
43021125	Entire intralobular lactiferous ductule (body structure)	4180186
43021128	Entire main lactiferous duct (body structure)	4180186
43021129	Structure of extralobular part of terminal lactiferous ductule (body structure)	4180186
43021131	Structure of lumen of lactiferous duct (body structure)	4180186
43021132	Toxic metabolic encephalopathy (disorder)	4180186
43021132	Toxic and/or metabolic encephalopathy	4180186
43021133	Collection of device for submission as specimen (procedure)	4180186
43021134	Substance specimen obtained from device (specimen)	4180186
43021135	Device submitted as specimen (specimen)	4180186
43021139	Peripheral vascular catheter tip submitted as specimen (specimen)	4180186
43021140	Pulmonary artery flotation catheter tip submitted as specimen (specimen)	4180186
43021140	Pulmonary artery floatation catheter tip submitted as specimen	4180186
43021141	Chest drain tip submitted as specimen	4180186
43021141	Chest tube tip submitted as specimen (specimen)	4180186
43021143	Umbilical artery catheter tip submitted as specimen (specimen)	4180186
43021151	Double J stent submitted as specimen (specimen)	4180186
43021151	Double pigtail stent submitted as specimen	4180186
43021151	JJ stent submitted as specimen	4180186
43021152	Tracheostomy tube submitted as specimen (specimen)	4180186
43021153	Intracranial ventricular catheter submitted as specimen (specimen)	4180186
43021157	Previously asexual transsexual (finding)	4180186
43021158	Previously heterosexual transsexual (finding)	4180186
43021159	Cross-dressing (finding)	4180186
43021159	Cross-dresser	4180186
43021159	Transvestism	4180186
43021159	Transvestitism	4180186
43021161	Secondary transvestism (finding)	4180186
43021163	Engages in sexual activity outside marriage (finding)	4180186
43021163	Engages in extramarital sexual activity	4180186
43021165	History of disorder of soft tissue (situation)	4180186
43021165	H/O disorder of soft tissue	4180186
43021166	History of tonsillitis (situation)	4180186
43021167	History of acute lower respiratory tract infection (situation)	4180186
43021171	Allergic sensitisation process	4180186
43021171	Allergic sensitization process (qualifier value)	4180186
43021173	History of diabetes mellitus type 2 (situation)	4180186
43021173	History of diabetes mellitus type II	4180186
43021173	H/O diabetes mellitus type 2	4180186
43021174	History of diabetes mellitus type 1 (situation)	4180186
43021174	History of diabetes mellitus type I	4180186
43021174	H/O diabetes mellitus type 1	4180186
43021175	History of maturity onset diabetes mellitus in young (situation)	4180186
43021175	History of autosomal dominant diabetes mellitus	4180186
43021177	History of arteritis (situation)	4180186
43021177	H/O arteritis	4180186
43021181	Systemic to pulmonary collateral artery from left carotid artery (disorder)	4180186
43021184	Myocarditis caused by Genus Aspergillus (disorder)	4180186
43021184	Aspergillosis myocarditis	4180186
43021184	Myocarditis caused by Genus Aspergillus	4180186
43021185	Myocarditis caused by echovirus (disorder)	4180186
43021185	Echovirus myocarditis	4180186
43021185	Myocarditis caused by echovirus	4180186
43021187	Infective endocarditis at site of patch of ventricular septal defect (disorder)	4180186
43021187	Infectious endocarditis at site of patch of ventricular septal defect	4180186
43021188	Systemic to pulmonary collateral artery from right renal artery (disorder)	4180186
43021190	Systemic to pulmonary collateral artery from right innominate artery	4180186
43021190	Systemic to pulmonary collateral artery from right brachiocephalic artery (disorder)	4180186
43021192	22q11 microdeletion with complete DiGeorge sequence (disorder)	4180186
43021192	22q11 microdeletion with full DiGeorge sequence	4180186
43021193	Anomalous origin of dual left anterior descending coronary arteries from right coronary artery and left coronary artery (disorder)	4180186
43021193	Abnormal origin of dual left anterior descending coronary arteries from right coronary artery and left coronary artery	4180186
43021195	Broad based intervertebral disc protrusion (disorder)	4180186
43021198	Androphilic sexual orientation	4180186
43021198	Sexually attracted to male gender (finding)	4180186
43021198	Sexually attracted to men	4180186
43021202	Sexually active with men (finding)	4180186
43021204	Sexually active with transgender person (finding)	4180186
43021207	Abnormal development of sexuality (finding)	4180186
43021208	Normal development of secondary sexual characteristics (finding)	4180186
43021209	Abnormal development of secondary sexual characteristics (finding)	4180186
43021210	Freudian phase of psychosexual development (finding)	4180186
43021211	Phallic psychosexual phase (finding)	4180186
43021212	Latent psychosexual phase (finding)	4180186
43021214	Finding of number of historical sexual partners (finding)	4180186
43021217	Sexuality matured to pubertal state (finding)	4180186
43021217	Pubertal sexuality state	4180186
43021218	Sexuality matured to prepubertal state (finding)	4180186
43021218	Prepubertal sexuality state	4180186
43021220	Feminisation	4180186
43021220	Feminization (finding)	4180186
43021224	Buccal region pain	4180186
43021224	Pain in cheek (finding)	4180186
43021226	Hypersensitivity condition (finding)	4180186
43021229	Finding relating to sexual behaviour	4180186
43021229	Finding relating to sexual behavior (finding)	4180186
43021229	Finding relating to sexual practice	4180186
43021234	MV - megavolt	4180186
43021234	megavolt (qualifier value)	4180186
43021236	Primary erectile dysfunction (disorder)	4180186
43021236	Primary impotence	4180186
43021238	Celibate	4180186
43021238	Celibacy	4180186
43021238	Purposely unmarried and sexually abstinent (finding)	4180186
43021240	Complication associated with musculoskeletal implant (disorder)	4180186
43021241	Complication associated with vagal nerve stimulator (disorder)	4180186
43021242	Saline breast implant (physical object)	4180186
43021245	Complication associated with vascular device (disorder)	4180186
43021248	Complication associated with urogenital device	4180186
43021248	Complication associated with genitourinary device (disorder)	4180186
43021251	Mechanical complication associated with orthopaedic device	4180186
43021251	Mechanical complication associated with orthopedic device (disorder)	4180186
43021252	Mechanical complication of implant (disorder)	4180186
43021253	Mechanical complication of musculoskeletal implant (disorder)	4180186
43021258	Infection associated with implant (disorder)	4180186
43021259	Infection associated with internal fixation device (disorder)	4180186
43021261	Infection associated with totally implantable venous access device (disorder)	4180186
43021264	Infection associated with urogenital device	4180186
43021264	Infection associated with genitourinary device (disorder)	4180186
43021265	History of lymphoid leukaemia	4180186
43021265	History of lymphoid leukemia (situation)	4180186
43021267	Infection associated with cardiac implant (disorder)	4180186
43021268	History of malignant tumor of stomach	4180186
43021268	History of malignant neoplasm of stomach (situation)	4180186
43021268	History of malignant tumour of stomach	4180186
43021269	History of malignant tumor of oral cavity	4180186
43021269	History of malignant neoplasm of oral cavity (situation)	4180186
43021269	History of malignant tumour of oral cavity	4180186
43021269	History of cancer of oral cavity	4180186
43021269	History of oral cancer	4180186
43021271	History of malignant tumor of testis	4180186
43021271	History of malignant neoplasm of testis (situation)	4180186
43021271	History of malignant tumour of testis	4180186
43021276	No history of hearing loss (situation)	4180186
43021276	No H/O hearing impairment	4180186
43021276	No H/O hearing loss	4180186
43021278	Infection associated with intrauterine contraceptive device (disorder)	4180186
43021282	History of allergy to raloxifene (situation)	4180186
43021283	Infection associated with vascular device (disorder)	4180186
43021284	Infection associated with vascular implant (disorder)	4180186
43021285	Recent cruise travel (event)	4180186
43021287	History of recent cruise travel (situation)	4180186
43021288	History of recent air travel (situation)	4180186
43021289	Pericarditis with pericardial effusion caused by Mycobacterium tuberculosis complex	4180186
43021289	Pericarditis with pericardial effusion caused by Mycobacterium tuberculosis complex (disorder)	4180186
43021289	Tuberculous pericarditis with pericardial effusion	4180186
43021290	Viral pericarditis with pericardial effusion (disorder)	4180186
43021293	Constrictive pericarditis caused by Mycobacterium tuberculosis complex (disorder)	4180186
43021293	Tuberculous constrictive pericarditis	4180186
43021293	Constrictive pericarditis caused by Mycobacterium tuberculosis complex	4180186
43021295	Sinus node artery course posterior relative to superior caval vein	4180186
43021295	Posterior course of sinus node artery relative to superior vena cava (finding)	4180186
43021296	Anterior course of sinus node artery relative to superior vena cava (finding)	4180186
43021296	Sinus node artery course anterior relative to superior caval vein	4180186
43021297	Infective endocarditis at site of patch of interatrial communication (disorder)	4180186
43021297	Infectious endocarditis at site of patch of interatrial communication	4180186
43021298	Long QT syndrome with genetic marker (disorder)	4180186
43021300	Obstruction of right atrial conduit after prior total cavopulmonary connection procedure (disorder)	4180186
43021302	Anomalous origin of coronary arteries from both aortic sinuses of bicuspid valve (disorder)	4180186
43021303	Abnormal origin of right coronary artery from left anterior descending coronary artery	4180186
43021303	Anomalous origin of right coronary artery from left anterior descending coronary artery (disorder)	4180186
43021305	Abnormal origin of left coronary artery from right coronary artery	4180186
43021305	Anomalous origin of left coronary artery from right coronary artery (disorder)	4180186
43021308	Anomalous origin of left coronary artery and right coronary artery from pulmonary artery (disorder)	4180186
43021310	Anomalous course of coronary artery posterior to pulmonary trunk (disorder)	4180186
43021312	Abnormal origin of right coronary artery from left coronary artery	4180186
43021312	Anomalous origin of right coronary artery from left coronary artery (disorder)	4180186
43021316	Vascular ring with right aortic arch and left arterial ligament with aberrant retroesophageal left subclavian artery	4180186
43021316	Vascular ring with right aortic arch and left ligamentum arteriosum with anomalous retroesophageal left subclavian artery (disorder)	4180186
43021316	Vascular ring with right aortic arch and left ligamentum arteriosum with anomalous retroesophageal left subclavian artery	4180186
43021318	Vascular ring with right aortic arch and left arterial duct from retroesophageal diverticulum of aorta and aberrant left subclavian artery	4180186
43021318	Vascular ring with right aortic arch and left ductus arteriosus from retroesophageal diverticulum of aorta and anomalous left subclavian artery	4180186
43021318	Vascular ring with right aortic arch and left ductus arteriosus from retroesophageal diverticulum of aorta and anomalous left subclavian artery (disorder)	4180186
43021319	Vascular ring with right aortic arch and left ductus arteriosus from anomalous retroesophageal brachiocephalic artery	4180186
43021319	Vascular ring with right aortic arch and left ductus arteriosus from anomalous retroesophageal brachiocephalic artery (disorder)	4180186
43021319	Vascular ring with right aortic arch and left arterial duct from aberrant retroesophageal innominate artery	4180186
43021320	Vascular ring with right aortic arch and left ductus arteriosus from retroesophageal diverticulum of aorta (disorder)	4180186
43021320	Vascular ring with right aortic arch and left ductus arteriosus from retroesophageal diverticulum of aorta	4180186
43021323	Systemic to pulmonary collateral artery connecting with tracheobronchial arteries (disorder)	4180186
43021325	Dysfunction of left atrioventricular (nonmitral) valve papillary muscle	4180186
43021325	Dysfunction of left atrioventricular (not morphologically mitral) valve papillary muscle (disorder)	4180186
43021326	Dysfunction of right atrioventricular (not morphologically tricuspid) valve papillary muscle (disorder)	4180186
43021326	Dysfunction of right atrioventricular (nontricuspid) valve papillary muscle	4180186
43021328	Anomalous origin of ductus arteriosus from right carotid artery (disorder)	4180186
43021328	Anomalous origin of ductus arteriosus from right carotid artery	4180186
43021329	Anomalous origin of ductus arteriosus from left carotid artery (disorder)	4180186
43021329	Anomalous origin of ductus arteriosus from left carotid artery	4180186
43021331	Anomalous origin of ductus arteriosus from left brachiocephalic artery	4180186
43021331	Anomalous origin of ductus arteriosus from left brachiocephalic artery (disorder)	4180186
43021334	Anomalous insertion of ductus arteriosus into right pulmonary artery	4180186
43021334	Anomalous insertion of ductus arteriosus into right pulmonary artery (disorder)	4180186
43021340	Myocarditis caused by Genus Borrelia	4180186
43021340	Borrelia myocarditis	4180186
43021340	Myocarditis caused by Genus Borrelia (disorder)	4180186
43021345	Inflammatory reaction associated with urogenital device	4180186
43021345	Inflammation associated with genitourinary device (disorder)	4180186
43021349	Inflammation associated with internal fixation device (disorder)	4180186
43021349	Inflammatory reaction associated with internal fixation device	4180186
43021350	History of use of hormone releasing intrauterine device contraception (situation)	4180186
43021350	History of use of intrauterine system contraception	4180186
43021352	Inflammation associated with vascular implant (disorder)	4180186
43021352	Inflammatory reaction associated with vascular implant	4180186
43021355	Allergic reaction caused by hair dye (disorder)	4180186
43021355	Allergic reaction caused by hair dye	4180186
43021356	History of allergic reaction to hair dye (situation)	4180186
43021356	H/O allergic reaction to hair dye	4180186
43021357	Difficult fitting of intrauterine contraceptive device (finding)	4180186
43021358	History of difficult fitting of intrauterine contraceptive device (situation)	4180186
43021358	History of difficult IUCD (intrauterine contraceptive device) fitting	4180186
43021358	H/O difficult fitting of intrauterine contraceptive device	4180186
43021360	History of peripheral vascular disease (situation)	4180186
43021361	History of proteinuria (situation)	4180186
43021361	H/O proteinuria	4180186
43021362	History of microalbuminuria (situation)	4180186
43021362	H/O microalbuminuria	4180186
43021365	History of active tuberculosis (situation)	4180186
43021366	Loosening of musculoskeletal implant (disorder)	4180186
43021367	History of recurrent urinary tract infection (situation)	4180186
43021368	History of viral hepatitis (situation)	4180186
43021370	Breakage of musculoskeletal implant (disorder)	4180186
43021371	History of osteoporosis (situation)	4180186
43021372	Loosening of internal fixation device (disorder)	4180186
43021374	Suspected hypothyroidism (situation)	4180186
43021375	Migration of vascular stent (disorder)	4180186
43021376	Suspected diabetes mellitus (situation)	4180186
43021377	Suspected transient ischaemic attack	4180186
43021377	Suspected transient ischemic attack (situation)	4180186
43021379	Suspected sickling disorder due to haemoglobin S	4180186
43021379	Suspected sickling disorder due to hemoglobin S	4180186
43021379	Suspected sickle cell disease (situation)	4180186
43021381	No symptomatic diabetic peripheral neuropathy	4180186
43021381	Symptomatic diabetic peripheral neuropathy absent (situation)	4180186
43021383	Migration of central venous catheter (disorder)	4180186
43021384	Acanthosis nigricans absent (situation)	4180186
43021384	No acanthosis nigricans	4180186
43021386	Chronic disease absent (situation)	4180186
43021387	Chronic disease present (situation)	4180186
43021389	Malfunction of peritoneal dialysis catheter (disorder)	4180186
43021393	Retained ureteric catheter (disorder)	4180186
43021393	Retained ureteral catheter	4180186
43021395	Retention of ureteric stent (disorder)	4180186
43021395	Retention of ureteric stent	4180186
43021395	Retained ureteric stent (disorder)	4180186
43021395	Retained ureteral stent	4180186
43021396	Pacemaker battery depletion (disorder)	4180186
43021396	Pacemaker battery exhaustion	4180186
43021397	History of surgical procedure on vein (situation)	4180186
43021397	History of vein surgery	4180186
43021398	Migration of nasogastric tube (disorder)	4180186
43021399	History of stem cell donation	4180186
43021399	History of harvesting of stem cells for allotransplant (situation)	4180186
43021401	History of pneumococcal vaccination (situation)	4180186
43021404	History of tuberculosis vaccination	4180186
43021404	History of bacillus Calmette-Guerin vaccination (situation)	4180186
43021405	Haematoma of pacemaker pulse generator site	4180186
43021405	Hematoma of pacemaker pulse generator site (disorder)	4180186
43021406	History of abdominal hysterectomy (situation)	4180186
43021408	Displacement of orthopedic device (disorder)	4180186
43021408	Displacement of orthopaedic device	4180186
43021411	Discussion about hypoglycemia in pregnancy (procedure)	4180186
43021411	Discussion about hypoglycaemia in pregnancy	4180186
43021412	Obstruction of totally implantable venous access device (disorder)	4180186
43021412	Blockage of totally implantable venous access device	4180186
43021414	Discussion about preexisting hypertension in pregnancy (procedure)	4180186
43021415	Migration of Tenckhoff catheter (disorder)	4180186
43021418	Leakage of peritoneal dialysis catheter (disorder)	4180186
43021420	Mode of dialysis access by patient choice (finding)	4180186
43021423	Transesophageal echocardiography for congenital heart disease (procedure)	4180186
43021423	Transoesophageal echocardiography for congenital heart disease	4180186
43021428	Tortuosity of systemic artery (disorder)	4180186
43021429	Anomalous common origin of brachiocephalic artery and left common carotid artery (disorder)	4180186
43021429	Bovine arch	4180186
43021429	Anomalous common origin of innominate artery and left common carotid artery	4180186
43021432	Systemic to coronary collateral artery (disorder)	4180186
43021433	Abnormality within thorax due to coarctation of aorta (disorder)	4180186
43021435	Abnormal origin of left coronary artery from right coronary aortic sinus of Valsalva	4180186
43021435	Anomalous origin of left coronary artery from right coronary aortic sinus (disorder)	4180186
43021436	Abnormal origin of single coronary artery from right coronary artery aortic sinus of Valsalva	4180186
43021436	Anomalous origin of single coronary artery from right coronary artery aortic sinus (disorder)	4180186
43021440	Anomalous insertion of ligamentum arteriosum	4180186
43021440	Abnormal insertion of arterial ligament	4180186
43021440	Anomalous insertion of ligamentum arteriosum (disorder)	4180186
43021443	Anomalous insertion of ligamentum arteriosum into right pulmonary artery	4180186
43021443	Anomalous insertion of ligamentum arteriosum into right pulmonary artery (disorder)	4180186
43021446	Anomalous origin of ligamentum arteriosum from ascending aorta	4180186
43021446	Anomalous origin of ligamentum arteriosum from ascending aorta (disorder)	4180186
43021448	Anomalous origin of ligamentum arteriosum from right brachiocephalic artery	4180186
43021448	Anomalous origin of ligamentum arteriosum from right brachiocephalic artery (disorder)	4180186
43021450	Anomalous origin of ligamentum arteriosum from right subclavian artery	4180186
43021450	Anomalous origin of ligamentum arteriosum from right subclavian artery (disorder)	4180186
43021454	Right ligamentum arteriosum (disorder)	4180186
43021454	Right ligamentum arteriosum	4180186
43021455	Anomalous origin of right ligamentum arteriosum from right aortic arch (disorder)	4180186
43021455	Anomalous origin of right ligamentum arteriosum from right aortic arch	4180186
43021456	Anomalous origin of right ligamentum arteriosum from left aortic arch	4180186
43021456	Anomalous origin of right ligamentum arteriosum from left aortic arch (disorder)	4180186
43021460	Spontaneous closure of residual atrial septal defect within oval fossa (finding)	4180186
43021461	Bilateral ductus arteriosus (disorder)	4180186
43021461	Bilateral ductus arteriosus	4180186
43021462	Bilateral arterial duct with closed left arterial duct and patent right arterial duct	4180186
43021462	Bilateral ductus arteriosus with closed left ductus arteriosus and patent right ductus arteriosus (disorder)	4180186
43021464	Bilateral closed ductus arteriosus (disorder)	4180186
43021464	Bilateral closed ductus arteriosus	4180186
43021465	Cardiovascular abnormality due to bilateral ductus arteriosus	4180186
43021465	Cardiovascular abnormality due to bilateral ductus arteriosus (disorder)	4180186
43021467	Anomalous origin of ductus arteriosus from distal descending aorta	4180186
43021467	Anomalous origin of ductus arteriosus from distal descending aorta (disorder)	4180186
43021468	Anomalous insertion of ductus arteriosus into distal left pulmonary artery (disorder)	4180186
43021468	Anomalous insertion of ductus arteriosus into distal left pulmonary artery	4180186
43021469	Anomalous origin of ductus arteriosus from right subclavian artery (disorder)	4180186
43021469	Anomalous origin of ductus arteriosus from right subclavian artery	4180186
43021471	Normal origins of coronary arteries (finding)	4180186
43021474	Anomalous course of coronary artery posterior to pulmonary trunk and aorta (disorder)	4180186
43021475	Anomalous course of coronary artery anterior to aorta (disorder)	4180186
43021479	Acquired abnormality of right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43021479	Acquired abnormality of right atrioventricular (nontricuspid) valve	4180186
43021480	Acquired interatrial communication (disorder)	4180186
43021481	Screening for malignant tumour of ovary	4180186
43021481	Screening for malignant neoplasm of ovary (procedure)	4180186
43021481	Screening for malignant tumor of ovary	4180186
43021490	Assessment of lymphoedema	4180186
43021490	Assessment of lymphedema (procedure)	4180186
43021491	Lipid disorder follow up assessment (regime/therapy)	4180186
43021492	Lipid disorder initial assessment (regime/therapy)	4180186
43021494	Suture plication of artery for control of gastric haemorrhage	4180186
43021494	Suture plication of artery for control of gastric hemorrhage (procedure)	4180186
43021495	Suture plication of artery for control of gastric ulcer hemorrhage (procedure)	4180186
43021495	Suture plication of artery for control of bleeding stomach ulcer	4180186
43021495	Suture plication of artery for control of gastric ulcer haemorrhage	4180186
43021496	Suture plication of artery for control of bleeding duodenal ulcer	4180186
43021496	Suture plication of artery for control of duodenal ulcer hemorrhage (procedure)	4180186
43021496	Suture plication of artery for control of duodenal ulcer haemorrhage	4180186
43021497	Decompression of intervertebral disc prolapse (procedure)	4180186
43021498	Excisional debridement of infected wound	4180186
43021498	Excisional debridement of wound for infection (procedure)	4180186
43021499	Cardiovascular disorder medication review (procedure)	4180186
43021500	Hematologic disorder medication review (procedure)	4180186
43021500	Haematologic disorder medication review	4180186
43021501	Pulmonary disorder medication review (procedure)	4180186
43021505	Hypertension medication review (procedure)	4180186
43021506	Heart failure medication review (procedure)	4180186
43021511	Kidney disease medication review	4180186
43021511	Renal disorder medication review (procedure)	4180186
43021512	Infectious disease medication review (procedure)	4180186
43021515	Endocrine disorder medication review (procedure)	4180186
43021516	Resuturing of caesarean wound	4180186
43021516	Suture of caesarean wound for dehiscence	4180186
43021516	Resuturing of cesarean wound	4180186
43021516	Suture of cesarean wound for dehiscence (procedure)	4180186
43021517	Stereotactic radiosurgery for acoustic neuroma (procedure)	4180186
43021518	Endoscopic decompression of orbit for exophthalmos (procedure)	4180186
43021519	Excision of bilateral ovaries for malignant neoplasm of ovary (procedure)	4180186
43021519	Excision of bilateral ovaries for malignant neoplasm of ovary	4180186
43021519	Excision of both ovaries for malignant neoplasm of ovary	4180186
43021519	Bilateral oophorectomy for ovarian malignancy	4180186
43021519	Bilateral oophorectomy for malignant tumor of ovary	4180186
43021519	Bilateral oophorectomy for malignant neoplasm of ovary (procedure)	4180186
43021519	Bilateral oophorectomy for malignant tumour of ovary	4180186
43021520	Sequestrectomy of facial bone for osteoradionecrosis (procedure)	4180186
43021521	Sequestrectomy of infected facial bone	4180186
43021521	Sequestrectomy of facial bone for infection (procedure)	4180186
43021522	Control of postoperative hemorrhage of prostate (procedure)	4180186
43021522	Control of postoperative haemorrhage of prostate	4180186
43021523	Burn of eye region with burn of face (disorder)	4180186
43021525	Burn of eye region with second degree burn of face	4180186
43021525	Burn of eye region with partial thickness burn of face (disorder)	4180186
43021527	Burn of eye region with burn of head and/or neck (disorder)	4180186
43021528	Burn of eye region with first degree burn of head and/or neck	4180186
43021528	Burn of eye region with epidermal burn of head and/or neck (disorder)	4180186
43021528	Burn of eye region with superficial burn of head and/or neck	4180186
43021530	Burn of eye region with full thickness burn of head and/or neck (disorder)	4180186
43021530	Burn of eye region with third degree burn of head and/or neck	4180186
43021531	Partial thickness burn of multiple sites of face, head and/or neck without involvement of eye proper (disorder)	4180186
43021531	Second degree burn of multiple sites of face, head and/or neck without involvement of eye proper	4180186
43021532	Burn of multiple sites of face without involvement of eye proper (disorder)	4180186
43021533	Burn erythema of multiple sites of face without involvement of eye proper	4180186
43021533	Superficial burn of multiple sites of face without involvement of eye proper	4180186
43021533	Epidermal burn of multiple sites of face without involvement of eye proper (disorder)	4180186
43021533	First degree burn of multiple sites of face without involvement of eye proper	4180186
43021534	Second degree burn of multiple sites of face without involvement of eye proper	4180186
43021534	Partial thickness burn of multiple sites of face without involvement of eye proper (disorder)	4180186
43021535	Third degree burn of multiple sites of face without involvement of eye proper	4180186
43021535	Full thickness burn of multiple sites of face without involvement of eye proper (disorder)	4180186
43021538	Partial thickness burn of multiple sites of head without involvement of eye proper (disorder)	4180186
43021538	Second degree burn of multiple sites of head without involvement of eye proper	4180186
43021542	Full thickness burn of multiple sites of neck (disorder)	4180186
43021542	Third degree burn of multiple sites of neck	4180186
43021543	Burn of multiple sites of hand (disorder)	4180186
43021545	Burn of multiple sites of wrist (disorder)	4180186
43021546	First degree burn of multiple sites of wrist	4180186
43021546	Epidermal burn of multiple sites of wrist (disorder)	4180186
43021546	Burn erythema of multiple sites of wrist	4180186
43021546	Superficial burn of multiple sites of wrist	4180186
43021547	Third degree burn of multiple sites of wrist	4180186
43021547	Full thickness burn of multiple sites of wrist (disorder)	4180186
43021548	Burn of multiple sites of upper limb without involvement of wrist and without involvement of hand (disorder)	4180186
43021549	Epidermal burn of multiple sites of upper limb without involvement of wrist and without involvement of hand (disorder)	4180186
43021549	First degree burn of multiple sites of upper limb without involvement of wrist and without involvement of hand	4180186
43021549	Superficial burn of multiple sites of upper limb without involvement of wrist and without involvement of hand	4180186
43021550	Full thickness burn of multiple sites of upper limb without involvement of wrist and without involvement of hand (disorder)	4180186
43021550	Third degree burn of multiple sites of upper limb without involvement of wrist and without involvement of hand	4180186
43021554	Intercarpal fusion for scapholunate advanced collapse (procedure)	4180186
43021555	Photodynamic therapy of chorioretinal lesion (procedure)	4180186
43021556	Incision of bile duct for obstruction (procedure)	4180186
43021556	Incision of bile duct for relief of obstruction	4180186
43021557	Obstruction of CBD (common bile duct)	4180186
43021557	Obstruction of common bile duct (disorder)	4180186
43021559	HPeV4 - Human parechovirus 4	4180186
43021559	Human parechovirus 4 (organism)	4180186
43021561	Human parechovirus 7 (organism)	4180186
43021561	HPeV7 - Human parechovirus 7	4180186
43021564	Psychotic symptom rating scales observable (observable entity)	4180186
43021566	Psychotic symptom rating scales auditory hallucination subscale emotional characteristics score (observable entity)	4180186
43021566	PSYRATS (psychotic symptom rating scales) auditory hallucination subscale emotional characteristics score	4180186
43021568	Psychotic symptom rating scales delusions subscale cognitive interpretation score (observable entity)	4180186
43021568	PSYRATS (psychotic symptom rating scales) delusions subscale cognitive interpretation score	4180186
43021575	Congenital hypoplasia of descending aorta (disorder)	4180186
43021578	Anomalous intramural course of proximal portion of coronary artery within aortic sinus of Valsalva	4180186
43021578	Anomalous intramural course of proximal portion of coronary artery within aortic sinus (disorder)	4180186
43021579	Anomalous intramural course of proximal portion of coronary artery across commissure of aortic valve (disorder)	4180186
43021582	Aberrant course of coronary artery through infundibular septum	4180186
43021582	Anomalous course of coronary artery through infundibular septum (disorder)	4180186
43021584	Anomalous origin of left ductus arteriosus from right aortic arch (disorder)	4180186
43021584	Anomalous origin of left ductus arteriosus from right aortic arch	4180186
43021586	Anomalous origin of ductus arteriosus from aortic diverticulum (disorder)	4180186
43021586	Anomalous origin of ductus arteriosus from aortic diverticulum	4180186
43021587	Anomalous insertion of ductus arteriosus into unknown site (disorder)	4180186
43021587	Anomalous insertion of ductus arteriosus into unknown site	4180186
43021588	Ductus arteriosus finding	4180186
43021588	Ductus arteriosus finding (finding)	4180186
43021589	Ductus arteriosus in normal left sided position (finding)	4180186
43021589	Ductus arteriosus in normal left sided position	4180186
43021590	Normal origin of ductus arteriosus from proximal descending aorta	4180186
43021590	Normal origin of ductus arteriosus from proximal descending aorta (finding)	4180186
43021591	Normal origin of ductus arteriosus from left aortic arch (finding)	4180186
43021591	Normal origin of ductus arteriosus from left aortic arch	4180186
43021593	Functional closure of ductus arteriosus present	4180186
43021593	Functional closure of ductus arteriosus present (finding)	4180186
43021594	Patent ductus arteriosus with normal origin and insertion and within normal period for functional closure	4180186
43021594	Patent ductus arteriosus with normal origin and insertion and within normal period for functional closure (finding)	4180186
43021596	Anomalous origin of ligamentum arteriosum from right aortic arch	4180186
43021596	Anomalous origin of ligamentum arteriosum from right aortic arch (disorder)	4180186
43021599	Ligamentum arteriosum finding	4180186
43021599	Ligamentum arteriosum finding (finding)	4180186
43021600	Ligamentum arteriosum in normal left sided position	4180186
43021600	Ligamentum arteriosum in normal left sided position (finding)	4180186
43021601	Normal insertion of ligamentum arteriosum into proximal left pulmonary artery	4180186
43021601	Normal insertion of ligamentum arteriosum into proximal left pulmonary artery (finding)	4180186
43021604	Acquired stenosis of pulmonary venous structure (disorder)	4180186
43021606	Acquired abnormality of right femoral vein (disorder)	4180186
43021607	Acquired abnormality of left femoral vein (disorder)	4180186
43021611	Hereditary dysplasia of blood vessel (disorder)	4180186
43021617	Arteriovenous fistula of coronary artery to coronary sinus (disorder)	4180186
43021618	Type A coronary artery fistula	4180186
43021618	Coronary artery fistula with dilatation of proximal coronary artery and without dilatation of distal coronary artery (disorder)	4180186
43021618	Coronary artery fistula with dilation of proximal coronary artery and without dilation of distal coronary artery	4180186
43021619	Coronary artery fistula with dilation of entire coronary artery	4180186
43021619	Coronary artery fistula with dilatation of entire coronary artery (disorder)	4180186
43021619	Type B coronary artery fistula	4180186
43021620	Normal position of coronary artery orifice (finding)	4180186
43021620	Normal position of coronary artery ostium	4180186
43021621	Restriction of coronary artery ostium due to neoplasm	4180186
43021621	Restriction of coronary artery orifice due to neoplasm (disorder)	4180186
43021621	Restriction of coronary artery orifice due to tumor	4180186
43021621	Restriction of coronary artery orifice due to tumour	4180186
43021623	Abscess of vascular cardiac conduit (disorder)	4180186
43021624	Failure of cardiac valve prosthesis (disorder)	4180186
43021624	Prosthetic cardiac valve failure	4180186
43021625	Abscess at site of cardiac valve prosthesis (disorder)	4180186
43021625	Abscess at site of prosthetic cardiac valve	4180186
43021626	Major systemic to pulmonary collateral artery with pulmonary artery proximal to hilar bifurcation (disorder)	4180186
43021628	Anomalous origin of dual left anterior descending coronary arteries (disorder)	4180186
43021628	Abnormal origin of dual left anterior descending coronary arteries	4180186
43021629	Abscess at site of systemic to pulmonary arterial shunt (disorder)	4180186
43021630	Double barrel dual coronary artery orifices within aortic sinus (disorder)	4180186
43021630	Double barrel dual coronary artery ostia within aortic sinus of Valsalva	4180186
43021631	Widely spaced right coronary artery and left coronary artery orifices within single aortic sinus (disorder)	4180186
43021631	Widely spaced right coronary artery and left coronary artery ostia within single aortic sinus of Valsalva	4180186
43021632	Congenital abnormality of systemic artery (disorder)	4180186
43021634	Type A atresia of aortic arch with fibrous cord distal to subclavian artery	4180186
43021634	Atresia of aortic arch with fibrous cord distal to subclavian artery (disorder)	4180186
43021637	Psychotic symptom rating scales delusions subscale score (observable entity)	4180186
43021637	PSYRATS (psychotic symptom rating scales) delusions subscale score	4180186
43021644	Aware of diagnosis (finding)	4180186
43021644	Diagnosis known to patient	4180186
43021645	Assessment using Addenbrooke's cognitive examination revised (procedure)	4180186
43021645	Assessment using ACE-R (Addenbrooke's cognitive examination revised)	4180186
43021649	Assessment using Addenbrooke's cognitive examination revised memory subscale (procedure)	4180186
43021649	Assessment using ACE-R (Addenbrooke's cognitive examination revised) memory subscale	4180186
43021650	Caregiver aware of diagnosis (situation)	4180186
43021650	Carer aware of diagnosis	4180186
43021652	Assessment using Addenbrooke's cognitive examination revised fluency subscale (procedure)	4180186
43021652	Assessment using ACE-R (Addenbrooke's cognitive examination revised) fluency subscale	4180186
43021654	Addenbrooke's cognitive examination revised attention and orientation subscale (assessment scale)	4180186
43021654	ACE-R (Addenbrooke's cognitive examination revised) attention and orientation subscale	4180186
43021655	Addenbrooke's cognitive examination revised memory subscale (assessment scale)	4180186
43021655	ACR-R (Addenbrooke's cognitive examination revised) memory subscale	4180186
43021657	Addenbrooke's cognitive examination revised fluency subscale (assessment scale)	4180186
43021657	ACE-R (Addenbrooke's cognitive examination revised) fluency subscale	4180186
43021659	Assessment using ages and stages questionnaires third edition communication subscale (procedure)	4180186
43021659	Assessment using ASQ-3 (ages and stages questionnaires third edition) communication subscale	4180186
43021660	Assessment using ages and stages questionnaires third edition fine motor subscale (procedure)	4180186
43021660	Assessment using ASQ-3 (ages and stages questionnaires third edition) fine motor subscale	4180186
43021661	Assessment using ages and stages questionnaires third edition gross motor subscale (procedure)	4180186
43021661	Assessment using ASQ-3 (ages and stages questionnaires third edition) gross motor subscale	4180186
43021662	Assessment using ages and stages questionnaires third edition personal-social subscale (procedure)	4180186
43021662	Assessment using ASQ-3 (ages and stages questionnaires third edition) personal-social subscale	4180186
43021663	Assessment using ages and stages questionnaires third edition problem solving subscale (procedure)	4180186
43021663	Assessment using ASQ-3 (ages and stages questionnaires third edition) problem solving subscale	4180186
43021667	Ages and Stages Questionnaires Third Edition personal-social subscale (assessment scale)	4180186
43021667	ASQ-3 (ages and stages questionnaires third edition) personal-social subscale	4180186
43021668	Ages and Stages Questionnaires Third Edition problem solving subscale (assessment scale)	4180186
43021668	ASQ-3 (ages and stages questionnaires third edition) problem solving subscale	4180186
43021669	Complaining of erectile dysfunction (finding)	4180186
43021669	Complaining of impotence	4180186
43021669	C/O erectile dysfunction	4180186
43021670	Does not complain of erectile dysfunction (situation)	4180186
43021670	Does not complain of impotence	4180186
43021671	Chronic respiratory disease questionnaire observable (observable entity)	4180186
43021672	Chronic respiratory disease questionnaire dyspnea subscale score (observable entity)	4180186
43021672	Chronic respiratory disease questionnaire dyspnoea subscale score	4180186
43021673	Chronic respiratory disease questionnaire emotional function subscale score (observable entity)	4180186
43021676	Assessment using chronic respiratory disease questionnaire dyspnea subscale (procedure)	4180186
43021676	Assessment using chronic respiratory disease questionnaire dyspnoea subscale	4180186
43021677	Assessment using chronic respiratory disease questionnaire emotional function subscale (procedure)	4180186
43021678	Assessment using chronic respiratory disease questionnaire fatigue subscale (procedure)	4180186
43021682	Chronic respiratory disease questionnaire emotional function subscale (assessment scale)	4180186
43021685	Eating disorder examination questionnaire observable (observable entity)	4180186
43021686	Eating disorder examination questionnaire eating concern subscale score (observable entity)	4180186
43021686	EDE-Q (eating disorder examination questionnaire) eating concern subscale score	4180186
43021691	Eating disorder examination questionnaire weight concern subscale (assessment scale)	4180186
43021691	EDE-Q (eating disorder examination questionnaire) weight concern subscale	4180186
43021693	Mobility inventory for agoraphobia when accompanied score (observable entity)	4180186
43021694	Mobility inventory for agoraphobia when alone score (observable entity)	4180186
43021695	Acquired abnormality of systemic vein (disorder)	4180186
43021696	Diagnostic procedure on pancreas (procedure)	4180186
43021697	Thrombus of right atrium (disorder)	4180186
43021697	Right atrial thrombus	4180186
43021698	Left atrial thrombus	4180186
43021698	Thrombus of left atrium (disorder)	4180186
43021700	Taking cervical culture	4180186
43021700	Taking of culture from cervix (procedure)	4180186
43021705	Drainage of suprachoroidal fluid after choroidal detachment (procedure)	4180186
43021706	Drainage of subretinal fluid after choroidal detachment (procedure)	4180186
43021707	Electromyography for disorder of central nervous system (procedure)	4180186
43021712	Suture plication of artery by transanal approach for control of anorectal haemorrhage	4180186
43021712	Suture plication of artery by transanal approach for control of anorectal hemorrhage (procedure)	4180186
43021714	Congenital luminal atresia of aortic arch (disorder)	4180186
43021715	Congenital luminal atresia of aortic arch distal to subclavian artery (disorder)	4180186
43021715	Type A congenital luminal atresia of aortic arch distal to subclavian artery	4180186
43021717	Type C congenital luminal atresia of aortic arch between left common carotid artery and right common carotid artery	4180186
43021717	Congenital luminal atresia of aortic arch between left common carotid artery and right common carotid artery (disorder)	4180186
43021720	Acquired luminal obstruction of aortic arch distal to subclavian artery (disorder)	4180186
43021720	Type A acquired luminal obstruction of aortic arch distal to subclavian artery	4180186
43021722	Type C acquired luminal obstruction of aortic arch between left common carotid artery and right common carotid artery	4180186
43021722	Acquired luminal obstruction of aortic arch between left common carotid artery and right common carotid artery (disorder)	4180186
43021723	Right aortic arch branching pattern (disorder)	4180186
43021726	Foetal fluid retention restricted to one foetal compartment	4180186
43021726	Fetal fluid retention restricted to one fetal compartment (disorder)	4180186
43021727	Diffuse fetal skin edema (disorder)	4180186
43021727	Generalised foetal skin oedema	4180186
43021727	Diffuse fetal skin oedema	4180186
43021727	Diffuse foetal skin oedema	4180186
43021727	Generalised fetal skin oedema	4180186
43021727	Generalized fetal skin edema	4180186
43021728	Foetal pleural effusion	4180186
43021728	Fetal pleural effusion (disorder)	4180186
43021732	Foetal mediastinal shift to left	4180186
43021732	Fetal mediastinal shift to left (disorder)	4180186
43021741	Not tolerating oral fluid (situation)	4180186
43021742	Never used condom (situation)	4180186
43021748	Hypertensive nephrosclerosis (disorder)	4180186
43021749	Congenital occlusion of coronary sinus (disorder)	4180186
43021752	Attended breast screening clinic (situation)	4180186
43021754	Dialysis catheter in situ unusable (finding)	4180186
43021756	Swab from tooth (specimen)	4180186
43021757	Cotton wool ball submitted as specimen (specimen)	4180186
43021758	Percutaneous nephrostomy tube tip submitted as specimen (specimen)	4180186
43021758	Percutaneous nephrostomy catheter tip submitted as specimen	4180186
43021759	Rickham reservoir submitted as specimen (specimen)	4180186
43021760	Cerebrospinal fluid specimen obtained from Rickham reservoir (specimen)	4180186
43021763	Umbilical artery catheter submitted as specimen (specimen)	4180186
43021765	Peripheral vascular catheter submitted as specimen (specimen)	4180186
43021767	Endotracheal tube submitted as specimen (specimen)	4180186
43021770	Intrauterine contraceptive device submitted as specimen (specimen)	4180186
43021773	Intraductal papillary mucinous neoplasm with intermediate dysplasia of pancreas	4180186
43021773	Intraductal papillary mucinous neoplasm with low grade dysplasia of pancreas	4180186
43021773	Intraductal papillary mucinous neoplasm with moderate dysplasia of pancreas	4180186
43021773	Intraductal papillary mucinous adenoma of pancreas (disorder)	4180186
43021774	Intraductal papillary mucinous neoplasm with high grade dysplasia of pancreas	4180186
43021774	Intraductal papillary mucinous carcinoma in situ of pancreas (disorder)	4180186
43021774	Non-invasive intraductal papillary mucinous carcinoma of pancreas	4180186
43021775	Twins with discordant foetal growth	4180186
43021775	Twins with discordant fetal growth (disorder)	4180186
43021775	Twin growth discordance	4180186
43021777	Deafness of left ear (disorder)	4180186
43021782	Primary tuberculous complex confirmed histologically (disorder)	4180186
43021783	Primary tuberculous complex confirmed by microscopic examination (disorder)	4180186
43021784	Tuberculoma of spinal cord confirmed (disorder)	4180186
43021787	Settle culture plate submitted as specimen (specimen)	4180186
43021787	Settle plate submitted as specimen	4180186
43021788	Protected specimen brush submitted as specimen (specimen)	4180186
43021790	Three column burst fracture of vertebra	4180186
43021790	Three column classification system burst fracture of vertebra (disorder)	4180186
43021791	Parosteal lipoma (disorder)	4180186
43021792	Chance fracture of vertebra	4180186
43021792	Chance flexion distraction fracture of vertebra (disorder)	4180186
43021795	Anomalous origin of right coronary artery (disorder)	4180186
43021796	Anomalous origin of left coronary artery (disorder)	4180186
43021799	Non-coronary systemic artery structure (body structure)	4180186
43021801	Finding of aorta (finding)	4180186
43021802	Child victim of psychological or emotional abuse (finding)	4180186
43021802	Child abuse, emotional or psychological	4180186
43021804	Compulsive personality disorder (disorder)	4180186
43021805	Obsessional personality disorder (disorder)	4180186
43021806	Regurgitation of atrioventricular (not morphologically mitral or tricuspid) valve (disorder)	4180186
43021806	Regurgitation of atrioventricular (nonmitral, nontricuspid) valve	4180186
43021808	Educated to high school level (finding)	4180186
43021809	Received early childhood education (finding)	4180186
43021810	Mild receptive language delay (disorder)	4180186
43021814	Severe receptive language delay (disorder)	4180186
43021816	Mixed dementia (disorder)	4180186
43021816	Dementia with mixed aetiology	4180186
43021816	Dementia with mixed etiology	4180186
43021816	MVAD - Mixed vascular Alzheimer dementia	4180186
43021817	Stroke care management (procedure)	4180186
43021818	Sleep disorder care management (procedure)	4180186
43021819	Life circumstance problem (finding)	4180186
43021820	Bipolar 2 disorder, most recent episode rapid cycling	4180186
43021820	Bipolar II disorder, most recent episode rapid cycling (disorder)	4180186
43021822	Malfunction of biventricular automatic implantable cardioverter defibrillator (disorder)	4180186
43021823	Severe expressive language delay (disorder)	4180186
43021826	Congestive heart failure stage C (disorder)	4180186
43021831	Antihypertensive agent surveillance (regime/therapy)	4180186
43021832	Peer problem (finding)	4180186
43021833	Syphilitic valvular endocarditis (disorder)	4180186
43021836	Hypertensive heart AND chronic kidney disease stage 2 (disorder)	4180186
43021837	Localized chest pain (finding)	4180186
43021837	Localised chest pain	4180186
43021841	Diastolic heart failure stage D (disorder)	4180186
43021841	Diastolic heart failure, stage D	4180186
43021842	Diastolic heart failure, stage C	4180186
43021842	Diastolic heart failure stage C (disorder)	4180186
43021843	Complication, aortic graft, endoleak	4180186
43021843	Persistent flow of blood into graft of aorta (disorder)	4180186
43021844	Drug dependence, episodic (disorder)	4180186
43021846	Peripheral arterial insufficiency (disorder)	4180186
43021846	Peripheral artery insufficiency	4180186
43021848	High lumbar myelomeningocele (disorder)	4180186
43021849	Mood disorder with manic feature	4180186
43021849	Mood disorder of manic type (disorder)	4180186
43021852	Malignant hypertensive chronic kidney disease (disorder)	4180186
43021854	Malignant hypertensive chronic kidney disease stage 2 (disorder)	4180186
43021855	Malfunction of biventricular automatic implantable cardioverter defibrillator generator (disorder)	4180186
43021856	Malfunction of biventricular cardiac pacemaker battery (disorder)	4180186
43021862	Total anomalous pulmonary venous connection to hepatic vein (disorder)	4180186
43021863	Total anomalous pulmonary venous connection to superior vena cava (disorder)	4180186
43021867	Problem related to social environment (finding)	4180186
43021870	Epiphyseal fracture, Salter-Harris type IX	4180186
43021870	Salter-Harris type IX (morphologic abnormality)	4180186
43021871	Progression of fetal right ventricular outflow tract obstruction (disorder)	4180186
43021871	Progression of foetal right ventricular outflow tract obstruction	4180186
43021872	Aversion to substrate for elimination of bodily waste	4180186
43021872	Aversion to substrate for elimination of bodily waste (finding)	4180186
43021873	Extended radical mastectomy of both breasts	4180186
43021873	Extended radical mastectomy of bilateral breasts	4180186
43021873	Extended radical mastectomy of bilateral breasts (procedure)	4180186
43021873	Bilateral extended radical mastectomy (procedure)	4180186
43021875	Flutemetamol F^18^	4180186
43021875	Product containing flutemetamol (18-F) (medicinal product)	4180186
43021876	Fluciclatide F^18^	4180186
43021876	Product containing fluciclatide (18-F) (medicinal product)	4180186
43021879	Escherichia coli serotype Orough:H16 (organism)	4180186
43021879	E. coli Orough:H16	4180186
43021883	Reverse curve of Spee (finding)	4180186
43021888	Anomalous origin of single coronary artery from nonfacing aortic sinus of Valsalva	4180186
43021888	Anomalous origin of single coronary artery from sinus 3	4180186
43021888	Anomalous origin of single coronary artery from nonfacing aortic sinus (disorder)	4180186
43021891	Rupture of tricuspid papillary muscle	4180186
43021891	Rupture of tricuspid valve papillary muscle (disorder)	4180186
43021893	Dehiscence of pulmonary valve annulus as complication of procedure (disorder)	4180186
43021894	Thrombosis of truncal valve (disorder)	4180186
43021896	Thrombosis of right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43021896	Thrombosis of right atrioventricular (nontricuspid) valve	4180186
43021897	Rupture of right atrioventricular (nontricuspid) valve papillary muscle	4180186
43021897	Rupture of right atrioventricular (not morphologically tricuspid) valve papillary muscle (disorder)	4180186
43021898	Rupture of left atrioventricular (not morphologically mitral) valve chordae tendinae (disorder)	4180186
43021898	Rupture of left atrioventricular (nonmitral) valve chordae tendinae	4180186
43021899	E. coli serotype O168:H14	4180186
43021899	Escherichia coli serotype O168:H14 (organism)	4180186
43021900	Escherichia coli serotype O165:H25 (organism)	4180186
43021900	E. coli serotype O165:H25	4180186
43021901	Escherichia coli serotype O162:H11 (organism)	4180186
43021901	E. coli serotype O162:H11	4180186
43021903	Ventricular myocardial noncompaction cardiomyopathy (disorder)	4180186
43021907	E. coli serotype O123:H2	4180186
43021907	Escherichia coli serotype O123:H2 (organism)	4180186
43021915	Escherichia coli serotype O8:H9 (organism)	4180186
43021915	E. coli serotype O8:H9	4180186
43021918	Escherichia coli serotype O26:H11 (organism)	4180186
43021918	E. coli serotype O26:H11	4180186
43021920	Escherichia coli serotype O28:H174 (organism)	4180186
43021920	E. coli serotype O28:H174	4180186
43021924	Live oak pollen allergen	4180186
43021924	Quercus virginiana pollen allergen (substance)	4180186
43021925	Quercus nigra pollen (substance)	4180186
43021925	Water oak pollen	4180186
43021926	Ficus pollen allergen (substance)	4180186
43021927	Broussonetia papyrifera pollen allergen (substance)	4180186
43021927	Paper mulberry pollen allergen	4180186
43021930	Cerebrovascular disorder due to paradoxical embolus (disorder)	4180186
43021933	Pulmonary venous hypertension due to compression of pulmonary great vein by neoplasm (disorder)	4180186
43021933	Pulmonary venous hypertension due to compression of pulmonary great vein by tumour	4180186
43021933	Pulmonary venous hypertension due to compression of pulmonary great vein by tumor	4180186
43021935	Infective endocarditis of heterograft (disorder)	4180186
43021935	Infectious endocarditis of heterograft	4180186
43021939	Far eastern spotted fever (disorder)	4180186
43021940	Recurrent respiratory papillomatosis (disorder)	4180186
43021941	Disorder of mitral valve prosthesis (disorder)	4180186
43021943	Regurgitation of fetal tricuspid valve (disorder)	4180186
43021943	Regurgitation of foetal tricuspid valve	4180186
43021944	Regurgitation of fetal mitral valve (disorder)	4180186
43021944	Regurgitation of foetal mitral valve	4180186
43021945	Regurgitation of foetal aortic valve	4180186
43021945	Regurgitation of fetal aortic valve (disorder)	4180186
43021949	Abscess at site of aortic coarctation (disorder)	4180186
43021951	Monochorionic diamniotic twin pregnancy (disorder)	4180186
43021953	Abscess of left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43021953	Abscess of left atrioventricular (nonmitral) valve	4180186
43021957	Vascular catheter submitted as specimen (specimen)	4180186
43021960	Previously homosexual transsexual (finding)	4180186
43021962	History of impaired hearing	4180186
43021962	History of hearing loss (situation)	4180186
43021962	H/O impaired hearing	4180186
43021963	History of arthralgia of multiple joints	4180186
43021963	History of pain of multiple joints (situation)	4180186
43021963	H/O: pain of multiple joints	4180186
43021968	History of gestational diabetes mellitus (situation)	4180186
43021968	H/O gestational diabetes mellitus	4180186
43021969	History of vasculitis (situation)	4180186
43021969	H/O vasculitis	4180186
43021975	Complication associated with peripherally inserted central catheter (disorder)	4180186
43021975	Complication associated with PICC (peripherally inserted central catheter) line	4180186
43021976	Complication associated with vascular implant (disorder)	4180186
43021980	Infection associated with musculoskeletal implant (disorder)	4180186
43021981	Infection associated with orthopaedic device	4180186
43021981	Infection associated with orthopedic device (disorder)	4180186
43021983	History of recurrent malignant tumour of breast	4180186
43021983	History of recurrent malignant tumor of breast	4180186
43021983	History of recurrent malignant neoplasm of breast (situation)	4180186
43021984	Infection associated with retained intrauterine contraceptive device (disorder)	4180186
43021985	Infection associated with peritoneal dialysis catheter (disorder)	4180186
43021986	Infection associated with neurological device (disorder)	4180186
43021988	History of allergy to teriparatide (situation)	4180186
43021989	Infection and inflammation associated with retained intrauterine contraceptive device (disorder)	4180186
43021991	Acquired stenosis of superior vena cava (disorder)	4180186
43021991	Acquired stenosis of superior caval vein	4180186
43021994	Ductus arteriosus dependent pulmonary circulation	4180186
43021994	Ductus arteriosus dependent pulmonary circulation (disorder)	4180186
43021998	History of bronchiolitis (situation)	4180186
43021999	Suspected depressive disorder (situation)	4180186
43021999	Suspected depression	4180186
43022000	Suspected drug overdose (situation)	4180186
43022005	Protrusion of internal fixation device (disorder)	4180186
43022006	Possible familial hypercholesterolaemia	4180186
43022006	Possible familial hypercholesterolemia (situation)	4180186
43022008	History of tuberculosis chemotherapy	4180186
43022008	History of tuberculosis drug therapy (situation)	4180186
43022010	History of partial hepatectomy for liver donation	4180186
43022010	History of live donor partial hepatectomy (situation)	4180186
43022010	History of liver donation	4180186
43022012	History of varicella vaccination (situation)	4180186
43022015	History of vaginal hysterectomy (situation)	4180186
43022016	Displacement of internal fixation device (disorder)	4180186
43022018	Discussion about gestational hypertension (procedure)	4180186
43022018	Discussion about pregnancy induced hypertension	4180186
43022019	On subcutaneous insulin for diabetes mellitus (finding)	4180186
43022020	Wheelchair in good repair (finding)	4180186
43022021	Transluminal intracardiac echocardiography for congenital heart disease (procedure)	4180186
43022023	Bilateral ductus arteriosus with patent left ductus arteriosus and closed right ductus arteriosus	4180186
43022023	Bilateral ductus arteriosus with patent left ductus arteriosus and closed right ductus arteriosus (disorder)	4180186
43022024	Cardiovascular abnormality due to anomalous origin of ductus arteriosus	4180186
43022024	Cardiovascular abnormality due to anomalous origin of ductus arteriosus (disorder)	4180186
43022026	Anomalous course of coronary artery anterior to pulmonary trunk and aorta (disorder)	4180186
43022027	Acquired abnormality of left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43022027	Acquired abnormality of left atrioventricular (nonmitral) valve	4180186
43022028	Right ventricular hypertension (disorder)	4180186
43022030	Epidermal burn of multiple sites of hand (disorder)	4180186
43022030	Burn erythema of multiple sites of hand	4180186
43022030	First degree burn of multiple sites of hand	4180186
43022030	Superficial burn of multiple sites of hand	4180186
43022031	Partial thickness burn of multiple sites of wrist (disorder)	4180186
43022031	Second degree burn of multiple sites of wrist	4180186
43022032	Partial thickness burn of multiple sites of upper limb without involvement of wrist and without involvement of hand (disorder)	4180186
43022032	Second degree burn of multiple sites of upper limb without involvement of wrist and without involvement of hand	4180186
43022033	Human parechovirus 6 (organism)	4180186
43022033	HPeV6 - Human parechovirus 6	4180186
43022040	Atresia of aortic arch with fibrous cord (disorder)	4180186
43022041	History of osteoporosis resolved (situation)	4180186
43022043	Standing-start 180 degree turn test number of steps (observable entity)	4180186
43022045	Congenital stenosis of distal coronary artery (disorder)	4180186
43022047	Calcification of mitral valve (disorder)	4180186
43022053	Foetal supraventricular tachycardia with short ventriculoatrial interval	4180186
43022053	Fetal supraventricular tachycardia with short ventriculoatrial interval (disorder)	4180186
43022053	Fetal supraventricular tachycardia with short RP interval	4180186
43022053	Foetal supraventricular tachycardia with short RP interval	4180186
43022054	Foetal heart failure with myocardial hypertrophy	4180186
43022054	Fetal heart failure with myocardial hypertrophy (disorder)	4180186
43022058	Acquired abnormality of iliac vein (disorder)	4180186
43022059	Disease of non-coronary systemic artery (disorder)	4180186
43022060	Atypical psychosis (disorder)	4180186
43022061	Disorder of right atrioventricular (nontricuspid) valve	4180186
43022061	Disorder of right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43022065	Moderate expressive language delay (disorder)	4180186
43022066	Left atrial enlargement (disorder)	4180186
43022068	Exacerbation of congestive heart failure (disorder)	4180186
43054872	Lung; PF; Point in time; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SpO2; Tissue; Tissue, unspecified; Velocity ratio	4180186
43054872	Perfusion index Tiss PulseOx	4180186
43054872	灌注指数:速度比率:时间点:组织与涂片:定量型:脉搏血氧定量法	4182948
43054877	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
43054877	癌症事件报告:发现:时间点:{环境}:文档型:{角色}	4182948
43054878	CA; Cancer Dx; DOC.MISC; Dx; Finding; Findings; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
43054878	Cancer Dx	4180186
43054878	癌症诊断:发现:时间点:癌.XXX:叙述型	4182948
43054879	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Risk for VTE; Screen; Survey; SURVEY.GNHLTH	4180186
43054880	Brst; Brst-R; CorePlaybook; DBT; Document; Dx; Finding; Findings; Imaging; Mammography tomo; Mammography tomosynthesis; Playbook; Point in time; R; Rad; RADIOLOGY; Random; RT	4180186
43054880	DBT Brst-R Dx	4180186
43054880	诊断类多层:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术.断层合成	4182948
43054885	Asympt; Asymptomatic; Bil; Bilat; Both; Breast-Bl; Breasts; Brst; Brst-Bl; CorePlaybook; DBT; Document; Finding; Findings; Imaging; Mammography tomo; Mammography tomosynthesis; Playbook; Point in time; Rad; Radiology; Random; Scn	4180186
43054885	DBT Brst-Bl Screening	4180186
43054885	筛查类多层:发现:时间点:乳腺.双侧:文档型:乳房X线摄影术.断层合成	4182948
43054888	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054895	AIDS; Finding; Findings; Human immunodeficiency virus; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054896	Birth status; Finding; Findings; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054898	Fetal; Finding; Findings; Gyn; Gynecology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH; Womb presentation	4180186
43054900	2; Apo-HC-II; apo-TC-I; Apotranscobalamin; Chemistry; Cobalamin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration; TC; TC-2; TCII; TC-II; Transcobalamin 1; Transcobalamin 2; transcobalamin I; Vit B12; Vitamin B12	4180186
43054900	Apo-HC-II Ser-sCnc	4180186
43054900	Apo-运钴胺素蛋白 II:物质的量浓度:时间点:血清:定量型	4182948
43054901	apo-haptocorrin; apo-HC; Apo-TC-1; Apotranscobalamin; Chemistry; Cobalamin; haptocorrin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration; TC; TC-1; TCI; TC-I; Transcobalamin; Transcobalamin 1; Vit B12; Vitamin B12	4180186
43054901	Apo-TC-1 Ser-sCnc	4180186
43054901	Apo-运钴胺素蛋白 I:物质的量浓度:时间点:血清:定量型	4182948
43054906	Gram Stn; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified; WBC; WBCs; White blood cell; White blood cells	4180186
43054906	WBC Spec Ql Gram Stn	4180186
43054906	白细胞:存在情况或阈值:时间点:XXX:序数型:革兰氏染色法	4182948
43054907	BP; Dias; Diast; Diastoli; Gender; PEDS; Peds DBP percentile; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
43054908	BP; Gender; PEDS; Peds SBP percentile; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
43054909	Tobac smoke stat	4180186
43054909	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Tobac smoke stat	4180186
43054909	烟草吸食状况:发现:时间点:^患者:名义型	4182948
43054910	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
43054911	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c409; Floxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
43054911	Ofloxacin 1.5 ug/mL Islt SlowMyco	4180186
43054911	氧氟沙星 1.5 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
43054913	DOC.ONT; Document; Finding; Findings; Photo image; Point in time; Random	4180186
43054913	Photo image	4180186
43054913	数字摄影图像:发现:时间点:{环境}:文档型:{角色}	4182948
43054915	MoCA; Montreal Cognitive Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
43054916	Blessed Orientation-Memory-Concentration Test; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
43054921	Finding; Findings; Given mosquito net; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054922	Daraprim; Fansidar; Finding; Findings; Given pyrimethamine sulfadoxine 4th Mo; month; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054923	Acd; Acids; Fe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054924	AIDS; Finding; Findings; HIV results shared w partner; Human immunodeficiency virus; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054925	AIDS; Finding; Findings; Human immunodeficiency virus; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054926	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054927	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054929	Finding; Findings; Nominal; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054937	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Sx	4180186
43054939	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
43054942	Pan; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
43054942	HEDIS 2013 组套:-:时间点:^患者:-	4182948
43054945	CARE Survey; Continuity assessment record and evaluation; Disch; Discharge disposition LTCH; Discharge location; Discharge status; Hosp; Nominal; Point in time; Random; Survey; Typ	4180186
43054946	Chemistry; Intact Parathormone; intact parathyroid hormone; iPTH; Pan; PANEL.CHEMISTRY; Panl; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Pnl; Point in time; PTH; PTH-Intact; PTH-Intact IO pnl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
43054946	PTH-Intact IO pnl SerPl	4180186
43054946	甲状旁腺素.完整型 术中组套:-:时间点:血清/血浆:-	4182948
43054949	ABS; Aby; ANA IgG; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ColRto; EBNA; EBV; EBV NA; EBV NA 1; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; i; IAA; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Nominal; Nuc; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
43054949	EBV NA 1 IgG+IgM SerPl IA.rapid-ColRto	4180186
43054949	Epstein Barr 病毒细胞核 1 抗体.IgG 与 IgM:颜色比率:时间点:血清/血浆:名义型:免疫测定法.快速	4182948
43054952	inv(16)(p13;q22)/control Mar	4180186
43054952	ABL; ABL1; ABL1 transcript; Acute myeloid leukemia; AML; BM; BON; Bone marrow; control gene; DNA; gene fusion; gene translocation; inv(16)(CBFB,MYH11) gene inversion; inv(16)(p13;q22); Inversion 16; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.INV; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; translocation	4180186
43054952	inv(16)(p13.1;q22.1)(MYH11,CBFB) 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054953	inv(16)(p13;q22)/control Bld/T	4180186
43054953	ABL; ABL1; ABL1 transcript; Acute myeloid leukemia; AML; Blood; control gene; DNA; gene fusion; gene translocation; inv(16)(CBFB,MYH11) gene inversion; inv(16)(p13;q22); Inversion 16; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.INV; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43054953	inv(16)(p13.1;q22.1)(MYH11,CBFB) 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43054955	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; BM; BON; Bone marrow; breakpoint cluster region 1; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; long form; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(PML,RARA) gene translocation breakpoint cluster region 1; t(15,17)(q22,q11.2-q12); t(15;17) BCR1; t(15;17)(PML,RARA); translocation	4180186
43054955	t(15;17) BCR1/control Mar	4180186
43054955	t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054956	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; BM; BON; Bone marrow; breakpoint cluster region 3; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(q22,q11.2-q12); t(15;17) BCR3; t(15;17)(PML,RARA); translocation	4180186
43054956	t(15;17) BCR3/control Mar	4180186
43054956	t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054958	BldA+BldMV Fshunt vol temp adj VFr	4180186
43054958	ABG; adj; ART; Art bld; Art blood; Arterial; Arterial blood; Bld mixed venous; Blood - mixed venous; Blood arterial; Fshunt; Fshunt vol; Hemodynamics; HEMODYNAMICS.MOLEC; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Temp; temp adj; Vol; Volfr; Volume fraction	4180186
43054958	功能分流体积^^调整至病人实际体温的:体积分数:时间点:动脉全血+混合静脉全血:定量型	4182948
43054960	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Fshunt; Fshunt vol; Hemodynamics; HEMODYNAMICS.MOLEC; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volfr; Volume fraction	4180186
43054960	BldA Fshunt vol VFr	4180186
43054960	功能分流体积:体积分数:时间点:动脉全血:定量型	4182948
43054961	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; breast cancer; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stiff Man Syndrome; SUDS	4180186
43054961	Amphiphysin IgG Ser Ql IA	4180186
43054961	双载蛋白 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43054965	100 rnd; Anuc bdy; bod; Body; Cell; Cellularity; EPS; expressed prostatic secretion; FERTILITY TESTING; Genitourinary; GU; Manl; Number fraction; Percent; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; Rnd Cells; Unnucleated; URO; Urology	4180186
43054965	Anuc bdy/100 rnd NFr Prost fld Manual	4180186
43054965	无核小体/100 个圆形细胞:计数型分数:时间点:前列腺液:定量型:手工计数方法	4182948
43054967	BM; BON; Bone marrow; Erythrocytosis; Genetics; Heredity; Heritable; Inherited; JAK2 p.V617F; Janus kinase 2; Janus kinase 2 gene; JTK10; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PCR; Point in time; Polycythemia vera; PR; PV; QL; Qual; Qualitative; Random; Screen; THCYT3	4180186
43054967	JAK2 p.V617F Mar Ql	4180186
43054967	JAK2 基因.p.V617F:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
43054968	ABL; ABL1; ABL1 transcript; B23; BM; BON; Bone marrow; control gene; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut B; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43054968	NPM1 gene mut B/control Mar	4180186
43054968	NPM1 基因.c.960insCATG 转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054970	ABL; ABL1; ABL1 transcript; B23; BM; BON; Bone marrow; control gene; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut D; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43054970	NPM1 gene mut D/control Mar	4180186
43054970	NPM1 基因.c.960insCCTG 转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054971	Antigen; Antigens; Arbitrary concentration; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; MEIA; MNSs Blood Group System; Plas; Platelet poor plasma; Point in time; PR; Prot; Prot S; PS; QNT; Quan; Quant; Quantitative; Random; S prime; SUDS	4180186
43054971	Prot S Ag PPP IA-aCnc	4180186
43054971	蛋白 S 抗原:任意型浓度:时间点:贫血小板血浆:定量型:免疫测定法	4182948
43054973	c470; Choline phosphoglyceride; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Phosphatidylcholine; Point in time; PR; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QL; Qual; Qualitative; Random; Screen	4180186
43054973	Lecithin Prost fld Ql Micro	4180186
43054973	磷脂酰胆碱:存在情况或阈值:时间点:前列腺液:序数型:显微镜检查.光学	4182948
43054975	bod; Body; EPS; expressed prostatic secretion; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QL; Qual; Qualitative; Random; Screen; URO; Urology	4180186
43054975	Amyloid Prost fld Ql Micro	4180186
43054975	淀粉样小体:存在情况或阈值:时间点:前列腺液:序数型:显微镜检查.光学	4182948
43054976	100 rnd; Cell; Cellularity; Ejaculate; Genitourinary; GU; HEMATOLOGY/CELL COUNTS; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnd Cells; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
43054976	Neutrophils/100 rnd NFr Smn Manual	4180186
43054976	嗜中性粒细胞/100 个圆形细胞:计数型分数:时间点:精液:定量型:手工计数方法	4182948
43054978	100 rnd; Cell; Cellularity; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; Manl; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; Rnd Cells	4180186
43054978	Monocytes/100 rnd NFr Prost fld Manual	4180186
43054978	单核细胞/100 个圆形细胞:计数型分数:时间点:前列腺液:定量型:手工计数方法	4182948
43054981	Neutrophils # Prost fld Manual	4180186
43054981	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; Manl; Neut; Neutr; Neutrophil; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random	4180186
43054981	嗜中性粒细胞:计数型浓度:时间点:前列腺液:定量型:手工计数方法	4182948
43054985	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Othr; QL; Qual; Qualitative; Screen; Social interaction over past 1Mo; Survey; SURVEY.GNHLTH	4180186
43054986	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
43054989	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
43054991	Acd; Acid fast Stn; Acids; AFB stain; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
43054991	Acid fast Stn Spec Ql	4180186
43054991	显微镜观察:存在情况或阈值:时间点:XXX:序数型:抗酸染色法	4182948
43054995	100WBC; Eye; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Ophthalmology; Ophtho; Ophthy; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour; WBC; WBCs; White blood cell; White blood cells	4180186
43054995	Lymphocytes/leuk NFr Vitf Manual	4180186
43054995	淋巴细胞/100 个白细胞:计数型分数:时间点:玻璃体液:定量型:手工计数方法	4182948
43054996	A,B; ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; Identity or presence; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Nasal; Nominal; Nos; Nose (nasal passage); Point in time; Random; Smell; Time Resolved Fluorescence; TRF	4180186
43054996	FLUAV + FLUBV Ag Nose IF	4180186
43054996	流感病毒 A 型与 B 型 抗原:存在与否或特征标识:时间点:鼻:名义型:免疫荧光法	4182948
43054998	A,B; Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; SUDS	4180186
43054998	FLUAV+FLUBV Ag Nose Ql IA.rapid	4180186
43054998	流感病毒 A+B 型 抗原:存在情况或阈值:时间点:鼻:序数型:免疫测定法.快速	4182948
43055000	Bdy site; bod; Bodies; Body site Pnl; H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random	4180186
43055000	Body site Pnl	4180186
43055000	身体部位标识组套:-:时间点:^患者:-	4182948
43055004	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nasopharynx; Nominal; Point in time; Random	4180186
43055004	Virus Nph Cult	4180186
43055004	病毒 已鉴定的:存在与否或特征标识:时间点:鼻咽:名义型:培养	4182948
43055008	Nordiazepam Sal-mCnc	4180186
43055008	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Oral fluid; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Sal; Stilny; Tranxilium N; Vegesan	4180186
43055008	去甲基安定:质量浓度:时间点:唾液:定量型	4182948
43055009	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oral fluid; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Sal; Serax; Temazepam metabolite	4180186
43055009	Oxazepam Sal-mCnc	4180186
43055009	去甲羟安定:质量浓度:时间点:唾液:定量型	4182948
43055011	Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055011	LORazepam Sal-mCnc	4180186
43055011	氯羟安定:质量浓度:时间点:唾液:定量型	4182948
43055015	Addiction; Algil; Alodan; Centralgine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Meperidine metabolite; Norpethidine; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
43055015	Meperidine+Nor Ur Ql Cfm	4180186
43055015	哌替啶+去甲哌替啶:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055017	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; Methadone metabolite; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055017	EDDP Sal Ql Cfm	4180186
43055017	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055019	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; METD; Methadose; MTD; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055019	Methadone Sal Cfm-mCnc	4180186
43055019	美沙酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055020	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C krusei; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055020	C krusei DNA Vag Ql NAA+probe	4180186
43055020	克鲁斯假丝酵母 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
43055021	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C lusitaniae; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055021	C lusitaniae DNA Vag Ql NAA+probe	4180186
43055021	葡萄牙假丝酵母 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
43055022	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055022	C tropicls DNA Vag Ql NAA+probe	4180186
43055022	热带假丝酵母 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
43055023	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 17-Hydroxycorticosterone; c155; Compound E; Compound F; Coritsol; Cort; DRUG/TOXICOLOGY; Drugs; F; hydrocortisone; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055023	Cortis/Cortisone SerPl	4180186
43055023	皮质醇/可的松:质量比率:时间点:血清/血浆:定量型	4182948
43055024	Cell Cnt + Diff Pnl; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Manl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour	4180186
43055024	Cell Cnt + Diff Pnl Vitf Manual	4180186
43055024	细胞计数与分类组套:-:时间点:玻璃体液:-:手工计数方法	4182948
43055026	Diff Pnl Vitf	4180186
43055026	Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour	4180186
43055026	细胞分类组套:-:时间点:玻璃体液:-	4182948
43055028	Addiction; Barbiturate; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Secobarb; Seconal; WB; Whole blood	4180186
43055028	Secobarbital Bld Cfm-mCnc	4180186
43055028	司可巴比妥:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43055029	Addiction; Allylbarbital; Allylbarbituric acid; Barbiturate; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fiorinal; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43055029	Butalbital Bld Cfm-mCnc	4180186
43055029	布他比妥:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43055030	Addiction; Amobarb; Amylobarbitone; Amytal; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43055030	Amobarbital Bld Cfm-mCnc	4180186
43055030	异戊巴比妥:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43055034	3-epi-25(OH)D3; 3-epi-25-Hydroxy vitamin D3; C-3 epimer of 25OHD3; Chemistry; III; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055034	3-epi-25(OH)D3 SerPl-mCnc	4180186
43055034	3-表-25-羟维生素 D3:质量浓度:时间点:血清/血浆:定量型	4182948
43055038	BEC; BEG; Benz; Benzoylec; Blood; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; WB; Whole blood	4180186
43055038	BZE Bld Ql Scn	4180186
43055038	苯甲酰芽子碱:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
43055039	Anus; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Rectal specimen; St; Stains; Stn	4180186
43055039	Gram Stn Anal	4180186
43055039	显微镜观察:存在与否或特征标识:时间点:肛门:名义型:革兰氏染色法	4182948
43055040	After; CHEMISTRY.CHALLENGE TESTING; Chorionic gonadotropin stimulation test; Level; p dose; p HCG; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost	4180186
43055040	Testost p HCG SerPl-sCnc	4180186
43055040	睾酮^在剂量HCG之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055041	Testost pre HCG SerPl-sCnc	4180186
43055041	Before; CHEMISTRY.CHALLENGE TESTING; Chorionic gonadotropin stimulation test; Level; Pl; Plasma; Plsm; Point in time; pre HCG; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost	4180186
43055041	睾酮^在剂量HCG之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055042	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
43055042	Monos+Macros CSF Manual	4180186
43055042	单核细胞+巨噬细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
43055045	Acetoacet pre-meal Bld-sCnc	4180186
43055045	3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; Before; Beta-ketobutyrate; Blood; CHEMISTRY.CHALLENGE TESTING; Diacetate; Diacetic acid; Level; oxobutyrate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055045	乙酰乙酸^在进餐之前:物质的量浓度:时间点:全血:定量型	4182948
43055046	3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; After; Beta-ketobutyrate; Blood; CHEMISTRY.CHALLENGE TESTING; Diacetate; Diacetic acid; Level; oxobutyrate; p meal; PC; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055046	Acetoacet p meal Bld-sCnc	4180186
43055046	乙酰乙酸^在进餐之后:物质的量浓度:时间点:全血:定量型	4182948
43055047	B-OH-Butyr p meal Bld-sCnc	4180186
43055047	3-hydroxybutyrate; 3-hydroxybutyric acid; After; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; Blood; BOHB; B-OH-Butyr; CHEMISTRY.CHALLENGE TESTING; Hydroxybutyric acid; Level; p meal; PC; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055047	Beta 羟基丁酸^在进餐之后:物质的量浓度:时间点:全血:定量型	4182948
43055049	3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; B; Before; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; Beta-ketobutyrate; BHB; Blood; BOHB; B-OH-Butyr; B-OH-Butyr+Acetoacet; CHEMISTRY.CHALLENGE TESTING; Diacetate; Diacetic acid; Hydroxybutyric acid; Ketone body ratio; oxobutyrate; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
43055049	B-OH-Butyr/Acetoacet pre-meal Bld-sRto	4180186
43055049	Beta 羟基丁酸/乙酰乙酸^在进餐之前:物质的量比率:时间点:全血:定量型	4182948
43055050	3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; After; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; Beta-ketobutyrate; BHB; Blood; BOHB; B-OH-Butyr; B-OH-Butyr+Acetoacet; CHEMISTRY.CHALLENGE TESTING; Diacetate; Diacetic acid; Hydroxybutyric acid; Ketone body ratio; oxobutyrate; p meal; PC; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
43055050	B-OH-Butyr/Acetoacet p meal Bld-sRto	4180186
43055050	Beta 羟基丁酸/乙酰乙酸^在进餐之后:物质的量比率:时间点:全血:定量型	4182948
43055057	5OH-Hexanoate SerPl-sCnc	4180186
43055057	5-Hydroxy hexanoate; 5-Hydroxycaproate; 5-Hydroxycaproic acid; 5-hydroxyhexanoic acid; 5-hydroxy-hexanoic acid; 5-OH-caproate; 5OH-Hexanoate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055057	5-羟基己酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055059	4HPP; 4-Hydroxy phenylpyruvate; 4-hydroxyphenylpyruvic acid; 4OH-phenylpyruvate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055059	4OH-phenylpyruvate SerPl-sCnc	4180186
43055059	4-羟基苯丙酮酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055060	4HPLA; 4-Hydroxy phenyllactate; 4-hydroxyphenyllactic acid; 4OH-phenyllactate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055060	4OH-phenyllactate CSF-sCnc	4180186
43055060	4-羟基苯乳酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055062	4HPA; 4-Hydroxy phenylacetate; 4-hydroxyphenylacetic acid; 4OH-phenylacetate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hydroxyphenylacetic acid; Level; p-hydroxyphenylacetate; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055062	4OH-phenylacetate CSF-sCnc	4180186
43055062	4-羟基苯乙酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055068	Phenyllactate SerPl-sCnc	4180186
43055068	Chemistry; Level; Phenyllactic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055068	苯乳酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055069	3Me-glutarate CSF-sCnc	4180186
43055069	3Me-glutarate; 3-methylglutaric acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055069	3-甲基戊二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055072	3Me-crotonylglycine; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; beta-methylcrotonylglycine; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43055072	3Me-crotonylglycine Amn-sCnc	4180186
43055072	3-甲基丁烯酰甘氨酸:物质的量浓度:时间点:羊水:定量型	4182948
43055073	3Me-crotonylglycine; beta-methylcrotonylglycine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055073	3Me-crotonylglycine CSF-sCnc	4180186
43055073	3-甲基丁烯酰甘氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055075	3OH-Tdecanedioate SerPl-sCnc	4180186
43055075	3-Hydroxy tetradecanedioate; 3-hydroxytetradecanedioic acid; 3OH-Tdecanedioate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055075	3-羟基十四烷二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055076	3-hydroxy suberate; 3-hydroxyoctanedioate; 3-hydroxyoctanedioic acid; 3-hydroxysuberic acid; 3OHsuberate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055076	3OHsuberate CSF-sCnc	4180186
43055076	3-羟基辛二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055077	3-hydroxy suberate; 3-hydroxyoctanedioate; 3-hydroxyoctanedioic acid; 3-hydroxysuberic acid; 3OHsuberate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055077	3OHsuberate SerPl-sCnc	4180186
43055077	3-羟基辛二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055078	3OHsebacate CSF-sCnc	4180186
43055078	3-hydroxy sebacate; 3-hydroxysebacic acid; 3OHsebacate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055078	3-羟基癸二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055079	3-hydroxy sebacate; 3-hydroxysebacic acid; 3OHsebacate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055079	3OHsebacate SerPl-sCnc	4180186
43055079	3-羟基癸二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055081	3-HIA; 3-hydroxy-isovalerate; 3-hydroxyisovaleric acid; 3OH-Isovalerate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055081	3OH-Isovalerate SerPl-sCnc	4180186
43055081	3-羟基异戊酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055082	Addiction; Barb; Barbiturate; Barbs; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055082	Barbiturates Sal Ql Cfm	4180186
43055082	巴比妥类药物:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055083	Addiction; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Secobarb; Seconal	4180186
43055083	Secobarbital Sal Cfm-mCnc	4180186
43055083	司可巴比妥:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055084	Barbiturate; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Luminal; Mass concentration; Nirvonal; Oral fluid; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055084	Phenobarb Sal Cfm-mCnc	4180186
43055084	苯巴比妥:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055087	Benzodiaz Sal Ql Cfm	4180186
43055087	Benz; Benzodiaz; Benzodiazepine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055087	苯并二氮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055095	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-073 4OH-butyl; JWH-073 N-(4-hydroxybutyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055095	JWH-073 4OH-butyl Ur Ql Cfm	4180186
43055095	JWH-073 4-羟丁基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055098	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-250 N-(5-carboxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055098	JWH-250 5-carboxypentyl Ur Ql Cfm	4180186
43055098	JWH-250 5-羧戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055101	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; MAM-2201 N-pentanoic acid metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055101	MAM-2201 pentanoate Ur Ql Cfm	4180186
43055101	MAM-2201 戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055103	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; UR-144 N-pentanoic acid metabolite; Urn; Yucatan Fire	4180186
43055103	UR-144 pentanoate Ur Ql Cfm	4180186
43055103	UR-144 戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055104	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-398 5OH-pentyl; JWH-398 N-(5 hydroxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055104	JWH-398 5OH-pentyl Ur Ql Cfm	4180186
43055104	JWH-398 5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055106	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055106	Methadone+metab Sal Ql Cfm	4180186
43055106	美沙酮+代谢产物:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055107	Cannabinoid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; GCMS; Marijuana; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Synthetic cannabinoids pnl; THC; UA; UR; Urn	4180186
43055107	Synthetic cannabinoids pnl Ur Cfm	4180186
43055107	合成大麻素组套:-:时间点:尿液:-:毒理学确认试验	4182948
43055108	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cand; Candida sp 6 pnl; Candidiasis; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; species; spp; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055108	Candida sp 6 pnl Vag NAA+probe	4180186
43055108	假丝酵母属 6 项组套:-:时间点:阴道:-:探针法.基因扩增.靶向	4182948
43055109	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; BKV subtyp; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Typ	4180186
43055109	BKV subtyp Tiss NAA+probe	4180186
43055109	BK 病毒亚型:类型:时间点:组织与涂片:名义型:探针法.基因扩增.靶向	4182948
43055111	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; BKV subtyp; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Typ; WB; Whole blood	4180186
43055111	BKV subtyp Bld NAA+probe	4180186
43055111	BK 病毒亚型:类型:时间点:全血:名义型:探针法.基因扩增.靶向	4182948
43055112	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nucynta; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tapal; UA; UR; Urn	4180186
43055112	Tapentadol Ur Ql Scn	4180186
43055112	他喷他多:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
43055113	Lab director name; MISC; Nominal; Person name; Point in time; Random	4180186
43055113	Lab director name Provider	4180186
43055113	实验室主任姓名:人员姓名:时间点:服务提供者:名义型	4182948
43055115	APOH; Apolipoprotein H; B; B2 glycoprot 1 IgG+IgM pnl; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; II; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; Random; Serum; SR; UniversalLabOrders	4180186
43055115	B2 glycoprot 1 IgG+IgM pnl Ser	4180186
43055115	Beta 2 糖蛋白 1 抗体.IgA 与 IgM 组套:-:时间点:血清:-	4182948
43055117	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Chemistry; Hydroxyproges; Hydroxyprogstron; Level; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
43055117	17OHP Sal-sCnc	4180186
43055117	17-羟孕酮:物质的量浓度:时间点:唾液:定量型	4182948
43055118	Acd; Acids; Bile acid.total; Bile salt; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration	4180186
43055118	Bile Ac Stl-sCnc	4180186
43055118	胆汁酸:物质的量浓度:时间点:大便:定量型	4182948
43055119	A-esterase; aromatic esterase 1; aryldialkylphosphatase 1; Catalytic Concentration; Chemistry; i; Point in time; PON1; PON-1; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43055119	PON1 Ser-cCnc	4180186
43055119	对氧磷酶-芳香酯酶 1:催化浓度:时间点:血清:定量型	4182948
43055120	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
43055120	CMV DNA SerPl NAA+probe-aCnc	4180186
43055120	巨细胞病毒 DNA:任意型浓度:时间点:血清/血浆:定量型:探针法.基因扩增.靶向	4182948
43055123	dsDNA Spec-mCnc	4180186
43055123	Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Level; Mass concentration; Misc; Miscellaneous; Molecular pathology; MOLPATH; Native DNA; N-DNA; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Stranded; Strnd; To be specified in another part of the message; Unspecified	4180186
43055123	双链 DNA:质量浓度:时间点:XXX:定量型	4182948
43055124	DHP Reduct DBS-cCnt	4180186
43055124	Blood; Catalytic Content; Chemistry; DBS; DHP Reduct; DHPR; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43055124	二氢蝶啶还原酶:催化含量:时间点:全血.斑点:定量型	4182948
43055129	Hcys 6h p Met-CFst SerPl-SCDiff	4180186
43055129	&gt;6h; 6h p Met; 6h p Met-CFst; After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HCY; Hcys; Hcyst; homocysteine; homocystine; Met; p dose; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055129	同型半胱氨酸或同型胱氨酸^在给予剂量蛋氨酸-同型胱氨酸之后6小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
43055131	CV2 Ab SerPl Ql IF	4180186
43055131	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; CRMP5; CRMP-5; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; POP66; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF; ULIP	4180186
43055131	CV2 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
43055136	Report rate RptPeriod NFr Pop Calc	4180186
43055136	Calc; Calculation; DOCUMENT QUALITY; Number Fraction; Percent; QNT; Quality; Quan; Quant; Quantitative; Report period; Report rate	4180186
43055136	报告比率:计数型分数:报告期:{环境}^人群:定量型:计算法	4182948
43055137	Calc; Calculation; DOCUMENT QUALITY; Number Fraction; Percent; Perform rate; QNT; Quality; Quan; Quant; Quantitative; Report period	4180186
43055137	Perform rate RptPeriod NFr Pop Calc	4180186
43055137	绩效比率:计数型分数:报告期:{环境}^人群:定量型:计算法	4182948
43055144	After; Cnt; Count; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; URO; Urology	4180186
43055144	Sperm post ejac Smn	4180186
43055144	精子^在射精之后:数量(计数):时间点:精液:定量型	4182948
43055145	Blood; CDS1; checkpoint kinase 2; CHEK2 c.470C&gt;T+1100delC; CHK2; Genetics; hCds1; Heredity; Heritable; HuCds1; I157T; Identity or presence; Inherited; LFS2; Li-Fraumeni syndrome; Li-Fraumeni syndrome 2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; PP1425; RAD53; Random; rs17879961; T prime; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055145	CHEK2 c.470C>T+1100delC Bld/T	4180186
43055145	CHEK2 基因.c.470C>T 与 1100delC:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43055147	FLT3 基因.p.Asp835+Ile836 突变:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
43055147	Acute myeloid leukemia; AML; Blood; CD135; FL cytokine receptor precursor; FLK2; FLK-2; FLT3 p.D835; FLT3 p.D835+I836; FLT3 TKD; FLT3 tyrosine kinase domain; fms-like tyrosine kinase 3; fms-related tyrosine kinase 3; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Muts; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stem cell tyrosine kinase 1; STK1; STK-1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055147	FLT3 p.D835+I836 Bld/T Ql	4180186
43055150	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Insulin-Dependent Diabetes Mellitus; Ordinal; Paraneoplastic neurological syndrome; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
43055150	GAD65 Ab SerPl Ql IF	4180186
43055150	谷氨酸脱羧酶-65 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
43055154	Finding; Findings; H+P; H+P.PX; Injury; Nominal; P prime; Point in time; Pressure injuries; pressure injury; Random	4180186
43055155	US Axilla-R	4180186
43055155	Ax; Axilla-R; Document; Echography; Finding; Findings; Imaging; Point in time; R; Radiology; Random; RT; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound; Upper extremity	4180186
43055155	多层:发现:时间点:胸部>腋窝.右侧:文档型:超声	4182948
43055158	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Colonography; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; LGI; Pelvic; Playbook; Point in time; Rad; Radiology; Random; Rectal; Rectum+colon; Virtual colonoscopy; W Air contr PR; W contr IV; W contr IV+Air contr PR; WC	4180186
43055158	CT Colon+Rect W contr IV+Air contr PR	4180186
43055158	多层^采用静脉注射对比剂+采用经直肠给予空气对比剂:发现:时间点:腹部+盆腔>结肠+直肠:文档型:CT	4182948
43055162	Document; Echography; EXT; Extr v; Extr v-L; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous	4180186
43055162	US Guided Extr v-L Laser ablation	4180186
43055162	旨在激光消融术的引导:发现:时间点:肢体.左侧>肢体静脉:文档型:超声	4182948
43055165	Cardio; Cardiology; Cath; Document; Extraction; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Periph CVC rem; Peripherally Inserted Central Venous Catheter; PIC; PICC; Point in time; Rad; Radiology; Random; Remove; RFA; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
43055165	RFA Guided Vein Periph CVC rem	4180186
43055165	旨在去除外周插入型中心静脉导管装置的引导:发现:时间点:XXX>静脉:文档型:放射荧光透视法.血管造影术	4182948
43055169	Abd; Abdo; Abdomen+; Abdominal; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Jnt; L/sp; L-spine; L-spine facet joint; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Zygapophysial Joint	4180186
43055169	RF Guided L-spine facet joint Denerv	4180186
43055169	旨在去神经的引导:发现:时间点:腹部>脊椎.腰段小面关节:文档型:放射荧光透视法	4182948
43055170	Document; Dorsal spine; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; T-spine ICN	4180186
43055170	RF Guided T-spine ICN Denerv	4180186
43055170	旨在去神经的引导:发现:时间点:胸部>脊椎.胸段 肋间神经:文档型:放射荧光透视法	4182948
43055171	Abd; Abdo; Abdomen+; Abdominal; Bil; Bilat; Both; c; Contr; Contra; Contrst; Document; Extraction; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Kdny-Bl; Kidney; Kidneys; Nephric; Nephrology; NT; Perc; PNT removal; Point in time; Rad; RADIOLOGY; Random; Remove; Renal; WC	4180186
43055171	RF Guided Kdny-Bl PNT removal--W contr	4180186
43055171	旨在去除经皮穿刺肾脏造瘘管装置的引导^采用对比剂:发现:时间点:腹部>肾脏.双侧:文档型:放射荧光透视法	4182948
43055172	Abd; Abdo; Abdomen+; Abdominal; BDs; BDs+GB; Bile tract; Biliary tract; Cath; Cholecystostomy; Document; Drain; Exudate; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Gall bladder; GB; Guid; Guide; Guided; Hepatobiliary; Imaging; PC drain cath replace; Perc; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
43055172	RF Guided BDs+GB PC drain cath replace	4180186
43055172	旨在经皮更换引流管的引导:发现:时间点:腹部>胆管+胆囊:文档型:放射荧光透视法	4182948
43055173	Cardio; Cardiology; Cath; CVC lumen obs rem; Document; Extraction; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Remove; RFA; Spec; Subs; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
43055173	RFA Guided Vein CVC lumen obs rem	4180186
43055173	旨在清除中心静脉导管管腔阻塞物质的引导:发现:时间点:XXX>静脉:文档型:放射荧光透视法.血管造影术	4182948
43055174	Cardio; Cardiology; Cath; CVC pericath obs rem; Document; Extraction; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Remove; RFA; Spec; Subs; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
43055174	RFA Guided Vein CVC pericath obs rem	4180186
43055174	旨在清除中心静脉导管周围阻塞物质的引导:发现:时间点:XXX>静脉:文档型:放射荧光透视法.血管造影术	4182948
43055175	c; Cardio; Cardiology; Cath; Contr; Contra; Contrst; CVC rem; Document; Extraction; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Remove; RFA; Spec; To be specified in another part of the message; Unspecified; Ven; Venogram; Venography; Venous; W contr IV; WC	4180186
43055175	RFA Guided Vein CVC rem--W contr IV	4180186
43055175	旨在去除中心静脉导管装置的引导^采用静脉注射对比剂:发现:时间点:XXX>静脉:文档型:放射荧光透视法.血管造影术	4182948
43055178	Cardio; Cardiology; Cath; CVC WO pump repair; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
43055178	RFA Guided Vein CVC WO pump repair	4180186
43055178	旨在修复不带输液港或输液泵的中心静脉导管的引导:发现:时间点:XXX>静脉:文档型:放射荧光透视法.血管造影术	4182948
43055181	Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Musc; Muscl; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; TPI; Unspecified	4180186
43055181	RF Guided Muscle TPI	4180186
43055181	旨在触痛点注射的引导:发现:时间点:XXX>肌肉:文档型:放射荧光透视法	4182948
43055182	IR Consult note	4180186
43055182	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Point in time; Random; Visit note	4180186
43055182	会诊记录:发现:时间点:{环境}:文档型:介入放射医学	4182948
43055185	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; Blood; breakpoint cluster region 2; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(PML,RARA) gene translocation breakpoint cluster region 2; t(15,17)(q22,q11.2-q12); t(15;17) BCR2; t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055185	t(15;17) BCR2/control Bld/T	4180186
43055185	t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055187	21q22.3; ABL; ABL1; ABL1 transcript; Acute lymphoblastic leukaemia; Acute lymphocytic leukemia; Acute myeloid leukemia 1; ALL; AML1; B-cell ALL; B-cell precursor acute lymphoblastic leukemia; BCP ALL; BM; BON; Bone marrow; CBFA2; control gene; DNA; ets variant gene 6; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(12,21)(ETV6,RUNX1) gene translocation; t(12;21)(ETV6,RUNX1); TEL; Tel oncogene; TEL1; translocation; Translocation ets leukemia	4180186
43055187	t(12;21)(ETV6,RUNX1)/control Mar	4180186
43055187	t(12;21)(p13;q22.3)(ETV6,RUNX1) 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43055191	Echography; Fetal; Finding; Findings; Gyn; Gynecology; Nominal; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Random; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound; YS	4180186
43055191	US Yolk sac Fetus Study	4180186
43055191	检查观察结果:发现:时间点:卵黄囊^胎儿:名义型:超声	4182948
43055192	Auto; Automated detection; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
43055192	Yeast Ur Ql Auto	4180186
43055192	酵母:存在情况或阈值:时间点:尿液:序数型:自动化法	4182948
43055193	Auto; Automated detection; Cast; Elec; Elect; Electr; Kidney; Nephrology; Ordinal; Path; Path casts; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urn	4180186
43055193	Path casts Ur Ql Auto	4180186
43055193	病理性管型:存在情况或阈值:时间点:尿液:序数型:自动化法	4182948
43055195	Congenital dyserythropoietic anaemia; Encounter; Evaluation and management; Evaluation and management note; notes; Operative note; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; Surg; Surg Op C-CDA R1.1+2.0+2.1 Sections; Visit note	4180186
43055195	Surg Op C-CDA R1.1+2.0+2.1 Sections	4180186
43055195	外科手术记录 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055196	Congenital dyserythropoietic anaemia; Encounter; Evaluation and management; Evaluation and management note; H&P note; H+P C-CDA R1.1+2.0+2.1 Sections; Hx; notes; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; Visit note	4180186
43055196	H+P C-CDA R1.1+2.0+2.1 Sections	4180186
43055196	病史与体格检查记录 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055197	Congenital dyserythropoietic anaemia; Disch; Discharge Sum C-CDA R1.1 Sections; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
43055197	Discharge Sum C-CDA R1.1 Sections	4180186
43055197	出院摘要 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055202	MiniCog; Mini-Cog Dementia Screen; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
43055205	c; Contr; Contra; Contrst; Distal metatarsals; Document; EXT; Extr-R; Finding; Findings; Imaging; Interphalangeal joints; LE; Leg; LE-R; Low; Metatarsophalangeal Joints; Mitral regurgitation maximum velocity; MRI; Phalanges; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; Toe; Toes-R; W contr IV; WC	4180186
43055205	MR Toes-R W contr IV	4180186
43055205	多层^采用静脉注射对比剂:发现:时间点:下肢.右侧>脚趾类:文档型:MR	4182948
43055209	c; Contr; Contra; Contrst; CorePlaybook; Document; Finding; Findings; Imaging; Mitral regurgitation maximum velocity; MRI; Pelvic; Playbook; Point in time; Rad; Radiology; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
43055209	MR Pelvis Endorectal WO+W contr IV	4180186
43055209	直肠内多层^不采用 & 采用静脉注射对比剂:发现:时间点:盆腔:文档型:MR	4182948
43055210	at rest & maximal sphincter contraction during straining & defecation; c; Contr; Contra; Contrst; Defecagram; Defecogram; Defecography; Document; Finding; Findings; Imaging; Mitral regurgitation maximum velocity; MRI; Pelvic; Point in time; Rad; RADIOLOGY; Random; Resting; W cntr PR+rest+max sph con+def; W contr PR; WC	4180186
43055210	MR Pelvis Defe W cntr PR	4180186
43055210	多层^采用在尽量使用肌肉过程中+在排便过程中经直肠给予对比剂+静息状态+最大括约肌收缩:发现:时间点:盆腔:文档型:MR	4182948
43055213	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; CAG; CHGM; Cholangiogram; Cholangiography; Contr; Contra; Contrst; Document; Endoscopic guidance; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Liver+BD+Pancreas; Magnetic resonance cholangiopancreatography; Mitral regurgitation maximum velocity; MR Angiogram; MRCP; MRI; MRI angiogram; Pancr; Pancreatc; Pancreatic; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
43055213	MRCP Abd W+WO contr IV	4180186
43055213	旨在内镜检查的引导^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>肝脏+胆管类+胰:文档型:MR	4182948
43055216	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; for PE; Imaging; PA; PAA; PE; Point in time; Pulm; Rad; RADIOLOGY; Random; Thorax	4180186
43055216	CT PA for PE	4180186
43055216	针对肺栓塞的多层:发现:时间点:胸部>肺动脉类:文档型:CT	4182948
43055217	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
43055217	CT Chest+Abd+Pelvis WO+W contr IV	4180186
43055217	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部+腹部+盆腔:文档型:CT	4182948
43055218	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
43055218	CT Chest+Abd+Pelvis WO contr	4180186
43055218	多层^不采用对比剂:发现:时间点:胸部+腹部+盆腔:文档型:CT	4182948
43055219	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC	4180186
43055219	CT Chest+Abd+Pelvis W contr IV	4180186
43055219	多层^采用静脉注射对比剂:发现:时间点:胸部+腹部+盆腔:文档型:CT	4182948
43055220	Ang; Angio; Angiography; Angm; AO; Aorta+Fem a; Aorta+Fem a-Bl; Aortic; Art; Arteriogram; Bil; Bilat; Both; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Fem a; Finding; Findings; Heart Disease; Imaging; Point in time; Radiology; Random; Thigh; W contr IV; WC	4180186
43055220	Deprecated Aorta+Fem a-Bl CT.Angio W con	4180186
43055222	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Adrenalin; Adrenaline; Adreneline; ANED; Blood; Close Tme Coll+ADP + Epinep pnl; Closure time; Closure Tme; Closure Tme Coll+ADP; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; FCN; Func; Funct; Medication stress; Pan; PANEL.COAGULATION; Panl; Pl; Platelets; Platelt; Plt; Pnl; Point in time; Random; Thrombocyte; Thrombocytes; UniversalLabOrders; WB; Whole blood	4180186
43055222	Close Tme Coll+ADP + Epinep pnl Bld	4180186
43055222	血小板功能.胶原+ 二磷酸腺苷诱导型与 肾上腺素诱导型组套:-:时间点:全血:-	4182948
43055224	Adefovir SerPl LC/MS/MS-mCnc	4180186
43055224	ADV; bis-POM-PMEA; DRUG/TOXICOLOGY; Drugs; Hepsera; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Preveon; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055224	阿德福韦:质量浓度:时间点:血清/血浆:定量型:LC/MS/MS	4182948
43055226	Bilirubin excess Ser+CSF-sCnc	4180186
43055226	Bili; Bilirubins; Billirubin; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR; Substance concentration; TBIL	4180186
43055226	胆红素过多:物质的量浓度:时间点:血清+脑脊液:定量型	4182948
43055229	Alb; Bili; Bilirubins; Billirubin; Bld pigments Pnl; Blood pigments; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; EXS; Haemoglobin oxygenated; HbO2; Hemiglobin; Hemoglobin oxygenated; Hi; Methaemoglobin; MetHb; Methgb; O2Hb; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Protein.albumin; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR; subarachnoidal hemorrhage; TBIL; Xanthchromia; Xanthochromic	4180186
43055229	Bld pigments Pnl Ser+CSF	4180186
43055229	胆红素过多与氧合血红蛋白与高铁血红蛋白与黄变与白蛋白比值组套:-:时间点:血清+脑脊液:-	4182948
43055230	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
43055230	FLUBV IgA Ser IA-aCnc	4180186
43055230	流感病毒 B 型 抗体.IgA:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
43055231	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
43055231	FLUAV IgA Ser IA-aCnc	4180186
43055231	流感病毒 A 型 抗体.IgA:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
43055232	Eval incapacity cert	4180186
43055232	Assessment; Conservatorship; DOC.ONT; Document; Eval; Eval incapacity cert; Finding; Findings; Guardianship; H&P; History and physical; Point in time; Random	4180186
43055232	精神上和身体上无行为能力评价证书:发现:时间点:{环境}:文档型:{角色}	4182948
43055234	pH Vag Strip	4180186
43055234	pH:对数型物质的量浓度:时间点:阴道:定量型:试纸条	4182948
43055234	Chemistry; Dip stick; Dipstick; Genital vaginal; Log molar concentration; Point in time; Random; SmQn; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055235	Before; Blood urea nitrogen; BUN; c; Chemistry; Contr; Contra; Contrst; Kidney; Level; Mass concentration; N; N2; Nephrology; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN	4180186
43055235	BUN pre contrast SerPl-mCnc	4180186
43055235	尿素氮^在对比剂之前:质量浓度:时间点:血清/血浆:定量型	4182948
43055240	Dedication+Inspiration; H+P; H+P.HX; History; Honorary; In; Insp; Inspiratory; Jaci Phillips; Narrative; P prime; Point in time; Random; Report	4180186
43055240	Dedication to Excellence and Inspiration to all	4180186
43055240	Dedication+Inspiration	4180186
43055240	追求卓越 + 鼓励大家:历史记录:时间点:^患者:叙述型:嘉熙·菲利普斯	4182948
43055243	Specimen vol Prost fld	4180186
43055243	EPS; expressed prostatic secretion; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; Spec; Vol; Volume	4180186
43055243	标本体积:体积型属性:时间点:前列腺液:定量型	4182948
43055244	Epid Allerg Mix71 IgE Qn	4180186
43055244	(鸡羽毛+鸭羽毛+鹅羽毛+吐绶鸡羽毛) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43055244	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dander; e070; e085; e086; e70; e85; e86; e89; EP71; Epid Allerg Mix A; Epid Allerg Mix71; ex71; f083; f158; f83; Feather mix; Feathers; Gallus spp; Immune globulin E; Immunoglobulin E; Meleagis gallopavo; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43055245	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; Date and time; Exp; GLB; Glob; Glob%; Globul; Globulins; Imm; Imun; Imune; Point in time; QNT; Quan; Quant; Quantitative; Random; Rh Ig; Rh Ig expire; Rh phenotyping; Rh typing; RHIG; RhoGAM; Time stamp; Timestamp	4180186
43055245	Rh Ig expire BPU	4180186
43055245	Rh 免疫球蛋白过期:时间戳:时间点:^血液制品单位:定量型	4182948
43055247	bod; Bodies; CLIN; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
43055247	矢状面体位:角度:时间点:^患者:序数型	4182948
43055250	Dressing purpose Wnd	4180186
43055250	H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; Wnd	4180186
43055250	敷料用途:类型:时间点:伤口:名义型	4182948
43055251	Wnd dress pnl	4180186
43055251	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd; Wnd dress pnl	4180186
43055251	伤口敷料组套:-:时间点:伤口:-	4182948
43055252	Wnd size pnl	4180186
43055252	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd; Wnd size pnl	4180186
43055252	伤口大小组套:-:时间点:伤口:-	4182948
43055253	Odor Wnd.exdte	4180186
43055253	Exud; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; Wnd; Wnd.exdte	4180186
43055253	气味:类型:时间点:伤口.渗出物:名义型	4182948
43055254	Color Wnd.exdte	4180186
43055254	Appearance; Colour; Exud; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; Wnd; Wnd.exdte	4180186
43055254	颜色:类型:时间点:伤口.渗出物:名义型	4182948
43055255	Appear; Appearance; Appr; Exud; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Wnd; Wnd.exdte	4180186
43055255	Appearance Wnd.exdte	4180186
43055255	外观:外观:时间点:伤口.渗出物:名义型	4182948
43055258	Undermining Wnd Len	4180186
43055258	H+P; H+P.PX; Length; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Wnd	4180186
43055258	潜行:长度:时间点:伤口:定量型	4182948
43055260	Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Wnd	4180186
43055260	Undermining Wnd	4180186
43055260	潜行:发现:时间点:伤口:序数型	4182948
43055261	Tunneling Len Wnd	4180186
43055261	H+P; H+P.PX; Length; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Wnd	4180186
43055261	窦道:长度:时间点:伤口:定量型	4182948
43055263	Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Wnd	4180186
43055263	Tunneling Wnd	4180186
43055263	窦道:发现:时间点:伤口:序数型	4182948
43055264	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd; Wnd Tunnel+Under pnl	4180186
43055264	Wnd Tunnel+Under pnl	4180186
43055264	伤口窦道与潜行组套:-:时间点:伤口:-	4182948
43055265	H+P; H+P.PX; Nominal; P prime; Point in time; Random; Skin alteration; Typ; Wnd; wound	4180186
43055265	伤口类型:类型:时间点:伤口:名义型	4182948
43055267	Texture Nail	4180186
43055267	H+P; H+P.PX; Nails; Nominal; P prime; Point in time; Random; Typ; Ungal nail	4180186
43055267	纹理:类型:时间点:甲:名义型	4182948
43055268	Shape Nail	4180186
43055268	H+P; H+P.PX; Nails; Nominal; P prime; Point in time; Random; Typ; Ungal nail	4180186
43055268	形状:类型:时间点:甲:名义型	4182948
43055270	Wnd Close type	4180186
43055270	H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; Wnd; Wnd Close type	4180186
43055270	伤口闭合类型:类型:时间点:伤口:名义型	4182948
43055273	Brucella IgG sp1 Titr Ser	4180186
43055273	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Dilution factor; Dilution Factor (Titer); First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Random; Serum; SmQn; sp1; Spec; species; spp; SR; Titer; Titered; Titre; Ttr	4180186
43055273	布鲁氏菌属单个未知种 抗体.IgG^第1个标本:滴定度:时间点:血清:定量型	4182948
43055278	ABL; ABL1; ABL1 transcript; AF4; ALL1; ALL-1; Blood; control gene; DNA; FEL; gene fusion; gene translocation; Genetics; Heredity; Heritable; Homolog of trithorax; HRX; HTRX; HTRX1; Inherited; MLLT2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila)); Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(4,11)(MLLT2,MLL) gene translocation; t(4;11)(AFF1,MLL); Tissue; Tissue, unspecified; translocation; TRX1; WB; Whole blood; Whole blood or Tissue	4180186
43055278	t(4;11)(AFF1,MLL)/control Bld/T	4180186
43055278	t(4;11)(q21.3;q23)(AFF1,MLL) 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055280	PDGFR IgG SerPl Ql IA	4180186
43055280	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; PDGFR; PDGF-R; PDGFR Ab; Pl; Plasma; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thrombocyte; Thrombocytes	4180186
43055280	血小板衍生生长因子受体 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055282	RNAp III RP11 IgG SerPl Ql IA	4180186
43055282	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; Pol III; POL3RK; POL3RK gene; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RNAp III; RNAp III RP11; RNAp III RP11 Ab; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
43055282	RNA 聚合酶 III RP11 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055286	HLA-A+B+C IgG SerPl Ql IA	4180186
43055286	A,B; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; HLA class I; Human Leukocyte Antigen; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
43055286	HLA-A+B+C 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055287	Macrophages NFr.DF Bronch Manual	4180186
43055287	Bro; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055287	巨噬细胞/白细胞:计数型分数.小数型:时间点:支气管来源的标本:定量型:手工计数方法	4182948
43055288	Basophils NFr.DF Bronch Manual	4180186
43055288	Baso; Basophil; Basos; Bph; Bro; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055288	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:支气管来源的标本:定量型:手工计数方法	4182948
43055294	WBC Other NFr.DF Pcar Manual	4180186
43055294	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBC Other; WBCs; White blood cell; White blood cells	4180186
43055294	其他白细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055295	Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055295	Basophils NFr.DF Pcar Manual	4180186
43055295	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055296	Eosinophil NFr.DF Pcar Manual	4180186
43055296	Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055296	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055297	Monocytes NFr.DF Pcar Manual	4180186
43055297	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055297	单核细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055298	Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055298	Lymphocytes NFr.DF Pcar Manual	4180186
43055298	淋巴细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055299	Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; PCAR; Pericardial Fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055299	Neutrophils NFr.DF Pcar Manual	4180186
43055299	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055300	Mesothl Cell NFr.DF Plr Manual	4180186
43055300	Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number fraction; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055300	间皮细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055304	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells	4180186
43055304	WBC Other NFr.DF Plr Manual	4180186
43055304	其他白细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055312	Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mononuc; Mononuc Cells; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055312	Mononuc Cells NFr.DF Snv Manual	4180186
43055312	单个核细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055315	Eosinophil NFr.DF Snv Manual	4180186
43055315	Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055315	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055316	Monocytes NFr.DF Snv Manual	4180186
43055316	HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055316	单核细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055317	HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055317	Lymphocytes NFr.DF Snv Manual	4180186
43055317	淋巴细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055321	Macrophages NFr.DF Prt Manual	4180186
43055321	Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055321	巨噬细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055323	WBC Other NFr.DF Prt Manual	4180186
43055323	Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBC Other; WBCs; White blood cell; White blood cells	4180186
43055323	其他白细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055326	Monocytes NFr.DF Prt Manual	4180186
43055326	Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055326	单核细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055328	Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Peritoneal fluid; PMN; PNM; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055328	Neutrophils NFr.DF Prt Manual	4180186
43055328	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055329	Plasma Cells NFr.DF Fld Manual	4180186
43055329	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myeloma cells; Number fraction; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055329	浆细胞类/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055332	Monos+Macros NFr.DF Fld Manual	4180186
43055332	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055332	单核细胞+巨噬细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055333	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055333	Mesothl Cell NFr.DF Fld Manual	4180186
43055333	间皮细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055337	Blasts NFr.DF Fld Manual	4180186
43055337	B/F; BF; Blast; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055337	幼稚细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055339	Eosinophil NFr.DF Fld Manual	4180186
43055339	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Eos; Eosin; Eosino; Eosinophil; Eosins; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055339	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055340	B/F; Baso; Basophil; Basos; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bph; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055340	Basophils NFr.DF Fld Manual	4180186
43055340	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055342	Lymphocytes NFr.DF Fld Manual	4180186
43055342	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055342	淋巴细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055347	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myel; Myelo; Myelocyte; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055347	Myelocytes NFr.DF CSF Manual	4180186
43055347	中幼粒细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055349	Blasts NFr.DF CSF Manual	4180186
43055349	Blast; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055349	幼稚细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055356	Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Myeloma cells; Number fraction; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055356	Plasma Cells NFr.DF Bld	4180186
43055356	浆细胞类/白细胞:计数型分数.小数型:时间点:全血:定量型	4182948
43055360	Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myel; Myelo; Myelocyte; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055360	Myelocytes NFr.DF Bld Manual	4180186
43055360	中幼粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055363	Bands; Blood; bnd; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055363	Neuts Band NFr.DF Bld Manual	4180186
43055363	嗜中性粒细胞.带状核/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055364	Neutrophils NFr.DF Bld Manual	4180186
43055364	Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055364	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055365	Monocytes NFr.DF Bld Manual	4180186
43055365	Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055365	单核细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055367	Eosinophil NFr.DF Bld Manual	4180186
43055367	Blood; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055367	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055368	Baso; Basophil; Basos; Blood; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055368	Basophils NFr.DF Bld Manual	4180186
43055368	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055369	Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055369	Neutrophils NFr.DF Bld Auto	4180186
43055369	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:自动化计数方法	4182948
43055370	Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mono; Monocyte; Monos; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055370	Monocytes NFr.DF Bld Auto	4180186
43055370	单核细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:自动化计数方法	4182948
43055388	Variable nucleotide	4180186
43055389	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Pheno; Phenotype; Phenotypic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
43055389	Rilpivirine Islt Phenotyp	4180186
43055389	利匹韦林:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
43055393	HIV INI Susc Pnl Islt Phenotyp	4180186
43055393	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; HIV INI Susc Pnl; Human immunodeficiency virus; Inhib; Inhibit; INI; Islt; Isol; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pheno; Phenotype; Phenotypic; Pnl; Point in time; Random; Sus; Susc; Suscept; Susceptibilities; Susceptibilty	4180186
43055393	HIV 整合酶抑制剂敏感性组套:-:时间点:分离株:-:表现型分型	4182948
43055395	CK-AB CFr.DF SerPl Elph	4180186
43055395	Aberrant CK band; Bands; bnd; Chemistry; CK; CK-AB; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Split CKMM bands; SR; Tot; Totl	4180186
43055395	肌酸激酶.异常区带/肌酸激酶总计:催化分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055400	Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Che; Chemistry; Choline esterase II; CHS; Pl; Plasma; Plsm; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random; Scoline number; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055400	Scoline Inhib/CHe CFr.DF SerPl	4180186
43055400	胆碱酯酶.氯化丁二酰胆碱抑制型/胆碱酯酶:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055403	Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Che; Chemistry; Chincocaine; Choline esterase II; CHS; dibucaine/CHe; Nupercainal; Pl; Plasma; Plsm; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055403	CHe dibuc/CHe CFr.DF SerPl	4180186
43055403	胆碱酯酶^辛可卡因/胆碱酯酶:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055404	Chloride Inhib/CHe CFr.DF SerPl	4180186
43055404	Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Che; Chemistry; Chloride number; Choline esterase II; CHS; Cl; Cl-; Pl; Plasma; Plsm; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055404	胆碱酯酶.氯化物抑制型/胆碱酯酶:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055405	Alpha amylase; Ams; Amyl; Amylase P; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43055405	Amylase P CFr.DF SerPl	4180186
43055405	淀粉酶.胰/淀粉酶.总计:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055406	Alpha amylase; Ams; Amyl; Amylase S; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Pl; Plasma; Plsm; Point in time; Ptyalin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43055406	Amylase S CFr.DF SerPl	4180186
43055406	淀粉酶.唾液/淀粉酶.总计:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055407	1 day; 24 hours; 24HR; Chemistry; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Tot; Totl; UA; UR; Urn; Urophorph	4180186
43055407	Uropor 24h SFr.DF Ur	4180186
43055407	尿卟啉/卟啉.总计:物质的量分数.小数型:24小时:尿液:定量型	4182948
43055411	1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; M Protein; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055411	M Protein 24h MFr.DF Ur Elph	4180186
43055411	蛋白质.单克隆型/蛋白质.总计:质量分数.小数型:24小时:尿液:定量型:电泳	4182948
43055412	Prealb MFr.DF Ur Elph	4180186
43055412	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; PALB; PEUR; Point in time; PR; Pre albumin; Prot; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; Transthyretin; UA; UPEP; UR; Urn	4180186
43055412	前白蛋白/蛋白质.总计:质量分数.小数型:时间点:尿液:定量型:电泳	4182948
43055413	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Neuro; Neurology; PALB; Point in time; PR; Pre albumin; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP; Transthyretin	4180186
43055413	Prealb MFr.DF CSF Elph	4180186
43055413	前白蛋白/蛋白质.总计:质量分数.小数型:时间点:脑脊液:定量型:电泳	4182948
43055416	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
43055416	Gamma glob MFr.DF SerPl Elph	4180186
43055416	Gamma 球蛋白/蛋白质.总计:质量分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055417	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Neuro; Neurology; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP	4180186
43055417	Gamma glob MFr.DF CSF Elph	4180186
43055417	Gamma 球蛋白/蛋白质.总计:质量分数.小数型:时间点:脑脊液:定量型:电泳	4182948
43055420	B-Globulin MFr.DF SerPl Elph	4180186
43055420	B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
43055420	Beta 球蛋白/蛋白质.总计:质量分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055421	B; B-Globulin; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Neuro; Neurology; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP	4180186
43055421	B-Globulin MFr.DF CSF Elph	4180186
43055421	Beta 球蛋白/蛋白质.总计:质量分数.小数型:时间点:脑脊液:定量型:电泳	4182948
43055424	Alpha2 Glob MFr.DF SerPl Elph	4180186
43055424	A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
43055424	Alpha 2 球蛋白/蛋白质.总计:质量分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055425	A2; Alfa; Alpha2 Glob; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Neuro; Neurology; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP	4180186
43055425	Alpha2 Glob MFr.DF CSF Elph	4180186
43055425	Alpha 2 球蛋白/蛋白质.总计:质量分数.小数型:时间点:脑脊液:定量型:电泳	4182948
43055426	1 day; 24 hours; 24HR; A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; PEUR; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055426	Alpha1 Glob 24h MFr.DF Ur Elph	4180186
43055426	Alpha 1 球蛋白/蛋白质.总计:质量分数.小数型:24小时:尿液:定量型:电泳	4182948
43055427	A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; PEUR; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055427	Alpha1 Glob MFr.DF Ur Elph	4180186
43055427	Alpha 1 球蛋白/蛋白质.总计:质量分数.小数型:时间点:尿液:定量型:电泳	4182948
43055430	1 day; 24 hours; 24HR; Alb; Albumin fraction; Albumin%; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; Nephrology; PEUR; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055430	Albumin 24h MFr.DF Ur Elph	4180186
43055430	白蛋白/蛋白质.总计:质量分数.小数型:24小时:尿液:定量型:电泳	4182948
43055431	Alb; Albumin fraction; Albumin%; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; Nephrology; PEUR; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055431	Albumin MFr.DF Ur Elph	4180186
43055431	白蛋白/蛋白质.总计:质量分数.小数型:时间点:尿液:定量型:电泳	4182948
43055434	Albumin MFr.DF Fld Elph	4180186
43055434	Alb; Albumin fraction; Albumin%; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Fl; Fld; FLU; Fluid; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP	4180186
43055434	白蛋白/蛋白质.总计:质量分数.小数型:时间点:体液:定量型:电泳	4182948
43055439	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; CMV gp; Cytomegalo virus; Cytomgal; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; gG; Glycoprot; Glycoproteins; GP; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified	4180186
43055439	CMV gp Gentyp Spec NAA+probe	4180186
43055439	巨细胞病毒糖蛋白 基因型:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
43055440	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Delta hepatitis; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; HDV; HDV genotype; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
43055440	HDV Gentyp Spec NAA+probe	4180186
43055440	丁型肝炎病毒 基因型:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
43055442	Apixaban SerPl-mCnc	4180186
43055442	DRUG/TOXICOLOGY; Drugs; Eliquis; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055442	阿哌沙班:质量浓度:时间点:血清/血浆:定量型	4182948
43055445	Addiction; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Stesolid; Valium	4180186
43055445	diazePAM Sal Ql	4180186
43055445	安定:存在情况或阈值:时间点:唾液:序数型	4182948
43055448	Oxazepam Sal Ql	4180186
43055448	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Oral fluid; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Sal; Screen; Serax; Temazepam metabolite	4180186
43055448	去甲羟安定:存在情况或阈值:时间点:唾液:序数型	4182948
43055449	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Madar; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Oral fluid; Ordinal; Point in time; PR; Praxadium; Prazepam metabolite; QL; Qual; Qualitative; Random; Sal; Screen; Stilny; Tranxilium N; Vegesan	4180186
43055449	Nordiazepam Sal Ql	4180186
43055449	去甲基安定:存在情况或阈值:时间点:唾液:序数型	4182948
43055450	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055450	Benzodiaz Sal Ql	4180186
43055450	苯并二氮:存在情况或阈值:时间点:唾液:序数型	4182948
43055452	Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Napsalgesic; n-desmethylproproxyphene; Norpropoxyp; Oral fluid; Ordinal; Point in time; PR; Propoxyph+Nor; Propoxyphene metabolite; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055452	Propoxyph+Nor Sal Ql	4180186
43055452	丙氧氨酚+去甲基丙氧氨酚:存在情况或阈值:时间点:唾液:序数型	4182948
43055454	DRUG/TOXICOLOGY; Drugs; n-desmethylproproxyphene; Norpropoxyp; Oral fluid; Ordinal; Point in time; PR; Propoxyphene metabolite; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055454	Norpropoxyph Sal Ql	4180186
43055454	去甲基丙氧氨酚:存在情况或阈值:时间点:唾液:序数型	4182948
43055455	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Napsalgesic; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055455	Propoxyph Sal-mCnc	4180186
43055455	丙氧氨酚:质量浓度:时间点:唾液:定量型	4182948
43055457	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Gastro; Gastroenterology; GI; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Remicade; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055457	inFLIXimab Ab SerPl-mCnc	4180186
43055457	英利昔单抗 抗体:质量浓度:时间点:血清/血浆:定量型	4182948
43055460	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
43055460	Methadone Sal Ql Scn	4180186
43055460	美沙酮:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
43055461	Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
43055461	Barbiturates Sal Ql Scn	4180186
43055461	巴比妥类药物:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
43055463	Addiction; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Secobarb; Seconal	4180186
43055463	Secobarbital Sal Ql Cfm	4180186
43055463	司可巴比妥:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055465	Addiction; Amobarb; Amylobarbitone; Amytal; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055465	Amobarbital Sal Ql Cfm	4180186
43055465	异戊巴比妥:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055468	Temazepam Sal Ql	4180186
43055468	DRUG/TOXICOLOGY; Drugs; Normison; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Restoril; Sal; Screen	4180186
43055468	羟基安定:存在情况或阈值:时间点:唾液:序数型	4182948
43055469	Addiction; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Nembutal; Oral fluid; Pentobarb; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055469	Pentobarb Sal Cfm-mCnc	4180186
43055469	戊巴比妥:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055471	1 week; Ashamed of uncontrollable sexual encounters; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055472	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Outbreaks of anger; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055475	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055478	US Guided Extr v-R Vasc sclerotherapy	4180186
43055478	Document; Echography; EXT; Extr v; Extr v-R; Extr-R; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; R; Radiology; Random; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vasc sclerotherapy; Ven; Venous	4180186
43055478	旨在血管硬化疗法的引导:发现:时间点:肢体.右侧>肢体静脉:文档型:超声	4182948
43055479	Document; Echography; EXT; Extr v; Extr v-L; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vasc sclerotherapy; Ven; Venous	4180186
43055479	US Guided Extr v-L Vasc sclerotherapy	4180186
43055479	旨在血管硬化疗法的引导:发现:时间点:肢体.左侧>肢体静脉:文档型:超声	4182948
43055483	Ascites; Ascitic fluid; Ascitis; Chemistry; Glu; Gluc; glucose gradient; Glucose ser - prt fld; Glucoseur; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; SCDiff; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055483	Glucose ser - prt fld-SCDiff	4180186
43055483	葡萄糖.血清-葡萄糖.腹膜液:物质的量浓度差:时间点:腹膜液+血清/血浆:定量型	4182948
43055484	Cardio; Cardiology; Chemistry; Glu; Gluc; glucose gradient; Glucose ser - peric fld; Glucoseur; Heart Disease; Pcar; Pericard fld+SerPl; Pericardial Fluid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SCDiff; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055484	Glucose ser - peric fld-SCDiff	4180186
43055484	葡萄糖.血清-葡萄糖.心包液:物质的量浓度差:时间点:心包液+血清/血浆:定量型	4182948
43055485	Glucose ser - plr fld-SCDiff	4180186
43055485	Chemistry; Glu; Gluc; glucose gradient; Glucose ser - plr fld; Glucoseur; Pl; Plasma; Pleural; Pleural fluid; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SCDiff; Ser; SerP; SerPl; SerPl+Plr; SerPlas; Serum; Serum or plasma; SR; thoracentesis fluid	4180186
43055485	葡萄糖.血清-葡萄糖.胸膜液:物质的量浓度差:时间点:血清/血浆+胸膜液:定量型	4182948
43055487	Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; Point in time; Random; Report; Subtelomere.p arm; Tissue; Tissue, unspecified; Upper extremity; WB; Whole blood; Whole blood or Tissue	4180186
43055487	Subtelomere.p arm Bld/T FISH-Imp	4180186
43055487	亚端粒分析.短臂:印象:时间点:全血/组织:叙述型:FISH	4182948
43055490	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Risperidal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055490	risperiDONE Trough SerPl-mCnc	4180186
43055490	利培酮^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055492	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Paxil; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055492	PARoxetine Trough SerPl-mCnc	4180186
43055492	帕罗西汀^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055493	OXcarbazepine Trough SerPl-mCnc	4180186
43055493	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; OXC; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trileptal	4180186
43055493	奥卡西平^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055494	Beta-trace protein Ear fld-mCnc	4180186
43055494	B; beta TP; BTP; Cerebrin-28; Chemistry; Ear fld; Glutathione-independent PGD synthase; Hearing; Level; Lipocalin-type prostaglandin-D synthase; Mass concentration; Otologic; PGD2 synthase; PGDS2; Point in time; PR; Prostaglandin-D2 synthase; Prostaglandin-H2 D-isomerase; Prot; QNT; Quan; Quant; Quantitative; Random	4180186
43055494	Beta-微量蛋白:质量浓度:时间点:耳液:定量型	4182948
43055495	Activ; Actvty; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Intrnsc coag fctr act pnl; Movements; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; Random; Tilt tube	4180186
43055495	Intrnsc coag fctr act pnl PPP	4180186
43055495	内源性凝血因子活性 4 项组套:-:时间点:贫血小板血浆:-:凝血功能分析	4182948
43055498	6-phosphofructokinase; Catalytic Content; Chemistry; Erythrocytes; PFK; Phosphohexokinase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
43055498	PFK RBC-cCnt	4180186
43055498	磷酸果糖激酶:催化含量:时间点:红细胞:定量型	4182948
43055499	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; t,t-muconate; Trans,trans-muconic acid; UA; UR; Urn	4180186
43055499	t,t-muconate Ur-mCnc	4180186
43055499	反式,反式-己二烯二酸:质量浓度:时间点:尿液:定量型	4182948
43055501	Mycophenolate Trough SerPl-mCnc	4180186
43055501	Cellcept; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055501	吗替麦考酚酯^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055502	Mirtazapine Trough SerPl-mCnc	4180186
43055502	Avanza; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Reflex; Remeron; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zispin	4180186
43055502	米氮平^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055505	Everolimus Trough Plas-mCnc	4180186
43055505	Afinitor; Certican; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; RAD-001; Random; Zortress	4180186
43055505	依维莫司^波谷:质量浓度:时间点:血浆:定量型	4182948
43055508	Acetylsulfamethoxazole; c203; c223; C61; DRUG/TOXICOLOGY; Drugs; Gantanol; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SMX; SR; Sulfa; Sulfamethox	4180186
43055508	Sulfamethoxazole Trough SerPl-mCnc	4180186
43055508	磺胺甲噁唑^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055510	Sirolimus Trough Plas-mCnc	4180186
43055510	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Rapamune; Rapamycin; SRL	4180186
43055510	西罗莫司^波谷:质量浓度:时间点:血浆:定量型	4182948
43055511	Salicylates Trough SerPl-mCnc	4180186
43055511	2-Hydroxybenzoate; 2-Hydroxybenzoic Acid; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; o-Hydroxybenzoate; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoate; ortho-Hydroxybenzoic Acid; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Sali; Salicilates; Salicylate; Salicylic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055511	水杨酸^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055516	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055517	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055518	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055520	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055522	Average; Avg; Borderline Symptom List - 23 item; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
43055524	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055526	1 week; Borderline Symptom List - 23 item; Disgusted by self; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055531	Blood; CP35; CYP3A5*3; CYPIIIA5; cytochrome P450, family 3, subfamily A, polypeptide 5; Genetics; Heredity; Heritable; III; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Ordinal; P450PCN3; PCN3; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055531	CYP3A5*3 Bld/T Ql	4180186
43055531	CYP3A5 基因.c.6986A>G(*3):存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
43055533	1 week; Borderline Symptom List - 23 item; Everything senseless; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055534	1 week; Borderline Symptom List - 23 item; Fascination with death; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055536	1 week; Borderline Symptom List - 23 item; Criticism devastating effect; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055543	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055545	1 week; Borderline Symptom List - 23 item; Didn't believe right to live; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.MTLHLTH; T prime	4180186
43055548	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055551	1 week; Borderline Symptom List - 23 item; Cnc; Conc; Finding; Findings; Hard to concentrate; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055556	Base ex; Base ex.oxy; BE; Bld mixed venous; Blood - mixed venous; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SBE; std; Substance Concentration	4180186
43055556	Base ex.oxy std BldMV Calc-sCnc	4180186
43055556	碱剩余.100% 氧合^^标准:物质的量浓度:时间点:混合静脉全血:定量型:计算法	4182948
43055557	Base ex; Base ex.oxy; BE; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SBE; std; Substance Concentration; Venous	4180186
43055557	Base ex.oxy std BldV Calc-sCnc	4180186
43055557	碱剩余.100% 氧合^^标准:物质的量浓度:时间点:静脉全血:定量型:计算法	4182948
43055565	7-hydroxy mitragynine; 7-OH-mitragynine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Kratom; Level; Mass concentration; Mitragynine hydroxyindolenine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055565	7-OH-mitragynine Ur Cfm-mCnc	4180186
43055565	7-羟基帽柱碱:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055567	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydromorphinone; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055567	HYDROmorphone Sal Cfm-mCnc	4180186
43055567	二氢吗啡酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055569	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Methamphet; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055569	Methamphet Sal Cfm-mCnc	4180186
43055569	甲基苯丙胺:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055570	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055570	MDA Sal Cfm-mCnc	4180186
43055570	亚甲基二氧苯丙胺:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055571	Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Snow	4180186
43055571	Cocaine Sal Cfm-mCnc	4180186
43055571	可卡因:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055572	Temazepam Sal Cfm-mCnc	4180186
43055572	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Normison; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; Sal	4180186
43055572	羟基安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055574	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Tramal; Ultram	4180186
43055574	traMADol Sal Cfm-mCnc	4180186
43055574	曲马多:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055576	Noroxycodone Sal Cfm-mCnc	4180186
43055576	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055576	去甲基羟考酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055579	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055579	Norfentanyl Sal Cfm-mCnc	4180186
43055579	去甲基芬太尼:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055582	Addiction; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055582	Meprobamate Sal Cfm-mCnc	4180186
43055582	氨甲丙二酯:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055585	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Lortab; Mass concentration; Oral fluid; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Scn; Scr; Scrn; Vicodin	4180186
43055585	oxyCODONE Sal Scn-mCnc	4180186
43055585	羟考酮:质量浓度:时间点:唾液:定量型:毒理学筛查试验	4182948
43055586	Addiction; c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Morphine sulfate; MS; MSO4; OMPH; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055586	Morphine Sal Cfm-mCnc	4180186
43055586	吗啡:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055591	Benzodiaz Sal Scn-mCnc	4180186
43055591	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Scn; Scr; Scrn	4180186
43055591	苯并二氮:质量浓度:时间点:唾液:定量型:毒理学筛查试验	4182948
43055595	Carisoma; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flexartal; GCMS; Isopropylmeprobamate; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Rela; Sal; Sanoma; Soma; Somadril; Somalgit	4180186
43055595	Carisoprodol Sal Cfm-mCnc	4180186
43055595	异丙基甲丁双脲:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055598	11-nor-9-carboxy-delta-9-THC; 11-nor-9-carboxy-THC; 11-nor-delta-9-THC-9-COOH; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; Addiction; Carboxytetrahydrocannabinol; CarboxyTHC; Carboxy-THC-delta-9; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Marijuana; Mass concentration; Nabilone; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; THC; THCA; THCC; THCCOOH; THC-COOH	4180186
43055598	CarboxyTHC Sal Cfm-mCnc	4180186
43055598	羧基四氢大麻酚:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055601	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV HA; FLUAV HA seg sequence ID; FLUV; Fowl plague; HA; high-throughput sequencing; HTS; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
43055601	FLUAV HA seg sequence ID Islt Seq	4180186
43055601	流感病毒 A 型血凝素片段序列标识符:标识符:时间点:分离株:名义型:序列测定	4182948
43055603	Adormix; Ambien; Ambien CR; CR; Crea; Creat; Damixan; DRUG/TOXICOLOGY; Drugs; Edluar; Hypnogen; Ivedal; Lioran; Mass concentration ratio; Mass ratio; MCRto; Myslee; Nasen; Nytamel; Point in time; QNT; Quan; Quant; Quantitative; Random; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UCr; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
43055603	Zolpidem phenyl-4-carb/Creat Ur	4180186
43055603	唑吡坦 苯基-4-羧酸酯/肌酐:质量比率:时间点:尿液:定量型	4182948
43055604	Addiction; Adormix; Ambien; Ambien CR; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; GCMS; Hypnogen; Illicit; Ivedal; Level; Lioran; Mass concentration; Myslee; Nasen; Nytamel; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
43055604	Zolpidem Ur Cfm-mCnc	4180186
43055604	唑吡坦:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055608	Venlafaxine Ur Cfm-mCnc	4180186
43055608	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Venlafaxin	4180186
43055608	文拉法辛:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055610	1-butanol; Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-018 N-butanol metabolite; K2; Level; Mass concentration; n-butanol; n-butyl alcohol; Point in time; PotentialForAbuse; Propyl carbinol; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055610	Deprecated JWH-018 butanol Ur Cfm-mCnc	4180186
43055637	1-butanol; AM-678; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; JWH-018 N-butanol metabolite; K2; Mass concentration ratio; Mass ratio; MCRto; n-butanol; n-butyl alcohol; Point in time; Propyl carbinol; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055637	Deprecated JWH-018 butanol/Creat Ur	4180186
43055643	AM-678; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; JWH-018 N-pentanoate metabolite; JWH-018 N-pentanoic acid metabolite; JWH-018 N-valeric metabolite; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055643	JWH-018 pentanoate/Creat Ur	4180186
43055643	JWH-018 戊酸/肌酐:质量比率:时间点:尿液:定量型	4182948
43055645	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055645	PARoxetine/Creat Ur	4180186
43055645	帕罗西汀/肌酐:质量比率:时间点:尿液:定量型	4182948
43055650	PPAA Ur Cfm-mCnc	4180186
43055650	Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; GCMS; II; Level; Mass concentration; Methylphenidate metabolite; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Point in time; PPAA; QNT; Quan; Quant; Quantitative; Random; Ritalinate; Ritalinic acid; UA; UR; Urn	4180186
43055650	Alpha-苯基-2-乙酸哌啶:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055651	Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; II; Mass concentration ratio; Mass ratio; MCRto; Methylphenidate metabolite; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Point in time; PPAA; QNT; Quan; Quant; Quantitative; Random; Ritalinate; Ritalinic acid; UA; UCr; UR; Urn	4180186
43055651	PPAA/Creat Ur	4180186
43055651	Alpha-苯基-2-乙酸哌啶/肌酐:质量比率:时间点:尿液:定量型	4182948
43055652	Me-phenidate/Creat Ur	4180186
43055652	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Me-phenidate; Point in time; QNT; Quan; Quant; Quantitative; Random; Ritalin; UA; UCr; UR; Urn	4180186
43055652	哌甲酯/肌酐:质量比率:时间点:尿液:定量型	4182948
43055655	4-methylephedrone; 4-methylmethcathinone; 4-MMC; Addiction; Bath salts; Cfm; Charge Plus; Cloud 9; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ivory Wave Ocean; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; White Lightning	4180186
43055655	Mephedrone Ur Cfm-mCnc	4180186
43055655	甲氧麻黄酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055656	Mephedrone/Creat Ur	4180186
43055656	4-methylephedrone; 4-methylmethcathinone; 4-MMC; Bath salts; Charge Plus; Cloud 9; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ivory Wave Ocean; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; White Lightning	4180186
43055656	甲氧麻黄酮/肌酐:质量比率:时间点:尿液:定量型	4182948
43055658	MDPV/Creat Ur	4180186
43055658	Bath salts; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; MDPV; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055658	亚甲基二氧吡咯戊酮/肌酐:质量比率:时间点:尿液:定量型	4182948
43055659	Norketamine Ur Cfm-mCnc	4180186
43055659	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ketamine metabolite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055659	去甲基氯胺酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055660	Norketamine/Creat Ur	4180186
43055660	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ketamine metabolite; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055660	去甲基氯胺酮/肌酐:质量比率:时间点:尿液:定量型	4182948
43055661	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ketalar; Ketaset; Ketavet; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055661	Ketamine/Creat Ur	4180186
43055661	氯胺酮/肌酐:质量比率:时间点:尿液:定量型	4182948
43055663	JWH-250 5-carboxypentyl/Creat Ur	4180186
43055663	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; JWH-250 N-(5-carboxypentyl) metabolite; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055663	JWH-250 5-羧戊基/肌酐:质量比率:时间点:尿液:定量型	4182948
43055665	JWH-210 carboxypentyl/Creat Ur	4180186
43055665	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; JWH-210 carboxypentyl; JWH-210 N-(5-carboxypentyl) metabolite; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055665	JWH-210 5-羧戊基/肌酐:质量比率:时间点:尿液:定量型	4182948
43055666	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055666	JWH-073 carboxylated Ur Cfm-mCnc	4180186
43055666	JWH-073 羧基化:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055668	Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055668	JWH-018 carboxylated Ur Cfm-mCnc	4180186
43055668	JWH-018 羧基化:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055669	AM-678; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055669	JWH-018 carboxylated/Creat Ur	4180186
43055669	JWH-018 羧基化/肌酐:质量比率:时间点:尿液:定量型	4182948
43055678	AM-2201 4OH-pentyl/Creat Ur	4180186
43055678	AM-2201 4OH-pentyl; AM-2201 N-(4-hydroxypentyl) metabolite; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; Synthetic marijuana; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055678	AM-2201 4-羟戊基/肌酐:质量比率:时间点:尿液:定量型	4182948
43055680	5HIA; 5HIAA; 5-HIAA; 5-Hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5OH-indoleacetate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxyindoacet; Level; Mass concentration; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serotonin metabolite; Tumor marker; UA; UR; Urn	4180186
43055680	5OH-indoleacetate Ur Cfm-mCnc	4180186
43055680	5-羟基吲哚乙酸:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055681	?Tm; Calc; Calculation; Chemistry; CR; Crea; Creat; Kidney; Mass Rate; mRate; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn	4180186
43055681	Creat ?Tm Ur Calc-mRate	4180186
43055681	肌酐:质量速率:XXX:尿液:定量型:计算法	4182948
43055683	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Etx; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m223; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rm223; S aureus; S aureus Etx; S aureus Etx C; S aureus Etx C gene; Screen; SDA; Spec; St a SEC; Staph; Staphylococcal enterotoxin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
43055683	S aureus Etx C gene Spec Ql NAA+probe	4180186
43055683	金黄色葡萄球菌肠毒素 C sec 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
43055689	H+P; H+P.HX; History; Honorary; Kathy Mercer; Narrative; P prime; Point in time; Random; Report; StalStn+VocCurVo	4180186
43055689	StalStn+VocCurVo	4180186
43055689	标准化的忠实拥护者+词表管理的行家里手:历史记录:时间点:^患者:叙述型:凯西·默瑟	4182948
43055692	Axilla.right	4180186
43055700	Aorta+Femoral artery.bilateral	4180186
43055720	Lower extremity.left>Toes	4180186
43055726	NPM1 gene.c.960insCCTG transcript	4180186
43055759	Beta hydroxybutyrate+Acetoacetate	4180186
43055764	CHEK2 gene.c.470C>T & 1100delC	4180186
43055881	CV2 Ab.IgG	4180186
43530605	Pulmonary embolism with pulmonary infarction (disorder)	4180186
43530605	Pulmonary embolism with infarction	4180186
43530608	Post surgical neuroma of lower limb (disorder)	4180186
43530610	Chronic pain due to malignancy (finding)	4180186
43530612	Tetraplegia or tetraparesis as sequela of stroke	4180186
43530612	Paralytic syndrome of all four limbs as sequela of stroke (disorder)	4180186
43530613	Restrictive lung disease due to amyotrophic lateral sclerosis (disorder)	4180186
43530615	Colloid brain cyst (disorder)	4180186
43530617	Organic mixed sleep disorder (disorder)	4180186
43530619	Refractory complex partial seizure with impairment of consciousness (disorder)	4180186
43530623	Late effects of cerebrovascular accident	4180186
43530623	Sequela of cerebrovascular accident (disorder)	4180186
43530625	Recurrent inguinal hernia (disorder)	4180186
43530633	Congenital hypoplasia of brain (disorder)	4180186
43530637	Fever after procedure	4180186
43530637	Pyrexia postprocedure	4180186
43530637	Postprocedural fever (finding)	4180186
43530639	History of urinary tract infection (situation)	4180186
43530640	Hypnic headache (disorder)	4180186
43530640	Hypnic headache (associated with sleep)	4180186
43530641	Primary thunderclap headache (disorder)	4180186
43530642	Systolic heart failure stage B (disorder)	4180186
43530643	Diastolic heart failure stage B (disorder)	4180186
43530644	History of aortic valve replacement (situation)	4180186
43530645	Functional quadriplegia (disorder)	4180186
43530645	Functional tetraplegia	4180186
43530646	Fever after vaccination	4180186
43530646	Postvaccination fever	4180186
43530646	Post vaccination fever (disorder)	4180186
43530649	History of total knee arthroplasty (situation)	4180186
43530650	Menstrual status migrainosus (disorder)	4180186
43530651	History of mitral valve replacement (situation)	4180186
43530652	Chronic intractable migraine without aura (disorder)	4180186
43530654	History of atypical naevus	4180186
43530654	History of atypical nevus (situation)	4180186
43530655	Compression of brain due to focal lesion (disorder)	4180186
43530659	Necrosis of central nervous system caused by exposure to ionising radiation	4180186
43530659	Necrosis of central nervous system caused by exposure to ionizing radiation	4180186
43530659	Necrosis of central nervous system due to exposure to ionising radiation	4180186
43530659	Radiation necrosis of CNS	4180186
43530659	Necrosis of central nervous system caused by exposure to ionizing radiation (disorder)	4180186
43530661	Chronic thoracic back pain (finding)	4180186
43530663	Chronic hoarseness (finding)	4180186
43530665	Seizure disorder as sequela of stroke (disorder)	4180186
43530666	Dementia with behavioural disturbance	4180186
43530666	Dementia with behavioral disturbance (disorder)	4180186
43530668	History of haemorrhagic stroke with hemiplegia	4180186
43530668	History of hemorrhagic stroke with hemiplegia (situation)	4180186
43530670	Ischemic stroke without coma (disorder)	4180186
43530670	Ischaemic stroke without coma	4180186
43530671	Nontraumatic subdural hematoma with brain compression (disorder)	4180186
43530671	Nontraumatic subdural haematoma with brain compression	4180186
43530672	History of embolic stroke with deficits (situation)	4180186
43530673	Family history of colorectal cancer (situation)	4180186
43530676	Partial frontal lobe epilepsy (disorder)	4180186
43530681	Drug abuse in remission (disorder)	4180186
43530682	History of primary malignant neoplasm of oropharynx (situation)	4180186
43530683	Cerebral infarction due to carotid artery occlusion (disorder)	4180186
43530684	Chronic pain in male pelvis (finding)	4180186
43530686	Temporal lobe sclerosis (disorder)	4180186
43530687	Dysarthria as late effects of cerebrovascular disease (disorder)	4180186
43530688	Fluency disorder as sequela of cerebrovascular disease (disorder)	4180186
43530691	Sequela of intracranial injury (disorder)	4180186
43530693	Acute exacerbation of chronic obstructive airways disease with asthma (disorder)	4180186
43530695	Group B Streptococcus carrier (finding)	4180186
43530696	Metastasis to lung from adenocarcinoma (disorder)	4180186
43530703	Monoplegia of arm dominant side as sequela of cerebrovascular disease (disorder)	4180186
43530704	Atypical absence epilepsy (disorder)	4180186
43530705	Multiple cranial neuropathy (disorder)	4180186
43530706	Partial occipital lobe epilepsy (disorder)	4180186
43530708	Partial parietal lobe epilepsy (disorder)	4180186
43530709	Arnold Chiari type 2 without hydrocephalus (disorder)	4180186
43530712	Stumbling gait (finding)	4180186
43530713	Acute inflammatory demyelinating polyneuropathy (disorder)	4180186
43530716	Neuroma of ankle (disorder)	4180186
43530718	Complete paraplegia (disorder)	4180186
43530721	Intracranial granuloma (disorder)	4180186
43530722	Intracranial subdural granuloma (disorder)	4180186
43530723	Intraspinal granuloma (disorder)	4180186
43530724	Intraspinal subdural granuloma (disorder)	4180186
43530726	Eaton Lambert syndrome without underlying malignancy (disorder)	4180186
43530727	Nontraumatic intracerebral hemorrhage	4180186
43530727	Spontaneous cerebral hemorrhage (disorder)	4180186
43530727	Nontraumatic intracerebral haemorrhage	4180186
43530727	Spontaneous cerebral haemorrhage	4180186
43530731	Chronic nonmalignant pain (finding)	4180186
43530733	Daytime hypersomnia (disorder)	4180186
43530736	Sequela of cardioembolic stroke (disorder)	4180186
43530739	Nocturnal myoclonus (disorder)	4180186
43530742	Paralytic syndrome on one side of the body as late effect of cerebrovascular accident (disorder)	4180186
43530745	Asthma with irreversible airway obstruction (disorder)	4180186
43530752	Non-labyrinthine vertigo (disorder)	4180186
43530753	Bacteraemia due to Gram-positive bacteria	4180186
43530753	Bacteremia caused by Gram-positive bacteria (finding)	4180186
43530753	Bacteremia due to Gram-positive bacteria	4180186
43530753	Bacteraemia caused by Gram-positive bacteria	4180186
43530754	Static encephalopathy (disorder)	4180186
43530756	Post-traumatic nerve entrapment (disorder)	4180186
43530756	Posttraumatic nerve entrapment	4180186
43530757	Primary generalised absence epilepsy	4180186
43530757	Primary generalized absence epilepsy (disorder)	4180186
43530761	Endoscopic destruction of tissue of large intestine (procedure)	4180186
43530762	Endoscopic laser surgery on esophagus	4180186
43530762	Endoscopic laser therapy of esophagus	4180186
43530762	Endoscopic surgical procedure on oesophagus using laser	4180186
43530762	Endoscopic laser therapy of oesophagus	4180186
43530762	Endoscopic laser surgery on oesophagus	4180186
43530762	Endoscopic surgical procedure on esophagus using laser (procedure)	4180186
43530764	Endoscopic laser therapy of colon and rectum	4180186
43530764	Endoscopic surgical procedure on colon and rectum using laser (procedure)	4180186
43530764	Endoscopic laser surgery on colon and rectum	4180186
43530765	Endoscopic laser surgery on stomach and duodenum	4180186
43530765	Endoscopic surgical procedure on stomach and duodenum using laser (procedure)	4180186
43530765	Endoscopic laser therapy of stomach and duodenum	4180186
43530766	Endoscopic thermocoagulation of small intestine for control of haemorrhage	4180186
43530766	Endoscopic thermocoagulation of small intestine for control of hemorrhage (procedure)	4180186
43530770	Microscopic examination of bacterial smear of blood specimen (procedure)	4180186
43530771	Microscopic examination of bacterial smear of specimen from bone marrow (procedure)	4180186
43530772	Laparoscopic left oophorectomy after prior right oophorectomy (procedure)	4180186
43530774	Laparoscopic left salpingo-oophorectomy after prior right salpingo-oophorectomy (procedure)	4180186
43530775	Laparoscopic right salpingo-oophorectomy after prior left salpingo-oophorectomy (procedure)	4180186
43530776	Microscopic cytologic examination of smear of specimen from lower gastrointestinal tract prepared using Papanicolaou technique (procedure)	4180186
43530778	Microscopic cytologic examination of smear of blood specimen prepared using Papanicolaou technique (procedure)	4180186
43530782	Trophozoite of Endolimax nana	4180186
43530782	Trophozoite of Endolimax nana (organism)	4180186
43530784	Trophozoite of Naegleria fowleri (organism)	4180186
43530784	Trophozoite of Naegleria fowleri	4180186
43530788	Microscopic cytologic examination of specimen from perivesical tissue (procedure)	4180186
43530790	Microscopic cytologic examination of specimen from seminal vesicle (procedure)	4180186
43530794	Microscopic cytologic examination of specimen from urethra (procedure)	4180186
43530801	Endoscopic occlusion of remaining right fallopian tube using intrafallopian implant (procedure)	4180186
43530803	Revision of appendicovesicostomy (procedure)	4180186
43530803	Revision of Mitrofanoff appendicovesicostomy	4180186
43530806	Allergic sensitisation	4180186
43530806	Allergic sensitization (finding)	4180186
43530808	Catastrophic antiphospholipid syndrome (disorder)	4180186
43530808	Asherson's syndrome	4180186
43530812	Escherichia coli serotype O144:nonmotile (organism)	4180186
43530812	E. coli serotype O144:nonmotile	4180186
43530813	Superficial injury of lower extremity without infection (disorder)	4180186
43530817	Abrasion and/or friction burn of upper limb, infected (disorder)	4180186
43530819	Deep incisional surgical site infection (disorder)	4180186
43530820	Organ-space surgical site infection (disorder)	4180186
43530824	Disrupted episiotomy wound (morphologic abnormality)	4180186
43530826	Abrasion and/or friction burn of lower leg without infection (disorder)	4180186
43530827	Abrasion and/or friction burn of lower limb without infection (disorder)	4180186
43530829	E. coli serotype O not typeable:nonmotile	4180186
43530829	Escherichia coli serotype O not typeable:nonmotile (organism)	4180186
43530832	Escherichia coli serotype O127:H9 (organism)	4180186
43530832	E. coli serotype O127:H9	4180186
43530833	E. coli serotype O127:nonmotile	4180186
43530833	Escherichia coli serotype O127:nonmotile (organism)	4180186
43530834	Escherichia coli serotype O15:H11 (organism)	4180186
43530834	E. coli serotype O15:H11	4180186
43530835	E. coli serotype O159:H4	4180186
43530835	Escherichia coli serotype O159:H4 (organism)	4180186
43530836	Escherichia coli serotype O159:nonmotile (organism)	4180186
43530836	E. coli serotype O159:nonmotile	4180186
43530838	Escherichia coli serotype O164:nonmotile (organism)	4180186
43530838	E. coli serotype O164:nonmotile	4180186
43530840	Escherichia coli serotype O169:H41 (organism)	4180186
43530840	E. coli serotype O169:H41	4180186
43530842	Frankl behavioural rating definitely negative	4180186
43530842	Frankl behavioral rating definitely negative (finding)	4180186
43530844	Frankl behavioural rating definitely positive	4180186
43530844	Frankl behavioral rating definitely positive (finding)	4180186
43530848	Angulation deformity (morphologic abnormality)	4180186
43530853	Monochloramine measurement (procedure)	4180186
43530854	At risk for heart failure (finding)	4180186
43530855	High risk of heart failure, stage A (finding)	4180186
43530856	High risk of heart failure, stage B (disorder)	4180186
43530857	Somatic nerve plexus structure (body structure)	4180186
43530858	Entire somatic nerve plexus (body structure)	4180186
43530860	Entire subdivision of somatic nerve plexus (body structure)	4180186
43530862	Injury of somatic nerve plexus (disorder)	4180186
43530863	Non-allergic hypersensitivity disposition (finding)	4180186
43530863	Pseudoallergic disposition	4180186
43530863	Nonallergic hypersensitivity disposition	4180186
43530864	Substance pseudoallergy	4180186
43530864	Non-allergic hypersensitivity to substance (finding)	4180186
43530864	Nonallergic hypersensitivity to substance	4180186
43530864	Pseudoallergy to substance	4180186
43530865	Nonallergic hypersensitivity to drug or medicament	4180186
43530865	Pseudoallergy to drug or medicament	4180186
43530865	Drug pseudoallergy	4180186
43530865	Non-allergic hypersensitivity to drug or medicament (finding)	4180186
43530868	At medium risk for dental caries	4180186
43530868	At moderate risk for dental caries (finding)	4180186
43530870	At extreme risk for dental caries (finding)	4180186
43530871	Non-allergic hypersensitivity process (qualifier value)	4180186
43530871	Pseudoallergic process	4180186
43530875	Pseudoallergic reaction to sulfite	4180186
43530875	Non-allergic hypersensitivity reaction caused by sulfite (disorder)	4180186
43530875	Pseudoallergic reaction caused by sulphite	4180186
43530875	Pseudoallergic reaction to sulphite	4180186
43530875	Pseudoallergic reaction caused by sulfite	4180186
43530878	Suspected or known present (qualifier value)	4180186
43530880	Known or suspected fetal abnormality (situation)	4180186
43530880	Known or suspected foetal abnormality	4180186
43530881	Suspected fetal disorder (situation)	4180186
43530881	Suspected foetal disorder	4180186
43530882	Suspected fetal anencephaly (situation)	4180186
43530882	Suspected foetal anencephaly	4180186
43530883	Foetal anencephaly	4180186
43530883	Fetal anencephaly (disorder)	4180186
43530884	Suspected foetal damage from maternal alcohol	4180186
43530884	Suspected fetal damage from maternal alcohol (situation)	4180186
43530886	Suspected foetal damage from disease in the mother	4180186
43530886	Suspected fetal damage from disease in the mother (situation)	4180186
43530887	Suspected damage to foetus from IUD	4180186
43530887	Suspected fetal damage from intrauterine contraceptive device (situation)	4180186
43530887	Suspected foetal damage from intrauterine contraceptive device	4180186
43530887	Suspected damage to fetus from IUD	4180186
43530889	Suspected fetal damage from environmental toxin (situation)	4180186
43530889	Suspected foetal damage from environmental toxin	4180186
43530890	Suspected foetal damage from maternal alcohol addiction	4180186
43530890	Suspected fetal damage from maternal alcohol addiction (situation)	4180186
43530893	Suspected fetal damage from viral disease in mother (situation)	4180186
43530893	Suspected foetal damage from viral disease in mother	4180186
43530894	Foetal disorder due to maternal disease	4180186
43530894	Fetal disorder due to maternal disease	4180186
43530894	Foetal disorder due to disease in mother	4180186
43530894	Fetal disorder due to disease in mother (disorder)	4180186
43530896	Concept model domain (foundation metadata concept)	4180186
43530896	Domain	4180186
43530897	Hypersensitivity disposition (finding)	4180186
43530898	Fetal damage from maternal rubella (disorder)	4180186
43530898	Foetal damage from maternal rubella	4180186
43530900	Fetal Alcohol Spectrum Disorder (disorder)	4180186
43530900	Foetal Alcohol Spectrum Disorder	4180186
43530902	Fetal effect of maternal toxaemia	4180186
43530902	Fetal effect of maternal toxemia (disorder)	4180186
43530902	Foetal effect of maternal toxaemia	4180186
43530904	Antenatal care for woman with history of recurrent miscarriage (regime/therapy)	4180186
43530906	Entrapment with compression (morphologic abnormality)	4180186
43530907	Induced termination of pregnancy with complication	4180186
43530907	Induced termination of pregnancy with complication (disorder)	4180186
43530908	Termination of pregnancy complicated by damage to pelvic organs and/or tissues	4180186
43530908	Induced termination of pregnancy complicated by damage to pelvic organs and/or tissues (disorder)	4180186
43530912	Termination of pregnancy complicated by renal failure	4180186
43530912	Induced termination of pregnancy complicated by renal failure (disorder)	4180186
43530914	Termination of pregnancy complicated by acute renal failure	4180186
43530914	Induced termination of pregnancy complicated by acute renal failure (disorder)	4180186
43530919	Termination of pregnancy complicated by cerebral anoxia	4180186
43530919	Induced termination of pregnancy complicated by cerebral anoxia (disorder)	4180186
43530921	Induced termination of pregnancy complicated by endometritis (disorder)	4180186
43530921	Termination of pregnancy complicated by endometritis	4180186
43530922	Termination of pregnancy complicated by fat embolism	4180186
43530922	Induced termination of pregnancy complicated by fat embolism (disorder)	4180186
43530924	Induced termination of pregnancy complicated by laceration of bowel (disorder)	4180186
43530924	Termination of pregnancy complicated by laceration of bowel	4180186
43530925	Termination of pregnancy complicated by laceration of broad ligament	4180186
43530925	Induced termination of pregnancy complicated by laceration of broad ligament (disorder)	4180186
43530927	Termination of pregnancy complicated by laceration of vagina	4180186
43530927	Induced termination of pregnancy complicated by laceration of vagina (disorder)	4180186
43530932	Termination of pregnancy complicated by perforation of uterus	4180186
43530932	Induced termination of pregnancy complicated by perforation of uterus (disorder)	4180186
43530933	Induced termination of pregnancy complicated by perforation of vagina (disorder)	4180186
43530933	Termination of pregnancy complicated by perforation of vagina	4180186
43530934	Induced termination of pregnancy complicated by pulmonary embolism (disorder)	4180186
43530934	Termination of pregnancy complicated by pulmonary embolism	4180186
43530935	Termination of pregnancy complicated by renal tubular necrosis	4180186
43530935	Induced termination of pregnancy complicated by renal tubular necrosis (disorder)	4180186
43530937	Termination of pregnancy complicated by salpingo-oophoritis	4180186
43530937	Induced termination of pregnancy complicated by salpingo-oophoritis (disorder)	4180186
43530938	Chronic back pain greater than three months duration (finding)	4180186
43530940	Termination of pregnancy complicated by septic embolism	4180186
43530940	Induced termination of pregnancy complicated by septic embolism (disorder)	4180186
43530941	Termination of pregnancy complicated by septic shock	4180186
43530941	Induced termination of pregnancy complicated by septic shock (disorder)	4180186
43530944	Termination of pregnancy complicated by uraemia	4180186
43530944	Induced termination of pregnancy complicated by uraemia	4180186
43530944	Induced termination of pregnancy complicated by uremia (disorder)	4180186
43530944	Termination of pregnancy complicated by uremia	4180186
43530948	Induced termination of pregnancy complicated by pelvic disorder (disorder)	4180186
43530948	Termination of pregnancy complicated by pelvic disorder	4180186
43530950	Complication occurring during pregnancy (disorder)	4180186
43530952	Induced termination of pregnancy complicated by laceration of bladder (disorder)	4180186
43530953	Induced termination of pregnancy complicated by laceration of periurethral tissue (disorder)	4180186
43530954	Induced termination of pregnancy complicated by perforation of bladder (disorder)	4180186
43530956	Induced termination of pregnancy complicated by perforation of periurethral tissue (disorder)	4180186
43530957	Induced termination of pregnancy complicated by bladder damage (disorder)	4180186
43530958	Induced termination of pregnancy complicated by bowel damage (disorder)	4180186
43530960	Induced termination of pregnancy complicated by cardiac arrest (disorder)	4180186
43530963	Soap embolus (morphologic abnormality)	4180186
43530966	Induced termination of pregnancy complicated by oliguria (disorder)	4180186
43530967	Induced termination of pregnancy complicated by uterus damage (disorder)	4180186
43530970	Gestational trophoblastic lesion (disorder)	4180186
43530971	Gestational trophoblastic neoplasia (morphologic abnormality)	4180186
43530974	Disorder of foetal structure	4180186
43530974	Disorder of fetal structure (disorder)	4180186
43530975	Disorder of embryonic structure (disorder)	4180186
43530979	Tubal abortion	4180186
43530979	Miscarriage of tubal ectopic pregnancy (disorder)	4180186
43530980	Referred itching (finding)	4180186
43530982	Posterior fossa arachnoid cyst (disorder)	4180186
43530984	Femoral nerve paralysis (disorder)	4180186
43530988	Pseudoallergy to angiotensin-converting enzyme inhibitor	4180186
43530988	Angiotensin-converting-enzyme inhibitor allergy	4180186
43530988	Angiotensin-converting-enzyme inhibitor pseudoallergy	4180186
43530988	Non-allergic hypersensitivity to angiotensin-converting enzyme inhibitor (finding)	4180186
43530988	Nonallergic hypersensitivity to angiotensin-converting enzyme inhibitor	4180186
43530990	Enalapril pseudoallergy	4180186
43530990	Pseudoallergy to enalapril	4180186
43530990	Enalapril allergy	4180186
43530990	Nonallergic hypersensitivity to enalapril	4180186
43530990	Non-allergic hypersensitivity to enalapril (finding)	4180186
43530994	Non-allergic hypersensitivity to trandolapril (finding)	4180186
43530994	Pseudoallergy to trandolapril	4180186
43530994	Nonallergic hypersensitivity to trandolapril	4180186
43530994	Trandolapril allergy	4180186
43530994	Trandolapril pseudoallergy	4180186
43530996	Angiotensin II receptor antagonist pseudoallergy	4180186
43530996	Nonallergic hypersensitivity to angiotensin II receptor antagonist	4180186
43530996	Non-allergic hypersensitivity to angiotensin II receptor antagonist (finding)	4180186
43530996	Pseudoallergy to angiotensin II receptor antagonist	4180186
43530996	Angiotensin II receptor antagonist allergy	4180186
43530998	Contrast media pseudoallergy	4180186
43530998	Nonallergic hypersensitivity to contrast media	4180186
43530998	Non-allergic hypersensitivity to contrast media (finding)	4180186
43530998	Pseudoallergy to contrast media	4180186
43530999	Allergic reaction caused by radiocontrast media (disorder)	4180186
43530999	Allergic reaction caused by radiocontrast media	4180186
43531000	Paralytic syndrome of all four limbs (disorder)	4180186
43531001	Diastolic heart failure stage A (finding)	4180186
43531002	Systolic heart failure stage A (finding)	4180186
43531003	Essential tremor (disorder)	4180186
43531006	HNF4A (hepatocyte nuclear factor 4 alpha) monogenic diabetes mellitus	4180186
43531006	HNF4A monogenic diabetes mellitus	4180186
43531006	Maturity onset diabetes of the young, type 1 (disorder)	4180186
43531006	MODY1	4180186
43531008	Pre-existing type 1 diabetes mellitus in pregnancy (disorder)	4180186
43531010	Pre-existing type 2 diabetes mellitus in pregnancy (disorder)	4180186
43531011	Diabetes mellitus due to genetic defect in beta cell function (disorder)	4180186
43531017	Maturity-onset diabetes of the young, type 10 (disorder)	4180186
43531017	MODY10	4180186
43531018	MODY11	4180186
43531018	Maturity-onset diabetes of the young, type 11 (disorder)	4180186
43531020	TNDM3	4180186
43531020	Diabetes mellitus, transient neonatal 3 (disorder)	4180186
43531023	Sundowning (finding)	4180186
43531023	Sundown syndrome	4180186
43531025	Refused by parents of subject (qualifier value)	4180186
43531028	Mononeuropathy of lower limb (disorder)	4180186
43531029	Injury of branch of median nerve (disorder)	4180186
43531031	Structure of branch of common fibular nerve (body structure)	4180186
43531031	Structure of branch of common peroneal nerve	4180186
43531032	Structure of branch of tibial nerve (body structure)	4180186
43531033	Neuropathy of upper limb (disorder)	4180186
43531036	Structure of sural nerve in calf (body structure)	4180186
43531037	Structure of sural nerve in ankle region (body structure)	4180186
43531038	Structure of sural nerve in foot (body structure)	4180186
43531039	Sural neuropathy (calf)	4180186
43531039	Sural neuropathy in calf (disorder)	4180186
43531040	Structure of branch of cranial nerve (body structure)	4180186
43531041	Structure of branch of oculomotor nerve (body structure)	4180186
43531042	Structure of branch of vestibulocochlear nerve (body structure)	4180186
43531044	Structure of nerve root and/or plexus (body structure)	4180186
43531045	Lesion of nerve root and/or plexus (disorder)	4180186
43531051	Structure of pelvic segment of trunk (body structure)	4180186
43531051	Pelvic segment of trunk	4180186
43531051	Structure of pelvic region of trunk	4180186
43531051	Structure of pelvic segment of trunk including false pelvis	4180186
43531052	Disorder of abdominal segment of trunk (disorder)	4180186
43531054	Disorder of pelvis (disorder)	4180186
43531055	Disorder of perineum (disorder)	4180186
43531057	Finding of thoracic segment of trunk	4180186
43531057	Finding of upper trunk (finding)	4180186
43531059	Finding of pelvic region of trunk (finding)	4180186
43531061	Finding of abdominal segment of trunk (finding)	4180186
43531062	Structure of branch of sciatic nerve (body structure)	4180186
43531063	Structure of common peroneal nerve in popliteal region (body structure)	4180186
43531064	Finding of axilla (finding)	4180186
43531065	Finding of sacral region (finding)	4180186
43531066	Structure of pelvirectal compartment (body structure)	4180186
43531069	Structure of superficial perianal tissue (body structure)	4180186
43531072	Operation on pelvic region of trunk (procedure)	4180186
43531073	Structure of soft tissues of pelvic region of trunk (body structure)	4180186
43531077	Genitofemoral neuropathy (disorder)	4180186
43531078	Ulnar neuropathy at wrist (disorder)	4180186
43531079	Alcoholic mixed drink	4180186
43531079	Cocktail (substance)	4180186
43531082	Open reduction of mandibular fracture with fixation	4180186
43531082	Open reduction of fracture of mandible with fixation (procedure)	4180186
43531083	Open reduction of fracture of mandible with internal fixation (procedure)	4180186
43531083	Open reduction of mandibular fracture with internal fixation	4180186
43531084	Open reduction of fracture of clavicle with internal fixation (procedure)	4180186
43531086	Open reduction of dislocation of acromioclavicular joint (procedure)	4180186
43531087	Open reduction of dislocation of carpometacarpal joint (procedure)	4180186
43531088	Open reduction of fracture of carpal bone with internal fixation (procedure)	4180186
43531089	Open reduction of fracture of radius and ulna with internal fixation (procedure)	4180186
43531090	Open reduction of dislocation of interphalangeal joint of toe (procedure)	4180186
43531092	Open reduction of fracture of calcaneus with internal fixation (procedure)	4180186
43531093	Laparoscopic repair of femoral hernia (procedure)	4180186
43531095	Laparoscopic repair of spigelian hernia (procedure)	4180186
43531096	Laparoscopic repair of obstructed femoral hernia (procedure)	4180186
43531097	Laparoscopic repair of obstructed inguinal hernia (procedure)	4180186
43531098	Laparoscopic repair of strangulated inguinal hernia (procedure)	4180186
43531100	Open repair of inguinal hernia (procedure)	4180186
43531102	Open repair of strangulated femoral hernia (procedure)	4180186
43531104	Open reduction of fracture of metatarsal bone with internal fixation (procedure)	4180186
43531105	Open reduction of fracture of talus with internal fixation (procedure)	4180186
43531106	Laparoscopic assisted vaginal hysterectomy with repair of cystocoele	4180186
43531106	Laparoscopic assisted vaginal hysterectomy with repair of cystocele (procedure)	4180186
43531107	Laparoscopic assisted vaginal hysterectomy with repair of rectocoele	4180186
43531107	Laparoscopic assisted vaginal hysterectomy with repair of rectocele (procedure)	4180186
43531112	Open reduction of transverse fracture of acetabulum with internal fixation (procedure)	4180186
43531114	Open reduction of fracture of iliac spine of pelvis with internal fixation (procedure)	4180186
43531114	Open reduction of fracture of iliac spine with internal fixation	4180186
43531117	Open reduction of fracture of bone of posterior ring of pelvis with internal fixation (procedure)	4180186
43531123	Open reduction of epiphyseal fracture of fibula with internal fixation (procedure)	4180186
43531126	Open reduction of epiphyseal fracture of phalanx with internal fixation (procedure)	4180186
43531127	Cushing reflex	4180186
43531127	Cushing's reflex	4180186
43531127	Cushing phenomenon (disorder)	4180186
43531131	Discogenic pain (disorder)	4180186
43531132	Thoracic discogenic pain (disorder)	4180186
43531135	Laparoscopic repair of obstructed incisional hernia (procedure)	4180186
43531136	Laparoscopic repair of strangulated incisional hernia (procedure)	4180186
43531137	Microscopic examination of joint fluid specimen (procedure)	4180186
43531140	Microscopic examination of specimen from liver (procedure)	4180186
43531141	Specimen from lower gastrointestinal tract (specimen)	4180186
43531144	Microscopic examination of specimen from upper gastrointestinal tract (procedure)	4180186
43531145	History of inflammatory bowel disease (situation)	4180186
43531146	Microscopic examination of specimen from lymph node (procedure)	4180186
43531148	Microscopic examination of specimen from musculoskeletal system (procedure)	4180186
43531149	History of bariatric operative procedure	4180186
43531149	History of bariatric surgical procedure (situation)	4180186
43531149	History of bariatric surgery	4180186
43531151	History of laser eye surgery	4180186
43531151	History of surgical procedure on eye proper using laser (situation)	4180186
43531152	History of vitrectomy (situation)	4180186
43531153	Specimen from nervous system (specimen)	4180186
43531155	Microscopic examination of specimen from operative wound	4180186
43531155	Microscopic examination of specimen from surgical wound (procedure)	4180186
43531156	Microscopic examination of specimen from pancreas (procedure)	4180186
43531157	Specimen from perirenal tissue (specimen)	4180186
43531162	Microscopic examination of specimen from perivesical tissue (procedure)	4180186
43531165	Microscopic examination of specimen from ureter (procedure)	4180186
43531166	Microscopic examination of specimen from urethra (procedure)	4180186
43531167	Microscopic examination of specimen from bladder (procedure)	4180186
43531168	Open reduction of fracture of orbit with insertion of implant into bone of orbit (procedure)	4180186
43531169	Specimen from endocrine gland (specimen)	4180186
43531170	Microscopic examination of specimen from endocrine gland (procedure)	4180186
43531172	Microscopic examination of specimen from biliary tract (procedure)	4180186
43531173	Open reduction of dislocation of patella	4180186
43531173	Open reduction of dislocation of patellofemoral joint (procedure)	4180186
43531174	Open repair of thoracoabdominal aortic aneurysm (procedure)	4180186
43531176	Removal of implant from humerus (procedure)	4180186
43531180	Removal of implant from tibia and fibula (procedure)	4180186
43531181	Removal of implant from carpal and metacarpal bones (procedure)	4180186
43531185	Escherichia coli serogroup O44 (organism)	4180186
43531185	Escherichia coli serotype O44	4180186
43531185	E. coli O44	4180186
43531185	E. coli serogroup O44	4180186
43531185	E coli serotype O44	4180186
43531191	Laparoscopic salpingo-oophoroplasty	4180186
43531191	Laparoscopic repair of ovary and fallopian tube (procedure)	4180186
43531192	Microscopic examination of specimen from kidney for parasites (procedure)	4180186
43531196	Microscopic examination of specimen from ureter for parasites (procedure)	4180186
43531197	Microscopic examination of specimen from periureteral tissue for parasites (procedure)	4180186
43531199	Microscopic examination of bacterial smear of specimen from nervous system (procedure)	4180186
43531200	Microscopic examination of bacterial smear of specimen from biliary tract (procedure)	4180186
43531201	Microscopic examination of bacterial smear of specimen from bladder (procedure)	4180186
43531202	Microscopic examination of bacterial smear of specimen from endocrine gland (procedure)	4180186
43531205	Microscopic examination of bacterial smear of specimen from kidney (procedure)	4180186
43531206	Microscopic examination of bacterial smear of specimen from liver (procedure)	4180186
43531209	Microscopic examination of bacterial smear of specimen from musculoskeletal system (procedure)	4180186
43531210	Microscopic examination of bacterial smear of specimen from pancreas (procedure)	4180186
43531212	Microscopic examination of bacterial smear of specimen from periureteral tissue (procedure)	4180186
43531215	Microscopic examination of bacterial smear of specimen from spleen (procedure)	4180186
43531217	Microscopic examination of bacterial smear of specimen from ureter (procedure)	4180186
43531218	Microscopic examination of bacterial smear of specimen from urethra (procedure)	4180186
43531220	Trophozoite of Balantidium coli (organism)	4180186
43531220	Trophozoite of Balantidium coli	4180186
43531221	Trophozoite of Blastocystis hominis (organism)	4180186
43531221	Trophozoite of Blastocystis hominis	4180186
43531222	Trophozoite of Chilomastix mesnili	4180186
43531222	Trophozoite of Chilomastix mesnili (organism)	4180186
43531223	Trophozoite of genus Cryptosporidium	4180186
43531223	Cryptosporidium trophozoite	4180186
43531223	Trophozoite of genus Cryptosporidium (organism)	4180186
43531224	Microscopic examination of lymph fluid specimen (procedure)	4180186
43531227	Giardia trophozoite	4180186
43531227	Trophozoite of genus Giardia (organism)	4180186
43531227	Trophozoite of genus Giardia	4180186
43531229	Trophozoite of Cystoisospora belli	4180186
43531229	Trophozoite of Cystoisospora belli (organism)	4180186
43531229	Trophozoite of Isospora belli	4180186
43531229	Trophozoite of Isospora belli (organism)	4180186
43531231	Trophozoite of Plasmodium falciparum (organism)	4180186
43531231	Trophozoite of Plasmodium falciparum	4180186
43531233	Trophozoite of Plasmodium ovale	4180186
43531233	Trophozoite of Plasmodium ovale (organism)	4180186
43531235	Trophozoite of Retortamonas intestinalis	4180186
43531235	Trophozoite of Retortamonas intestinalis (organism)	4180186
43531237	Cyst of Balantidium coli (organism)	4180186
43531237	Cyst of Balantidium coli	4180186
43531240	Cyst of Enteromonas hominis (organism)	4180186
43531240	Cyst of Enteromonas hominis	4180186
43531244	Cyst of Giardia lamblia	4180186
43531244	Cyst of Giardia lamblia (organism)	4180186
43531247	Microscopic examination of bacterial smear of specimen from operative wound	4180186
43531247	Microscopic examination of bacterial smear of specimen from surgical wound (procedure)	4180186
43531248	Microscopic examination of bacterial smear of semen specimen specimen	4180186
43531248	Microscopic examination of bacterial smear of seminal fluid specimen (procedure)	4180186
43531250	Microscopic examination of bacterial smear of cerebrospinal fluid specimen (procedure)	4180186
43531255	Microscopic examination of bacterial smear of stool specimen (procedure)	4180186
43531259	Gametocyte of Plasmodium falciparum	4180186
43531259	Gametocyte of Plasmodium falciparum (organism)	4180186
43531260	Gametocyte of Plasmodium malariae (organism)	4180186
43531260	Gametocyte of Plasmodium malariae	4180186
43531261	Gametocyte of Plasmodium ovale	4180186
43531261	Gametocyte of Plasmodium ovale (organism)	4180186
43531263	Microscopic examination of specimen from integument (procedure)	4180186
43531265	Specimen from skin (specimen)	4180186
43531266	Cestode adult	4180186
43531266	Adult of class Cestoda (organism)	4180186
43531266	Adult of class Cestoda	4180186
43531267	Adult of Diphyllobothrium latum	4180186
43531267	Adult of Diphyllobothrium latum (organism)	4180186
43531269	Adult of Hymenolepis diminuta	4180186
43531269	Adult of Hymenolepis diminuta (organism)	4180186
43531272	Larva of Hymenolepis nana	4180186
43531272	Larva of Hymenolepis nana (organism)	4180186
43531276	Egg of Dipylidium caninum	4180186
43531276	Dipylidium caninum ovum	4180186
43531276	Egg of Dipylidium caninum (organism)	4180186
43531278	Hymenolepis diminuta ovum	4180186
43531278	Egg of Hymenolepis diminuta (organism)	4180186
43531278	Egg of Hymenolepis diminuta	4180186
43531279	Adult of class Trematoda (organism)	4180186
43531279	Trematode adult	4180186
43531279	Adult fluke	4180186
43531279	Adult of class Trematoda	4180186
43531285	Adult of Paragonimus westermani	4180186
43531285	Adult of Paragonimus westermani (organism)	4180186
43531290	Larva of genus Fasciola (organism)	4180186
43531290	Larva of genus Fasciola	4180186
43531293	Larva of Heterophyes heterophyes (organism)	4180186
43531293	Larva of Heterophyes heterophyes	4180186
43531295	Microscopic examination of bacterial smear of specimen from eye	4180186
43531295	Microscopic examination of bacterial smear of specimen from eye proper (procedure)	4180186
43531296	Larva of genus Schistosoma	4180186
43531296	Larva of genus Schistosoma (organism)	4180186
43531298	Egg of genus Fasciola	4180186
43531298	Genus Fasciola ovum	4180186
43531298	Egg of genus Fasciola (organism)	4180186
43531299	Microscopic examination of bacterial smear of urine specimen (procedure)	4180186
43531300	Egg of Fasciola hepatica	4180186
43531300	Egg of Fasciola hepatica (organism)	4180186
43531300	Fasciola hepatica ovum	4180186
43531302	Egg of Heterophyes heterophyes	4180186
43531302	Heterophyes heterophyes ovum	4180186
43531302	Egg of Heterophyes heterophyes (organism)	4180186
43531303	Microscopic examination of specimen from retroperitoneum (procedure)	4180186
43531303	Microscopic examination of retroperitoneal specimen	4180186
43531303	Microscopic examination of specimen from retroperitoneal space	4180186
43531306	Microscopic examination of specimen from bone marrow (procedure)	4180186
43531307	Microscopic examination of specimen from integument for parasites (procedure)	4180186
43531309	Microscopic examination of specimen from skin for parasites (procedure)	4180186
43531310	Microscopic examination of cerebrospinal fluid specimen for parasites (procedure)	4180186
43531311	Microscopic examination of stool specimen for parasites (procedure)	4180186
43531312	Microscopic cytologic examination of smear of specimen from nervous system prepared using Papanicolaou technique (procedure)	4180186
43531315	Microscopic cytologic examination of smear of specimen from spleen prepared using Papanicolaou technique (procedure)	4180186
43531316	Microscopic cytologic examination of smear of specimen from upper gastrointestinal tract prepared using Papanicolaou technique (procedure)	4180186
43531317	Microscopic cytologic examination of smear of specimen from ureter prepared using Papanicolaou technique (procedure)	4180186
43531323	Microscopic cytologic examination of smear of specimen from seminal vesicle prepared using Papanicolaou technique (procedure)	4180186
43531325	Microscopic cytologic examination of smear of specimen from biliary tract prepared using Papanicolaou technique (procedure)	4180186
43531326	Microscopic cytologic examination of smear of specimen from peritoneum prepared using Papanicolaou technique (procedure)	4180186
43531330	Microscopic cytologic examination of smear of specimen from integument prepared using Papanicolaou technique (procedure)	4180186
43531332	Adult of phylum Nemata	4180186
43531332	Adult nematode	4180186
43531332	Adult of phylum Nemata (organism)	4180186
43531333	Adult of Angiostrongylus cantonensis (organism)	4180186
43531333	Adult of Angiostrongylus cantonensis	4180186
43531336	Microscopic cytologic examination of smear of specimen from periureteral tissue prepared using Papanicolaou technique (procedure)	4180186
43531337	Microscopic cytologic examination of smear of specimen from perivesical tissue prepared using Papanicolaou technique (procedure)	4180186
43531338	Adult of genus Enterobius	4180186
43531338	Adult of genus Enterobius (organism)	4180186
43531339	Adult of Loa loa	4180186
43531339	Adult of Loa loa (organism)	4180186
43531340	Adult of Enterobius vermicularis	4180186
43531340	Adult of Enterobius vermicularis (organism)	4180186
43531341	Adult of genus Strongyloides (organism)	4180186
43531341	Adult of genus Strongyloides	4180186
43531346	Adult of genus Trichuris (organism)	4180186
43531346	Adult of genus Trichuris	4180186
43531349	Larva of Angiostrongylus cantonensis (organism)	4180186
43531349	Larva of Angiostrongylus cantonensis	4180186
43531351	Microscopic cytologic examination of smear of specimen from bone marrow prepared using Papanicolaou technique (procedure)	4180186
43531352	Microscopic examination of specimen from retroperitoneum prepared using Papanicolaou technique (procedure)	4180186
43531352	Microscopic cytologic examination of smear of retroperitoneal specimen prepared using Papanicolaou technique	4180186
43531352	Microscopic examination of specimen from retroperitoneal space prepared using Papanicolaou technique	4180186
43531354	Larva of genus Enterobius (organism)	4180186
43531354	Larva of genus Enterobius	4180186
43531356	Larva of genus Strongyloides	4180186
43531356	Larva of genus Strongyloides (organism)	4180186
43531361	Larva of Toxocara canis	4180186
43531361	Larva of Toxocara canis (organism)	4180186
43531363	Larva of genus Trichinella (organism)	4180186
43531363	Larva of genus Trichinella	4180186
43531364	Larva of Trichinella spiralis	4180186
43531364	Larva of Trichinella spiralis (organism)	4180186
43531365	Larva of genus Trichuris	4180186
43531365	Larva of genus Trichuris (organism)	4180186
43531367	Larva of genus Trichostrongylus (organism)	4180186
43531367	Larva of genus Trichostrongylus	4180186
43531373	Adult of Ancylostoma duodenale	4180186
43531373	Adult of Ancylostoma duodenale (organism)	4180186
43531374	Adult of Necator americanus	4180186
43531374	Adult of Necator americanus (organism)	4180186
43531375	Larva of Ancylostoma braziliense	4180186
43531375	Larva of Ancylostoma braziliense (organism)	4180186
43531377	Larva of Chrysomya bezziana (organism)	4180186
43531377	Larva of Chrysomya bezziana	4180186
43531378	Larva of Cochliomyia hominivorax	4180186
43531378	Larva of Cochliomyia hominivorax (organism)	4180186
43531380	Larva of Schistosoma mansoni	4180186
43531380	Larva of Schistosoma mansoni (organism)	4180186
43531382	Main spoken language Konkani (finding)	4180186
43531384	Advised about Influenza A virus subtype H1N1 infection	4180186
43531384	Educated about Influenza A virus subtype H1N1 infection (situation)	4180186
43531385	Microscopic cytologic examination of smear of specimen from operative wound prepared using Papanicolaou technique	4180186
43531385	Microscopic cytologic examination of smear of specimen from surgical wound prepared using Papanicolaou technique (procedure)	4180186
43531386	Microscopic cytologic examination of smear of joint fluid specimen prepared using Papanicolaou technique (procedure)	4180186
43531387	Microscopic cytologic examination of smear of lymph fluid specimen prepared using Papanicolaou technique (procedure)	4180186
43531389	Educated about risk of unprotected sexual intercourse (situation)	4180186
43531389	Advised about risk of unprotected sexual intercourse	4180186
43531391	Educated about wound care (situation)	4180186
43531393	Removal of intraluminal foreign body from small intestine without incision (procedure)	4180186
43531397	Microscopic examination of cell block of specimen from liver (procedure)	4180186
43531398	Removal of intraluminal foreign body from urethra without incision (procedure)	4180186
43531399	Removal of foreign body from vulva without incision (procedure)	4180186
43531402	Microscopic examination of cell block of specimen from lymph node (procedure)	4180186
43531403	Removal of foreign body from head without incision (procedure)	4180186
43531404	Microscopic examination of cell block of specimen from pancreas (procedure)	4180186
43531410	Revision of internal fixation of humerus (procedure)	4180186
43531411	Acquired sensorineural hearing loss (disorder)	4180186
43531412	Revision of internal fixation of radius (procedure)	4180186
43531413	Revision of internal fixation of ulna (procedure)	4180186
43531416	Revision of internal fixation of femur (procedure)	4180186
43531420	Revision of internal fixation of tibia and fibula (procedure)	4180186
43531421	Revision of internal fixation of patella (procedure)	4180186
43531422	Revision of internal fixation of metatarsal bone (procedure)	4180186
43531424	Revision of internal fixation of tarsal and metatarsal bones (procedure)	4180186
43531425	Revision of internal fixation of calcaneus (procedure)	4180186
43531427	Revision of internal fixation of wall of acetabulum (procedure)	4180186
43531429	Eagle syndrome	4180186
43531429	Elongated styloid process syndrome (disorder)	4180186
43531433	Revision of internal fixation of vertebra (procedure)	4180186
43531437	Percutaneous removal of calculus from renal pelvis using fluoroscopic guidance (procedure)	4180186
43531437	Percutaneous pyelolithotomy using fluoroscopic guidance	4180186
43531439	Percutaneous insertion of drug eluting stent into coronary artery using fluoroscopic guidance with contrast (procedure)	4180186
43531439	Percutaneous insertion of drug eluting stent into coronary artery using fluoroscopic guidance with contrast	4180186
43531441	Percutaneous transcatheter coil embolization of fistula of coronary artery using fluoroscopic guidance with contrast	4180186
43531441	Fluoroscopy guided percutaneous transluminal coil embolisation of fistula of coronary artery with contrast	4180186
43531441	Percutaneous transluminal coil embolization of fistula of coronary artery using fluoroscopic guidance with contrast (procedure)	4180186
43531441	Percutaneous transluminal coil embolisation of fistula of coronary artery using fluoroscopic guidance with contrast	4180186
43531441	Percutaneous transluminal coil embolization of fistula of coronary artery using fluoroscopic guidance with contrast	4180186
43531441	Percutaneous transcatheter coil embolisation of fistula of coronary artery using fluoroscopic guidance with contrast	4180186
43531443	Revision of total prosthetic replacement of shoulder joint (procedure)	4180186
43531444	Percutaneous insertion of stent graft into vertebral artery using fluoroscopic guidance with contrast	4180186
43531444	Percutaneous insertion of stent graft into vertebral artery using fluoroscopic guidance with contrast (procedure)	4180186
43531445	Percutaneous transluminal angioplasty of superior vena cava using fluoroscopic guidance with contrast (procedure)	4180186
43531446	Percutaneous transluminal angioplasty of brachiocephalic vein using fluoroscopic guidance with contrast (procedure)	4180186
43531448	Percutaneous transluminal insertion of branched stent graft into aorta (procedure)	4180186
43531448	Endovascular insertion of branched stent graft into aorta	4180186
43531451	Percutaneous transluminal laser ablation of varicose vein of leg	4180186
43531451	Percutaneous transluminal laser ablation of varicose vein of lower limb (procedure)	4180186
43531452	Percutaneous transluminal angioplasty of lower limb	4180186
43531452	Percutaneous transluminal angioplasty of blood vessel of lower limb (procedure)	4180186
43531454	Percutaneous cryoablation of neoplasm of liver using computed tomography guidance (procedure)	4180186
43531454	Percutaneous cryotherapy ablation of tumour of liver using computed tomography guidance	4180186
43531454	CT guided percutaneous cryotherapy ablation of tumor of liver	4180186
43531454	Percutaneous cryotherapy ablation of tumor of liver using computed tomography guidance	4180186
43531454	CT guided percutaneous cryotherapy ablation of tumour of liver	4180186
43531457	CT guided percutaneous cryotherapy ablation of tumour	4180186
43531457	Percutaneous cryotherapy ablation of tumor using computed tomography guidance	4180186
43531457	CT guided percutaneous cryotherapy ablation of tumor	4180186
43531457	Percutaneous cryoablation of neoplasm using computed tomography guidance (procedure)	4180186
43531457	Percutaneous cryotherapy ablation of tumour using computed tomography guidance	4180186
43531458	Revision of prosthetic replacement of head of radius (procedure)	4180186
43531463	Revision of component of total prosthetic replacement of shoulder joint using cement (procedure)	4180186
43531464	Revision of component of total prosthetic replacement of elbow joint (procedure)	4180186
43531467	Revision of replacement of joint of upper extremity	4180186
43531467	Revision of replacement of joint of upper limb (procedure)	4180186
43531469	Percutaneous drainage of lesion of abdominal cavity using imaging guidance (procedure)	4180186
43531470	Percutaneous transluminal balloon dilatation of interposition tube prosthesis between pulmonary artery and aorta (procedure)	4180186
43531470	Percutaneous transluminal balloon dilation of interposition tube prosthesis between pulmonary artery and aorta	4180186
43531481	Endoscopic thermocoagulation of duodenum for control of haemorrhage	4180186
43531481	Endoscopic thermocoagulation of duodenum for control of hemorrhage (procedure)	4180186
43531482	Endoscopic procedure on small intestine for control of hemorrhage	4180186
43531482	Endoscopic procedure on small intestine for control of hemorrhage (procedure)	4180186
43531482	Endoscopic procedure on small intestine for control of haemorrhage	4180186
43531483	Hemorrhage of pancreatic duct (disorder)	4180186
43531483	Haemorrhage of pancreatic duct	4180186
43531484	Endoscopic procedure on pancreatic duct for control of hemorrhage (procedure)	4180186
43531484	Endoscopic procedure on pancreatic duct for control of haemorrhage	4180186
43531485	Revision of repair of major peripheral nerve	4180186
43531485	Revision of neuroplasty of major peripheral nerve (procedure)	4180186
43531486	Subchorionic hematoma (disorder)	4180186
43531486	Subchorionic haematoma	4180186
43531487	Revision of decompression of posterior fossa and upper cervical spinal cord (procedure)	4180186
43531488	Revision of anterolateral excision of thoracic intervertebral disc and graft	4180186
43531488	Revision of anterolateral excision of thoracic intervertebral disc with insertion of graft (procedure)	4180186
43531490	Revision of intestinal stoma	4180186
43531490	Revision of stoma of intestine (procedure)	4180186
43531491	Infection of preauricular sinus (disorder)	4180186
43531492	Revision of amputation stump of ankle (procedure)	4180186
43531496	Revision of amputation stump of hand (procedure)	4180186
43531497	Revision of amputation stump of humerus (procedure)	4180186
43531498	Revision of amputation stump of wrist (procedure)	4180186
43531499	Revision of below knee amputation stump (procedure)	4180186
43531500	Mount-Reback syndrome	4180186
43531500	Paroxysmal nonkinesigenic dyskinesia (disorder)	4180186
43531500	Paroxysmal dystonic choreoathetosis	4180186
43531500	Familial paroxysmal choreoathetosis	4180186
43531502	Magnetic resonance imaging of chest for mediastinal lymphadenopathy	4180186
43531502	Magnetic resonance imaging of chest for mediastinal lymphadenopathy (procedure)	4180186
43531503	Paroxysmal kinesigenic choreoathetosis	4180186
43531503	Paroxysmal kinesigenic dyskinesia (disorder)	4180186
43531505	Magnetic resonance imaging of breast for screening for malignant neoplasm	4180186
43531505	Magnetic resonance imaging of breast for screening for malignant neoplasm (procedure)	4180186
43531510	Percutaneous aspiration of substance from tunica vaginalis (procedure)	4180186
43531511	Percutaneous needle biopsy of bile duct (procedure)	4180186
43531512	Laparoscopic bilateral salpingo-oophorectomy (procedure)	4180186
43531513	Percutaneous needle biopsy of gallbladder (procedure)	4180186
43531514	Percutaneous microwave ablation of lesion of liver (procedure)	4180186
43531516	Percutaneous transluminal closure of defect of cardiac septum (procedure)	4180186
43531516	Percutaneous closure of cardiac septal defect	4180186
43531520	Percutaneous endopyelotomy (procedure)	4180186
43531521	Lives in noninstitutional accommodation (finding)	4180186
43531522	Lives in ground floor apartment (finding)	4180186
43531522	Lives in ground floor flat	4180186
43531523	Lives in flat with elevator access	4180186
43531523	Lives in apartment with elevator access (finding)	4180186
43531525	Lives in semidetached house (finding)	4180186
43531527	Lives in detached house (finding)	4180186
43531534	Filariform larva of family Ancylostomatidae	4180186
43531534	Filariform larva of hookworm	4180186
43531534	Filariform larva of family Ancylostomatidae (organism)	4180186
43531536	Larva of genus Sarcophaga (organism)	4180186
43531536	Larva of genus Sarcophaga	4180186
43531537	Trophozoite of Trichomonas vaginalis (organism)	4180186
43531537	Trophozoite of Trichomonas vaginalis	4180186
43531538	Laparoscopic repair of obstructed femoral hernia with prosthesis (procedure)	4180186
43531541	Laparoscopic repair of recurrent femoral hernia with prosthesis (procedure)	4180186
43531542	Laparoscopic repair of recurrent inguinal hernia with prosthesis (procedure)	4180186
43531543	Laparoscopic repair of recurrent paraumbilical hernia with prosthesis (procedure)	4180186
43531544	Laparoscopic repair of recurrent spigelian hernia with prosthesis (procedure)	4180186
43531545	Laparoscopic repair of strangulated femoral hernia with prosthesis (procedure)	4180186
43531546	Laparoscopic repair of strangulated inguinal hernia with prosthesis (procedure)	4180186
43531549	Open repair of recurrent paraumbilical hernia with prosthesis (procedure)	4180186
43531550	Open repair of strangulated inguinal hernia with prosthesis (procedure)	4180186
43531551	Laparoscopic repair of spigelian hernia with prosthesis (procedure)	4180186
43531558	Endoscopic excision of tissue of stomach (procedure)	4180186
43531559	Chronic kidney disease stage 1 due to type II diabetes mellitus	4180186
43531559	Diabetic stage 1 chronic renal impairment due to type 2 diabetes mellitus	4180186
43531559	Chronic kidney disease stage 1 due to type 2 diabetes mellitus (disorder)	4180186
43531560	Myasthenia gravis with exacerbation (disorder)	4180186
43531562	Chronic kidney disease stage 5 due to type II diabetes mellitus	4180186
43531562	Chronic kidney disease stage 5 due to type 2 diabetes mellitus (disorder)	4180186
43531562	Diabetic stage 5 chronic renal impairment due to type 2 diabetes mellitus	4180186
43531565	Erectile dysfunction with type 1 diabetes mellitus	4180186
43531565	Erectile dysfunction due to type 1 diabetes mellitus (disorder)	4180186
43531567	Extension Namespace {1000152} (namespace concept)	4180186
43531567	Extension Namespace {1000152}	4180186
43531569	Extension Namespace {1000155} (namespace concept)	4180186
43531569	Extension Namespace {1000155}	4180186
43531570	Extension Namespace {1000156} (namespace concept)	4180186
43531570	Extension Namespace {1000156}	4180186
43531572	Extension Namespace {1000159} (namespace concept)	4180186
43531572	Extension Namespace {1000159}	4180186
43531573	Extension Namespace {1000161} (namespace concept)	4180186
43531573	Extension Namespace {1000161}	4180186
43531574	Extension Namespace {1000162} (namespace concept)	4180186
43531574	Extension Namespace {1000162}	4180186
43531576	Extension Namespace {1000165} (namespace concept)	4180186
43531576	Extension Namespace {1000165}	4180186
43531578	Chronic kidney disease due to type 2 diabetes mellitus (disorder)	4180186
43531578	Diabetic chronic renal impairment due to type 2 diabetes mellitus	4180186
43531578	Chronic renal impairment due to type 2 diabetes mellitus	4180186
43531578	Chronic renal impairment due to type II diabetes mellitus	4180186
43531580	On rectal examination of prostate abnormality detected (finding)	4180186
43531580	On rectal examination, prostate abnormal	4180186
43531581	Arterial thoracic outlet syndrome (disorder)	4180186
43531585	Central sleep apnea due to periodic breathing (disorder)	4180186
43531585	Central sleep apnoea due to periodic breathing	4180186
43531586	Symptomatic human immunodeficiency virus infection (disorder)	4180186
43531586	Symptomatic HIV (human immunodeficiency virus) infection	4180186
43531588	Angina due to type 2 diabetes mellitus	4180186
43531588	Angina due to type 2 diabetes mellitus (disorder)	4180186
43531589	Complex regional pain syndrome, Type I, of head and/or trunk (disorder)	4180186
43531590	History of flexible sigmoidoscopy (situation)	4180186
43531592	Sequela of thrombotic stroke (disorder)	4180186
43531594	Organic sleep related movement disorder (disorder)	4180186
43531595	Weakness of extremities as sequela of stroke (disorder)	4180186
43531596	Metastasis to lymph node from adenocarcinoma (disorder)	4180186
43531600	Fatigue due to chemotherapy or radiation therapy (finding)	4180186
43531602	Paraplegia with neurogenic bladder (disorder)	4180186
43531603	History of parietal cerebrovascular accident (situation)	4180186
43531605	Occlusion of cerebral artery with stroke (disorder)	4180186
43531608	Vitreous haemorrhage with type 2 diabetes mellitus	4180186
43531608	Vitreous haemorrhage due to type 2 diabetes mellitus	4180186
43531608	Vitreous hemorrhage due to type 2 diabetes mellitus (disorder)	4180186
43531608	Vitreous hemorrhage with type 2 diabetes mellitus	4180186
43531609	Sequela of ischaemic cerebral infarction	4180186
43531609	Sequela of ischemic cerebral infarction (disorder)	4180186
43531612	Chronic postoperative pain (finding)	4180186
43531613	Allergic migraine (disorder)	4180186
43531614	History of peanut allergy (situation)	4180186
43531622	Ataxia as sequela of cerebrovascular disease (disorder)	4180186
43531623	Multisystem degeneration of autonomic nervous system (disorder)	4180186
43531627	Idiopathic hypersomnia (disorder)	4180186
43531628	Myelomeningocele without hydrocephalus (disorder)	4180186
43531630	Intractable absence seizures (disorder)	4180186
43531633	Non-allergic hypersensitivity to dextran (finding)	4180186
43531633	Dextran pseudoallergy	4180186
43531633	Dextran allergy	4180186
43531633	Pseudoallergy to dextran	4180186
43531633	Nonallergic hypersensitivity to dextran	4180186
43531634	Captopril pseudoallergy	4180186
43531634	Pseudoallergy to captopril	4180186
43531634	Captopril allergy	4180186
43531634	Non-allergic hypersensitivity to captopril (finding)	4180186
43531634	Nonallergic hypersensitivity to captopril	4180186
43531639	Hemiparesis/hemiplegia (one sided weakness/paralysis)	4180186
43531639	Paralytic syndrome on one side of the body (disorder)	4180186
43531641	Permanent neonatal diabetes mellitus (disorder)	4180186
43531641	Permanent diabetes mellitus of infancy	4180186
43531642	Diabetes mellitus due to genetic defect in insulin action (disorder)	4180186
43531644	MODY8	4180186
43531644	Diabetes-pancreatic exocrine dysfunction syndrome	4180186
43531644	Maturity-onset diabetes of the young, type 8 (disorder)	4180186
43531649	Injury of branch of ulnar nerve (disorder)	4180186
43531654	Cervical plexopathy (disorder)	4180186
43531655	Vermouth (substance)	4180186
43531657	Open reduction of fracture of metacarpal bone with internal fixation (procedure)	4180186
43531658	Laparoscopic repair of strangulated femoral hernia (procedure)	4180186
43531660	Open reduction of fracture of tarsal bone with internal fixation (procedure)	4180186
43531661	Functional gait abnormality (finding)	4180186
43531662	Vaccine declined by patient	4180186
43531662	Vaccine declined by patient (situation)	4180186
43531662	Vaccine refused by patient (situation)	4180186
43531666	Microscopic examination of specimen from nervous system for parasites (procedure)	4180186
43531673	Larva of Schistosoma japonicum (organism)	4180186
43531673	Larva of Schistosoma japonicum	4180186
43531674	Microscopic examination of specimen from peritoneum (procedure)	4180186
43531675	Main spoken language Dari (finding)	4180186
43531677	Educated about antimalarial prophylaxis (situation)	4180186
43531678	Percutaneous transluminal occlusion of vein (procedure)	4180186
43531679	Revision of reverse polarity total prosthetic replacement of shoulder joint (procedure)	4180186
43531680	Revision of component of total prosthetic replacement of shoulder joint (procedure)	4180186
43531682	Disrupted surgical incision wound (morphologic abnormality)	4180186
43531686	Conjunctival abrasion (disorder)	4180186
43531686	Abrasion of conjunctiva	4180186
43531687	E. coli serotype O167:H5	4180186
43531687	Escherichia coli serotype O167:H5 (organism)	4180186
43531690	Acquired lymphedema of lower extremity (disorder)	4180186
43531690	Acquired lymphoedema of lower extremity	4180186
43531694	Removal of intraluminal foreign body from larynx without incision (procedure)	4180186
43531699	Extension Namespace {1000151}	4180186
43531699	Extension Namespace {1000151} (namespace concept)	4180186
43531700	Extension Namespace {1000154}	4180186
43531700	Extension Namespace {1000154} (namespace concept)	4180186
43531701	Extension Namespace {1000157} (namespace concept)	4180186
43531701	Extension Namespace {1000157}	4180186
43531703	Extension Namespace {1000163}	4180186
43531703	Extension Namespace {1000163} (namespace concept)	4180186
43531705	Foetal damage from maternal infectious disorder	4180186
43531705	Fetal damage from maternal infectious disorder (disorder)	4180186
43531706	Concept model range (foundation metadata concept)	4180186
43531706	Range	4180186
43531707	Foetal damage from maternal listeriosis	4180186
43531707	Fetal damage from maternal listeriosis (disorder)	4180186
43531711	Induced termination of pregnancy complicated by shock (disorder)	4180186
43531711	Termination of pregnancy complicated by shock	4180186
43531712	Termination of pregnancy complicated by amniotic fluid embolism	4180186
43531712	Induced termination of pregnancy complicated by amniotic fluid embolism (disorder)	4180186
43531716	Induced termination of pregnancy complicated by postoperative shock (disorder)	4180186
43531716	Termination of pregnancy complicated by postoperative shock	4180186
43531717	Anterior choroidal artery thrombosis (disorder)	4180186
43531720	History of colonoscopy (situation)	4180186
43531721	Narcolepsy without cataplexy (disorder)	4180186
43531723	Cirrhosis of liver due to chronic hepatitis C (disorder)	4180186
43531723	Chronic hepatitis C with stage 4 fibrosis	4180186
43533384	Drugs of abuse Pnl Bld Scn	4180186
43533384	Blood; DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood	4180186
43533384	滥用药物组套:-:时间点:全血:-:毒理学筛查试验	4182948
43533385	Barbiturates Pnl Bld Cfm	4180186
43533385	Barb; Barbiturate; Barbiturates Pnl; Barbs; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
43533385	巴比妥酸类组套:-:时间点:全血:-:毒理学确认试验	4182948
43533389	BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
43533389	BZE Ur Scn-mCnc	4180186
43533389	苯甲酰芽子碱:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
43533393	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Nasogastric; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn	4180186
43533393	Opiates Ur Ql Scn>300 ng/mL	4180186
43533393	阿片制剂:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 300 纳克/毫升	4182948
43533395	Sample Hemolyzed CSF Ql	4180186
43533395	Cerebral spinal fluid; Cerebrospinal Fl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
43533395	溶血性标本:存在情况或阈值:时间点:脑脊液:序数型	4182948
43533397	FLUoxetine ind plt IgM SerPl Ql FC	4180186
43533397	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prozac; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533397	氟西汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533399	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Diflucan; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533399	Fluconazole ind plt IgG SerPl Ql FC	4180186
43533399	氟康唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533401	Finasteride ind plt IgM SerPl Ql FC	4180186
43533401	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Propecia; Proscar; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533401	非那雄胺 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533402	Finasteride ind plt IgG SerPl Ql FC	4180186
43533402	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Propecia; Proscar; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533402	非那雄胺 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533403	Fexofenadine ind plt IgM SerPl Ql FC	4180186
43533403	ABS; Aby; Allegra; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Fastofen; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Telfast; Thrombocyte; Thrombocytes; Tilfur; Vifas	4180186
43533403	非索非那定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533405	fentaNYL ind plt IgG SerPl Ql FC	4180186
43533405	ABS; Aby; Actiq; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Duragesic; Durogesic; Dynamic; FC; Fenpat; fentanil; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sublimaze; Thrombocyte; Thrombocytes	4180186
43533405	芬太尼 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533407	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tricor	4180186
43533407	Fenofibrate ind plt IgM SerPl Ql FC	4180186
43533407	非诺贝特 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533410	Famotidine ind plt IgG SerPl Ql FC	4180186
43533410	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pepcid; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533410	法莫替丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533411	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Ezetrol; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zetia	4180186
43533411	Ezetimibe ind plt IgM SerPl Ql FC	4180186
43533411	依泽替米贝 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533420	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Integrilin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533420	Eptifibatide ind plt IgG SerPl Ql FC	4180186
43533420	依替巴肽 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533422	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; EPO; Epoetin; Erthropoyetin; Erythropoetin; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533422	EPO ind plt IgG SerPl Ql FC	4180186
43533422	促红细胞生成素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533423	Enalapril ind plt IgM SerPl Ql FC	4180186
43533423	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Enacard; Enaladex; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vasotec	4180186
43533423	依那普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533425	Doxycycline ind plt IgG SerPl Ql FC	4180186
43533425	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c206; c216; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vibramycin	4180186
43533425	强力霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533431	Docusate ind plt IgM SerPl Ql FC	4180186
43533431	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dioctyl sodium sulfosuccinate; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533431	多库酯 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533433	Dipyridamole ind plt IgM SerPl Ql FC	4180186
43533433	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Medication stress; Ordinal; Persantine; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533433	潘生丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533436	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Co-phenotrope; Diphenox+Atropine; Dynamic; Enlon; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lomotil; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533436	Diphenox+Atropine ind plt IgG SP Ql FC	4180186
43533436	苯乙哌啶+阿托品 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533437	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Benadryl; Circulating platelet ab; Diphenhydr; Diphenylhydramine; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533437	Diphenhy ind plt IgM SerPl Ql FC	4180186
43533437	苯海拉明 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533440	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cardizem; Cartia; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tiamate; Tiazac	4180186
43533440	dilTIAZem ind plt IgM SerPl Ql FC	4180186
43533440	硫氮卓酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533441	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; DGXN; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lanoxin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533441	Digoxin ind plt IgG SerPl Ql FC	4180186
43533441	地高辛 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533442	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; DGXN; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lanoxin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533442	Digoxin ind plt IgM SerPl Ql FC	4180186
43533442	地高辛 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533443	Dicyclomine ind plt IgM SerPl Ql FC	4180186
43533443	(Bicyclohexyl)-1-carboxylic acid; 2-(diethylamino)ethyl ester; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bemote; Bentyl; Byclomine; C19H36ClN02; Circulating platelet ab; Dicycloverine; DI-SPAZ; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Merbentyl; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533443	双环胺 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533444	(Bicyclohexyl)-1-carboxylic acid; 2-(diethylamino)ethyl ester; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bemote; Bentyl; Byclomine; C19H36ClN02; Circulating platelet ab; Dicycloverine; DI-SPAZ; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Merbentyl; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533444	Dicyclomine ind plt IgG SerPl Ql FC	4180186
43533444	双环胺 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533446	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c311; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stesolid; Thrombocyte; Thrombocytes; Valium	4180186
43533446	diazePAM ind plt IgG SerPl Ql FC	4180186
43533446	安定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533449	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ciclosporin; Ciclosporine; Circulating platelet ab; CsA; Cyclosporin a; Cyclosporins; Dynamic; FC; Gengraf; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Neoral; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Restasis; Sandimmune; SangCya; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533449	cycloSPORINE ind plt IgM SerPl Ql FC	4180186
43533449	环孢菌素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533451	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C22H25NO6; Circulating platelet ab; Colchiceine methyl ether; Colchineos; Colchisol; Colcin; Colgout; Colsaloid; Condylon; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; n-acetyltrimethylcolchicinic acid methyl ether; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533451	Colchicine ind plt IgG SerPl Ql FC	4180186
43533451	秋水仙碱 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533453	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plavix; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533453	Clopidogrel ind plt IgG SerPl Ql FC	4180186
43533453	氯吡格雷 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533454	Clopidogrel ind plt IgM SerPl Ql FC	4180186
43533454	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plavix; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533454	氯吡格雷 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533458	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Klonopin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533458	clonazePAM ind plt IgM SerPl Ql FC	4180186
43533458	氯硝安定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533460	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c306; Circulating platelet ab; Cleocin; CLIJ; Clindamycin.induced; Dalacin; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sobelin; SR; Thrombocyte; Thrombocytes; Topical	4180186
43533460	Clindamycin ind plt IgG SerPl Ql FC	4180186
43533460	氯洁霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533461	Clavulanate ind plt IgM SerPl Ql FC	4180186
43533461	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c305; Circulating platelet ab; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533461	克拉维酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533463	Clarithro ind plt IgM SerPl Ql FC	4180186
43533463	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Biaxin; Circulating platelet ab; Claripen; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Klacid; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533463	克拉霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533464	Clarithro ind plt IgG SerPl Ql FC	4180186
43533464	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Biaxin; Circulating platelet ab; Claripen; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Klacid; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533464	克拉霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533465	Citalopram ind plt IgM SerPl Ql FC	4180186
43533465	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celexa; Cipramil; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533465	西酞普兰 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533471	Cilastatin ind plt IgG SerPl Ql FC	4180186
43533471	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533471	西司他丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533472	Cilastatin ind plt IgM SerPl Ql FC	4180186
43533472	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533472	西司他丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533473	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Hygroton; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thalitone; Thrombocyte; Thrombocytes	4180186
43533473	Chlorthalidone ind plt IgM SerPl Ql FC	4180186
43533473	氯噻酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533475	chlorproPAMIDE ind plt IgM SerPl Ql FC	4180186
43533475	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Diabinese; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533475	氯磺丙脲 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533476	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Diabinese; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533476	chlorproPAMIDE ind plt IgG SerPl Ql FC	4180186
43533476	氯磺丙脲 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533477	chlorproMAZINE ind plt IgG SerPl Ql FC	4180186
43533477	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlopromazine; Chlorpromaz; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thorazine; Thrombocyte; Thrombocytes	4180186
43533477	氯丙嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533478	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlopromazine; Chlorpromaz; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thorazine; Thrombocyte; Thrombocytes	4180186
43533478	chlorproMAZINE ind plt IgM SerPl Ql FC	4180186
43533478	氯丙嗪 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533479	Chlordiazep ind plt IgM SerPl Ql FC	4180186
43533479	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlordiaz; Chlordiaze; Chlordiazep; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Librium; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533479	甲氨二氮卓 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533481	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefadine; Circulating platelet ab; Dynamic; FC; GRACEF; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Keflex; Losporal; Ordinal; Palitrex; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Salitex; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533481	Cephalexin ind plt IgG SerPl Ql FC	4180186
43533481	头孢氨苄 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533482	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefadine; Circulating platelet ab; Dynamic; FC; GRACEF; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Keflex; Losporal; Ordinal; Palitrex; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Salitex; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533482	Cephalexin ind plt IgM SerPl Ql FC	4180186
43533482	头孢氨苄 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533483	Celecoxib ind plt IgM SerPl Ql FC	4180186
43533483	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celebrex; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533483	塞来昔布 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533487	cefTRIAXone ind plt IgG SerPl Ql FC	4180186
43533487	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c9; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rocephin; ROCJ; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533487	头孢三嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533490	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefizox; Ceftrix; Circulating platelet ab; Dynamic; Eposelin; Eposerin; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533490	Ceftizoxime ind plt IgM SerPl Ql FC	4180186
43533490	头孢唑肟 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533491	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ceftaz; Circulating platelet ab; Dynamic; FC; Forj; Fortaz; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazicef; Tazj; Thrombocyte; Thrombocytes	4180186
43533491	cefTAZidime ind plt IgG SerPl Ql FC	4180186
43533491	头孢他啶 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533492	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ceftaz; Circulating platelet ab; Dynamic; FC; Forj; Fortaz; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazicef; Tazj; Thrombocyte; Thrombocytes	4180186
43533492	cefTAZidime ind plt IgM SerPl Ql FC	4180186
43533492	头孢他啶 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533494	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefipime; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Maxipime; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533494	Cefepime ind plt IgG SerPl Ql FC	4180186
43533494	头孢吡肟 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533499	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533499	Caspofungin ind plt IgM SerPl Ql FC	4180186
43533499	卡泊芬净 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533504	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carvil; Circulating platelet ab; Coreg; Dilatrend; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533504	Carvedilol ind plt IgG SerPl Ql FC	4180186
43533504	卡维地洛 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533505	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carisoma; Circulating platelet ab; Dynamic; FC; Flexartal; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Isopropylmeprobamate; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rela; Sanoma; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Soma; Somadril; Somalgit; SR; Thrombocyte; Thrombocytes	4180186
43533505	Carisoprodol ind plt IgM SerPl Ql FC	4180186
43533505	异丙基甲丁双脲 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533506	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carisoma; Circulating platelet ab; Dynamic; FC; Flexartal; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Isopropylmeprobamate; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rela; Sanoma; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Soma; Somadril; Somalgit; SR; Thrombocyte; Thrombocytes	4180186
43533506	Carisoprodol ind plt IgG SerPl Ql FC	4180186
43533506	异丙基甲丁双脲 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533509	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carbamazapine; Carbamezapine; Carbazepine; Circulating platelet ab; CRBM; Dynamic; Epitol; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril; Thrombocyte; Thrombocytes	4180186
43533509	carBAMazepine ind plt IgG SerPl Ql FC	4180186
43533509	卡马西平 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533512	Captopril ind plt IgG SerPl Ql FC	4180186
43533512	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c246; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533512	卡托普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533513	Candesartan ind plt IgM SerPl Ql FC	4180186
43533513	ABS; Aby; Amias; Antby; Anti; Antibodies; Antibody; Atacand; Autoantibodies; Autoantibody; Blopress; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Ratacand; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533513	坎地沙坦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533515	Butalb+ASA+Caff ind plt IgM SerPl Ql FC	4180186
43533515	ABS; Aby; Acetylsalicylic acid; Allylbarbital; Allylbarbituric acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; Barbiturate; Butalb+ASA+Caff; c207; c217; CAFFN; Circulating platelet ab; Dynamic; Esgic; FC; Fioricet; Fiorinal; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533515	布他比妥+乙酰水杨酸+咖啡因 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533516	Butalb+ASA+Caff ind plt IgG SerPl Ql FC	4180186
43533516	ABS; Aby; Acetylsalicylic acid; Allylbarbital; Allylbarbituric acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; Barbiturate; Butalb+ASA+Caff; c207; c217; CAFFN; Circulating platelet ab; Dynamic; Esgic; FC; Fioricet; Fiorinal; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533516	布他比妥+乙酰水杨酸+咖啡因 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533517	busPIRone ind plt IgM SerPl Ql FC	4180186
43533517	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Buspar; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533517	丁螺旋酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533521	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bumex; Burinex; Butinat; Circulating platelet ab; Dynamic; Farmadiuril; FC; Fontego; Fordiuran; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533521	Bumetanide ind plt IgM SerPl Ql FC	4180186
43533521	布美他尼 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533523	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Entocort; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rhinocort; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533523	Budesonide ind plt IgM SerPl Ql FC	4180186
43533523	布地缩松 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533525	ABS; Aby; Angiomax; Angiox; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533525	Bivalirudin ind plt IgM SerPl Ql FC	4180186
43533525	比伐卢定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533526	Bivalirudin ind plt IgG SerPl Ql FC	4180186
43533526	ABS; Aby; Angiomax; Angiox; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533526	比伐卢定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533527	Benztropine ind plt IgG SerPl Ql FC	4180186
43533527	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Cogentin; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533527	苯扎托品 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533529	Benazepril ind plt IgG SerPl Ql FC	4180186
43533529	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BZ; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lotensin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533529	苯那普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533531	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Azactam; Azaj; azthreonam; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533531	Aztreonam ind plt IgM SerPl Ql FC	4180186
43533531	噻肟单酰胺菌素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533532	Aztreonam ind plt IgG SerPl Ql FC	4180186
43533532	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Azactam; Azaj; azthreonam; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533532	噻肟单酰胺菌素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533534	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zithromax	4180186
43533534	Azithromycin ind plt IgG SerPl Ql FC	4180186
43533534	阿齐霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533537	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strattera; Thrombocyte; Thrombocytes	4180186
43533537	Atomoxetine ind plt IgM SerPl Ql FC	4180186
43533537	托莫西汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533545	ABS; Aby; Amcil; Amicil; Amp; Ampicilloyl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c5; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Omnipen; Ordinal; Penbritin; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polycillin; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533545	Ampicillin ind plt IgM SerPl Ql FC	4180186
43533545	氨苄青霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533547	ABS; Aby; Amox; Amoxicillin+clavulanic acid; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Augmentin; Autoantibodies; Autoantibody; Bristamox; c204; c305; c6; Circulating platelet ab; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Larotid; Moxalin; Moxicillin+clavulanic acid; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polymox; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sumox; Thrombocyte; Thrombocytes; Trimox; Wymox	4180186
43533547	Amoxicillin+Clav ind plt IgM SerPl Ql FC	4180186
43533547	羟氨苄青霉素+棒酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533548	ABS; Aby; Amox; Amoxicillin+clavulanic acid; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Augmentin; Autoantibodies; Autoantibody; Bristamox; c204; c305; c6; Circulating platelet ab; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Larotid; Moxalin; Moxicillin+clavulanic acid; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polymox; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sumox; Thrombocyte; Thrombocytes; Trimox; Wymox	4180186
43533548	Amoxicillin+Clav ind plt IgG SerPl Ql FC	4180186
43533548	羟氨苄青霉素+棒酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533549	Amoxicillin ind plt IgM SerPl Ql FC	4180186
43533549	ABS; Aby; Amox; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bristamox; c204; c6; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Larotid; Moxalin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polymox; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sumox; Thrombocyte; Thrombocytes; Trimox; Wymox	4180186
43533549	羟氨苄青霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533550	Amoxicillin ind plt IgG SerPl Ql FC	4180186
43533550	ABS; Aby; Amox; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bristamox; c204; c6; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Larotid; Moxalin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polymox; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sumox; Thrombocyte; Thrombocytes; Trimox; Wymox	4180186
43533550	羟氨苄青霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533553	amLODIPine ind plt IgM SerPl Ql FC	4180186
43533553	ABS; Aby; AM; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Norvasc; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533553	阿莫洛地平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533554	amLODIPine ind plt IgG SerPl Ql FC	4180186
43533554	ABS; Aby; AM; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Norvasc; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533554	阿莫洛地平 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533555	Amitrip ind plt IgG SerPl Ql FC	4180186
43533555	ABS; Aby; Amit; Amitrip; Amitriptylene; Amitriptyln; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Elatrol; Elavil; Endep; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Trepiline; Tryptanol; Tryptizol	4180186
43533555	阿米替林 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533556	Amitrip ind plt IgM SerPl Ql FC	4180186
43533556	ABS; Aby; Amit; Amitrip; Amitriptylene; Amitriptyln; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Elatrol; Elavil; Endep; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Trepiline; Tryptanol; Tryptizol	4180186
43533556	阿米替林 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533557	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Cordarone; Dynamic; Esoteric; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pacerone; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533557	Amiodarone ind plt IgG SerPl Ql FC	4180186
43533557	胺碘酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533560	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Niravam; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Xanax	4180186
43533560	Alpraz ind plt IgG SerPl Ql FC	4180186
43533560	阿普唑仑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533561	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lopurin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zyloprim	4180186
43533561	Allopurinol ind plt IgG SerPl Ql FC	4180186
43533561	别嘌呤醇 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533563	Alendronate ind plt IgM SerPl Ql FC	4180186
43533563	ABS; Aby; Alendronic acid; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Fosamax; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533563	阿仑膦酸盐 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533566	Albuterol ind plt IgG SerPl Ql FC	4180186
43533566	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Proventil; QL; Qual; Qualitative; Random; Salbutamol; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Ventolin	4180186
43533566	舒喘宁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533569	APAP ind plt IgG SerPl Ql FC	4180186
43533569	ABS; Aby; ACET; Acetamidophenol; Acetaminoph; Acetominophen; Antby; Anti; Antibodies; Antibody; APAP; Autoantibodies; Autoantibody; c209; C55; Circulating platelet ab; Dynamic; FC; Hydroxyacetanilide; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tylenol; u209	4180186
43533569	对乙酰氨基酚 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533570	ABS; Aby; ACET; Acetamidophenol; Acetaminoph; Acetominophen; Antby; Anti; Antibodies; Antibody; APAP; Autoantibodies; Autoantibody; c209; C55; Circulating platelet ab; Dynamic; FC; Hydroxyacetanilide; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tylenol; u209	4180186
43533570	APAP ind plt IgM SerPl Ql FC	4180186
43533570	对乙酰氨基酚 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533572	Acebutolol ind plt IgG SerPl Ql FC	4180186
43533572	ABS; Aby; Acecor; ALOL; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Monitan; Neptal; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prent; QL; Qual; Qualitative; Random; Rhotral; Screen; Sectral; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533572	醋丁洛尔 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533573	Acarbose ind plt IgM SerPl Ql FC	4180186
43533573	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Glucobay; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prandase; Precose; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533573	阿卡波糖 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533574	Acarbose ind plt IgG SerPl Ql FC	4180186
43533574	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Glucobay; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prandase; Precose; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533574	阿卡波糖 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533575	Drug ind plt Ab SerPl-Imp	4180186
43533575	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Drugs; Impression; Impression/interpretation of study; Impressions; ind plt Ab; Interp; Interpretation; Narrative; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Random; Report; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533575	药物 诱导型血小板抗体:印象:时间点:血清/血浆:叙述型	4182948
43533577	Abciximab ind plt IgM SerPl Ql FC	4180186
43533577	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c7E3 Fab; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; ReoPro; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533577	阿昔单抗 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533580	Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Endocrine; Endocrinology; FR; FreeT4; FT4; Gyn; Gynecology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
43533580	T4 Free BldCo-mCnc	4180186
43533580	甲状腺素.游离型:质量浓度:时间点:脐带全血:定量型	4182948
43533581	Bld Pos; Blood; Coag neg Staph; CoNS; Fluorescent in situ hybridization; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; NEG; Nominal; o71; Point in time; Random; ribosomal RNA; S aureus; S aureus+CoNS; S aureus+CoNS rRNA; species; spp; Staph; WB; Whole blood	4180186
43533581	S aureus+CoNS rRNA Bld Pos FISH	4180186
43533581	金黄色葡萄球菌与葡萄球菌属.凝固酶阴性 rRNA:存在与否或特征标识:时间点:血液.生长阳性:名义型:FISH	4182948
43533582	HSV1 IgG Titr Ser IF	4180186
43533582	单纯疱疹病毒 1 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
43533582	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
43533583	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Epidemic Parotitis; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Mumps virus antibody; Mumps virus IgG; Mumps virus IgM; MuV; Nominal; Point in time; Random; Serum; SR	4180186
43533583	MuV IgG+IgM Ser-Imp	4180186
43533583	流行性腮腺炎病毒 抗体.IgG 与 IgM:印象:时间点:血清:名义型	4182948
43533585	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; Mass Content; Mec; Methadone metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
43533585	EDDP Mec Cfm-mCnt	4180186
43533585	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
43533588	Trenbolone Ur Ql	4180186
43533588	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
43533588	群勃龙:存在情况或阈值:时间点:尿液:序数型	4182948
43533592	Description; DOC.MISC; Document; Dx Imaging; Exp; MISC; Point in time; Rad expo+protect info; Random	4180186
43533592	Rad expo+protect info Doc Dx Imaging	4180186
43533592	辐射暴露与防护信息:描述:时间点:^患者:文档型:诊断成像	4182948
43533594	Osmol gap Stl	4180186
43533594	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Osmo; Osmolality; osmolarity; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
43533594	摩渗间隙:渗透压:时间点:大便:定量型	4182948
43533599	Aciclovir; Acifur; ACV; Acycloguanosine; ANTIBIOTIC SUSCEPTIBILITIES; AST; Avirax; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zovirax	4180186
43533599	Acyclovir Islt Genotyp	4180186
43533599	阿昔洛韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43533600	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Rad; Radiology; Random; Visit note	4180186
43533600	会诊记录:发现:时间点:{环境}:文档型:放射医学	4182948
43533601	Ag; AnGAP; Anion Gap4; Bld cord; Chemistry; Cord BldV; Cord venous blood; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43533601	Anion Gap4 BldCoV-sCnc	4180186
43533601	阴离子间隙 4:物质的量浓度:时间点:脐带静脉全血:定量型	4182948
43533602	Ag; AnGAP; Anion Gap4; Bld cord; Chemistry; Cord arterial blood; Cord BldA; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43533602	Anion Gap4 BldCoA-sCnc	4180186
43533602	阴离子间隙 4:物质的量浓度:时间点:脐带动脉全血:定量型	4182948
43533603	Anion Gap4 BldV-sCnc	4180186
43533603	Ag; AnGAP; Anion Gap4; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous	4180186
43533603	阴离子间隙 4:物质的量浓度:时间点:静脉全血:定量型	4182948
43533606	ABG; Ag; AnGAP; Anion Gap4; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43533606	Anion Gap4 BldA-sCnc	4180186
43533606	阴离子间隙 4:物质的量浓度:时间点:动脉全血:定量型	4182948
43533608	Molybdenum/Creat Ur	4180186
43533608	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Mo; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43533608	钼/肌酐:质量比率:时间点:尿液:定量型	4182948
43533610	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533610	Tizoxanide Susc Islt	4180186
43533610	替唑尼特:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533611	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Torezolid	4180186
43533611	Tedizolid Susc Islt	4180186
43533611	泰地唑胺:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533612	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533612	Solithromycin Susc Islt	4180186
43533612	索利霉素:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533614	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533614	rifAXIMin Susc Islt	4180186
43533614	利福昔明:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533615	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533615	Razupenem Susc Islt	4180186
43533615	阿祖培南:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533617	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533617	Plazomicin Susc Islt	4180186
43533617	普拉佐米星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533618	Acetylsulfamethoxazole; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c223; C61; Gantanol; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Primor; Random; SMX; Sulfa; Sulfamethox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533618	Ormetroprim+Sulfamethoxazole Susc Islt	4180186
43533618	奥美普林+磺胺甲噁唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533621	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Marbocyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zeniquin	4180186
43533621	Marbofloxacin Susc Islt	4180186
43533621	马波沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533622	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533622	Iclaprim Susc Islt	4180186
43533622	艾拉普林:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533628	ANTIBIOTIC SUSCEPTIBILITIES; AST; AVYCAZ; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; Zavicefta	4180186
43533628	cefTAZidime+Avibactam Susc Islt	4180186
43533628	头孢他啶+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533631	ANTIBIOTIC SUSCEPTIBILITIES; AST; Besivance; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533631	Besifloxacin Susc Islt	4180186
43533631	贝西沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533634	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533634	Solithromycin Islt MIC	4180186
43533634	索利霉素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533635	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533635	Sarafloxacin Islt MIC	4180186
43533635	沙拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533638	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533638	Premafloxacin Islt MIC	4180186
43533638	沛马沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533639	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533639	Plazomicin Islt MIC	4180186
43533639	普拉佐米星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533643	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Marbocyl; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zeniquin	4180186
43533643	Marbofloxacin Islt MIC	4180186
43533643	马波沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533644	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533644	Iclaprim Islt MIC	4180186
43533644	艾拉普林:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533645	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533645	Finafloxacin Islt MIC	4180186
43533645	非那沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533646	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dificid; Dificlir; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533646	Fidaxomicin Islt MIC	4180186
43533646	非达霉素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533650	ANTIBIOTIC SUSCEPTIBILITIES; AST; AVYCAZ; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; Zavicefta	4180186
43533650	cefTAZidime+Avibactam Islt MIC	4180186
43533650	头孢他啶+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533651	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Teflaro	4180186
43533651	Ceftaroline+Avibactam Islt MIC	4180186
43533651	头孢洛林+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533652	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Teflaro	4180186
43533652	Ceftaroline Islt MIC	4180186
43533652	头孢洛林:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533655	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vibativ	4180186
43533655	Telavancin Islt KB	4180186
43533655	特拉万星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533656	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Torezolid	4180186
43533656	Tedizolid Islt KB	4180186
43533656	泰地唑胺:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533658	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533658	Sarafloxacin Islt KB	4180186
43533658	沙拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533661	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533661	Premafloxacin Islt KB	4180186
43533661	沛马沙星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533665	Alinia; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Nitaxide; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533665	Nitazoxanide Islt KB	4180186
43533665	硝唑尼特:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533669	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dificid; Dificlir; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533669	Fidaxomicin Islt KB	4180186
43533669	非达霉素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533671	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533671	Danofloxacin Islt KB	4180186
43533671	达氟沙星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533673	ANTIBIOTIC SUSCEPTIBILITIES; AST; AVYCAZ; Ceftaz; Disk diffusion; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; Zavicefta	4180186
43533673	cefTAZidime+Avibactam Islt KB	4180186
43533673	头孢他啶+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533674	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Teflaro	4180186
43533674	Ceftaroline+Avibactam Islt KB	4180186
43533674	头孢洛林+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533675	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Teflaro	4180186
43533675	Ceftaroline Islt KB	4180186
43533675	头孢洛林:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533677	ANTIBIOTIC SUSCEPTIBILITIES; Apralan; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533677	Apramycin Islt MIC	4180186
43533677	阿普拉霉素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533678	ANTIBIOTIC SUSCEPTIBILITIES; Apralan; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533678	Apramycin Islt KB	4180186
43533678	阿普拉霉素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533680	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HCV; HCV NS5; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Mut; Mut Det; Mutation; Muts; Nominal; Point in time; Random	4180186
43533680	HCV NS5 Mut Det Islt Genotyp	4180186
43533680	丙型肝炎病毒 NS5 基因 已检出的突变:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43533682	ANTIBIOTIC SUSCEPTIBILITIES; Chicken pox; Chicken pox virus; Chickenpox; Gentyp; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Nominal; Point in time; Random; Shingles; Thymidine kinase; TK; VZ; VZV; VZV ORF36; Zoster	4180186
43533682	VZV ORF36 Gentyp Islt	4180186
43533682	水痘带状疱疹病毒 ORF36 基因型:存在与否或特征标识:时间点:分离株:名义型	4182948
43533684	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified	4180186
43533684	HIV 2 subtype Spec NAA+probe	4180186
43533684	HIV 2 亚型:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
43533686	Methadone pnl Sal Scn	4180186
43533686	Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; METD; Methadone pnl; Methadose; MTD; Oral fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Sal; Scn; Scr; Scrn	4180186
43533686	美沙酮组套:-:时间点:唾液:-:毒理学筛查试验	4182948
43533690	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533690	Optochin Islt KB	4180186
43533690	奥谱托欣:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533691	B; B-Hem Strep; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; Latex agglutination; Microbiology; Nominal; Point in time; Random; Strep; Strept; Typ	4180186
43533691	B-Hem Strep Islt LA	4180186
43533691	链球菌.Beta-溶血性:类型:时间点:分离株:名义型:胶乳凝集试验法	4182948
43533692	Bact; Bacteria hippuricase; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533692	Bacteria hippuricase Islt Ql	4180186
43533692	马尿酸酶产生型细菌:存在情况或阈值:时间点:分离株:序数型	4182948
43533697	ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Sal; Salmonel; Salmonella phage type; species; spp; Typ	4180186
43533697	Salmonella phage type Islt	4180186
43533697	沙门菌属噬菌体型:类型:时间点:分离株:名义型	4182948
43533698	Agg; Agglut; Agglutination; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Sertyp; Typ; Y enterocol; Y enterocolitica	4180186
43533698	Y enterocol Sertyp Islt Aggl	4180186
43533698	小肠结肠炎耶尔森氏菌 血清型:类型:时间点:分离株:名义型:凝集试验法	4182948
43533699	Agg; Agglut; Agglutination; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Random; S pneum serotype; S pneumo; S pneumoniae; Sertyp; Spn; Strep; Strept; Typ	4180186
43533699	S pneum Sertyp Islt Aggl	4180186
43533699	肺炎链球菌 血清型:类型:时间点:分离株:名义型:凝集试验法	4182948
43533700	Adenosine 5'-Pyrophosphate; Adenosine 5'-triphosphate; Adenosine Pyrophosphate; ADO; ADP; ANED; ATP; Chemistry; Medication stress; Platelet; Plt; Plts; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes	4180186
43533700	ATP/ADP Plts-EntSRto	4180186
43533700	三磷酸腺苷/二磷酸腺苷:实体物质的量比率:时间点:血小板:定量型	4182948
43533703	Topotecan Trough SerPl-mCnc	4180186
43533703	DRUG/TOXICOLOGY; Drugs; Hycamtin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43533703	拓扑替康^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43533704	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nexavar; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43533704	SORAfenib SerPl-mCnc	4180186
43533704	索拉非尼:质量浓度:时间点:血清/血浆:定量型	4182948
43533706	CYP2D6 allele 2 Bld/T	4180186
43533706	Blood; CPD6; CYP2D; CYP2D@; CYP2D6 allele; CYP2D6 allele 2; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; Cytochrome p450; cytochrome P450, family 2, subfamily D, polypeptide 6; Debrisoquine hydroxylation gene; HGNC:2629; Identity or presence; II; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P450C2D; P450DB1; P450-DB1; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533706	CYP2D6 基因 等位基因 2:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43533711	3,4-Methylenedioxy-N-Methylcathinone; Addiction; Bath salts; bk-MDMA; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; M1; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
43533711	Methylone Ur Ql Scn	4180186
43533711	亚甲基双氧甲基卡西酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
43533713	Danazol Ur Ql Scn	4180186
43533713	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
43533713	丹那唑:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
43533717	Addiction; Cipralex; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Lexamil; Lexapro; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Seroplex; UA; UR; Urn	4180186
43533717	Escitalopram Ur-mCnc	4180186
43533717	右旋西酞普兰:质量浓度:时间点:尿液:定量型	4182948
43533718	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ASFV; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pig; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
43533718	ASFV DNA Ct Tiss Qn NAA+probe	4180186
43533718	非洲猪瘟病毒 DNA:阈值循环圈数:时间点:组织与涂片:定量型:探针法.基因扩增.靶向	4182948
43533721	Bld Postductal; Bld Preductal; Bld.foot; Bld.pre+post; Bld.right hand; BldA.foot; BldA.right hand; Blood; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; O2; Point in time; Postductal blood; Preductal blood; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SaO2%.pre-post; SAT; Satn; SO2; tO2; WB; Whole blood	4180186
43533721	SaO2%.pre-post MFrDiff Bld.pre+post	4180186
43533721	氧饱和度.导管前-氧饱和度.导管后:质量分数差:时间点:全血.导管前+全血.导管后:定量型	4182948
43533723	Asympt; Asymptomatic; CCHD SaO2 scrn not prfrmd; Finding; Findings; H+P; H+P.PX; Nominal; O2; P prime; Point in time; Random; SaO2; SAT; Satn; Scn; SO2; tO2	4180186
43533723	CCHD SaO2 scrn not prfrmd	4180186
43533723	未进行 CCHD 氧饱和度筛查的原因:发现:时间点:^患者:名义型	4182948
43533726	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MCD; Mult; Multi; Nominal; Point in time; Random; WB; Whole blood	4180186
43533726	MCD DBS-Imp	4180186
43533726	多种羧化酶缺陷症:印象:时间点:全血.斑点:名义型	4182948
43533729	Fld; Fluid output NG-tube; IO_OUTPUT; IO_OUTPUT.MOLEC; Nasal tube; Point in time; QNT; Quan; Quant; Quantitative; Random; UGI; Up; Upr GI Tract; Volume	4180186
43533729	Fluid output NG-tube Measured	4180186
43533729	液体排出.鼻胃管:体积型属性:时间点:上消化道:定量型:测量法	4182948
43533731	Extracell fld Vol Measured	4180186
43533731	Extracell fld; Fld; H+P; H+P.PX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
43533731	细胞外液:体积型属性:时间点:^患者:定量型:测量法	4182948
43533735	Weed Allerg Mix209 IgE Qn	4180186
43533735	A artemisiifolia; A elatior; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Ambrosia artemisiifolia; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common ragweed; Giant Ragweed; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rw209; Serum; Short ragweed; SR; w001; w002; w003; w1; w2; w209; w3; Weed Allerg Mix209; West Ragweed; Western ragweed; wx209	4180186
43533735	(豚草+多年生豚草+三裂叶豚草) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533736	Food Allerg Mix18 IgE Qn	4180186
43533736	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f012; f013; f014; f12; f13; f14; Food Allerg Mix18; fx18; Gly; Green pea; Immune globulin E; Immunoglobulin E; Largest; Maximal; Maximum; Pea; Peak; Peanut; peas; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; SR	4180186
43533736	(落花生+大豆+豌豆) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533737	Food Allerg Mix70 IgE Qn	4180186
43533737	A dracunculus; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Esdragol; f272; f273; f274; f275; Food Allerg Mix B; Food Allerg Mix70; fx70; Immune globulin E; Immunoglobulin E; Lovage; Marjoram; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf272; Rf273; Rf274; Rf275; Serum; Spice mix; SR; Tarragon; Thyme	4180186
43533737	(龙蒿+拉维纪草+香花薄荷+普通百里香) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533738	Epid Allerg Mix72 IgE Qn	4180186
43533738	(虎皮鹦鹉羽毛+金丝雀羽毛+雀科鸣禽羽毛+长尾鹦鹉羽毛+鹦鹉羽毛) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533738	ABS; Aby; African Gray Parrot; African Grey Parrot; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie Feather; Dander; Domestic bird feathers; e196; e201; e213; e214; e78; e91; Epid Allerg Mix72; ex72; Feathers; Immune globulin E; Immunoglobulin E; Macaw; Point in time; QNT; Quan; Quant; Quantitative; Random; Re214; Serum; SR	4180186
43533739	Food Allerg Mix71 IgE Qn	4180186
43533739	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Caraway; Cardamon; Clove; Cloves; Dried arrillus; f265; f266; f267; f268; Food Allerg Mix71; fx71; Immune globulin E; Immunoglobulin E; Myristica fragrans; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf265; Rf266; Rf267; Rf268; Serum; SR	4180186
43533739	(葛缕子+小豆蔻+肉豆蔻衣+丁香) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533742	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Carrot; Cucumber; f031; f035; f214; f244; f31; f35; Food Allerg Mix19; fx19; Gherkin; Immune globulin E; Immunoglobulin E; Point in time; Potato; QNT; Quan; Quant; Quantitative; Random; Rfx19; Serum; Spinach; SR; White potato	4180186
43533742	Food Allerg Mix19 IgE Qn	4180186
43533742	(黄瓜+胡萝卜+马铃薯+菠菜) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533743	1,2-benzenedicarboxylic acid anhydride; 1,2-benzenedicarboxylic anhydride; 1,3-dioxophthalan; 1,3-isobenzofurandione; 1,3-phthalandione; 1,6-diisocyanatohexane; 1,6-hexamethylene diisocyanate; 1,6-hexanediol diisocyanate; 1,6-hexylene diisocyanate; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Anhydrid; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; HDI; Hexane 1,6-diisocyanate; HMDI; Immune globulin E; Immunoglobulin E; Isocyanate HDI; Isocyanate MDI; Isocyanate TDI; Isocyanates; k75; k76; k77; k79; Methyl bisphenyl isocyanate; Methylbenzene; Occup Allerg Mix5; PAN; pax5; Phthalandione; Point in time; Polymethylene polyphenyl isocyanate; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43533743	Occup Allerg Mix5 IgE Qn	4180186
43533743	(六亚甲基二异氰酸酯 (HDI)+异氰酸亚甲基二对苯酯 (MDI)+甲苯二异氰酸酯 (TDI)+邻苯二甲酸酐) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533744	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f014; f14; f431; Gly; Immune globulin E; Immunoglobulin E; Largest; M5; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; Soybean (nGly m) 5; SR	4180186
43533744	Soybean (nGly m) 5 IgE Qn	4180186
43533744	大豆 原生 (nGly m) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
43533747	Bile Ac Ur-sCnc	4180186
43533747	Acd; Acids; Bile acid.total; Bile salt; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533747	胆汁酸:物质的量浓度:时间点:尿液:定量型	4182948
43533751	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; LSD; Lysergic acid; Lysergic acid diethylamide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533751	LSD Hair Ql	4180186
43533751	麦角二乙胺:存在情况或阈值:时间点:毛发:序数型	4182948
43533752	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533752	Methadone Hair Ql	4180186
43533752	美沙酮:存在情况或阈值:时间点:毛发:序数型	4182948
43533757	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gen; Genital tract; Genital warts; HPV; HPV H risk 16; HPV26; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Urogenit; Urogenital	4180186
43533757	HPV H risk 16 DNA Genital Ql NAA+probe	4180186
43533757	人乳头瘤病毒 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 型 DNA:存在情况或阈值:时间点:生殖器:序数型:探针法.基因扩增.靶向	4182948
43533758	Bact; Bact biotype; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Typ	4180186
43533758	Bact biotype Islt	4180186
43533758	细菌生活型:类型:时间点:分离株:名义型	4182948
43533759	ACAD6; ACADVL mut anl; acyl-CoA dehydrogenase, very long chain; Blood; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Identity or presence; Inherited; LCACD; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; VLCAD; WB; Whole blood; Whole blood or Tissue	4180186
43533759	ACADVL Full Mut Anl Bld/T Seq	4180186
43533759	ACADVL 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
43533761	PLA2R IgG Ser IA-aCnc	4180186
43533761	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-PLA2R; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; k203; MEIA; Membranous Glomerulonephritis; Membranous Nephropathy; nApi m 1 Phospholipase A2, Bee; PLA2R; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Rk203; Serology; Serum; SR; SUDS	4180186
43533761	磷脂酶 A2 受体 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
43533762	NBS test results pnl - POC	4180186
43533762	Asympt; Asymptomatic; H+P; NBS test results pnl; New born; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Scn	4180186
43533762	新生儿筛查试验结果组套:-:时间点:^患者:-	4182948
43533764	Screen dur Ear-L	4180186
43533764	Asympt; Asymptomatic; Durat; Ear-L; H+P; H+P.PX; Hearing; L; LT; Otologic; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Screen dur	4180186
43533764	筛查持续时间:时间:时间点:耳.左侧:定量型	4182948
43533772	Apo B; ApoB; APOB R3500Q+R3500W; ApoB-100; apolipoprotein B; Apolipoprotein B gene; Autosomal dominant hypercholesterolemia; Blood; Familial defective apolipoprotein B-100; FDB; FLDB; Genetics; Heredity; Heritable; Identity or presence; Inherited; LDLCQ4; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; P prime; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533772	APOB R3500Q+R3500W Bld/T	4180186
43533772	APOB 基因.p.R3500Q 与 R3500W:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43533773	Blood; Chromosom; Chromosomes; Del; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533773	4p16.3 Del Bld/T FISH	4180186
43533773	4p16.3 染色体 缺失:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43533774	Amplification; Blood; Del; Del+Dup; Deletions; Dp; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Random; Retinoic acid induced 1; SMCR; SMS; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533774	RAI1 17p11.2 Del+Dup Bld/T FISH	4180186
43533774	RAI1 基因 17p11.2 缺失+重复:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43533778	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV C; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
43533778	AdV C DNA Nph Ql NAA+probe	4180186
43533778	腺病毒 C DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
43533779	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV B+E; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
43533779	AdV B+E DNA Nph Ql NAA+probe	4180186
43533779	腺病毒 B+E DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
43533780	Disch; Echography; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533781	Echography; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533784	Echography; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; Trial labor attempted; ULS; Ultrasound; US live birth	4180186
43533789	Echography; Finding; Findings; Mat; Maternal; Matnl; Ordinal; Planned deliver home; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533791	Echography; Finding; Findings; Ordinal; Placent; Placenta; Placntl; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US fetal death	4180186
43533795	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
43533796	Cnt; Count; Fatalities; No; Num; Num fetal deaths; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
43533798	Echography; Finding; Findings; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533803	Chromosome analysis; DS kryotpe stat; Echography; Finding; Findings; Genotype; Karyogram; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533804	Congen anomal nwbrn; Echography; Finding; Findings; New born; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533805	Echography; Finding; Findings; Mat morbidity; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533807	NSRAS total; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.NSRAS; Tot; Totl; Ulcer	4180186
43533810	Activ; Actvty; Finding; Findings; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS	4180186
43533813	Finding; Findings; Gen phys cond; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS	4180186
43533814	Integument; NSRAS pnl; Pan; PANEL.SURVEY.NSRAS; Panl; Pnl; Point in time; Random; Survey; SURVEY.NSRAS	4180186
43533816	Bld Postductal; Bld.foot; BldA.foot; Blood; Cardio; Cardiology; CARDIO-PULM; Finding; Findings; Heart Disease; Lung; Ordinal; Point in time; Postductal blood; PULMONARY; Pulmonology; PulseOx; Ql; Qual; Qualitative; Random; Respiratory; Screen; SpO2; WB; Whole blood	4180186
43533816	Signal quality Bld Postductal PulseOx	4180186
43533816	信号质量:发现:时间点:全血.导管后:序数型:脉搏血氧定量法	4182948
43533825	SaO2% Device SaO2% sens wrap name	4180186
43533825	Ident; Identifier; Nominal; O2; Point in time; Random; SaO2; SaO2% Device; SaO2% sens wrap name; SAT; Satn; SO2; tO2	4180186
43533825	氧饱和度传感器绑带名称:标识符:时间点:氧饱和度装置:名义型	4182948
43533826	Nominal; O2; Point in time; Random; SaO2; SaO2% Device; SaO2% sensor type; SAT; Satn; SO2; tO2; Typ	4180186
43533826	SaO2% Device SaO2% sensor type	4180186
43533826	氧饱和度传感器类型:类型:时间点:氧饱和度装置:名义型	4182948
43533827	SaO2% Device SaO2% sensor name	4180186
43533827	Ident; Identifier; Nominal; O2; Point in time; Random; SaO2; SaO2% Device; SaO2% sensor name; SAT; Satn; SO2; tO2	4180186
43533827	氧饱和度传感器名称:标识符:时间点:氧饱和度装置:名义型	4182948
43533830	B+T cell XM.auto Ser+Bld CDC-Imp	4180186
43533830	B 细胞+T 细胞交叉配型.自体:印象:时间点:血清+全血:序数型:补体依赖的细胞毒性试验	4182948
43533830	Autol; Autologus; B+T cell; B+T cell XM; B+T cell XM.auto; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; BLOOD BANK; Both serum and blood; CDC; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SerBld; Serum; Serum or whole blood; SR; T Cell XM; T prime; UCHL-1; WB; Whole blood	4180186
43533833	100 NK; Blood; CD3 Cells; CD3+CD16+ Cells; CD3+CD16+CD56+ Cells; CD3-CD16+ Cells; CD3-CD16+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; FCGR3A; Human Leukocyte Antigen; I3; Leu11; Leu-11; Leu11b; Leu-11B; Leu19; Leu-19; Leu4; Leu-4; Natural killer cells; NCAM; Neural cell adhesion molecule; NK activated; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
43533833	NK activated/100 NK NFr Bld FC	4180186
43533833	细胞.CD3-CD16+CD56+HLA-DR+/100 个细胞.CD3-CD16+CD56+:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
43533834	Echography; Est time fetal death; Finding; Findings; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US fetal death	4180186
43533835	abn; abnorm; Abnrml cond of nwbrn; Echography; Finding; Findings; New born; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533838	FDA insert Indexing - prod cncpt	4180186
43533838	DOCUMENT.REF; FDA insert; Indexing - prod cncpt; Narrative; Report; SPL; Structured Product Labelling	4180186
43533838	索引 - 产品概念:-:-:^FDA 包装说明书:叙述型	4182948
43533841	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Compx; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; HAT; Hep; Hepar; Heparin associated thrombycytopenia; Heparin dependent antibodies; Heparin induced thromocytopenia; Heparn; HIT; HITA; IAA; Immune globulin G; Immunoglobulin G; MEIA; Optical density; PF; PF4; PF4 heparin cmplx; PF4-heparin Ab; PI-factor 4; Pl; Plasma; Platelet Ab.heparin induced; Platelet type heparin inactivator; Platelets; Platelt; Plsm; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thrombocyte; Thrombocytes	4180186
43533841	PF4 heparin cmplx IgG SerPl IA	4180186
43533841	血小板因子 4 肝素复合物诱导型 抗体.IgG:光密度:时间点:血清/血浆:定量型:免疫测定法	4182948
43533843	EXT; Ext cephlc versn outcome; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
43533846	Addiction; BEC; BEG; Benz; Benzoylec; Benzoylmethylecgonine; Blood; BZE; Cocaine degradation production; Cocaine metabolite; Cocaine+BZE; Coke; Crack; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Snow; SR; WB; Whole blood	4180186
43533846	Cocaine+BZE SerPlBld Ql Scn	4180186
43533846	可卡因+苯甲酰芽子碱:存在情况或阈值:时间点:血清/血浆/全血:序数型:毒理学筛查试验	4182948
43533847	Chromosom; Chromosomes; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Ordinal; Patau syndrome; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Ts; Ts 13 risk	4180186
43533847	Fet Ts 13 risk Plas.cfDNA Ql	4180186
43533847	胎儿三体型 13 风险:印象:时间点:血浆.cfDNA:序数型:染色体特异性 cfDNA 剂量测定	4182948
43533851	Blood; Darkene; DRUG/TOXICOLOGY; Drugs; Hypnodorm; Hypnor; Level; Mass concentration; Narcozep; Noriel; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rohipnol; Rohypnol; Roipnol; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Valsera; WB; Whole blood	4180186
43533851	Flunitrazepam SerPlBld-mCnc	4180186
43533851	氟硝安定:质量浓度:时间点:血清/血浆/全血:定量型	4182948
43533853	H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
43533853	跌倒风险评估:印象:时间点:^患者:序数型	4182948
43533855	Adult depress scrn assess	4180186
43533855	Adult depress scrn assess; Asympt; Asymptomatic; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Scn; Screen	4180186
43533855	成年人抑郁筛查评估:印象:时间点:^患者:序数型	4182948
43533857	Anus; Bact; Bacteria.carbpm resist; C&S; Carbapenemase; carbapenem-resistant Enterobacteriaceae; carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; Cult; Cultures; Enterobacteriaceae; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Rectal specimen; Spec	4180186
43533857	Bacteria.carbpm resist Anal Cult	4180186
43533857	细菌.碳青酶烯类耐药性 已鉴定的:存在与否或特征标识:时间点:肛门:名义型:微生物特异性培养	4182948
43533858	Anus; B; Bact; Bacteria.ESBL; Betalactamase; B-Lactamase; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Rectal specimen; Resist; Resistanc; Resistant; Resistent; Spec	4180186
43533858	Bacteria.ESBL Anal Cult	4180186
43533858	细菌.超广谱 Beta 内酰胺酶耐药性:存在与否或特征标识:时间点:肛门:名义型:微生物特异性培养	4182948
43533860	A1; ABS; Aby; Alfa; Allergen; Allergens; ALLERGY TESTING; Alpha-Gal; Alpha-Gal Ab; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebrose; i; III; Immune globulin E; Immunoglobulin E; lone star tick; meat allergy; o215; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43533860	Alpha-Gal IgE Qn	4180186
43533860	半乳糖-alpha-1,3-半乳糖 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
43533864	TH-DC Ur-sCnc	4180186
43533864	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tetrahydro-11-deoxycortisol; TH-DC; UA; UR; Urn	4180186
43533864	四氢脱氧皮质醇:物质的量浓度:时间点:尿液:定量型	4182948
43533865	TH-DC 24h Ur-sCnc	4180186
43533865	1 day; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; tetrahydro-11-deoxycortisol; TH-DC; UA; UR; Urn	4180186
43533865	四氢脱氧皮质醇:物质的量浓度:24小时:尿液:定量型	4182948
43533868	1 day; 16 alphaOH-DHEA; 16A OH-DHEA; 16-Alpha hydroxy dehydroepiandrosterone; 16-alpha-hydroxy-DHEA; 24 hours; 24HR; Alfa; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533868	16A OH-DHEA 24h Ur-sRate	4180186
43533868	16-Alpha 羟-脱氢表雄甾酮:物质的量速率:24小时:尿液:定量型	4182948
43533869	1 day; 16 alphaOH-DHEA; 16A OH-DHEA; 16-Alpha hydroxy dehydroepiandrosterone; 16-alpha-hydroxy-DHEA; 24 hours; 24HR; Alfa; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533869	16A OH-DHEA 24h Ur-sCnc	4180186
43533869	16-Alpha 羟-脱氢表雄甾酮:物质的量浓度:24小时:尿液:定量型	4182948
43533870	1 day; 16-oxoandrostenediol; 24 hours; 24HR; 3 beta,17 beta-dihydroxyandrost-5-en-16-one; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533870	16-Ketoandrostenediol 24h Ur-sCnc	4180186
43533870	16-酮雄烯二醇:物质的量浓度:24小时:尿液:定量型	4182948
43533871	1 day; 16-oxoandrostenediol; 24 hours; 24HR; 3 beta,17 beta-dihydroxyandrost-5-en-16-one; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533871	16-Ketoandrostenediol 24h Ur-sRate	4180186
43533871	16-酮雄烯二醇:物质的量速率:24小时:尿液:定量型	4182948
43533873	GRA Ur-mCnc	4180186
43533873	B; Chemistry; GRA; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533873	18-Beta 甘草次酸:质量浓度:时间点:尿液:定量型	4182948
43533876	Aldost-18 G 24h Ur-sCnc	4180186
43533876	1 day; 24 hours; 24HR; Aldost-18 G; Aldosterone metabolite; Chemistry; Gluc; Glucouronide; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533876	醛固酮-18-葡糖苷酸:物质的量浓度:24小时:尿液:定量型	4182948
43533877	1 day; 24 hours; 24HR; Aldost-18 G; Aldosterone metabolite; Chemistry; Gluc; Glucouronide; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533877	Aldost-18 G 24h Ur-sRate	4180186
43533877	醛固酮-18-葡糖苷酸:物质的量速率:24小时:尿液:定量型	4182948
43533879	Allo-pregnanediol Ur-sCnc	4180186
43533879	5alpha-pregnane-3alpha-20alpha-diol; Chemistry; Level; Point in time; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533879	别-孕二醇:物质的量浓度:时间点:尿液:定量型	4182948
43533881	1 day; 24 hours; 24HR; 5alpha-pregnane-3alpha-20alpha-diol; Chemistry; Level; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533881	Allo-pregnanediol 24h Ur-sCnc	4180186
43533881	别-孕二醇:物质的量浓度:24小时:尿液:定量型	4182948
43533882	Allo-THB Ur-sCnc	4180186
43533882	5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; Allo-THB; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; THB; UA; UR; Urn	4180186
43533882	别-四氢皮质酮:物质的量浓度:时间点:尿液:定量型	4182948
43533884	Allo-THB 24h Ur-sRate	4180186
43533884	1 day; 24 hours; 24HR; 5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; Allo-THB; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; THB; UA; UR; Urn	4180186
43533884	别-四氢皮质酮:物质的量速率:24小时:尿液:定量型	4182948
43533886	Allo-THF Ur-sCnc	4180186
43533886	Allo THC; Allo-THF; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; THC; THF; UA; UR; Urn	4180186
43533886	别-四氢皮质醇:物质的量浓度:时间点:尿液:定量型	4182948
43533887	Allo-THF 24h Ur-sCnc	4180186
43533887	1 day; 24 hours; 24HR; Allo THC; Allo-THF; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; THC; THF; UA; UR; Urn	4180186
43533887	别-四氢皮质醇:物质的量浓度:24小时:尿液:定量型	4182948
43533888	Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines 3 Pnl; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; III; Level; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Substance concentration	4180186
43533888	Catecholamines 3 Pnl Plas-sCnc	4180186
43533888	儿茶酚胺类 3 项组套:物质的量浓度:时间点:血浆:-	4182948
43533895	A-cortolone 24h Ur-sCnc	4180186
43533895	1 day; 24 hours; 24HR; A-cortolone; Alfa; Chemistry; Cortisol metabolite; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533895	Alpha-皮酮四醇:物质的量浓度:24小时:尿液:定量型	4182948
43533896	1 day; 24 hours; 24HR; 5 androstene, 3beta, 7beta, 17beta triol; 5-androstene-3 beta-7 beta-17 beta-triol; 5-AT; AET; beta AET; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533896	AET 24h Ur-sCnc	4180186
43533896	雄烯三醇:物质的量浓度:24小时:尿液:定量型	4182948
43533898	5 androstene, 3beta, 7beta, 17beta triol; 5-androstene-3 beta-7 beta-17 beta-triol; 5-AT; AET; beta AET; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533898	AET Ur-sCnc	4180186
43533898	雄烯三醇:物质的量浓度:时间点:尿液:定量型	4182948
43533899	B-cortolone Ur-sCnc	4180186
43533899	B; B-cortolone; Chemistry; Cortisol metabolite; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533899	Beta-皮酮四醇:物质的量浓度:时间点:尿液:定量型	4182948
43533900	1 day; 24 hours; 24HR; B; B-cortolone; Chemistry; Cortisol metabolite; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533900	B-cortolone 24h Ur-sRate	4180186
43533900	Beta-皮酮四醇:物质的量速率:24小时:尿液:定量型	4182948
43533902	Catecholamines creat Pnl; Chemistry; CR; Crea; Creat; Creat Pnl; Metabolite; Metb; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UCr; UniversalLabOrders; UR; Urn	4180186
43533902	Catecholamines creat Pnl Ur	4180186
43533902	儿茶酚胺代谢产物与肌酐组套:-:时间点:尿液:-	4182948
43533903	1 day; 11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 24 hours; 24HR; c155; Chemistry; Compound E; Cortisone free; FR; Level; Non-protein bound; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533903	Cortisone free 24h Ur-sCnc	4180186
43533903	可的松.游离型:物质的量浓度:24小时:尿液:定量型	4182948
43533904	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; c155; Chemistry; Compound E; Cortisone free; FR; Level; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533904	Cortisone free Ur-sCnc	4180186
43533904	可的松.游离型:物质的量浓度:时间点:尿液:定量型	4182948
43533906	1 day; 24 hours; 24HR; Chemistry; Glycolic acid; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533906	Glycolate 24h Ur-sRate	4180186
43533906	羟乙酸:物质的量速率:24小时:尿液:定量型	4182948
43533907	Steroid Fract 24h Ur-Imp	4180186
43533907	1 day; 24 hours; 24HR; Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Report; UA; UR; Urn	4180186
43533907	类固醇类成分解释:印象:24小时:尿液:叙述型	4182948
43533910	1 day; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; THB; UA; UR; Urn	4180186
43533910	THB 24h Ur-sCnc	4180186
43533910	四氢皮质酮:物质的量浓度:24小时:尿液:定量型	4182948
43533911	1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; THB; UA; UR; Urn	4180186
43533911	THB 24h Ur-sRate	4180186
43533911	四氢皮质酮:物质的量速率:24小时:尿液:定量型	4182948
43533913	THF Ur-sCnc	4180186
43533913	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; THC; THF; UA; UR; Urn	4180186
43533913	四氢皮质醇:物质的量浓度:时间点:尿液:定量型	4182948
43533914	THF 24h Ur-sCnc	4180186
43533914	1 day; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; THC; THF; UA; UR; Urn	4180186
43533914	四氢皮质醇:物质的量浓度:24小时:尿液:定量型	4182948
43533915	THF 24h Ur-sRate	4180186
43533915	1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; THC; THF; UA; UR; Urn	4180186
43533915	四氢皮质醇:物质的量速率:24小时:尿液:定量型	4182948
43533918	Auto; Automated detection; Elec; Elect; Electr; Entitic substance; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43533918	Hgb EntSub Retic Auto	4180186
43533918	血红蛋白:实体物质的量:时间点:网织红细胞:定量型:自动化计数方法	4182948
43533921	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD57+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; FC; HNK1; Leu2; Leu-2; Leu4; Leu-4; Leu7; Leu-7; Lyme disease; Natural killer cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
43533921	CD3-CD8-CD57+ # Bld FC	4180186
43533921	细胞.CD3-CD8-CD57+:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
43533924	CD3-CD57+ Cells # Bld FC	4180186
43533924	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD57+ Cells; CD3-CD57+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; FC; HNK1; Leu4; Leu-4; Leu7; Leu-7; Lyme disease; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
43533924	细胞.CD3-CD57+:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
43533926	CD3-CD57+ Cells/lymph NFr Bld FC	4180186
43533926	Blood; CD3 Cells; CD3+CD57+ Cells; CD3-CD57+ Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HNK1; Leu4; Leu-4; Leu7; Leu-7; Lyme disease; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
43533926	细胞.CD3-CD57+/100 个淋巴细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
43533930	aIle; alloIle; Allo-isoleucine; Chemistry; CR; Crea; Creat; MSUD; MSUD (Maple Syrup Urine Disease); Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
43533930	Alloisoleucine/Creat Ur-Rto	4180186
43533930	别异亮氨酸/肌酐:比率:时间点:尿液:定量型	4182948
43533931	Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
43533931	D2-40 Ag Tiss Ql ImStn	4180186
43533931	D2-40 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
43533932	PAX8 Ag Tiss Ql ImStn	4180186
43533932	Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
43533932	PAX8 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
43533936	Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43533936	JWH-018 Ur Ql Cfm	4180186
43533936	JWH-018:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43533940	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43533940	JWH-073 Ur Ql Cfm	4180186
43533940	JWH-073:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43533941	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; MAM-2201 N-pentanoic acid metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533941	MAM-2201 pentanoate Bld Ql	4180186
43533941	MAM-2201 戊酸:存在情况或阈值:时间点:全血:序数型	4182948
43533942	1-pentyl-3-(1-naphthoyl)indole; Addiction; AM-678; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-018 4/5OH-pentyl; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533942	JWH-018 4/5OH-pentyl Bld Ql	4180186
43533942	JWH-018 4+5-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533944	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; RCS-4 5OH-pentyl; RCS-4 N-(5-hydroxypentyl) metabolite; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533944	RCS-4 5OH-pentyl Bld Ql	4180186
43533944	RCS-4 5-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533945	Addiction; AM-678; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-018 N-pentanoate metabolite; JWH-018 N-pentanoic acid metabolite; JWH-018 N-valeric metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533945	JWH-018 pentanoate Bld Ql	4180186
43533945	JWH-018 戊酸:存在情况或阈值:时间点:全血:序数型	4182948
43533946	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-200 4OH-indole; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533946	JWH-200 4OH-indole Bld Ql	4180186
43533946	JWH-200 4-羟基吲哚:存在情况或阈值:时间点:全血:序数型	4182948
43533947	Addiction; AM-2201 4OH-pentyl; AM-2201 N-(4-hydroxypentyl) metabolite; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; Synthetic marijuana; WB; Whole blood; Yucatan Fire	4180186
43533947	AM-2201 4OH-pentyl Bld Ql	4180186
43533947	AM-2201 4-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533951	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-250 N-(5-carboxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533951	JWH-250 5-carboxypentyl Bld Ql	4180186
43533951	JWH-250 5-羧戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533957	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Marijuana; Mass concentration; Nabilone; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; THC; WB; Whole blood	4180186
43533957	THC SerPlBld Cfm-mCnc	4180186
43533957	四氢大麻酚:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
43533959	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43533959	Norfentanyl Bld Cfm-mCnc	4180186
43533959	去甲基芬太尼:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43533963	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; 6MAM Free; Acetylmorphine; Blood; DRUG/TOXICOLOGY; Drugs; FR; Heroin metabolite; Level; MAM; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43533963	6MAM Free Bld-mCnc	4180186
43533963	6-单乙酰吗啡.游离型:质量浓度:时间点:全血:定量型	4182948
43533964	Addiction; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; Illicit; Norspan; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn; Suboxone; Subutex; Temgesic	4180186
43533964	Buprenorphine Sal Ql Scn	4180186
43533964	丁丙诺啡:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
43533965	Addiction; Blood; Cannabinoid; Cannabinoids synthetic; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; THC; WB; Whole blood	4180186
43533965	Cannabinoids synthetic Bld Ql	4180186
43533965	大麻类.合成型:存在情况或阈值:时间点:全血:序数型	4182948
43533966	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533966	MAM-2201 Bld Ql	4180186
43533966	MAM-2201:存在情况或阈值:时间点:全血:序数型	4182948
43533969	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533969	JWH-398 Bld Ql	4180186
43533969	JWH-398:存在情况或阈值:时间点:全血:序数型	4182948
43533971	Addiction; AM-678; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533971	JWH-018 Bld Ql	4180186
43533971	JWH-018:存在情况或阈值:时间点:全血:序数型	4182948
43533974	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533974	AM-2201 Bld Ql	4180186
43533974	AM-2201:存在情况或阈值:时间点:全血:序数型	4182948
43533975	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533975	JWH-073 Bld Ql	4180186
43533975	JWH-073:存在情况或阈值:时间点:全血:序数型	4182948
43533976	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-398 5OH-pentyl; JWH-398 N-(5 hydroxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533976	JWH-398 5OH-pentyl Bld Ql	4180186
43533976	JWH-398 5-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533977	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UR-144 4/5OH-pentyl; UR-144 N-(4/5-hydroxypentyl) metabolites; UR-144 N-pentanoic acid metabolite; WB; Whole blood; Yucatan Fire	4180186
43533977	UR-144 4/5OH-pentyl Bld Ql	4180186
43533977	UR-144 4+5-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533978	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-122 5OH-pentyl; JWH-122 N-(5-hydroxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533978	JWH-122 5OH-pentyl Bld Ql	4180186
43533978	JWH-122 5-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533979	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UR-144 N-pentanoic acid metabolite; WB; Whole blood; Yucatan Fire	4180186
43533979	UR-144 pentanoate Bld Ql	4180186
43533979	UR-144 戊酸:存在情况或阈值:时间点:全血:序数型	4182948
43533980	Cholest Est DBS-cCnc	4180186
43533980	Acid lipase; Blood; Catalytic Concentration; CE; Chemistry; Chol; Choles; Cholest; Cholest Est; Cholesterol total; Cholesterols; DBS; Dried blood spot; Filter paper; FP; Lipid; lysosomal acid lipase; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Wolman/cholesterol ester storage disease	4180186
43533980	胆固醇酯酶:催化浓度:时间点:全血.斑点:定量型	4182948
43533981	Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV H Risk 12; HPV16; HPV16 and 18; HPV16+18; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Papilloma virus high risk; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
43533981	HPV H Risk 12 DNA Tiss Ql Probe	4180186
43533981	人乳头瘤病毒 16+18+31+33+35+39+45+51+52+56+58+66 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:DNA探针	4182948
43533982	Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Oral; Point in time; Random	4180186
43533982	Bacteria Mouth Cult	4180186
43533982	细菌 已鉴定的:存在与否或特征标识:时间点:口:名义型:培养	4182948
43533984	Bld Pos; Blood; Cand; Candidiasis; Fluorescent in situ hybridization; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Monilia; Nominal; Point in time; Random; ribosomal RNA; species; spp; Thrush; WB; Whole blood	4180186
43533984	Candida rRNA Bld Pos FISH	4180186
43533984	假丝酵母属单个未知种 rRNA:存在与否或特征标识:时间点:血液.生长阳性:名义型:FISH	4182948
43533985	Bld Pos; Blood; E faecalis; E faecalis+othr E sp; E faecalis+othr E sp rRNA; Fluorescent in situ hybridization; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Othr; Point in time; Random; ribosomal RNA; species; spp; WB; Whole blood	4180186
43533985	E faecalis+othr E sp rRNA Bld Pos FISH	4180186
43533985	粪肠球菌与其他肠球菌单个未知种 rRNA:存在与否或特征标识:时间点:血液.生长阳性:名义型:FISH	4182948
43533986	Body muscle Calc	4180186
43533986	bod; Bodies; BODY WEIGHT.MOLEC; Calc; Calculation; Musc; Muscl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43533986	身体肌肉质量:质量:时间点:^患者:定量型:计算法	4182948
43533987	Body muscle/BW MFr Measured	4180186
43533987	Bdy weight; bod; Bodies; body muscle percentage; BODY WEIGHT.MOLEC; BW; Mass Fraction; Musc; Muscl; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
43533987	身体肌肉质量/体重:质量分数:时间点:^患者:定量型:测量法	4182948
43533991	Chromosom; Chromosomes; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Patau syndrome; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Spec; Ts; Ts 13 risk	4180186
43533991	Fet Ts 13 risk Plas.cfDNA Qn	4180186
43533991	胎儿三体型 13 风险:似然性:时间点:血浆.cfDNA:定量型:染色体特异性 cfDNA 剂量测定	4182948
43533995	Addiction; Blood; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite; WB; Whole blood	4180186
43533995	O-nortramadol Bld-mCnc	4180186
43533995	O-去甲基曲马多:质量浓度:时间点:全血:定量型	4182948
43533998	CD158b cells; Cell; CELL MARKERS; Cellularity; Gated cells; Killer cell Immunoglobulin-like Recptor; KIR family; KIR2DL3; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
43533998	CD158b cells NFr Spec	4180186
43533998	细胞.CD158b/100 个细胞:计数型分数:时间点:XXX:定量型	4182948
43534000	Activ; Actvty; Arbitrary concentration; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; MEIA; Movements; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; Von will; Vonwillebrand; vWf; vWf:Ac	4180186
43534000	vWf:Ac PPP IA-aCnc	4180186
43534000	von Willebrand 因子.活性:任意型浓度:时间点:贫血小板血浆:定量型:免疫测定法	4182948
43534001	KLH; KLH Ab Pnl; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534001	KLH Ab Pnl SerPl	4180186
43534001	钥孔戚血蓝蛋白抗体组套:-:时间点:血清/血浆:-	4182948
43534003	Bil; Bilat; Both; Cardio; Cardiology; Document; DOP; DUPLEX; Echography; EXT; Extr aa-Bl; Extr-Bl; Finding; Findings; Heart Disease; Imaging; Phys stdy; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound	4180186
43534003	DOP Extr aa-Bl Phys stdy	4180186
43534003	针对生理学动脉检查的多层:发现:时间点:肢体.双侧>肢体动脉类:文档型:超声.多普勒	4182948
43534005	Bil; Bilat; Both; Cardio; Cardiology; Document; DOP; DUPLEX; Echography; EXCZ; EXT; Extr aa-Bl; Extr-Bl; Finding; Findings; Heart Disease; Imaging; Phys stdy; Point in time; Radiology; Random; Rest+excz; Resting; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound	4180186
43534005	DOP Extr aa-Bl Phys stdy Rest+excz	4180186
43534005	针对生理学动脉检查的多层^静止状态+采用运动:发现:时间点:肢体.双侧>肢体动脉类:文档型:超声.多普勒	4182948
43534006	ANTIBIOTIC SUSCEPTIBILITIES; CMV; CMV UL97 gene; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Mut; Mut Det; Mutation; Muts; Nominal; Point in time; Random	4180186
43534006	CMV UL97 gene Mut Det Islt	4180186
43534006	巨细胞病毒 UL97 基因 已检出的突变:存在与否或特征标识:时间点:分离株:名义型	4182948
43534007	ANTIBIOTIC SUSCEPTIBILITIES; AST; FOS; Foscavir; ID; Infectious Disease; InfectiousDisease; Islt; Isol; PFA; Pheno; Phenotype; Phenotypic; Phosphonoformic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
43534007	Foscarnet Islt Phenotyp	4180186
43534007	膦甲酸:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
43534008	Raltegravir SerPl-mCnc	4180186
43534008	DRUG/TOXICOLOGY; Drugs; Isentress; Level; Mass concentration; MK-0518; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534008	雷特拉韦:质量浓度:时间点:血清/血浆:定量型	4182948
43534009	ANTIBIOTIC SUSCEPTIBILITIES; Bact; c162; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; VANC; Vancocin; Vancomycin resistance gene; Vancor	4180186
43534009	vanC2+vanC3 Islt/Spm Ql	4180186
43534009	细菌万古霉素耐药 vanC2+vanC3 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534011	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
43534011	HSV DNA Spec NAA+probe	4180186
43534011	单纯疱疹病毒 DNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
43534012	ANTIBIOTIC SUSCEPTIBILITIES; AST; Famvir; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43534012	Famciclovir Islt Genotyp	4180186
43534012	泛昔洛韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534013	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 250; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534013	HBV 250 Islt Genotyp	4180186
43534013	乙型肝炎病毒 密码子 250:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534014	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 237; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534014	HBV 237 Islt Genotyp	4180186
43534014	乙型肝炎病毒 密码子 237:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534016	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 215; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534016	HBV 215 Islt Genotyp	4180186
43534016	乙型肝炎病毒 密码子 215:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534017	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 214; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534017	HBV 214 Islt Genotyp	4180186
43534017	乙型肝炎病毒 密码子 214:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534021	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 184; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534021	HBV 184 Islt Genotyp	4180186
43534021	乙型肝炎病毒 密码子 184:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534023	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 85; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534023	HBV 85 Islt Genotyp	4180186
43534023	乙型肝炎病毒 密码子 85:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534024	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 84; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534024	HBV 84 Islt Genotyp	4180186
43534024	乙型肝炎病毒 密码子 84:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534028	ANTIBIOTIC SUSCEPTIBILITIES; AST; CDV; HPMPC; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Pheno; Phenotype; Phenotypic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype; Vistide	4180186
43534028	Cidofovir Islt Phenotyp	4180186
43534028	西多福韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
43534038	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M tuberculosis; Molecular genetics; Mtb; MTB ethB ethion res mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; TB; Trecator; Tuberculosis	4180186
43534038	MTB ethB ethion res mut Islt/Spm Ql	4180186
43534038	结核分枝杆菌 ethB 基因乙硫异烟胺耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534043	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; c301; Hansen Disease; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M leprae rpoB RIF res mut; Molecular genetics; Mut; Mutations; Myco; Mycobact; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; RIF; Rifadin; Rifampicin; Rimactane; Screen; Spec; Tuberculosis	4180186
43534043	M leprae rpoB RIF res mut Islt/Spm Ql	4180186
43534043	麻风分枝杆菌 rpoB 基因利福平耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534046	17-beta estradiol; Chemistry; E2; Gyn; Gynecology; HS; Level; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43534046	Estradiol SerPl HS-sCnc	4180186
43534046	雌二醇:物质的量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
43534052	Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Genetics; Heredity; Heritable; HLUG4; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 2 family, polypeptide B15; UDPGT 2B8; UDPGT2B15; UDPGTH3; UGT2B15 gene prod met act imp; UGT2B8; WB; Whole blood; Whole blood or Tissue	4180186
43534052	UGT2B15 gene prod met act imp Bld/T-Imp	4180186
43534052	UGT2B15 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
43534053	Bld/T/S; Blood; CPCJ; CYP2C; CYPIIC17; CYPIIC19; cytochrome P-450 II C; cytochrome P450, family 2, subfamily C, polypeptide 19; drg metab interp; Drug metab analysis interp; Drugs; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P450C2C; P450IIC19; PCR; Point in time; predicted phenotype; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534053	Deprecated CYP2C19 drg metab interp Bld/T/S-Imp	4180186
43534058	Blood; CP12; CYP1A2 allele; cytochrome P450, family 1, subfamily A, polypeptide 2; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P3-450; P450(PA); PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534058	CYP1A2 allele Geno Bld/T	4180186
43534058	CYP1A2 基因等位基因:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43534061	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; S aureus; Screen; SDA; Smell; Staficyn; Staph; Staphicillin; Staphylococcus cassette chromosome (SCCmec); Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
43534061	SCCmec Nose Ql NAA+probe	4180186
43534061	金黄色葡萄球菌甲氧西林耐药 SCCmec:存在情况或阈值:时间点:鼻:序数型:探针法.基因扩增.靶向	4182948
43534064	Progest Free/Total MFr SerPl	4180186
43534064	Chemistry; FR; Mass fraction; Non-protein bound; P4; Percent; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progest Free; Progestin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43534064	孕酮.游离型/孕酮.总计:质量分数:时间点:血清/血浆:定量型	4182948
43534067	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Doribax; Finibax; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43534067	Doripenem Islt KB	4180186
43534067	多尼培南:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43534071	Xanthine Ur-sCnc	4180186
43534071	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43534071	黄嘌呤:物质的量浓度:时间点:尿液:定量型	4182948
43534074	Insulin 3h p 75 g Glc PO SerPl-sCnc	4180186
43534074	3h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
43534074	胰岛素^在口服75 g葡萄糖之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
43534078	Addiction; Blood; c700; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Formic acid; Illicit; Level; methanoate; methanoic acid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43534078	Formate Bld-sCnc	4180186
43534078	甲酸:物质的量浓度:时间点:全血:定量型	4182948
43534080	HNA Ab pnl SerPl	4180186
43534080	HNA Ab pnl; Human Neutrophil Antigen; Human Neutrophil Antigens; Pan; PANEL.HNA; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534080	HNA 抗体组套:-:时间点:血清/血浆:-	4182948
43534083	Drug induced neutrophil Ab pnl SerPl	4180186
43534083	Drug induced neutrophil Ab pnl; Drugs; Granulocytic Ab; Neut; Neutr; Neutrophils; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; PMN; Pnl; PNM; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534083	药物诱导型嗜中性粒细胞抗体组套:-:时间点:血清/血浆:-	4182948
43534084	HNA 4a/4b Ab Ser Ql IA	4180186
43534084	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HNA 4a/4b; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534084	HNA 4a-4b 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534087	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CD177; EIA; ELFA; ELISA; Enzyme immunoassay; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; II; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534087	HNA 2 Ab Ser Ql IA	4180186
43534087	HNA 2 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534088	HNA 1c Ab Ser Ql IA	4180186
43534088	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534088	HNA 1c 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534089	HNA 1a/1b Ab Ser Ql IA	4180186
43534089	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HNA 1a/1b; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534089	HNA 1a-1b 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534090	HNA 1b/1b Ab Ser Ql IA	4180186
43534090	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HNA 1b/1b; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534090	HNA 1b-1b 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534095	Blood; CD16; Gentyp; Human Neutrophil Antigen; Human Neutrophil Antigens; i; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
43534095	HNA 1 Gentyp Bld	4180186
43534095	HNA 1 基因型:类型:时间点:全血:名义型	4182948
43534097	Identity or presence; Joint aspirate; Joint fld; Joint flu; Joint fluid; Nominal; Point in time; Random; SF; SNV; Spec; Srce; Syn; Syn fl; Synov; Synovial fluid	4180186
43534097	Specimen source Snv	4180186
43534097	标本来源:存在与否或特征标识:时间点:滑液:名义型	4182948
43534100	Urea BldV-sCnc	4180186
43534100	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous	4180186
43534100	尿素:物质的量浓度:时间点:静脉全血:定量型	4182948
43534103	(neut) Ab; (neut) IgM; 4-Hydroxycoumarin; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coumadin; Coumarin; Coumarins; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Panwarfin; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sofarin; SR	4180186
43534103	Warfarin (neut) IgM SerPl Ql FC	4180186
43534103	丙酮苄羟香豆素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534104	(neut) Ab; (neut) IgG; 4-Hydroxycoumarin; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coumadin; Coumarin; Coumarins; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Panwarfin; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sofarin; SR	4180186
43534104	Warfarin (neut) IgG SerPl Ql FC	4180186
43534104	丙酮苄羟香豆素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534105	Venlafaxine (neut) IgM SerPl Ql FC	4180186
43534105	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Efexor; Effexor; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Venlafaxin	4180186
43534105	文拉法辛 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534106	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Efexor; Effexor; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Venlafaxin	4180186
43534106	Venlafaxine (neut) IgG SerPl Ql FC	4180186
43534106	文拉法辛 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534108	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c162; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VANC; Vancocin; Vancor	4180186
43534108	Vancomycin (neut) IgG SerPl Ql FC	4180186
43534108	万古霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534109	Valproate (neut) IgM SerPl Ql FC	4180186
43534109	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Depakene; Divalproex; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VALP; Valproic acid	4180186
43534109	2-丙基戊酸 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534110	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Depakene; Divalproex; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VALP; Valproic acid	4180186
43534110	Valproate (neut) IgG SerPl Ql FC	4180186
43534110	2-丙基戊酸 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534111	Trimethoprim (neut) IgM SerPl Ql FC	4180186
43534111	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c202; c242; C62; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; Polytrim; PR; Primsol; Proloprim; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TMP; Trimeth; Trimpex	4180186
43534111	三甲氧苄二氨嘧啶 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534112	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c202; c242; C62; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; Polytrim; PR; Primsol; Proloprim; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TMP; Trimeth; Trimpex	4180186
43534112	Trimethoprim (neut) IgG SerPl Ql FC	4180186
43534112	三甲氧苄二氨嘧啶 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534113	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Atracurium besylate; Autoantibodies; Autoantibody; C12H21NO8S; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Lennox-Gastaut syndrome; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Qudexy XR; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Topamax; Toprimate; Tracrium; Trokendi XR	4180186
43534113	Topiramate (neut) IgM SerPl Ql FC	4180186
43534113	托吡酯 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534114	Topiramate (neut) IgG SerPl Ql FC	4180186
43534114	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Atracurium besylate; Autoantibodies; Autoantibody; C12H21NO8S; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Lennox-Gastaut syndrome; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Qudexy XR; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Topamax; Toprimate; Tracrium; Trokendi XR	4180186
43534114	托吡酯 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534116	Terazosin (neut) IgG SerPl Ql FC	4180186
43534116	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Hytrin; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534116	特拉唑嗪 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534117	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazobac	4180186
43534117	Tazobactam (neut) IgM SerPl Ql FC	4180186
43534117	他唑巴坦 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534118	Tazobactam (neut) IgG SerPl Ql FC	4180186
43534118	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazobac	4180186
43534118	他唑巴坦 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534120	Tacrolimus (neut) IgG SerPl Ql FC	4180186
43534120	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; FK506; FK-506; Fujimycin; Granulocytic Ab; Hecoria; Immune globulin G; Immunoglobulin G; L04AD02; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prograf; Protopic; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534120	他克莫司 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534121	(neut) Ab; (neut) IgM; ABS; Aby; Acetylsulfamethoxazole; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c223; C61; Dynamic; FC; Gantanol; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SMX; SR; Sulfa; Sulfamethox	4180186
43534121	Sulfamethoxazole (neut) IgM SerPl Ql FC	4180186
43534121	磺胺甲噁唑 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534123	Spironolactone (neut) IgM SerPl Ql FC	4180186
43534123	(neut) Ab; (neut) IgM; ABS; Aby; Aldactone; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Novospiroton; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534123	螺内酯 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534125	Simvastatin (neut) IgM SerPl Ql FC	4180186
43534125	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zocor	4180186
43534125	辛伐他汀 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534128	Sildenafil cit (neut) IgG SerPl Ql FC	4180186
43534128	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Citric acid; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Revatio; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viagra	4180186
43534128	枸橼酸西地那非 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534135	Ramipril (neut) IgM SerPl Ql FC	4180186
43534135	(neut) Ab; (neut) IgM; ABS; Aby; Altace; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534135	雷米普利 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534139	quiNIDine (neut) IgM SerPl Ql FC	4180186
43534139	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chinidine; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534139	奎尼丁 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534141	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Ketipinor; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xeroquel	4180186
43534141	QUEtiapine (neut) IgM SerPl Ql FC	4180186
43534141	喹硫平 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534143	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Piper; PIPJ; Pipracil; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534143	Piperacillin (neut) IgM SerPl Ql FC	4180186
43534143	氧哌嗪青霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534146	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; Dynamic; Epanutin; FC; Fenantoin; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Lehydan; Neut; Neutr; Neutrophils; Ordinal; Phenhydan; PHYT; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Zentropil	4180186
43534146	Phenytoin (neut) IgG SerPl Ql FC	4180186
43534146	苯妥英 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534149	Penicillin (neut) IgM SerPl Ql FC	4180186
43534149	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; PCN; Pen; Penicilloyl; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wycillin	4180186
43534149	青霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534152	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Paxil; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534152	PARoxetine (neut) IgG SerPl Ql FC	4180186
43534152	帕罗西汀 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534153	Pantoprazole (neut) IgM SerPl Ql FC	4180186
43534153	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Protonix; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534153	泮托拉唑 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534159	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cellcept; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534159	Mycophenolate (neut) IgM SerPl Ql FC	4180186
43534159	吗替麦考酚酯 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534160	Mycophenolate (neut) IgG SerPl Ql FC	4180186
43534160	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cellcept; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534160	吗替麦考酚酯 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534162	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Monteflo; Montelo-10; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Singulair; SR	4180186
43534162	Montelukast (neut) IgG SerPl Ql FC	4180186
43534162	孟鲁司特 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534163	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; LO; Lopressor; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534163	Metoprolol (neut) IgM SerPl Ql FC	4180186
43534163	美多洛尔 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534166	Metoclopramide (neut) IgG SerPl Ql FC	4180186
43534166	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Reglan; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534166	灭吐灵 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534167	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Me-phenidate; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Ritalin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534167	Me-phenidate (neut) IgM SerPl Ql FC	4180186
43534167	哌甲酯 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534168	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Me-phenidate; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Ritalin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534168	Me-phenidate (neut) IgG SerPl Ql FC	4180186
43534168	哌甲酯 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534169	metFORMIN (neut) IgM SerPl Ql FC	4180186
43534169	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Glucophage; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534169	二甲双胍 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534170	metFORMIN (neut) IgG SerPl Ql FC	4180186
43534170	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Glucophage; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534170	二甲双胍 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534174	Loratadine (neut) IgG SerPl Ql FC	4180186
43534174	(neut) Ab; (neut) IgG; ABS; Aby; Alavert; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Claritin; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534174	氯雷他定 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534175	Lisinopril (neut) IgM SerPl Ql FC	4180186
43534175	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prinivil; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tensopril	4180186
43534175	赖诺普利 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534177	levoFLOXacin (neut) IgM SerPl Ql FC	4180186
43534177	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534177	左氧氟沙星 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534178	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534178	levoFLOXacin (neut) IgG SerPl Ql FC	4180186
43534178	左氧氟沙星 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534180	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Keppra; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534180	levETIRAcetam (neut) IgG SerPl Ql FC	4180186
43534180	左乙拉西坦 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534183	(neut) Ab; (neut) IgM; ABS; Aby; Advil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c20; c235; c286; C53; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Motrin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534183	Ibuprofen (neut) IgM SerPl Ql FC	4180186
43534183	对异丁基苯异丙酸 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534184	Ibuprofen (neut) IgG SerPl Ql FC	4180186
43534184	(neut) Ab; (neut) IgG; ABS; Aby; Advil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c20; c235; c286; C53; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Motrin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534184	对异丁基苯异丙酸 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534187	Gentamicin (neut) IgM SerPl Ql FC	4180186
43534187	(neut) Ab; (neut) IgM; ABS; Aby; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c213; Dynamic; FC; Garamycin; Genirr; Genj; Gent; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534187	庆大霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534188	Gentamicin (neut) IgG SerPl Ql FC	4180186
43534188	(neut) Ab; (neut) IgG; ABS; Aby; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c213; Dynamic; FC; Garamycin; Genirr; Genj; Gent; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534188	庆大霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534189	Gabapentin (neut) IgM SerPl Ql FC	4180186
43534189	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Horizant; Immune globulin M; Immunoglobulin M; Neurontin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534189	加巴喷丁 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534191	Furosemide (neut) IgM SerPl Ql FC	4180186
43534191	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c210; Dynamic; FC; Furj; Granulocytic Ab; Immune globulin M; Immunoglobulin M; LASIX; LASJ; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534191	呋塞米 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534192	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c210; Dynamic; FC; Furj; Granulocytic Ab; Immune globulin G; Immunoglobulin G; LASIX; LASJ; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534192	Furosemide (neut) IgG SerPl Ql FC	4180186
43534192	呋塞米 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534193	Fluconazole (neut) IgM SerPl Ql FC	4180186
43534193	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Diflucan; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534193	氟康唑 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534194	Fluconazole (neut) IgG SerPl Ql FC	4180186
43534194	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Diflucan; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534194	氟康唑 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534199	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cipralex; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Lexamil; Lexapro; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534199	Escitalopram (neut) IgM SerPl Ql FC	4180186
43534199	右旋西酞普兰 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534204	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plavix; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534204	Clopidogrel (neut) IgG SerPl Ql FC	4180186
43534204	氯吡格雷 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534205	cloNIDine (neut) IgM SerPl Ql FC	4180186
43534205	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Catapres; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534205	可乐定 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534206	cloNIDine (neut) IgG SerPl Ql FC	4180186
43534206	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Catapres; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534206	可乐定 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534207	Clindamycin (neut) IgM SerPl Ql FC	4180186
43534207	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c306; Cleocin; CLIJ; Clindamycin.induced; Dalacin; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sobelin; SR; Topical	4180186
43534207	氯洁霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534210	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celexa; Cipramil; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534210	Citalopram (neut) IgG SerPl Ql FC	4180186
43534210	西酞普兰 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534211	Ciprofloxacin (neut) IgM SerPl Ql FC	4180186
43534211	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534211	环丙沙星 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534212	Ciprofloxacin (neut) IgG SerPl Ql FC	4180186
43534212	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534212	环丙沙星 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534214	Celecoxib (neut) IgG SerPl Ql FC	4180186
43534214	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celebrex; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534214	塞来昔布 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534222	ceFAZolin (neut) IgG SerPl Ql FC	4180186
43534222	(neut) Ab; (neut) IgG; ABS; Aby; Ancef; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C32; Cefamezin; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Kefj; Kefzol; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Totacef; Zolicef	4180186
43534222	头孢唑林 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534223	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carbamazapine; Carbamezapine; Carbazepine; CRBM; Dynamic; Epitol; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril	4180186
43534223	carBAMazepine (neut) IgM SerPl Ql FC	4180186
43534223	卡马西平 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534225	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wellbutrin; Zyban	4180186
43534225	buPROPion (neut) IgM SerPl Ql FC	4180186
43534225	丁氨苯丙酮 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534228	Atorvastatin (neut) IgG SerPl Ql FC	4180186
43534228	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Lipitor; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534228	阿托伐他汀 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534230	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tenormin	4180186
43534230	Atenolol (neut) IgG SerPl Ql FC	4180186
43534230	氨酰心安 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534231	Acetylsalicylate (neut) IgM SerPl Ql FC	4180186
43534231	(neut) Ab; (neut) IgM; ABS; Aby; Acetylsalicylic acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; c207; c217; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534231	乙酰水杨酸 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534232	Acetylsalicylate (neut) IgG SerPl Ql FC	4180186
43534232	(neut) Ab; (neut) IgG; ABS; Aby; Acetylsalicylic acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; c207; c217; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534232	乙酰水杨酸 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534233	(neut) Ab; (neut) IgM; ABS; Aby; Amcil; Amicil; Amp; Ampicilloyl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c5; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Omnipen; Ordinal; Penbritin; Pl; Plasma; Plsm; PMN; PNM; Point in time; Polycillin; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534233	Ampicillin (neut) IgM SerPl Ql FC	4180186
43534233	氨苄青霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534234	Ampicillin (neut) IgG SerPl Ql FC	4180186
43534234	(neut) Ab; (neut) IgG; ABS; Aby; Amcil; Amicil; Amp; Ampicilloyl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c5; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Omnipen; Ordinal; Penbritin; Pl; Plasma; Plsm; PMN; PNM; Point in time; Polycillin; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534234	氨苄青霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534235	Amoxicillin (neut) IgM SerPl Ql FC	4180186
43534235	(neut) Ab; (neut) IgM; ABS; Aby; Amox; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bristamox; c204; c6; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Larotid; Moxalin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; Polymox; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sumox; Trimox; Wymox	4180186
43534235	羟氨苄青霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534240	(neut) Ab; (neut) IgG; ABS; Aby; Amit; Amitrip; Amitriptylene; Amitriptyln; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Elatrol; Elavil; Endep; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trepiline; Tryptanol; Tryptizol	4180186
43534240	Amitrip (neut) IgG SerPl Ql FC	4180186
43534240	阿米替林 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534241	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cordarone; Dynamic; Esoteric; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pacerone; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534241	Amiodarone (neut) IgM SerPl Ql FC	4180186
43534241	胺碘酮 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534242	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cordarone; Dynamic; Esoteric; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pacerone; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534242	Amiodarone (neut) IgG SerPl Ql FC	4180186
43534242	胺碘酮 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534245	(neut) Ab; (neut) IgM; ABS; Aby; Alendronic acid; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Fosamax; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534245	Alendronate (neut) IgM SerPl Ql FC	4180186
43534245	阿仑膦酸盐 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534246	(neut) Ab; (neut) IgG; ABS; Aby; Alendronic acid; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Fosamax; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534246	Alendronate (neut) IgG SerPl Ql FC	4180186
43534246	阿仑膦酸盐 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534249	(neut) Ab; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Drugs; Dynamic; FC; Granulocytic Ab; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Neut; Neutr; Neutrophils; Pl; Plasma; Plsm; PMN; PNM; Point in time; Random; Report; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534249	Drug (neut) Ab SerPl FC-Imp	4180186
43534249	药物 诱导型嗜中性粒细胞抗体:印象:时间点:血清/血浆:叙述型:流式细胞测量术	4182948
43534250	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534250	Neutrophil IgM SerPl Ql FC	4180186
43534250	嗜中性粒细胞 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534254	Voriconazole ind plt IgM SerPl Ql FC	4180186
43534254	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vfend	4180186
43534254	伏立康唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534255	Voriconazole ind plt IgG SerPl Ql FC	4180186
43534255	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vfend	4180186
43534255	伏立康唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534257	ABS; Aby; Antby; Anti; Antibodies; Antibody; APO-TRIMIP; Autoantibodies; Autoantibody; Calan; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Isoptin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534257	Verapamil ind plt IgG SerPl Ql FC	4180186
43534257	维拉帕米 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534258	Venlafaxine ind plt IgM SerPl Ql FC	4180186
43534258	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Efexor; Effexor; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Venlafaxin	4180186
43534258	文拉法辛 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534262	ABS; Aby; Angiotan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Diovan; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534262	Valsartan ind plt IgG SerPl Ql FC	4180186
43534262	缬沙坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534265	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Depakene; Divalproex; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; VALP; Valproic acid	4180186
43534265	Valproate ind plt IgG SerPl Ql FC	4180186
43534265	2-丙基戊酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534268	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bextra; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534268	Valdecoxib ind plt IgG SerPl Ql FC	4180186
43534268	戊地昔布 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534269	Valdecoxib ind plt IgM SerPl Ql FC	4180186
43534269	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bextra; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534269	戊地昔布 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534273	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; UDC; UDCA; Ursodeoxycholic acid; Ursodiol	4180186
43534273	Ursodeoxycholate ind plt IgM SerPl Ql FC	4180186
43534273	熊去氧胆酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534274	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c202; c242; C62; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polytrim; PR; Primsol; Proloprim; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; TMP; Trimeth; Trimpex	4180186
43534274	Trimethoprim ind plt IgG SerPl Ql FC	4180186
43534274	三甲氧苄二氨嘧啶 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534275	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c202; c242; C62; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polytrim; PR; Primsol; Proloprim; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; TMP; Trimeth; Trimpex	4180186
43534275	Trimethoprim ind plt IgM SerPl Ql FC	4180186
43534275	三甲氧苄二氨嘧啶 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534278	Triamterene ind plt IgG SerPl Ql FC	4180186
43534278	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Dyrenium; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534278	氨苯蝶啶 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534279	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Dyrenium; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534279	Triamterene ind plt IgM SerPl Ql FC	4180186
43534279	氨苯蝶啶 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534280	ABS; Aby; Antby; Anti; Antibodies; Antibody; Aristocort; Atolone; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Kenacort; Kenalog; Mycolog II; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534280	Triamcinolone ind plt IgM SerPl Ql FC	4180186
43534280	曲安西龙 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534281	ABS; Aby; Antby; Anti; Antibodies; Antibody; Aristocort; Atolone; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Kenacort; Kenalog; Mycolog II; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534281	Triamcinolone ind plt IgG SerPl Ql FC	4180186
43534281	曲安西龙 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534283	traMADol ind plt IgG SerPl Ql FC	4180186
43534283	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tramal; Ultram	4180186
43534283	曲马多 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534284	ABS; Aby; Antby; Anti; Antibodies; Antibody; Atracurium besylate; Autoantibodies; Autoantibody; C12H21NO8S; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lennox-Gastaut syndrome; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Qudexy XR; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Topamax; Toprimate; Tracrium; Trokendi XR	4180186
43534284	Topiramate ind plt IgM SerPl Ql FC	4180186
43534284	托吡酯 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534287	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Detrol; Detrusitol; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534287	Tolterodine ind plt IgM SerPl Ql FC	4180186
43534287	托特罗定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534288	Tobramycin ind plt IgM SerPl Ql FC	4180186
43534288	ABS; Aby; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; NEBCIN; NEBDIN; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; TOBJ; TOBRA	4180186
43534288	妥布霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534289	ABS; Aby; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; NEBCIN; NEBDIN; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; TOBJ; TOBRA	4180186
43534289	Tobramycin ind plt IgG SerPl Ql FC	4180186
43534289	妥布霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534290	Tirofiban ind plt IgM SerPl Ql FC	4180186
43534290	ABS; Aby; Aggrastat; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534290	替罗非班 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534291	Tirofiban ind plt IgG SerPl Ql FC	4180186
43534291	ABS; Aby; Aggrastat; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534291	替罗非班 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534294	ABS; Aby; Achromycin V; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C18; c211; C75; Chemiciclina; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Panmycin; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrabioptal; Thrombocyte; Thrombocytes	4180186
43534294	Tetracycline ind plt IgM SerPl Ql FC	4180186
43534294	四环素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534295	ABS; Aby; Achromycin V; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C18; c211; C75; Chemiciclina; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Panmycin; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrabioptal; Thrombocyte; Thrombocytes	4180186
43534295	Tetracycline ind plt IgG SerPl Ql FC	4180186
43534295	四环素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534296	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Hytrin; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534296	Terazosin ind plt IgM SerPl Ql FC	4180186
43534296	特拉唑嗪 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534300	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazobac; Thrombocyte; Thrombocytes	4180186
43534300	Tazobactam ind plt IgM SerPl Ql FC	4180186
43534300	他唑巴坦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534301	Tazobactam ind plt IgG SerPl Ql FC	4180186
43534301	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazobac; Thrombocyte; Thrombocytes	4180186
43534301	他唑巴坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534302	Tamsulosin ind plt IgM SerPl Ql FC	4180186
43534302	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Flomax; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534302	坦索罗辛 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534305	Tamoxifen ind plt IgG SerPl Ql FC	4180186
43534305	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Nolvadex; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534305	他莫西芬 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534309	Sulindac ind plt IgG SerPl Ql FC	4180186
43534309	ABS; Aby; ACLIN; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C20H17FO3S; Circulating platelet ab; Clinoril; Clusinol; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Saldac; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534309	舒林酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534310	Sulfisoxaz ind plt IgM SerPl Ql FC	4180186
43534310	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Gantrisin; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sulfizole; Thrombocyte; Thrombocytes	4180186
43534310	磺胺异嘧唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534312	ABS; Aby; Accucol; Antby; Anti; Antibodies; Antibody; Asulfidine; Autoantibodies; Autoantibody; Azopyrin; Azulfidine; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rorasul; Salazopyrin; Salazosulfapyridine; Salicylazosulfapyridine; SASP; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SSZ; Sulcolon; Thrombocyte; Thrombocytes	4180186
43534312	sulfaSALAzine ind plt IgM SerPl Ql FC	4180186
43534312	柳氮磺胺吡啶 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534314	ABS; Aby; Acetylsulfamethoxazole; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c223; C61; Circulating platelet ab; Dynamic; FC; Gantanol; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SMX; SR; Sulfa; Sulfamethox; Thrombocyte; Thrombocytes	4180186
43534314	Sulfamethoxazole ind plt IgG SerPl Ql FC	4180186
43534314	磺胺甲噁唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534316	Sucralfate ind plt IgM SerPl Ql FC	4180186
43534316	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carafate; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534316	硫糖铝 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534318	ABS; Aby; Aldactone; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Novospiroton; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534318	Spironolactone ind plt IgG SerPl Ql FC	4180186
43534318	螺内酯 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534322	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zocor	4180186
43534322	Simvastatin ind plt IgM SerPl Ql FC	4180186
43534322	辛伐他汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534323	Simvastatin ind plt IgG SerPl Ql FC	4180186
43534323	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zocor	4180186
43534323	辛伐他汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534325	Simethicone ind plt IgG SerPl Ql FC	4180186
43534325	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Maalox; Mylanta; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534325	聚二甲基硅氧烷 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534326	Sildenafil cit ind plt IgM SerPl Ql FC	4180186
43534326	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Citric acid; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Revatio; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Viagra	4180186
43534326	枸橼酸西地那非 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534327	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Citric acid; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Revatio; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Viagra	4180186
43534327	Sildenafil cit ind plt IgG SerPl Ql FC	4180186
43534327	枸橼酸西地那非 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534328	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zoloft	4180186
43534328	Sertraline ind plt IgM SerPl Ql FC	4180186
43534328	舍曲林 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534329	Sertraline ind plt IgG SerPl Ql FC	4180186
43534329	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zoloft	4180186
43534329	舍曲林 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534330	Rosuvastatin ind plt IgM SerPl Ql FC	4180186
43534330	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Crestor; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534330	罗伐他汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534334	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ceeoxx; Ceoxx; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vioxx	4180186
43534334	Rofecoxib ind plt IgG SerPl Ql FC	4180186
43534334	罗非昔布 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534335	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ceeoxx; Ceoxx; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vioxx	4180186
43534335	Rofecoxib ind plt IgM SerPl Ql FC	4180186
43534335	罗非昔布 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534339	ABS; Aby; Actonel; Antby; Anti; Antibodies; Antibody; Atelvia; Autoantibodies; Autoantibody; Benet; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Risedronic acid; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534339	Risedronate ind plt IgG SerPl Ql FC	4180186
43534339	利塞膦酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534340	rifAMPin ind plt IgG SerPl Ql FC	4180186
43534340	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c301; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; RIF; Rifadin; Rifampicin; Rimactane; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534340	利福平 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534341	rifAMPin ind plt IgM SerPl Ql FC	4180186
43534341	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c301; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; RIF; Rifadin; Rifampicin; Rimactane; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534341	利福平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534342	raNITIdine ind plt IgG SerPl Ql FC	4180186
43534342	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zantac	4180186
43534342	雷尼替丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534349	RABEprazole ind plt IgM SerPl Ql FC	4180186
43534349	ABS; Aby; AcipHex; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534349	雷贝拉唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534350	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534350	quiNINE ind plt IgM SerPl Ql FC	4180186
43534350	奎宁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534352	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chinidine; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534352	quiNIDine ind plt IgG SerPl Ql FC	4180186
43534352	奎尼丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534353	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chinidine; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534353	quiNIDine ind plt IgM SerPl Ql FC	4180186
43534353	奎尼丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534356	QUEtiapine ind plt IgM SerPl Ql FC	4180186
43534356	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ketipinor; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Xeroquel	4180186
43534356	喹硫平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534357	QUEtiapine ind plt IgG SerPl Ql FC	4180186
43534357	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ketipinor; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Xeroquel	4180186
43534357	喹硫平 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534361	Propranolol ind plt IgG SerPl Ql FC	4180186
43534361	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Inderal; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534361	普萘洛尔 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534362	Propoxyph+APAP ind plt IgM SerPl Ql FC	4180186
43534362	ABS; Aby; ACET; Acetamidophenol; Acetaminoph; Acetominophen; Algaphan; Antby; Anti; Antibodies; Antibody; APAP; Autoantibodies; Autoantibody; c209; C55; Circulating platelet ab; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; Dynamic; FC; Hydroxyacetanilide; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Napsalgesic; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Propoxyph+APAP; Ql; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tylenol; u209	4180186
43534362	丙氧氨酚+对乙酰氨基酚 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534363	ABS; Aby; ACET; Acetamidophenol; Acetaminoph; Acetominophen; Algaphan; Antby; Anti; Antibodies; Antibody; APAP; Autoantibodies; Autoantibody; c209; C55; Circulating platelet ab; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; Dynamic; FC; Hydroxyacetanilide; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Napsalgesic; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Propoxyph+APAP; Ql; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tylenol; u209	4180186
43534363	Propoxyph+APAP ind plt IgG SerPl Ql FC	4180186
43534363	丙氧氨酚+对乙酰氨基酚 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534365	Propoxyph ind plt IgM SerPl Ql FC	4180186
43534365	ABS; Aby; Algaphan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Napsalgesic; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534365	丙氧氨酚 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534367	Procainamide ind plt IgG SerPl Ql FC	4180186
43534367	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; PA; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Procan; Pronestyl; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534367	普鲁卡因胺 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534368	Primidone ind plt IgM SerPl Ql FC	4180186
43534368	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Mysoline; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534368	扑米酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534370	predniSONE ind plt IgM SerPl Ql FC	4180186
43534370	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C254; Circulating platelet ab; Cortan; Deltasone; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Liquid Pred; Meticorten; Orasone; Ordinal; Panasol-S; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prednicen-M; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534370	泼尼松 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534371	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C254; Circulating platelet ab; Cortan; Deltasone; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Liquid Pred; Meticorten; Orasone; Ordinal; Panasol-S; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prednicen-M; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534371	predniSONE ind plt IgG SerPl Ql FC	4180186
43534371	泼尼松 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534374	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pip+Tazo; Piper; PIPJ; Pipracil; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazobac; Tazocilline; Tazocin; Thrombocyte; Thrombocytes; Zosyn	4180186
43534374	Pip+Tazo ind plt IgM SerPl Ql FC	4180186
43534374	氧哌嗪青霉素+他唑巴坦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534375	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pip+Tazo; Piper; PIPJ; Pipracil; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazobac; Tazocilline; Tazocin; Thrombocyte; Thrombocytes; Zosyn	4180186
43534375	Pip+Tazo ind plt IgG SerPl Ql FC	4180186
43534375	氧哌嗪青霉素+他唑巴坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534377	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Piper; PIPJ; Pipracil; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534377	Piperacillin ind plt IgM SerPl Ql FC	4180186
43534377	氧哌嗪青霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534378	Pioglitazone ind plt IgM SerPl Ql FC	4180186
43534378	ABS; Aby; Actos; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534378	吡格列酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534381	Phenytoin ind plt IgM SerPl Ql FC	4180186
43534381	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; Dynamic; Epanutin; FC; Fenantoin; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lehydan; Ordinal; Phenhydan; PHYT; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Thrombocyte; Thrombocytes; Zentropil	4180186
43534381	苯妥英 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534382	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barbiturate; c417; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Luminal; Nirvonal; Ordinal; PHBR; Phenobarb; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534382	Phenobarb ind plt IgM SerPl Ql FC	4180186
43534382	苯巴比妥 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534384	Perphenazine ind plt IgM SerPl Ql FC	4180186
43534384	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Trilafon	4180186
43534384	奋乃静 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534388	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Paxil; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534388	PARoxetine ind plt IgM SerPl Ql FC	4180186
43534388	帕罗西汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534391	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CereSer; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pavobid; Pl; Plasan; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534391	Papaverine ind plt IgM SerPl Ql FC	4180186
43534391	罂粟碱 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534392	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Protonix; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534392	Pantoprazole ind plt IgM SerPl Ql FC	4180186
43534392	泮托拉唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534394	oxyCODONE+ASA ind plt IgM SerPl Ql FC	4180186
43534394	ABS; Aby; Acetylsalicylic acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; c207; c217; Circulating platelet ab; Dynamic; Endodan; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lortab; Ordinal; oxyCODONE+ASA; OxyContin; Percocet; Percodan; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Roxiprin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vicodin	4180186
43534394	羟考酮+乙酰水杨酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534396	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lortab; Ordinal; OxyContin; Percocet; Percodan; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vicodin	4180186
43534396	oxyCODONE ind plt IgG SerPl Ql FC	4180186
43534396	羟考酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534397	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lortab; Ordinal; OxyContin; Percocet; Percodan; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vicodin	4180186
43534397	oxyCODONE ind plt IgM SerPl Ql FC	4180186
43534397	羟考酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534401	Oxaliplatin ind plt IgG SerPl Ql FC	4180186
43534401	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Eloxatin; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534401	奥沙利铂 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534403	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bactocill; c116; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prostaphlin; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534403	Oxacillin ind plt IgG SerPl Ql FC	4180186
43534403	甲苯异恶唑青霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534406	Omeprazole ind plt IgM SerPl Ql FC	4180186
43534406	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prilosec; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534406	奥美拉唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534411	Nystatin ind plt IgG SerPl Ql FC	4180186
43534411	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c216; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534411	制真菌素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534412	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Axid; C12H21N5O2S2; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534412	Nizatidine ind plt IgM SerPl Ql FC	4180186
43534412	尼扎替丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534413	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Axid; C12H21N5O2S2; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534413	Nizatidine ind plt IgG SerPl Ql FC	4180186
43534413	尼扎替丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534418	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Procardia; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534418	NIFEdipine ind plt IgM SerPl Ql FC	4180186
43534418	硝苯地平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534420	Niacin+Lovastatin ind plt IgM SP Ql FC	4180186
43534420	ABS; Aby; Advicor; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Mevacor; Nicotinic acid; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vit B3; Vitamin B3	4180186
43534420	烟酸+洛伐他汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534422	Naproxen ind plt IgM SerPl Ql FC	4180186
43534422	ABS; Aby; Anaprox; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c228; c283; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534422	甲氧萘丙酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534424	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; NAFJ; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Unipen	4180186
43534424	Nafcillin ind plt IgM SerPl Ql FC	4180186
43534424	乙氧萘青霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534425	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; NAFJ; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Unipen	4180186
43534425	Nafcillin ind plt IgG SerPl Ql FC	4180186
43534425	乙氧萘青霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534426	Mycophenolate ind plt IgM SerPl Ql FC	4180186
43534426	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cellcept; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534426	吗替麦考酚酯 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534429	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avelox; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534429	Moxifloxacin ind plt IgM SerPl Ql FC	4180186
43534429	莫西沙星 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534430	Morphine ind plt IgM SerPl Ql FC	4180186
43534430	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c260; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Morphine sulfate; MS; MSO4; OMPH; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534430	吗啡 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534434	Mirtazapine ind plt IgM SerPl Ql FC	4180186
43534434	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avanza; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Reflex; Remeron; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zispin	4180186
43534434	米氮平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534435	Mirtazapine ind plt IgG SerPl Ql FC	4180186
43534435	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avanza; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Reflex; Remeron; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zispin	4180186
43534435	米氮平 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534437	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rogaine; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534437	Minoxidil ind plt IgG SerPl Ql FC	4180186
43534437	米诺地尔 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534438	ABS; Aby; Aknemin; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c128; Circulating platelet ab; Dentomycin; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Klinomysin; Lederderm; Mestacine; Mino-50; Minocin; Minomycin; Mynocine; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534438	Minocycline ind plt IgM SerPl Ql FC	4180186
43534438	二甲胺四环素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534441	Milrinone ind plt IgM SerPl Ql FC	4180186
43534441	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Primacor; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534441	米力农 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534444	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c237; c398; Circulating platelet ab; Dynamic; FC; Flagyl; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Metrogel; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534444	metroNIDAZOLE ind plt IgM SerPl Ql FC	4180186
43534444	甲硝唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534445	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c237; c398; Circulating platelet ab; Dynamic; FC; Flagyl; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Metrogel; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534445	metroNIDAZOLE ind plt IgG SerPl Ql FC	4180186
43534445	甲硝唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534448	Metoclopramide ind plt IgM SerPl Ql FC	4180186
43534448	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Reglan; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534448	灭吐灵 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534452	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Me-phenidate; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Ritalin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534452	Me-phenidate ind plt IgG SerPl Ql FC	4180186
43534452	哌甲酯 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534453	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Me-phenidate; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Ritalin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534453	Me-phenidate ind plt IgM SerPl Ql FC	4180186
43534453	哌甲酯 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534454	ABS; Aby; ALDJ; Aldomet; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dopamet; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Novomedopa; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534454	Methyldopa ind plt IgM SerPl Ql FC	4180186
43534454	甲基多巴 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534455	ABS; Aby; ALDJ; Aldomet; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dopamet; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Novomedopa; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534455	Methyldopa ind plt IgG SerPl Ql FC	4180186
43534455	甲基多巴 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534456	ABS; Aby; Amethoperin; Amethopterin; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Methotrexat; MTX; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534456	MTX ind plt IgM SerPl Ql FC	4180186
43534456	氨甲喋呤 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534457	MTX ind plt IgG SerPl Ql FC	4180186
43534457	ABS; Aby; Amethoperin; Amethopterin; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Methotrexat; MTX; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534457	氨甲喋呤 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534459	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carbacot; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Robaxin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Skelex; SR; Thrombocyte; Thrombocytes	4180186
43534459	Methocarbamol ind plt IgG SerPl Ql FC	4180186
43534459	美索巴莫 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534460	metFORMIN ind plt IgM SerPl Ql FC	4180186
43534460	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Glucophage; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534460	二甲双胍 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534463	Meropenem ind plt IgG SerPl Ql FC	4180186
43534463	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Meronem; Merrem; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534463	美罗培南 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534464	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Mevacor; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534464	Lovastatin ind plt IgM SerPl Ql FC	4180186
43534464	洛伐他汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534469	LORazepam ind plt IgG SerPl Ql FC	4180186
43534469	ABS; Aby; Antby; Anti; Antibodies; Antibody; Ativan; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534469	氯羟安定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534471	Loratadine ind plt IgG SerPl Ql FC	4180186
43534471	ABS; Aby; Alavert; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Claritin; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534471	氯雷他定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534473	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C29H33ClN2O2; Circulating platelet ab; Dynamic; FC; Immodium; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534473	Loperamide ind plt IgG SerPl Ql FC	4180186
43534473	洛哌丁胺 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534474	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prinivil; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tensopril; Thrombocyte; Thrombocytes	4180186
43534474	Lisinopril ind plt IgM SerPl Ql FC	4180186
43534474	赖诺普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534475	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prinivil; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tensopril; Thrombocyte; Thrombocytes	4180186
43534475	Lisinopril ind plt IgG SerPl Ql FC	4180186
43534475	赖诺普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534476	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zyvox	4180186
43534476	Linezolid ind plt IgG SerPl Ql FC	4180186
43534476	利奈唑胺 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534477	Linezolid ind plt IgM SerPl Ql FC	4180186
43534477	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zyvox	4180186
43534477	利奈唑胺 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534481	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534481	levoFLOXacin ind plt IgG SerPl Ql FC	4180186
43534481	左氧氟沙星 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534483	3,4-Dihydroxyphenylalanine; 3-Hydroxy-L-tyrosine; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dihydroxyphenylalanine; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; L-Dopa; Levo-dopa; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinemet; SR; Thrombocyte; Thrombocytes	4180186
43534483	L-Dopa ind plt IgG SerPl Ql FC	4180186
43534483	左旋多巴 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534484	levETIRAcetam ind plt IgM SerPl Ql FC	4180186
43534484	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Keppra; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534484	左乙拉西坦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534485	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Keppra; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534485	levETIRAcetam ind plt IgG SerPl Ql FC	4180186
43534485	左乙拉西坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534488	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Leuprorelin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534488	Leuprolide ind plt IgM SerPl Ql FC	4180186
43534488	亮丙瑞林 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534489	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Leuprorelin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534489	Leuprolide ind plt IgG SerPl Ql FC	4180186
43534489	亮丙瑞林 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534490	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Refludan; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534490	Lepirudin ind plt IgM SerPl Ql FC	4180186
43534490	来匹卢定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534491	Lepirudin ind plt IgG SerPl Ql FC	4180186
43534491	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Refludan; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534491	来匹卢定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534493	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prevacid; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534493	Lansoprazole ind plt IgG SerPl Ql FC	4180186
43534493	兰索拉唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534494	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C15H13NO3; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534494	Ketorolac ind plt IgM SerPl Ql FC	4180186
43534494	酮咯酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534498	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534498	Isosorbide ind plt IgM SerPl Ql FC	4180186
43534498	异山梨醇 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534499	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534499	Isosorbide ind plt IgG SerPl Ql FC	4180186
43534499	异山梨醇 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534501	ABS; Aby; Aldactizide; Antby; Anti; Antibodies; Antibody; Aprovel; Autoantibodies; Autoantibody; Avalide; Avapro; c381; Circulating platelet ab; Dynamic; Esidrix; FC; HCTZ; HTCZ; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Irbesartan+HTCZ; Karvea; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534501	Irbesartan+HTCZ ind plt IgG SerPl Ql FC	4180186
43534501	厄贝沙坦+氢氯噻嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534504	Ipratropium ind plt IgM SerPl Ql FC	4180186
43534504	ABS; Aby; Aerovent; Antby; Anti; Antibodies; Antibody; Apovent; Atrovent; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ipraxa; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534504	异丙托溴铵 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534509	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Imipeneum; Immune globulin M; Immunoglobulin M; Imp; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Primaxin; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534509	Imipenem ind plt IgM SerPl Ql FC	4180186
43534509	亚胺培南 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534510	Ibuprofen ind plt IgG SerPl Ql FC	4180186
43534510	ABS; Aby; Advil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c20; c235; c286; C53; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Motrin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534510	对异丁基苯异丙酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534511	ABS; Aby; Advil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c20; c235; c286; C53; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Motrin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534511	Ibuprofen ind plt IgM SerPl Ql FC	4180186
43534511	对异丁基苯异丙酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534513	hydrOXYzine ind plt IgG SerPl Ql FC	4180186
43534513	ABS; Aby; Antby; Anti; Antibodies; Antibody; Atarax; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vistaril	4180186
43534513	羟嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534514	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dihydromorphinone; Dilaudid; Dynamic; FC; Hydromorphinone; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534514	HYDROmorphone ind plt IgM SerPl Ql FC	4180186
43534514	二氢吗啡酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534515	HYDROmorphone ind plt IgG SerPl Ql FC	4180186
43534515	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dihydromorphinone; Dilaudid; Dynamic; FC; Hydromorphinone; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534515	二氢吗啡酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534518	ABS; Aby; Anexsia; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHL; Chlorphenamine; Chlorphenir; Chlortrimeton; Chlor-tripolon; Circulating platelet ab; Dihydrocodeinone; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Piriton; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vicodin	4180186
43534518	HYDROcodone+CHL ind plt IgM SerPl Ql FC	4180186
43534518	氢可酮+氯苯朴尔敏 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534525	HTCZ+Losartan ind plt IgG SerPl Ql FC	4180186
43534525	ABS; Aby; Aldactizide; Antby; Anti; Antibodies; Antibody; Anzaplus; Autoantibodies; Autoantibody; c381; Circulating platelet ab; Cozaar; Dynamic; Esidrix; FC; HCTZ; HTCZ; HTCZ+Losartan; Hyzaar; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534525	氢氯噻嗪+氯沙坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534526	HTCZ ind plt IgM SerPl Ql FC	4180186
43534526	ABS; Aby; Aldactizide; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c381; Circulating platelet ab; Dynamic; Esidrix; FC; HCTZ; HTCZ; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534526	氢氯噻嗪 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534527	ABS; Aby; Aldactizide; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c381; Circulating platelet ab; Dynamic; Esidrix; FC; HCTZ; HTCZ; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534527	HTCZ ind plt IgG SerPl Ql FC	4180186
43534527	氢氯噻嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534531	Haloperidol ind plt IgM SerPl Ql FC	4180186
43534531	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Haldol; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serenace; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534531	氟哌啶醇 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534533	glyBURIDE ind plt IgG SerPl Ql FC	4180186
43534533	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; DiaBeta; Dynamic; FC; Glynase; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Micronase; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534533	格列苯脲 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534535	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Glucotrol; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534535	glipiZIDE ind plt IgM SerPl Ql FC	4180186
43534535	格列甲嗪 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534536	Glimepiride ind plt IgM SerPl Ql FC	4180186
43534536	ABS; Aby; Amaryl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Glista OD; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534536	格列美脲 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534537	ABS; Aby; Amaryl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Glista OD; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534537	Glimepiride ind plt IgG SerPl Ql FC	4180186
43534537	格列美脲 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534538	ABS; Aby; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c213; Circulating platelet ab; Dynamic; FC; Garamycin; Genirr; Genj; Gent; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534538	Gentamicin ind plt IgM SerPl Ql FC	4180186
43534538	庆大霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534539	ABS; Aby; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c213; Circulating platelet ab; Dynamic; FC; Garamycin; Genirr; Genj; Gent; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534539	Gentamicin ind plt IgG SerPl Ql FC	4180186
43534539	庆大霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534544	Fosinopril ind plt IgM SerPl Ql FC	4180186
43534544	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Monopril; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534544	福辛普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534628	Mycobacterium tuberculosis katG+inhA genes isoniazid resistance mutation	4180186
44777641	picomol per gram hemoglobin	4180186
44777642	picomol per hour and milligram of hemoglobin	4180186
44777643	picomol per kilogram	4180186
44782420	Mechanical complication of venous catheter (disorder)	4180186
44782421	Acute deep venous thrombosis of upper extremity (disorder)	4180186
44782422	Dementia due to Parkinsons disease	4180186
44782422	Dementia due to Parkinson's disease (disorder)	4180186
44782422	Dementia due to Parkinson disease	4180186
44782425	Venous thrombosis due to central venous access device (disorder)	4180186
44782426	Gangrene due to peripheral vascular disease (disorder)	4180186
44782427	Hemiparesis as late effect of cerebrovascular disease (disorder)	4180186
44782428	Congestive heart failure due to cardiomyopathy (disorder)	4180186
44782430	History of tricuspid valve replacement (situation)	4180186
44782432	Early onset Alzheimer disease with behavioral disturbance	4180186
44782432	Early onset Alzheimer's disease with behavioral disturbance (disorder)	4180186
44782432	Early onset Alzheimer's disease with behavioural disturbance	4180186
44782432	Early onset Alzheimers disease with behavioral disturbance	4180186
44782436	History of repair of ascending aorta (situation)	4180186
44782439	Nutrition therapy for congestive heart failure (regime/therapy)	4180186
44782441	Intermittent claudication due to atherosclerosis of native artery of limb (finding)	4180186
44782442	Atrial fibrillation with rapid ventricular response (disorder)	4180186
44782445	Thrombocytopaenia caused by alcohol	4180186
44782445	Thrombocytopaenia due to alcohol	4180186
44782445	Thrombocytopenia caused by alcohol (disorder)	4180186
44782445	Thrombocytopenia caused by alcohol	4180186
44782446	Pressure injury of ankle (disorder)	4180186
44782446	Pressure injury of ankle	4180186
44782446	Pressure ulcer of ankle (disorder)	4180186
44782448	Pressure injury of coccygeal region of back	4180186
44782448	Pressure injury of coccygeal region of back (disorder)	4180186
44782448	Pressure ulcer of coccygeal region (disorder)	4180186
44782449	Phantom taste (disorder)	4180186
44782451	Flat torus (morphologic abnormality)	4180186
44782452	Luminal unicystic ameloblastoma (morphologic abnormality)	4180186
44782453	Intraosseous mucoepidermoid carcinoma (morphologic abnormality)	4180186
44782455	Monoarthritis of knee (disorder)	4180186
44782461	History of construction of cutaneous stoma of urinary bladder (situation)	4180186
44782461	History of cutaneous vesicostomy	4180186
44782462	Fetal or neonatal effect of maternal renal disease (disorder)	4180186
44782464	Referral by podiatric surgeon (procedure)	4180186
44782466	Straight facial soft tissue profile (finding)	4180186
44782469	Interstitial deletion of chromosome 15q24	4180186
44782469	15q24 deletion	4180186
44782469	Microdeletion of chromosome 15q24 (disorder)	4180186
44782469	15q24 microdeletion syndrome	4180186
44782469	Microdeletion of chromosome 15q24	4180186
44782470	Persistent migraine aura	4180186
44782470	Migraine with persistent visual aura (disorder)	4180186
44782471	Supratentorial primitive neuroectodermal tumor (disorder)	4180186
44782471	Supratentorial primitive neuroectodermal tumour	4180186
44782475	Granular cell tumour of neurohypophysis	4180186
44782475	Granular cell tumor of neurohypophysis (disorder)	4180186
44782475	Granular cell tumour of posterior pituitary	4180186
44782475	Granular cell tumor of posterior pituitary	4180186
44782476	Bacillus aerophilus (organism)	4180186
44782478	Hereditary neoplastic syndrome	4180186
44782478	Hereditary cancer-predisposing syndrome (disorder)	4180186
44782479	Repair of ascending aorta (procedure)	4180186
44782480	Leiomyosarcoma of orbit (disorder)	4180186
44782481	Postnatal depression not discussed (situation)	4180186
44782482	Infant hypothyroidism caused by maternal drug	4180186
44782482	Infant hypothyroidism caused by maternal drug (disorder)	4180186
44782487	Main spoken language Faroese (finding)	4180186
44782487	Main spoken language Faeroese	4180186
44782490	Hemifacial myohyperplasia (disorder)	4180186
44782493	Posterior drawer sign test	4180186
44782493	Posterior drawer test (procedure)	4180186
44782495	Oocyst of genus Microsporidium (organism)	4180186
44782495	Microsporidium oocyst	4180186
44782495	Oocyst of genus Microsporidium	4180186
44782496	Trophozoite of Trypanosoma brucei rhodesiense (organism)	4180186
44782496	Trophozoite of Trypanosoma brucei rhodesiense	4180186
44782499	Excessive opening of mandible (disorder)	4180186
44782501	Masticatory muscle hypertrophy	4180186
44782501	Hypertrophy of muscles of mastication (finding)	4180186
44782503	Operative procedure on region of shoulder girdle (procedure)	4180186
44782504	Local anesthetic ulnar nerve block in upper arm (procedure)	4180186
44782504	Local anaesthetic ulnar nerve block in upper arm	4180186
44782504	Ulnar nerve block mid-humeral	4180186
44782505	Oxyuranus scutellatus antivenom	4180186
44782505	Oxyuranus scutellatus antivenom (substance)	4180186
44782506	Surgical oncology service (qualifier value)	4180186
44782507	Roxatidine acetate hydrochloride (substance)	4180186
44782509	Dental caries class I (disorder)	4180186
44782510	Dental caries class IV (disorder)	4180186
44782513	Main spoken language Marathi (finding)	4180186
44782514	Main spoken language Quechua (finding)	4180186
44782516	Fracture of dental implant (disorder)	4180186
44782519	No wound discharge	4180186
44782519	Absence of wound discharge (situation)	4180186
44782520	Chronic paralysis due to lesion of spinal cord (disorder)	4180186
44782520	Chronic spinal paralysis	4180186
44782526	Facial palsy House-Brackmann grade 2	4180186
44782526	Facial palsy House-Brackmann grade II (disorder)	4180186
44782529	Full thickness graft of skin to skin of thumb (procedure)	4180186
44782533	Structure of greater sac of peritoneum (body structure)	4180186
44782536	Skin structure of Achilles region (body structure)	4180186
44782540	Multiple open wounds of lower limb involving tendon (disorder)	4180186
44782544	Knee effusion stroke test (procedure)	4180186
44782547	Loosening of dental implant screw (disorder)	4180186
44782547	Loosening of screw that retains a dental prosthesis to the dental implant	4180186
44782550	Classic medulloblastoma (morphologic abnormality)	4180186
44782551	Embolism of middle cerebral artery (disorder)	4180186
44782552	Defective maxillary overdenture (finding)	4180186
44782554	Age more than 40 years (finding)	4180186
44782555	Asymmetric mandibular arch form (disorder)	4180186
44782556	Tubularised incised plate urethroplasty	4180186
44782556	Tubularized incised plate urethroplasty (procedure)	4180186
44782566	Pulmonary hypertension due to left-sided valvular heart disease (disorder)	4180186
44782567	Marginal ridge height discrepancy (finding)	4180186
44782568	Operation on urethra and periurethral tissue (procedure)	4180186
44782570	Patellar compression test (procedure)	4180186
44782571	McMurray circumduction test	4180186
44782571	McMurray test (procedure)	4180186
44782572	Subependymal nodular heterotopia (disorder)	4180186
44782573	Neoplasm of endolymphatic sac (disorder)	4180186
44782573	Neoplasm of endolymphatic sac	4180186
44782573	Endolymphatic sac tumour	4180186
44782575	Education about electroconvulsive therapy (procedure)	4180186
44782575	Education about ECT (electroconvulsive therapy)	4180186
44782576	Provision of written information about leishmaniasis (procedure)	4180186
44782581	BLVR - Bronchoscopic lung volume reduction	4180186
44782581	Bronchoscopic lung volume reduction (procedure)	4180186
44782582	Keratinizing squamous cell carcinoma of nasopharynx (disorder)	4180186
44782582	Keratinising squamous cell carcinoma of nasopharynx	4180186
44782583	Spleen palpable below costal margin (finding)	4180186
44782584	Escherichia coli serogroup O28ac (organism)	4180186
44782584	E. coli O28ac	4180186
44782584	E. coli serogroup O28ac	4180186
44782586	Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine/Hepatitis B Surface Antigen Vaccine (product)	4180186
44782588	Incomplete fracture of tooth (disorder)	4180186
44782591	Brivudine (substance)	4180186
44782592	Relative generalised microdontia	4180186
44782592	Relative generalized microdontia (disorder)	4180186
44782595	Entire skin of lateral cubital region of elbow	4180186
44782595	Entire skin of lateral cubital region of elbow (body structure)	4180186
44782595	Entire skin of lateral cubital region of upper limb (body structure)	4180186
44782596	Skin structure of lateral part of lower limb (body structure)	4180186
44782597	Skin structure of lower chest wall (body structure)	4180186
44782601	Entire skin of temple region of head (body structure)	4180186
44782602	Skin structure of upper chest wall (body structure)	4180186
44782603	Entire lateral chest wall (body structure)	4180186
44782606	Retained placenta due to morbidly adherent placenta (disorder)	4180186
44782607	Abscess of tendon of lower limb (disorder)	4180186
44782608	Biceps brachii muscle and/or tendon structure (body structure)	4180186
44782610	Swelling on flushing of implanted venous access device (finding)	4180186
44782612	Streptococcus pneumoniae serotype 44 (organism)	4180186
44782613	Streptococcus pneumoniae serotype 48 (organism)	4180186
44782614	Streptococcus pyogenes type emm104 (organism)	4180186
44782615	Streptococcus pyogenes type emm110 (organism)	4180186
44782617	Streptococcus agalactiae serotype II/R (organism)	4180186
44782618	Structure of lateral ulnar collateral ligament of elbow (body structure)	4180186
44782622	Peroneus longus muscle and/or tendon structure (body structure)	4180186
44782623	Supraspinatus muscle and/or tendon structure (body structure)	4180186
44782624	Dabigatran etexilate (substance)	4180186
44782626	Structure of vertex region of scalp (body structure)	4180186
44782629	Cared for by female head of household (finding)	4180186
44782630	Sepsis in asplenic subject (disorder)	4180186
44782631	Sepsis with cutaneous manifestations (disorder)	4180186
44782631	Sepsis affecting skin	4180186
44782632	ATLD	4180186
44782632	Ataxia-telangiectasia-like disorder (disorder)	4180186
44782635	Repair of blood vessel of abdomen with synthetic patch graft (procedure)	4180186
44782638	Marks and Mathews fear questionnaire total agoraphobia score (observable entity)	4180186
44782639	Fluctuating edema level (finding)	4180186
44782639	Fluctuating oedema level	4180186
44782640	Pseudomonas knackmussii (organism)	4180186
44782642	Family history of cardiac arrhythmia (situation)	4180186
44782644	Noninvasive carcinoma ex pleomorphic adenoma (morphologic abnormality)	4180186
44782644	Intracapsular carcinoma ex pleomorphic adenoma	4180186
44782648	Familial short QT syndrome	4180186
44782648	Genetic short QT syndrome (disorder)	4180186
44782651	Cartilaginous choristoma (morphologic abnormality)	4180186
44782651	Chondroid choristoma	4180186
44782655	Acute on chronic congestive heart failure	4180186
44782655	Acute exacerbation of chronic congestive heart failure (disorder)	4180186
44782656	Anaphylactoid reaction to food additive	4180186
44782656	Non-allergic anaphylaxis caused by food additive (disorder)	4180186
44782656	Anaphylactoid reaction caused by food additive	4180186
44782658	Family history of tendinous xanthoma in first degree relative (situation)	4180186
44782658	Family history of tendon xanthoma in first degree relative	4180186
44782659	Expiratory positive airway pressure (observable entity)	4180186
44782665	Endoscopic electrohydraulic lithotripsy of duodenal bezoar (procedure)	4180186
44782666	History of revision of ventriculoperitoneal shunt (situation)	4180186
44782668	History of grafting of amniotic membrane to eye (situation)	4180186
44782668	History of amniotic membrane graft to eye	4180186
44782672	History of creation of conduit of right atrium and pulmonary artery (situation)	4180186
44782672	History of Fontan operation	4180186
44782675	At risk of chronic kidney disease (finding)	4180186
44782676	At risk of lymphedema (finding)	4180186
44782676	At risk of lymphoedema	4180186
44782679	Normally functioning cardiac pacemaker in situ (finding)	4180186
44782684	History of mechanical aortic valve replacement (situation)	4180186
44782685	Continuous sedative abuse (disorder)	4180186
44782689	Chronic kidney disease stage 4 due to hypertension (disorder)	4180186
44782694	History of paroxysmal atrial tachycardia (situation)	4180186
44782697	Drug coated stent in branch of right coronary artery (finding)	4180186
44782698	Bare metal stent in branch of right coronary artery (finding)	4180186
44782699	Drug coated stent in circumflex branch of left coronary artery (finding)	4180186
44782700	Bare metal stent in circumflex branch of left coronary artery (finding)	4180186
44782703	Chronic kidney disease stage 1 due to hypertension (disorder)	4180186
44782705	History of sick sinus syndrome (situation)	4180186
44782706	Mood disorder of depressed type (disorder)	4180186
44782706	Mood disorder with depressive feature	4180186
44782708	Stent in anterior descending branch of left coronary artery (finding)	4180186
44782712	Acute myocardial infarction due to right coronary artery occlusion (disorder)	4180186
44782714	Drug dependence, continuous (disorder)	4180186
44782716	Venous ulcer of lower extremity due to chronic peripheral venous hypertension (disorder)	4180186
44782717	End stage renal disease on dialysis due to hypertension (disorder)	4180186
44782718	Acute combined systolic and diastolic heart failure (disorder)	4180186
44782719	Chronic combined systolic and diastolic heart failure (disorder)	4180186
44782721	History of repair of thoracic aortic aneurysm (situation)	4180186
44782723	History of repair of dissecting abdominal aortic aneurysm (situation)	4180186
44782726	Delusions in Alzheimers disease	4180186
44782726	Delusions in Alzheimer disease	4180186
44782726	Delusions in Alzheimer's disease (disorder)	4180186
44782728	Hypertensive heart AND chronic kidney disease with congestive heart failure (disorder)	4180186
44782729	Dementia due to Alzheimer disease	4180186
44782729	Dementia due to Alzheimers disease	4180186
44782729	Dementia due to Alzheimer's disease (disorder)	4180186
44782730	Nontraumatic intraparenchymal cerebral haemorrhage	4180186
44782730	Spontaneous intraparenchymal cerebral hemorrhage	4180186
44782730	Spontaneous intraparenchymal cerebral haemorrhage	4180186
44782730	Nontraumatic intraparenchymal cerebral hemorrhage (disorder)	4180186
44782732	Chronic pulmonary embolism (disorder)	4180186
44782733	Acute on chronic combined systolic and diastolic heart failure (disorder)	4180186
44782735	Chronic deep venous thrombosis of lower extremity (disorder)	4180186
44782736	Chronic deep venous thrombosis of popliteal vein (disorder)	4180186
44782737	Chronic deep venous thrombosis of tibial vein (disorder)	4180186
44782742	Acute deep venous thrombosis of calf (disorder)	4180186
44782743	Acute deep venous thrombosis of popliteal vein (disorder)	4180186
44782744	Acute deep venous thrombosis of tibial vein (disorder)	4180186
44782745	Acute deep venous thrombosis of thigh (disorder)	4180186
44782748	Acute deep venous thrombosis of ileofemoral vein	4180186
44782748	Acute deep venous thrombosis of iliofemoral vein (disorder)	4180186
44782750	Family history of substance abuse (situation)	4180186
44782751	Acute deep venous thrombosis of axillary vein (disorder)	4180186
44782753	Weakness as a late effect of cerebrovascular accident (disorder)	4180186
44782753	Weakness as a late effect of cerebrovascular accident	4180186
44782757	Acute thrombosis of superior vena cava (disorder)	4180186
44782758	Limb pain at rest due to atherosclerosis of native artery (disorder)	4180186
44782760	Acute thrombosis of superficial vein of upper extremity (disorder)	4180186
44782762	Acute thrombosis of subclavian vein (disorder)	4180186
44782768	Psychosexual dysfunction associated with inhibited sexual excitement (finding)	4180186
44782770	Presence of stent of bypass graft	4180186
44782770	Bypass stent graft present (finding)	4180186
44782771	Presenile dementia with delusions (disorder)	4180186
44782771	Early onset dementia with delusions	4180186
44782772	Gait disorder due to weakness (disorder)	4180186
44782772	Gait weakness	4180186
44782774	Chest pain of pericarditis	4180186
44782774	Chest pain due to pericarditis (finding)	4180186
44782777	History of correction of ventricular septal defect (situation)	4180186
44782784	History of anastomosis of vena cava to pulmonary artery (situation)	4180186
44782786	History of cardiac catheterization (situation)	4180186
44782786	History of cardiac catheterisation	4180186
44782790	Personality change due to organic disorder (finding)	4180186
44782792	Biventricular cardiac pacemaker present (finding)	4180186
44782792	Presence of biventricular cardiac pacemaker	4180186
44782794	Facial palsy House-Brackmann grade III (disorder)	4180186
44782794	Facial palsy House-Brackmann grade 3	4180186
44782796	Facial palsy House-Brackmann grade 5	4180186
44782796	Facial palsy House-Brackmann grade V (disorder)	4180186
44782798	History of interatrial transposition of venous return operation (situation)	4180186
44782798	History of interatrial transposition of venous return by Mustard operation	4180186
44782799	Phase contrast illumination (qualifier value)	4180186
44782800	Differential interference contrast (qualifier value)	4180186
44782802	Respiratory therapy by control of atmospheric pressure (procedure)	4180186
44782807	Technetium (99m-Tc) sulesomab (substance)	4180186
44782807	Technetium Tc^99m^ sulesomab	4180186
44782808	Ticagrelor (substance)	4180186
44782812	Abnormal radiographic imaging of pancreas (finding)	4180186
44782814	Recent rupture of posterior cruciate ligament (situation)	4180186
44782815	Closed fracture of vault of skull with concussion injury of brain (disorder)	4180186
44782816	Facial profile straight (finding)	4180186
44782817	Redundant tissue on maxillary residual ridge (disorder)	4180186
44782820	Dehiscence of postoperative abdominal wound (disorder)	4180186
44782825	Airway plateau pressure (observable entity)	4180186
44782826	Inspiratory tidal volume (observable entity)	4180186
44782826	Inspired tidal volume	4180186
44782827	Expiratory tidal volume (observable entity)	4180186
44782827	Expired tidal volume	4180186
44782828	Failed spinal anesthesia (situation)	4180186
44782828	Failed spinal anaesthesia	4180186
44782829	Failed epidural anaesthesia	4180186
44782829	Failed epidural anesthesia (situation)	4180186
44782830	Failed neuraxial nerve block	4180186
44782830	Failed neuraxial anaesthesia	4180186
44782830	Failed neuraxial nerve block (situation)	4180186
44782830	Failed neuraxial block	4180186
44782831	Circulatory arrest time (observable entity)	4180186
44782832	Straightforward decision making (observable entity)	4180186
44782833	Fresh gas oxygen concentration	4180186
44782833	Oxygen concentration at common gas outlet (observable entity)	4180186
44782835	Core body temperature measured at urinary bladder	4180186
44782835	Intravesical temperature	4180186
44782835	Temperature of urinary bladder	4180186
44782835	Core body temperature measured at urinary bladder (observable entity)	4180186
44782835	Temperature of bladder	4180186
44782837	Metabolic equivalent of task (observable entity)	4180186
44782837	MET - metabolic equivalent of task	4180186
44782838	Cortical myoclonus	4180186
44782838	Cerebral cortex myoclonus (disorder)	4180186
44782841	Pseudotumor cerebri due to drug	4180186
44782841	Benign intracranial hypertension due to drug (disorder)	4180186
44782841	Pseudotumour cerebri due to drug	4180186
44782844	Herpes barbae (disorder)	4180186
44782849	Udd-Markesbery muscular dystrophy	4180186
44782849	Tardive tibial muscular dystrophy	4180186
44782849	Tibial muscular dystrophy (disorder)	4180186
44782849	Udd myopathy	4180186
44782849	Udd distal myopathy	4180186
44782855	Repair of pseudoaneurysm of femoral artery (procedure)	4180186
44782858	Plastic operation on salivary duct (procedure)	4180186
44782860	Plastic operation on tongue (procedure)	4180186
44782861	Impaired nutrient utilization (finding)	4180186
44782861	Impaired nutrient utilisation	4180186
44782862	Endoscopic electrocoagulation of rectal haemorrhage	4180186
44782862	Endoscopic control of rectal bleeding using electrocoagulation (procedure)	4180186
44782862	Endoscopic electrocoagulation of rectal hemorrhage	4180186
44782865	Replacement of lead of automatic cardioverter/defibrillator (procedure)	4180186
44782866	At risk for surgical blood loss (finding)	4180186
44782867	Laparoscopic bilateral total nephrectomy (procedure)	4180186
44782868	2-hydroxyglutaric aciduria (disorder)	4180186
44782869	Triflusal (substance)	4180186
44782871	Cefminox (substance)	4180186
44782872	Vincamine (substance)	4180186
44782875	Generalized disseminated choroiditis (disorder)	4180186
44782875	Generalised disseminated choroiditis	4180186
44782878	Main spoken language Armenian (finding)	4180186
44782879	Main spoken language Aymara (finding)	4180186
44782883	Main spoken language Central Khmer (finding)	4180186
44782884	Main spoken language Danish (finding)	4180186
44782885	Main spoken language Esperanto (finding)	4180186
44782886	Main spoken language Fijian (finding)	4180186
44782887	Main spoken language Georgian (finding)	4180186
44782888	Main spoken language Hungarian (finding)	4180186
44782891	Main spoken language Javanese (finding)	4180186
44782892	Main spoken language Kanarese (finding)	4180186
44782892	Main spoken language Kannada	4180186
44782897	Main spoken language Moldovan	4180186
44782897	Main spoken language Moldavian (finding)	4180186
44782899	Main spoken language Ndebele (finding)	4180186
44782901	Main spoken language Oromo (finding)	4180186
44782902	Main spoken language West Greenlandic	4180186
44782902	Main spoken language Kalaallisut (finding)	4180186
44782902	Main spoken language Greenlandic	4180186
44782904	Main spoken language Romansh (finding)	4180186
44782905	Main spoken language Sango (finding)	4180186
44782906	Main spoken language Sindhi (finding)	4180186
44782907	Main spoken language Slovak (finding)	4180186
44782908	Main spoken language Slovenian (finding)	4180186
44782909	Main spoken language Southern Sotho (finding)	4180186
44782910	Main spoken language Swati	4180186
44782910	Main spoken language Swazi (finding)	4180186
44782912	Main spoken language Telugu (finding)	4180186
44782913	Main spoken language Tibetan (finding)	4180186
44782914	Main spoken language Tongan (finding)	4180186
44782914	Main spoken language Tonga	4180186
44782917	Main spoken language Uzbek (finding)	4180186
44782918	Monitoring of stoma output (regime/therapy)	4180186
44782919	Main spoken language Wolof (finding)	4180186
44782920	Main spoken language Xhosa (finding)	4180186
44782922	Main spoken language Chuang (finding)	4180186
44782922	Main spoken language Zhuang	4180186
44782923	Main spoken language Zulu (finding)	4180186
44782924	Misplacement of hemodialysis catheter (disorder)	4180186
44782924	Misplacement of haemodialysis catheter	4180186
44782925	Meshed split thickness autograft of skin to skin (procedure)	4180186
44782928	On examination - allodynia (finding)	4180186
44782931	History of closure of ventricular septal defect (situation)	4180186
44782932	Cyclothymia in remission (disorder)	4180186
44782936	Influenza A virus subtype H1N1 vaccination declined (situation)	4180186
44782937	Delusional disorder in remission (disorder)	4180186
44782942	Insertion of drain (procedure)	4180186
44782943	Depressive disorder in remission (disorder)	4180186
44782944	Delirium in remission (disorder)	4180186
44782946	Open fracture of sacrum without spinal cord injury (disorder)	4180186
44782947	Open fracture of coccyx without spinal cord injury (disorder)	4180186
44782949	Injury of multiple sites of rectum (disorder)	4180186
44782953	Material anatomical entity (body structure)	4180186
44782954	Material anatomical boundary (body structure)	4180186
44782955	Material anatomical point (body structure)	4180186
44782956	Congenital subaortic diverticulum (disorder)	4180186
44782958	Insertion of single incision mid-urethral mini-sling (procedure)	4180186
44782959	Oedema of extremity of sudden onset	4180186
44782959	Edema of extremity of sudden onset (finding)	4180186
44782960	Local myocutaneous flap to neck (procedure)	4180186
44782962	Local fasciocutaneous flap to neck (procedure)	4180186
44782963	Local fasciocutaneous flap to head (procedure)	4180186
44782964	Local flap of skin to head (procedure)	4180186
44782966	Femoral-popliteal artery bypass using autogenous vein graft (procedure)	4180186
44782966	Above knee femoral-popliteal artery bypass using autogenous vein graft	4180186
44782967	Long term dual antiplatelet drug therapy indicated (situation)	4180186
44782968	Below knee femoro-popliteal artery bypass with autogenous vein graft	4180186
44782968	Femoro-distal popliteal artery bypass with autogenous vein graft (procedure)	4180186
44782973	Emergency repair of ruptured infrarenal abdominal aortic aneurysm (procedure)	4180186
44782974	Multiple chop wounds of upper limb (disorder)	4180186
44782976	Elective repair of suprarenal abdominal aortic aneurysm (procedure)	4180186
44782977	Injury of multiple blood vessels of head (disorder)	4180186
44782978	Lymphoedema follow up assessment	4180186
44782978	Lymphedema follow up assessment (regime/therapy)	4180186
44782980	Thyroglossal duct sinus (disorder)	4180186
44782983	History of malignant hematologic neoplasm (situation)	4180186
44782983	History of malignant haematologic neoplasm	4180186
44782985	History of exposure to second hand smoke (situation)	4180186
44782986	History of inhalant intoxication (situation)	4180186
44782987	Accidental poisoning caused by sedative	4180186
44782987	Accidental poisoning caused by sedative (disorder)	4180186
44782988	Traumatic hemorrhage into peritoneal cavity (disorder)	4180186
44782988	Traumatic haemoperitoneum	4180186
44782988	Traumatic haemorrhage into peritoneal cavity	4180186
44782988	Traumatic hemorrhage into peritoneal cavity	4180186
44782990	Complication of intraocular lens implant (disorder)	4180186
44782991	Adverse reaction caused by vaccine properly administered	4180186
44782991	Adverse reaction caused by vaccine properly administered (disorder)	4180186
44782992	Poisoning caused by natural blood (disorder)	4180186
44782992	Poisoning caused by natural blood	4180186
44782993	Poisoning caused by coagulant (disorder)	4180186
44782993	Poisoning caused by coagulant	4180186
44782994	Poisoning caused by anabolic congener (disorder)	4180186
44782994	Poisoning caused by anabolic congener	4180186
44782995	Joint structure of wrist region (body structure)	4180186
44782995	Carpal joint	4180186
44782995	Joint of wrist	4180186
44782996	Measles vaccination requested (situation)	4180186
44782997	History of primitive neuroectodermal tumour	4180186
44782997	History of primitive neuroectodermal tumor (situation)	4180186
44782999	History of awareness under general anesthesia (situation)	4180186
44782999	History of awareness under general anaesthesia	4180186
44783001	Home oxygen therapy declined (situation)	4180186
44783002	At low risk of venous thromboembolism (finding)	4180186
44783004	Hepatitis B vaccination contraindicated (situation)	4180186
44783006	Stool monitoring (regime/therapy)	4180186
44783009	Hair bearing skin flap to scalp (procedure)	4180186
44783010	Cultured graft of skin to skin (procedure)	4180186
44783011	Closed fracture of frontal sinus (disorder)	4180186
44783018	Full thickness autograft of skin to skin (procedure)	4180186
44783021	Prominent renal pelvis (disorder)	4180186
44783027	Injury of face and neck (disorder)	4180186
44783028	Injury of shoulder and upper arm (disorder)	4180186
44783029	Injury of hip and thigh (disorder)	4180186
44783030	Poisoning caused by antimalarial and drug acting on blood protozoa (disorder)	4180186
44783030	Poisoning caused by antimalarial and drug acting on blood protozoa	4180186
44783032	Poisoning caused by synthetic ovarian hormone substitute	4180186
44783032	Poisoning caused by synthetic ovarian hormone substitute (disorder)	4180186
44783033	Poisoning caused by parathyroid derivative (disorder)	4180186
44783033	Poisoning caused by parathyroid derivative	4180186
44783034	Poisoning caused by thyroid hormone (disorder)	4180186
44783034	Poisoning caused by thyroid hormone	4180186
44783036	Repair of acquired femoral arteriovenous fistula (procedure)	4180186
44783038	Poisoning caused by antianemic agent	4180186
44783038	Poisoning by antianaemic agent	4180186
44783038	Poisoning caused by antianemic agent (disorder)	4180186
44783038	Poisoning caused by antianaemic agent	4180186
44783039	Reconstruction of carotid artery with graft (procedure)	4180186
44783040	Transgastric plication of esophageal varices (procedure)	4180186
44783040	Transgastric plication of oesophageal varices	4180186
44783041	Transurethral holmium laser enucleation of prostate (procedure)	4180186
44783041	Transurethral holmium laser enucleation of prostate	4180186
44783044	Repair of atrioventricular septal defect with atrial and ventricular components (procedure)	4180186
44783044	Repair of complete atrioventricular septal defect	4180186
44783045	Open subfascial ligation of varicose vein of lower limb (procedure)	4180186
44783049	Repair of blood vessel of extremity with tissue patch graft (procedure)	4180186
44783049	Repair of blood vessel of limb with tissue patch graft	4180186
44783050	Social phobia inventory physical symptoms subscore (observable entity)	4180186
44783050	SPIN (social phobia inventory) physical symptoms subscore	4180186
44783052	Repair blood vessel of neck with tissue patch graft (procedure)	4180186
44783054	Spiritual wellbeing (observable entity)	4180186
44783058	Marks and Mathews fear questionnaire total social phobia score (observable entity)	4180186
44783059	Marks and Mathews fear questionnaire total blood injury phobia score (observable entity)	4180186
44783064	Repair of aneurysm of abdominal aorta with insertion of endovascular stent (procedure)	4180186
44783069	Family history of tendinous xanthoma in second degree relative (situation)	4180186
44783069	Family history of tendon xanthoma in second degree relative	4180186
44783071	Second degree blood relative of subject (person)	4180186
44783072	Grafting of tendon of wrist (procedure)	4180186
44783073	Endovascular repair of abdominal aortic aneurysm using fluoroscopic guidance with contrast (procedure)	4180186
44783073	Fluoroscopy guided endovascular repair of abdominal aortic aneurysm	4180186
44783075	Ear examination abnormal (finding)	4180186
44783078	Arthroscopic repair of rotator cuff (procedure)	4180186
44783083	Risk assessment prior to nasogastric feeding (procedure)	4180186
44783086	Craniotomy and repair of intracranial aneurysm using intracranial approach	4180186
44783086	Incision of bone of cranium and repair of intracranial aneurysm using intracranial approach (procedure)	4180186
44783088	Caregiver annual health check (situation)	4180186
44783090	Insertion of pulse generator of implantable cardioverter defibrillator (procedure)	4180186
44783092	Carvedilol therapy (procedure)	4180186
44783097	Closed reduction of injury of epiphyseal growth plate of femur (procedure)	4180186
44783099	Internal fixation of ulna without fracture reduction (procedure)	4180186
44783102	Internal fixation of fibula without fracture reduction (procedure)	4180186
44783103	Internal fixation of tibia without fracture reduction (procedure)	4180186
44783106	Open reduction of fracture of scapula without internal fixation (procedure)	4180186
44783107	Open reduction of fracture of clavicle without internal fixation (procedure)	4180186
44783110	Excision arthroplasty of the knee (procedure)	4180186
44783110	Excision arthroplasty of knee	4180186
44783110	Excision arthroplasty of joint of knee	4180186
44783110	Excision arthroplasty of joint of knee (procedure)	4180186
44783111	Closed reduction of fracture of mandibular condyle (procedure)	4180186
44783111	Closed reduction of fracture of condyle of mandible	4180186
44783115	Open reduction of fracture of metacarpal without internal fixation (procedure)	4180186
44783117	Open reduction of fracture of tibia without internal fixation (procedure)	4180186
44783119	Open reduction of fracture of tarsus without internal fixation	4180186
44783119	Open reduction of fracture of tarsal bone without internal fixation (procedure)	4180186
44783121	Open reduction of fracture of talus without internal fixation (procedure)	4180186
44783122	Open reduction of fracture of calcaneus without internal fixation (procedure)	4180186
44783123	Internal fixation of tarsal bone without fracture reduction (procedure)	4180186
44783123	Internal fixation of tarsus without fracture reduction	4180186
44783124	Internal fixation of metatarsal bone without fracture reduction (procedure)	4180186
44783125	Closed reduction of fractured fibula with internal fixation (procedure)	4180186
44783126	Closed reduction of fracture of talus with internal fixation (procedure)	4180186
44783130	Closed reduction of fracture of scapula with internal fixation (procedure)	4180186
44783131	Internal fixation of phalangeal bone of foot without fracture reduction	4180186
44783131	Internal fixation of phalangeal bone of toe without fracture reduction (procedure)	4180186
44783132	Internal fixation of phalangeal bone of finger without fracture reduction (procedure)	4180186
44783133	Tiapride (substance)	4180186
44783135	Sulbutiamine (substance)	4180186
44783140	Promestriene (substance)	4180186
44783141	Propyphenazone (substance)	4180186
44783142	North American Indian childhood cirrhosis (disorder)	4180186
44783142	NAIC - North American Indian childhood cirrhosis	4180186
44783145	Multifocal nodular oncocytic hyperplasia of parotid gland (disorder)	4180186
44783150	Bimaxillary protrusion (disorder)	4180186
44783151	Conversion to total prosthetic replacement of shoulder joint (procedure)	4180186
44783156	Insertion of implantable venous access device using fluoroscopic guidance (procedure)	4180186
44783158	Arthritis of pelvis (disorder)	4180186
44783159	Hypopharyngeal lesion	4180186
44783159	Lesion of hypopharynx (finding)	4180186
44783160	Lesion of nasopharynx (finding)	4180186
44783161	Pressure injury of breast	4180186
44783161	Pressure injury of breast (disorder)	4180186
44783161	Pressure ulcer of breast (disorder)	4180186
44783162	Pressure injury of dorsum of foot (disorder)	4180186
44783162	Pressure injury of dorsum of foot	4180186
44783162	Pressure ulcer of dorsum of foot (disorder)	4180186
44783163	Pressure ulcer of lower back (disorder)	4180186
44783165	Pressure ulcer of upper back (disorder)	4180186
44783166	Spindle shaped torus palatinus	4180186
44783166	Spindle shaped torus palatinus (disorder)	4180186
44783167	Acral keratosis (disorder)	4180186
44783169	Melanotic macule	4180186
44783169	Focal melanosis (morphologic abnormality)	4180186
44783170	Osseous and chondromatous metaplasia (morphologic abnormality)	4180186
44783172	Discussion about domestic abuse (procedure)	4180186
44783177	Consent given for cardiovascular health risk assessment (finding)	4180186
44783177	Consent given for cardiovascular health check	4180186
44783178	History of fenfluramine therapy (situation)	4180186
44783182	Combined synchronous percutaneous antegrade fluoroscopic and retrograde ureteroscopic bypass of ureteric occlusion and insertion of ureteric stent (procedure)	4180186
44783182	Combined synchronous percutaneous antegrade fluoroscopic and retrograde ureteroscopic bypass of ureteric occlusion and insertion of ureteric stent	4180186
44783183	Combined intrauterine and ovarian pregnancy (disorder)	4180186
44783185	Closure of cerebrospinal fluid leak from spinal cord (procedure)	4180186
44783187	Latarjet procedure (procedure)	4180186
44783188	Emergency hospital admission for ischaemic heart disease	4180186
44783188	Emergency hospital admission for ischemic heart disease (procedure)	4180186
44783189	Carers of older people in Europe index quality of support score (observable entity)	4180186
44783189	COPE (carers of older people in Europe) index quality of support score	4180186
44783190	Carers of older people in Europe index positive value score (observable entity)	4180186
44783190	COPE (carers of older people in Europe) index positive value score	4180186
44783191	Carers of older people in Europe index negative impact score (observable entity)	4180186
44783191	COPE (carers of older people in Europe) index negative impact score	4180186
44783192	Alert received from telehealth monitoring system (situation)	4180186
44783194	Fibrous dysplasia with intramuscular myxoma	4180186
44783194	Mazabraud syndrome	4180186
44783194	Fibrous dysplasia of bone with intramuscular myxoma (disorder)	4180186
44783195	Rupatadine (substance)	4180186
44783197	Microdeletion of chromosome 15q13.3	4180186
44783197	Microdeletion of chromosome 15q13.3 (disorder)	4180186
44783197	15q13.3 deletion syndrome	4180186
44783199	Timothy syndrome type 1 (disorder)	4180186
44783199	Long QT syndrome with syndactyly	4180186
44783199	Timothy syndrome classic type	4180186
44783200	Increase in velocity of coronary artery of fetus (disorder)	4180186
44783204	Post infectious osteoarthritis (disorder)	4180186
44783205	Post traumatic osteoarthritis (disorder)	4180186
44783206	Postoperative haematoma of breast	4180186
44783206	Postoperative hematoma of breast (disorder)	4180186
44783208	Partial thickness graft of skin to skin of hand	4180186
44783208	Split thickness graft of skin to skin of hand (procedure)	4180186
44783209	Partial thickness graft of skin to skin of shin	4180186
44783209	Split thickness graft of skin to skin of shin (procedure)	4180186
44783211	Myopathy with deficiency of iron-sulfur cluster assembly enzyme (disorder)	4180186
44783211	Myopathy with deficiency of succinate dehydrogenase and aconitase	4180186
44783211	Myopathy with deficiency of iron-sulphur cluster assembly enzyme	4180186
44783211	Hereditary myopathy with lactic acidosis	4180186
44783211	Myoglobinuria due to abnormal glycolysis	4180186
44783211	Myopathy with exercise intolerance, Swedish type	4180186
44783213	CVA annual review	4180186
44783213	Cerebrovascular accident annual review (regime/therapy)	4180186
44783213	Stroke annual review	4180186
44783216	Prucalopride (substance)	4180186
44783222	Replacement of aortic arch (procedure)	4180186
44783222	Replacement of aortic arch	4180186
44783223	Repair of aortic root (procedure)	4180186
44783224	Focal motor weakness (finding)	4180186
44783225	Hypertension diet assessment (procedure)	4180186
44783225	Anti-hypertensive diet assessment	4180186
44783226	Mid-stream urine specimen obtained by single catheterisation of bladder	4180186
44783226	Mid-stream urine specimen obtained by single catheterization of bladder (specimen)	4180186
44783228	Urine specimen obtained from bladder by cystoscopy	4180186
44783228	Urine specimen obtained from bladder by cystoscopy (specimen)	4180186
44783229	Urine specimen obtained from kidney by aspiration (specimen)	4180186
44783229	Urine specimen obtained from kidney by aspiration	4180186
44783230	Urine specimen obtained via suprapubic indwelling urinary catheter (specimen)	4180186
44783232	Lichenoid inflammation (morphologic abnormality)	4180186
44783236	Denervation of external urethral sphincter (disorder)	4180186
44783238	Blepharophimosis-mental retardation syndrome, Maat-Kievit-Brunner type	4180186
44783238	Blepharophimosis-intellectual disability syndrome Maat-Kievit-Brunner type (disorder)	4180186
44783238	Blepharophimosis-intellectual disability syndrome Maat-Kievit-Brunner type	4180186
44783238	X-linked Ohdo syndrome	4180186
44783240	Ferritin related neurodegeneration	4180186
44783240	Adult onset basal ganglia disease	4180186
44783240	Neuroferritinopathy (disorder)	4180186
44783244	1q21.1 microdeletion syndrome (disorder)	4180186
44783244	1q21.1 microdeletion syndrome	4180186
44783244	1q21.1 contiguous gene deletion	4180186
44783244	Chromosome 1q21.1 deletion syndrome	4180186
44783244	Microdeletion of chromosome 1q21.1	4180186
44783246	Chromosome 16p11.2 deletion syndrome (disorder)	4180186
44783246	16p11.2 deletion syndrome	4180186
44783247	Monosomy 22q13	4180186
44783247	Phelan-McDermid syndrome	4180186
44783247	22q13.3 deletion syndrome (disorder)	4180186
44783248	22q11.2 duplication syndrome (disorder)	4180186
44783248	22q11.2 duplication	4180186
44783248	Chromosome 22q11.2 duplication syndrome	4180186
44783248	Chromosome 22q11.2 microduplication syndrome	4180186
44783250	Weissenbacher-Zweymuller syndrome (disorder)	4180186
44783250	Pierre Robin syndrome with fetal chondrodysplasia	4180186
44783250	Heterozygous OSMED (otospondylomegaepiphyseal dysplasia)	4180186
44783250	Heterozygous otospondylomegaepiphyseal dysplasia	4180186
44783252	Laryngotracheal stenosis, arthropathy, prognathism and short stature	4180186
44783252	Facial dysmorphism, intellectual deficit, short stature and hearing loss	4180186
44783252	Myhre syndrome (disorder)	4180186
44783253	Paratesticular malignant tumor	4180186
44783253	Paratesticular malignant neoplasm (disorder)	4180186
44783253	Paratesticular malignant tumour	4180186
44783255	Mandibular condyle neoplasm	4180186
44783255	Neoplasm of condyle of mandible (disorder)	4180186
44783255	Neoplasm of condyle of mandible	4180186
44783256	Matrix stone of kidney (disorder)	4180186
44783259	Accidental puncture of pleura (disorder)	4180186
44783264	Cohnella (organism)	4180186
44783264	Genus Cohnella	4180186
44783268	Bacillus oceanisediminis (organism)	4180186
44783269	Bacillus safensis (organism)	4180186
44783272	Brevundimonas staleyi (organism)	4180186
44783273	Brevundimonas bullata (organism)	4180186
44783273	Mycoplana bullata	4180186
44783275	Paenibacillus jilunlii (organism)	4180186
44783277	Shinella (organism)	4180186
44783277	Genus Shinella	4180186
44783278	Shinella zoogloeoides (organism)	4180186
44783278	Crabtreella saccharophila	4180186
44783281	Accidental poisoning caused by psychotropic agent	4180186
44783281	Accidental poisoning caused by psychotropic agent (disorder)	4180186
44783282	Insertion of programmable cystoperitoneal shunt of brain	4180186
44783282	Creation of programmable cystoperitoneal shunt of brain (procedure)	4180186
44783283	Local flap of skin to neck (procedure)	4180186
44783286	Low grade endometrial stromal sarcoma (disorder)	4180186
44783287	High grade endometrial stromal sarcoma (disorder)	4180186
44783289	Leeway space absent (finding)	4180186
44783290	Anterior labial vestibule absent (disorder)	4180186
44783292	Paracoccus caeni (organism)	4180186
44783293	Rhizobium pusense (organism)	4180186
44783295	Flavobacterium lindanitolerans (organism)	4180186
44783301	Symptom of neck (finding)	4180186
44783302	Exposure to asbestos (event)	4180186
44783303	Kroppenstedtia eburnea (organism)	4180186
44783305	Lip swelling (finding)	4180186
44783306	Twitching eye (finding)	4180186
44783307	Negativicutes (organism)	4180186
44783307	Class Negativicutes	4180186
44783310	OSD - Ocular skeletal dysplasia	4180186
44783310	Oculoskeletal dysplasia (disorder)	4180186
44783310	Ocular skeletal dysplasia	4180186
44783313	Haemangioma of salivary gland	4180186
44783313	Hemangioma of salivary gland (disorder)	4180186
44783317	Fear of medical treatment (finding)	4180186
44783318	Echo in ear (finding)	4180186
44783320	Itching of ear (finding)	4180186
44783322	Flash burn of eye (disorder)	4180186
44783323	Trophozoite of genus Leishmania (organism)	4180186
44783323	Trophozoite of genus Leishmania	4180186
44783323	Leishmania trophozite	4180186
44783326	Trophozoite of genus Acanthamoeba	4180186
44783326	Trophozoite of genus Acanthamoeba (organism)	4180186
44783326	Acanthamoeba trophozoite	4180186
44783327	Trophozoite of genus Entamoeba	4180186
44783327	Trophozoite of genus Entamoeba (organism)	4180186
44783327	Entamoeba trophozoite	4180186
44783328	Trophozoite of Entamoeba hartmanni	4180186
44783328	Trophozoite of Entamoeba hartmanni (organism)	4180186
44783330	Trophozoite of genus Microsporidium (organism)	4180186
44783330	Trophozoite of genus Microsporidium	4180186
44783330	Microsporidium trophozoite	4180186
44783331	Trophozoite of genus Trypanosoma (organism)	4180186
44783331	Trypanosoma trophozoite	4180186
44783331	Trophozoite of genus Trypanosoma	4180186
44783332	Cyst of Dientamoeba fragilis (organism)	4180186
44783332	Cyst of Dientamoeba fragilis	4180186
44783334	Trophozoite of Dientamoeba fragilis (organism)	4180186
44783334	Trophozoite of Dientamoeba fragilis	4180186
44783336	Cyst of Entamoeba coli	4180186
44783336	Cyst of Entamoeba coli (organism)	4180186
44783339	Trophozoite of Entamoeba polecki (organism)	4180186
44783339	Trophozoite of Entamoeba polecki	4180186
44783340	Trophozoite of Leishmania tropica (organism)	4180186
44783340	Trophozoite of Leishmania tropica	4180186
44783341	Trophozoite of Leishmania donovani complex	4180186
44783341	Trophozoite of Leishmania donovani complex (organism)	4180186
44783344	Cyst of Entamoeba histolytica-Entamoeba dispar complex	4180186
44783344	Cyst of Entamoeba histolytica-Entamoeba dispar complex (organism)	4180186
44783346	Shovel-shaped incisor (disorder)	4180186
44783348	Enamel dysplasia (disorder)	4180186
44783349	Peri-implantitis	4180186
44783349	Dental peri-implantitis (disorder)	4180186
44783349	Inflammation of gingival and periodontal tissues surrounding dental implant	4180186
44783351	Trophozoite of genus Iodamoeba (organism)	4180186
44783351	Trophozoite of genus Iodamoeba	4180186
44783351	Iodamoeba trophozoite	4180186
44783352	Cyst of genus Iodamoeba	4180186
44783352	Iodamoeba cyst	4180186
44783352	Cyst of genus Iodamoeba (organism)	4180186
44783353	Cyst of Iodamoeba bütschlii (organism)	4180186
44783353	Iodamoeba butschlii cyst	4180186
44783353	Cyst of Iodamoeba bütschlii	4180186
44783356	Human immunodeficiency virus carrier (finding)	4180186
44783356	Human immunodeficiency virus (HIV) carrier	4180186
44783359	Trophozoite of Trypanosoma brucei gambiense	4180186
44783359	Trophozoite of Trypanosoma brucei gambiense (organism)	4180186
44783360	Short lower third of face (finding)	4180186
44783365	Zimmermann-Laband syndrome (disorder)	4180186
44783365	Laband-Zimmermann syndrome	4180186
44783366	Phialophora cyanescens	4180186
44783366	Cylindrocarpon cyanescens (organism)	4180186
44783368	Aluminium magnesium hydroxide carbonate	4180186
44783368	Almagate (substance)	4180186
44783368	Aluminum magnesium hydroxide carbonate	4180186
44783371	Arthrotomy of joint of shoulder girdle (procedure)	4180186
44783373	Mesial tipping of tooth	4180186
44783373	Mesial tipping	4180186
44783373	Mesial inclination of tooth (finding)	4180186
44783374	Neoplasm of muscle of mastication (disorder)	4180186
44783374	Masticatory muscle neoplasm	4180186
44783376	Monoarthritis (disorder)	4180186
44783377	Intermittent pulse oximetry (procedure)	4180186
44783377	Spot-check pulse oximetry	4180186
44783379	Procedure on region of shoulder girdle (procedure)	4180186
44783380	Disorder of acromioclavicular joint (disorder)	4180186
44783383	Notechis scutatus antivenom	4180186
44783383	Notechis scutatus antivenom (substance)	4180186
44783387	Anterior tongue thrust (finding)	4180186
44783392	Lateral tongue thrust (finding)	4180186
44783393	Posterior tongue thrust (finding)	4180186
44783395	Renispora flavissima (organism)	4180186
44783399	Dental caries class V (disorder)	4180186
44783403	Neurovascular island sensory skin flap (procedure)	4180186
44783406	Reconstruction of cranial defect with skull plate (procedure)	4180186
44783407	Destruction of tissue of skin (procedure)	4180186
44783408	Shallow curve of Spee (finding)	4180186
44783409	Curvularia clavata (organism)	4180186
44783410	Acremonium blochii (organism)	4180186
44783411	Repair of myelomeningocele greater than 5 centimetres in diameter	4180186
44783411	Repair of myelomeningocele greater than 5 centimeters in diameter (procedure)	4180186
44783412	Structure of third molar region of oral cavity (body structure)	4180186
44783412	Structure of third molar region of oral cavity	4180186
44783412	Third molar region of oral cavity (body structure)	4180186
44783413	Genus Calidifontibacter	4180186
44783413	Genus Calidifontibacter (organism)	4180186
44783414	Structure of second molar region of oral cavity	4180186
44783414	Structure of second molar region of oral cavity (body structure)	4180186
44783414	Second molar region of oral cavity (body structure)	4180186
44783416	Structure of first molar region of oral cavity (body structure)	4180186
44783416	Structure of first molar region of oral cavity	4180186
44783416	First molar region of oral cavity (body structure)	4180186
44783417	Structure of second premolar region of oral cavity	4180186
44783417	Structure of second premolar region of oral cavity (body structure)	4180186
44783417	Second premolar region of oral cavity (body structure)	4180186
44783418	Structure of first premolar region of oral cavity (body structure)	4180186
44783418	Structure of first premolar region of oral cavity	4180186
44783418	First premolar region of oral cavity (body structure)	4180186
44783419	Structure of canine region of oral cavity	4180186
44783419	Structure of canine region of oral cavity (body structure)	4180186
44783419	Canine region of oral cavity (body structure)	4180186
44783420	Structure of lateral incisor region of oral cavity	4180186
44783420	Structure of lateral incisor region of oral cavity (body structure)	4180186
44783420	Lateral incisor region of oral cavity (body structure)	4180186
44783421	Atrax robustus antivenom (substance)	4180186
44783421	Atrax robustus antivenom	4180186
